id	sid	tid	token	lemma	pos
dpc-4793	1	1	dermatology	dermatology	NOUN
dpc-4793	1	2	:	:	PUNCT
dpc-4793	1	3	practical	practical	ADJ
dpc-4793	1	4	and	and	CCONJ
dpc-4793	1	5	conceptual	conceptual	ADJ
dpc-4793	1	6	review	review	NOUN
dpc-4793	1	7	|	|	ADV
dpc-4793	1	8	dermatol	dermatol	ADJ
dpc-4793	1	9	pract	pract	NOUN
dpc-4793	1	10	concept	concept	NOUN
dpc-4793	1	11	.	.	PUNCT
dpc-4793	2	1	2025;15(2):4793	2025;15(2):4793	NUM
dpc-4793	2	2	1	1	NUM
dpc-4793	2	3	biologic	biologic	NOUN
dpc-4793	2	4	and	and	CCONJ
dpc-4793	2	5	non	non	ADJ
dpc-4793	2	6	-	-	ADJ
dpc-4793	2	7	biologic	biologic	ADJ
dpc-4793	2	8	therapies	therapy	NOUN
dpc-4793	2	9	for	for	ADP
dpc-4793	2	10	scalp	scalp	NOUN
dpc-4793	2	11	psoriasis	psoriasis	NOUN
dpc-4793	2	12	:	:	PUNCT
dpc-4793	2	13	a	a	DET
dpc-4793	2	14	network	network	NOUN
dpc-4793	2	15	meta	meta	NOUN
dpc-4793	2	16	-	-	PUNCT
dpc-4793	2	17	analysis	analysis	NOUN
dpc-4793	2	18	of	of	ADP
dpc-4793	2	19	randomized	randomized	ADJ
dpc-4793	2	20	controlled	control	VERB
dpc-4793	2	21	trials	trial	NOUN
dpc-4793	2	22	hargun	hargun	VERB
dpc-4793	2	23	kaur1	kaur1	PROPN
dpc-4793	2	24	*	*	PROPN
dpc-4793	2	25	,	,	PUNCT
dpc-4793	2	26	tara	tara	PROPN
dpc-4793	2	27	behroozian1	behroozian1	PROPN
dpc-4793	3	1	*	*	PROPN
dpc-4793	3	2	,	,	PUNCT
dpc-4793	3	3	rafael	rafael	PROPN
dpc-4793	3	4	paolo	paolo	PROPN
dpc-4793	3	5	lansang1	lansang1	PROPN
dpc-4793	3	6	,	,	PUNCT
dpc-4793	3	7	saverio	saverio	PROPN
dpc-4793	3	8	caini2	caini2	PROPN
dpc-4793	3	9	,	,	PUNCT
dpc-4793	3	10	chiara	chiara	PROPN
dpc-4793	3	11	doccioli3	doccioli3	PROPN
dpc-4793	3	12	,	,	PUNCT
dpc-4793	3	13	mohannad	mohannad	PROPN
dpc-4793	3	14	abu	abu	PROPN
dpc-4793	3	15	-	-	PUNCT
dpc-4793	3	16	hilal4	hilal4	PROPN
dpc-4793	3	17	1	1	NUM
dpc-4793	3	18	michael	michael	PROPN
dpc-4793	3	19	g.	g.	PROPN
dpc-4793	3	20	degroote	degroote	PROPN
dpc-4793	4	1	school	school	PROPN
dpc-4793	4	2	of	of	ADP
dpc-4793	4	3	medicine	medicine	NOUN
dpc-4793	4	4	,	,	PUNCT
dpc-4793	4	5	hamilton	hamilton	PROPN
dpc-4793	4	6	,	,	PUNCT
dpc-4793	4	7	ontario	ontario	PROPN
dpc-4793	4	8	,	,	PUNCT
dpc-4793	4	9	canada	canada	PROPN
dpc-4793	4	10	2	2	NUM
dpc-4793	4	11	cancer	cancer	NOUN
dpc-4793	4	12	risk	risk	NOUN
dpc-4793	4	13	factors	factor	NOUN
dpc-4793	4	14	and	and	CCONJ
dpc-4793	4	15	lifestyle	lifestyle	NOUN
dpc-4793	4	16	epidemiology	epidemiology	NOUN
dpc-4793	4	17	unit	unit	NOUN
dpc-4793	4	18	,	,	PUNCT
dpc-4793	4	19	institute	institute	NOUN
dpc-4793	4	20	for	for	ADP
dpc-4793	4	21	cancer	cancer	NOUN
dpc-4793	4	22	research	research	NOUN
dpc-4793	4	23	,	,	PUNCT
dpc-4793	4	24	prevention	prevention	NOUN
dpc-4793	4	25	,	,	PUNCT
dpc-4793	4	26	and	and	CCONJ
dpc-4793	4	27	clinical	clinical	ADJ
dpc-4793	4	28	network	network	NOUN
dpc-4793	4	29	(	(	PUNCT
dpc-4793	4	30	ispro	ispro	PROPN
dpc-4793	4	31	)	)	PUNCT
dpc-4793	4	32	,	,	PUNCT
dpc-4793	4	33	florence	florence	NOUN
dpc-4793	4	34	,	,	PUNCT
dpc-4793	4	35	italy	italy	PROPN
dpc-4793	4	36	3	3	NUM
dpc-4793	4	37	clinical	clinical	ADJ
dpc-4793	4	38	epidemiology	epidemiology	NOUN
dpc-4793	4	39	unit	unit	NOUN
dpc-4793	4	40	,	,	PUNCT
dpc-4793	4	41	institute	institute	NOUN
dpc-4793	4	42	for	for	ADP
dpc-4793	4	43	cancer	cancer	NOUN
dpc-4793	4	44	research	research	NOUN
dpc-4793	4	45	,	,	PUNCT
dpc-4793	4	46	prevention	prevention	NOUN
dpc-4793	4	47	,	,	PUNCT
dpc-4793	4	48	and	and	CCONJ
dpc-4793	4	49	clinical	clinical	ADJ
dpc-4793	4	50	network	network	NOUN
dpc-4793	4	51	(	(	PUNCT
dpc-4793	4	52	ispro	ispro	PROPN
dpc-4793	4	53	)	)	PUNCT
dpc-4793	4	54	,	,	PUNCT
dpc-4793	4	55	florence	florence	NOUN
dpc-4793	4	56	,	,	PUNCT
dpc-4793	4	57	italy	italy	PROPN
dpc-4793	4	58	4	4	NUM
dpc-4793	4	59	division	division	NOUN
dpc-4793	4	60	of	of	ADP
dpc-4793	4	61	dermatology	dermatology	NOUN
dpc-4793	4	62	,	,	PUNCT
dpc-4793	4	63	mcmaster	mcmaster	PROPN
dpc-4793	4	64	university	university	PROPN
dpc-4793	4	65	,	,	PUNCT
dpc-4793	4	66	hamilton	hamilton	PROPN
dpc-4793	4	67	,	,	PUNCT
dpc-4793	4	68	ontario	ontario	PROPN
dpc-4793	4	69	,	,	PUNCT
dpc-4793	4	70	canada	canada	PROPN
dpc-4793	4	71	*	*	PUNCT
dpc-4793	4	72	authors	author	NOUN
dpc-4793	4	73	have	have	AUX
dpc-4793	4	74	contributed	contribute	VERB
dpc-4793	4	75	equally	equally	ADV
dpc-4793	4	76	to	to	ADP
dpc-4793	4	77	this	this	DET
dpc-4793	4	78	work	work	NOUN
dpc-4793	4	79	.	.	PUNCT
dpc-4793	5	1	key	key	ADJ
dpc-4793	5	2	words	word	NOUN
dpc-4793	5	3	:	:	PUNCT
dpc-4793	5	4	scalp	scalp	NOUN
dpc-4793	5	5	psoriasis	psoriasis	NOUN
dpc-4793	5	6	,	,	PUNCT
dpc-4793	5	7	treatment	treatment	NOUN
dpc-4793	5	8	outcome	outcome	NOUN
dpc-4793	5	9	,	,	PUNCT
dpc-4793	5	10	biologic	biologic	NOUN
dpc-4793	5	11	agents	agent	NOUN
dpc-4793	5	12	,	,	PUNCT
dpc-4793	5	13	antipsoriatic	antipsoriatic	ADJ
dpc-4793	5	14	agents	agent	NOUN
dpc-4793	5	15	,	,	PUNCT
dpc-4793	5	16	network	network	NOUN
dpc-4793	5	17	meta	meta	ADJ
dpc-4793	5	18	-	-	PUNCT
dpc-4793	5	19	analysis	analysis	NOUN
dpc-4793	5	20	,	,	PUNCT
dpc-4793	5	21	randomized	randomize	VERB
dpc-4793	5	22	controlled	control	VERB
dpc-4793	5	23	trials	trial	NOUN
dpc-4793	5	24	,	,	PUNCT
dpc-4793	5	25	comparative	comparative	ADJ
dpc-4793	5	26	efficacy	efficacy	NOUN
dpc-4793	5	27	,	,	PUNCT
dpc-4793	5	28	systematic	systematic	ADJ
dpc-4793	5	29	review	review	NOUN
dpc-4793	5	30	citation	citation	NOUN
dpc-4793	5	31	:	:	PUNCT
dpc-4793	5	32	kaur	kaur	PROPN
dpc-4793	5	33	j	j	PROPN
dpc-4793	5	34	,	,	PUNCT
dpc-4793	5	35	behroozian	behroozian	PROPN
dpc-4793	5	36	t	t	PROPN
dpc-4793	5	37	,	,	PUNCT
dpc-4793	5	38	lansang	lansang	PROPN
dpc-4793	5	39	rp	rp	PROPN
dpc-4793	5	40	,	,	PUNCT
dpc-4793	5	41	caini	caini	PROPN
dpc-4793	5	42	s	s	PROPN
dpc-4793	5	43	,	,	PUNCT
dpc-4793	5	44	doccioli	doccioli	PROPN
dpc-4793	5	45	c	c	NOUN
dpc-4793	5	46	,	,	PUNCT
dpc-4793	5	47	abu	abu	PROPN
dpc-4793	5	48	-	-	PUNCT
dpc-4793	5	49	hilal	hilal	PROPN
dpc-4793	5	50	m.	m.	PROPN
dpc-4793	5	51	biologic	biologic	NOUN
dpc-4793	5	52	and	and	CCONJ
dpc-4793	5	53	non	non	ADJ
dpc-4793	5	54	-	-	ADJ
dpc-4793	5	55	biologic	biologic	ADJ
dpc-4793	5	56	therapies	therapy	NOUN
dpc-4793	5	57	for	for	ADP
dpc-4793	5	58	scalp	scalp	NOUN
dpc-4793	5	59	psoriasis	psoriasis	NOUN
dpc-4793	5	60	:	:	PUNCT
dpc-4793	5	61	a	a	DET
dpc-4793	5	62	network	network	NOUN
dpc-4793	5	63	meta	meta	NOUN
dpc-4793	5	64	-	-	PUNCT
dpc-4793	5	65	analysis	analysis	NOUN
dpc-4793	5	66	of	of	ADP
dpc-4793	5	67	randomized	randomized	ADJ
dpc-4793	5	68	controlled	control	VERB
dpc-4793	5	69	trials	trial	NOUN
dpc-4793	5	70	.	.	PUNCT
dpc-4793	6	1	dermatol	dermatol	NOUN
dpc-4793	6	2	pract	pract	PROPN
dpc-4793	6	3	concept	concept	NOUN
dpc-4793	6	4	.	.	PUNCT
dpc-4793	7	1	2025;15(2):4793	2025;15(2):4793	NUM
dpc-4793	7	2	.	.	PUNCT
dpc-4793	7	3	doi	doi	NOUN
dpc-4793	7	4	:	:	PUNCT
dpc-4793	7	5	https://doi.org/10.5826	https://doi.org/10.5826	PROPN
dpc-4793	7	6	/dpc.1502a4793	/dpc.1502a4793	NOUN
dpc-4793	7	7	accepted	accept	VERB
dpc-4793	7	8	:	:	PUNCT
dpc-4793	7	9	february	february	PROPN
dpc-4793	7	10	5	5	NUM
dpc-4793	7	11	,	,	PUNCT
dpc-4793	7	12	2025	2025	NUM
dpc-4793	7	13	;	;	PUNCT
dpc-4793	7	14	published	publish	VERB
dpc-4793	7	15	:	:	PUNCT
dpc-4793	8	1	april	april	PROPN
dpc-4793	8	2	2025	2025	NUM
dpc-4793	8	3	copyright	copyright	NOUN
dpc-4793	8	4	:	:	PUNCT
dpc-4793	8	5	©	©	PROPN
dpc-4793	8	6	2025	2025	NUM
dpc-4793	8	7	kaur	kaur	NOUN
dpc-4793	8	8	et	et	PROPN
dpc-4793	8	9	al	al	PROPN
dpc-4793	8	10	.	.	PUNCT
dpc-4793	9	1	this	this	PRON
dpc-4793	9	2	is	be	AUX
dpc-4793	9	3	an	an	DET
dpc-4793	9	4	open	open	ADJ
dpc-4793	9	5	-	-	PUNCT
dpc-4793	9	6	access	access	NOUN
dpc-4793	9	7	article	article	NOUN
dpc-4793	9	8	distributed	distribute	VERB
dpc-4793	9	9	under	under	ADP
dpc-4793	9	10	the	the	DET
dpc-4793	9	11	terms	term	NOUN
dpc-4793	9	12	of	of	ADP
dpc-4793	9	13	the	the	DET
dpc-4793	9	14	creative	creative	ADJ
dpc-4793	9	15	commons	common	NOUN
dpc-4793	9	16	attributionnoncommercial	attributionnoncommercial	ADJ
dpc-4793	9	17	license	license	NOUN
dpc-4793	9	18	(	(	PUNCT
dpc-4793	9	19	by	by	ADP
dpc-4793	9	20	-	-	PUNCT
dpc-4793	9	21	nc-4.0	nc-4.0	NOUN
dpc-4793	9	22	)	)	PUNCT
dpc-4793	9	23	,	,	PUNCT
dpc-4793	9	24	https://creativecommons.org/licenses/by-nc/4.0/	https://creativecommons.org/licenses/by-nc/4.0/	PROPN
dpc-4793	9	25	,	,	PUNCT
dpc-4793	9	26	which	which	PRON
dpc-4793	9	27	permits	permit	VERB
dpc-4793	9	28	unrestricted	unrestricted	ADJ
dpc-4793	9	29	noncommercial	noncommercial	ADJ
dpc-4793	9	30	use	use	NOUN
dpc-4793	9	31	,	,	PUNCT
dpc-4793	9	32	distribution	distribution	NOUN
dpc-4793	9	33	,	,	PUNCT
dpc-4793	9	34	and	and	CCONJ
dpc-4793	9	35	reproduction	reproduction	NOUN
dpc-4793	9	36	in	in	ADP
dpc-4793	9	37	any	any	DET
dpc-4793	9	38	medium	medium	NOUN
dpc-4793	9	39	,	,	PUNCT
dpc-4793	9	40	provided	provide	VERB
dpc-4793	9	41	the	the	DET
dpc-4793	9	42	original	original	ADJ
dpc-4793	9	43	authors	author	NOUN
dpc-4793	9	44	and	and	CCONJ
dpc-4793	9	45	source	source	NOUN
dpc-4793	9	46	are	be	AUX
dpc-4793	9	47	credited	credit	VERB
dpc-4793	9	48	.	.	PUNCT
dpc-4793	10	1	funding	funding	NOUN
dpc-4793	10	2	:	:	PUNCT
dpc-4793	10	3	none	none	NOUN
dpc-4793	10	4	.	.	PUNCT
dpc-4793	11	1	competing	compete	VERB
dpc-4793	11	2	interests	interest	NOUN
dpc-4793	11	3	:	:	PUNCT
dpc-4793	11	4	tb	tb	X
dpc-4793	11	5	,	,	PUNCT
dpc-4793	11	6	hk	hk	PROPN
dpc-4793	11	7	pl	pl	PROPN
dpc-4793	11	8	,	,	PUNCT
dpc-4793	11	9	sc	sc	PROPN
dpc-4793	11	10	,	,	PUNCT
dpc-4793	11	11	and	and	CCONJ
dpc-4793	11	12	dc	dc	PROPN
dpc-4793	11	13	declare	declare	VERB
dpc-4793	11	14	no	no	DET
dpc-4793	11	15	conflict	conflict	NOUN
dpc-4793	11	16	of	of	ADP
dpc-4793	11	17	interest	interest	NOUN
dpc-4793	11	18	.	.	PUNCT
dpc-4793	12	1	mah	mah	PROPN
dpc-4793	12	2	has	have	AUX
dpc-4793	12	3	been	be	AUX
dpc-4793	12	4	speaker	speaker	NOUN
dpc-4793	12	5	,	,	PUNCT
dpc-4793	12	6	advisor	advisor	NOUN
dpc-4793	12	7	,	,	PUNCT
dpc-4793	12	8	and/or	and/or	CCONJ
dpc-4793	12	9	received	receive	VERB
dpc-4793	12	10	honoraria	honorarium	NOUN
dpc-4793	12	11	from	from	ADP
dpc-4793	12	12	:	:	PUNCT
dpc-4793	12	13	abbvie	abbvie	PROPN
dpc-4793	12	14	,	,	PUNCT
dpc-4793	12	15	biojamp	biojamp	PROPN
dpc-4793	12	16	,	,	PUNCT
dpc-4793	12	17	boehringer	boehringer	PROPN
dpc-4793	12	18	ingelheim	ingelheim	PROPN
dpc-4793	12	19	,	,	PUNCT
dpc-4793	12	20	bristol	bristol	PROPN
dpc-4793	12	21	myers	myers	PROPN
dpc-4793	12	22	squibb	squibb	PROPN
dpc-4793	12	23	,	,	PUNCT
dpc-4793	12	24	celltrion	celltrion	NOUN
dpc-4793	12	25	,	,	PUNCT
dpc-4793	12	26	eli	eli	PROPN
dpc-4793	12	27	lilly	lilly	PROPN
dpc-4793	12	28	,	,	PUNCT
dpc-4793	12	29	galderma	galderma	PROPN
dpc-4793	12	30	,	,	PUNCT
dpc-4793	12	31	hikma	hikma	PROPN
dpc-4793	12	32	pharmaceuticals	pharmaceutical	NOUN
dpc-4793	12	33	,	,	PUNCT
dpc-4793	12	34	incyte	incyte	PROPN
dpc-4793	12	35	,	,	PUNCT
dpc-4793	12	36	janssen	janssen	PROPN
dpc-4793	12	37	,	,	PUNCT
dpc-4793	12	38	leo	leo	PROPN
dpc-4793	12	39	,	,	PUNCT
dpc-4793	12	40	l’oreal	l’oreal	PROPN
dpc-4793	12	41	,	,	PUNCT
dpc-4793	12	42	la	la	ADJ
dpc-4793	12	43	roche	roche	PROPN
dpc-4793	12	44	posay	posay	PROPN
dpc-4793	12	45	,	,	PUNCT
dpc-4793	12	46	medexus	medexus	ADV
dpc-4793	12	47	,	,	PUNCT
dpc-4793	12	48	novartis	novartis	NOUN
dpc-4793	12	49	,	,	PUNCT
dpc-4793	12	50	pfizer	pfizer	NOUN
dpc-4793	12	51	,	,	PUNCT
dpc-4793	12	52	recordati	recordati	PROPN
dpc-4793	12	53	,	,	PUNCT
dpc-4793	12	54	sanofi	sanofi	PROPN
dpc-4793	12	55	regeneron	regeneron	PROPN
dpc-4793	12	56	,	,	PUNCT
dpc-4793	12	57	sun	sun	PROPN
dpc-4793	12	58	pharma	pharma	PROPN
dpc-4793	12	59	.	.	PUNCT
dpc-4793	13	1	authorship	authorship	NOUN
dpc-4793	13	2	:	:	PUNCT
dpc-4793	13	3	all	all	DET
dpc-4793	13	4	authors	author	NOUN
dpc-4793	13	5	have	have	AUX
dpc-4793	13	6	contributed	contribute	VERB
dpc-4793	13	7	significantly	significantly	ADV
dpc-4793	13	8	to	to	ADP
dpc-4793	13	9	this	this	DET
dpc-4793	13	10	publication	publication	NOUN
dpc-4793	13	11	.	.	PUNCT
dpc-4793	14	1	acknowledgements	acknowledgement	NOUN
dpc-4793	14	2	:	:	PUNCT
dpc-4793	15	1	ms	ms	PROPN
dpc-4793	15	2	.	.	PROPN
dpc-4793	15	3	behroozian	behroozian	PROPN
dpc-4793	15	4	received	receive	VERB
dpc-4793	15	5	funding	funding	NOUN
dpc-4793	15	6	support	support	NOUN
dpc-4793	15	7	for	for	ADP
dpc-4793	15	8	this	this	DET
dpc-4793	15	9	project	project	NOUN
dpc-4793	15	10	as	as	ADP
dpc-4793	15	11	a	a	DET
dpc-4793	15	12	recipient	recipient	NOUN
dpc-4793	15	13	of	of	ADP
dpc-4793	15	14	the	the	DET
dpc-4793	15	15	mcmaster	mcmaster	PROPN
dpc-4793	15	16	medical	medical	PROPN
dpc-4793	15	17	student	student	PROPN
dpc-4793	15	18	research	research	PROPN
dpc-4793	15	19	excellence	excellence	PROPN
dpc-4793	15	20	scholarships	scholarship	NOUN
dpc-4793	15	21	.	.	PUNCT
dpc-4793	16	1	corresponding	correspond	VERB
dpc-4793	16	2	author	author	NOUN
dpc-4793	16	3	:	:	PUNCT
dpc-4793	16	4	dr	dr	PROPN
dpc-4793	16	5	.	.	PROPN
dpc-4793	16	6	mohannad	mohannad	PROPN
dpc-4793	16	7	abu	abu	PROPN
dpc-4793	16	8	-	-	PUNCT
dpc-4793	16	9	hilal	hilal	PROPN
dpc-4793	16	10	.	.	PUNCT
dpc-4793	17	1	division	division	NOUN
dpc-4793	17	2	of	of	ADP
dpc-4793	17	3	dermatology	dermatology	NOUN
dpc-4793	17	4	,	,	PUNCT
dpc-4793	17	5	department	department	NOUN
dpc-4793	17	6	of	of	ADP
dpc-4793	17	7	medicine	medicine	NOUN
dpc-4793	17	8	,	,	PUNCT
dpc-4793	17	9	mcmaster	mcmaster	PROPN
dpc-4793	17	10	university	university	PROPN
dpc-4793	17	11	.	.	PUNCT
dpc-4793	18	1	100	100	NUM
dpc-4793	18	2	main	main	ADJ
dpc-4793	18	3	street	street	NOUN
dpc-4793	18	4	west	west	PROPN
dpc-4793	18	5	,	,	PUNCT
dpc-4793	18	6	hamilton	hamilton	PROPN
dpc-4793	18	7	,	,	PUNCT
dpc-4793	18	8	ontario	ontario	PROPN
dpc-4793	18	9	,	,	PUNCT
dpc-4793	18	10	canada	canada	PROPN
dpc-4793	18	11	,	,	PUNCT
dpc-4793	18	12	l8p	l8p	PROPN
dpc-4793	18	13	1h6	1h6	NUM
dpc-4793	18	14	.	.	PUNCT
dpc-4793	19	1	orcid	orcid	NOUN
dpc-4793	20	1	i	i	PRON
dpc-4793	20	2	d	d	NOUN
dpc-4793	20	3	:	:	PUNCT
dpc-4793	20	4	0000	0000	NUM
dpc-4793	20	5	-	-	PUNCT
dpc-4793	20	6	0001	0001	NUM
dpc-4793	20	7	-	-	PUNCT
dpc-4793	20	8	9702	9702	NUM
dpc-4793	20	9	-	-	PUNCT
dpc-4793	20	10	2086	2086	NUM
dpc-4793	20	11	.	.	PUNCT
dpc-4793	21	1	e	e	X
dpc-4793	21	2	-	-	NOUN
dpc-4793	21	3	mail	mail	NOUN
dpc-4793	21	4	:	:	PUNCT
dpc-4793	21	5	abuhilm@mcmaster.ca	abuhilm@mcmaster.ca	NOUN
dpc-4793	21	6	.	.	PUNCT
dpc-4793	22	1	introduction	introduction	NOUN
dpc-4793	22	2	:	:	PUNCT
dpc-4793	22	3	scalp	scalp	NOUN
dpc-4793	22	4	psoriasis	psoriasis	NOUN
dpc-4793	22	5	affects	affect	VERB
dpc-4793	22	6	up	up	ADV
dpc-4793	22	7	to	to	PART
dpc-4793	22	8	80	80	NUM
dpc-4793	22	9	%	%	NOUN
dpc-4793	22	10	of	of	ADP
dpc-4793	22	11	patients	patient	NOUN
dpc-4793	22	12	with	with	ADP
dpc-4793	22	13	plaque	plaque	NOUN
dpc-4793	22	14	-	-	PUNCT
dpc-4793	22	15	type	type	NOUN
dpc-4793	22	16	psoriasis	psoriasis	NOUN
dpc-4793	22	17	and	and	CCONJ
dpc-4793	22	18	is	be	AUX
dpc-4793	22	19	often	often	ADV
dpc-4793	22	20	resistant	resistant	ADJ
dpc-4793	22	21	to	to	ADP
dpc-4793	22	22	topical	topical	ADJ
dpc-4793	22	23	and	and	CCONJ
dpc-4793	22	24	conventional	conventional	ADJ
dpc-4793	22	25	systemic	systemic	ADJ
dpc-4793	22	26	agents	agent	NOUN
dpc-4793	22	27	.	.	PUNCT
dpc-4793	23	1	there	there	PRON
dpc-4793	23	2	is	be	VERB
dpc-4793	23	3	a	a	DET
dpc-4793	23	4	lack	lack	NOUN
dpc-4793	23	5	of	of	ADP
dpc-4793	23	6	consensus	consensus	NOUN
dpc-4793	23	7	on	on	ADP
dpc-4793	23	8	a	a	DET
dpc-4793	23	9	“	"	PUNCT
dpc-4793	23	10	gold	gold	ADJ
dpc-4793	23	11	standard	standard	NOUN
dpc-4793	23	12	”	"	PUNCT
dpc-4793	23	13	treatment	treatment	NOUN
dpc-4793	23	14	.	.	PUNCT
dpc-4793	24	1	objective	objective	NOUN
dpc-4793	24	2	:	:	PUNCT
dpc-4793	24	3	this	this	DET
dpc-4793	24	4	comprehensive	comprehensive	ADJ
dpc-4793	24	5	review	review	NOUN
dpc-4793	24	6	and	and	CCONJ
dpc-4793	24	7	network	network	NOUN
dpc-4793	24	8	meta	meta	ADJ
dpc-4793	24	9	-	-	PUNCT
dpc-4793	24	10	analysis	analysis	NOUN
dpc-4793	24	11	aimed	aim	VERB
dpc-4793	24	12	to	to	PART
dpc-4793	24	13	compare	compare	VERB
dpc-4793	24	14	the	the	DET
dpc-4793	24	15	efficacy	efficacy	NOUN
dpc-4793	24	16	and	and	CCONJ
dpc-4793	24	17	safety	safety	NOUN
dpc-4793	24	18	of	of	ADP
dpc-4793	24	19	studied	study	VERB
dpc-4793	24	20	interventions	intervention	NOUN
dpc-4793	24	21	.	.	PUNCT
dpc-4793	25	1	methods	method	NOUN
dpc-4793	25	2	:	:	PUNCT
dpc-4793	25	3	the	the	DET
dpc-4793	25	4	ovid	ovid	PROPN
dpc-4793	25	5	medline(r	medline(r	PROPN
dpc-4793	25	6	)	)	PUNCT
dpc-4793	25	7	,	,	PUNCT
dpc-4793	25	8	embase	embase	NOUN
dpc-4793	25	9	,	,	PUNCT
dpc-4793	25	10	and	and	CCONJ
dpc-4793	25	11	cochrane	cochrane	NOUN
dpc-4793	25	12	databases	database	NOUN
dpc-4793	25	13	were	be	AUX
dpc-4793	25	14	searched	search	VERB
dpc-4793	25	15	from	from	ADP
dpc-4793	25	16	01	01	NUM
dpc-4793	25	17	january	january	PROPN
dpc-4793	25	18	2000	2000	NUM
dpc-4793	25	19	to	to	ADP
dpc-4793	25	20	05	05	NUM
dpc-4793	25	21	october	october	PROPN
dpc-4793	25	22	2022	2022	NUM
dpc-4793	25	23	.	.	PUNCT
dpc-4793	26	1	all	all	DET
dpc-4793	26	2	english	english	ADJ
dpc-4793	26	3	-	-	PUNCT
dpc-4793	26	4	language	language	NOUN
dpc-4793	26	5	randomized	randomize	VERB
dpc-4793	26	6	controlled	control	VERB
dpc-4793	26	7	trials	trial	NOUN
dpc-4793	26	8	evaluating	evaluate	VERB
dpc-4793	26	9	an	an	DET
dpc-4793	26	10	intervention	intervention	NOUN
dpc-4793	26	11	for	for	ADP
dpc-4793	26	12	scalp	scalp	NOUN
dpc-4793	26	13	psoriasis	psoriasis	NOUN
dpc-4793	26	14	were	be	AUX
dpc-4793	26	15	included	include	VERB
dpc-4793	26	16	if	if	SCONJ
dpc-4793	26	17	they	they	PRON
dpc-4793	26	18	reported	report	VERB
dpc-4793	26	19	one	one	NUM
dpc-4793	26	20	of	of	ADP
dpc-4793	26	21	the	the	DET
dpc-4793	26	22	following	follow	VERB
dpc-4793	26	23	clinical	clinical	ADJ
dpc-4793	26	24	outcomes	outcome	NOUN
dpc-4793	26	25	:	:	PUNCT
dpc-4793	26	26	psoriasis	psoriasis	NOUN
dpc-4793	26	27	scalp	scalp	NOUN
dpc-4793	26	28	severity	severity	NOUN
dpc-4793	26	29	index	index	NOUN
dpc-4793	26	30	(	(	PUNCT
dpc-4793	26	31	pssi	pssi	ADJ
dpc-4793	26	32	)	)	PUNCT
dpc-4793	26	33	,	,	PUNCT
dpc-4793	26	34	scalp	scalp	NOUN
dpc-4793	26	35	physician	physician	NOUN
dpc-4793	26	36	global	global	ADJ
dpc-4793	26	37	assessment	assessment	NOUN
dpc-4793	26	38	(	(	PUNCT
dpc-4793	26	39	scpga	scpga	NOUN
dpc-4793	26	40	)	)	PUNCT
dpc-4793	26	41	,	,	PUNCT
dpc-4793	26	42	scalp	scalp	NOUN
dpc-4793	26	43	-	-	PUNCT
dpc-4793	26	44	specific	specific	ADJ
dpc-4793	26	45	investigator	investigator	NOUN
dpc-4793	26	46	or	or	CCONJ
dpc-4793	26	47	physician	physician	NOUN
dpc-4793	26	48	global	global	ADJ
dpc-4793	26	49	assessment	assessment	NOUN
dpc-4793	26	50	(	(	PUNCT
dpc-4793	26	51	iga	iga	PROPN
dpc-4793	26	52	/	/	SYM
dpc-4793	26	53	pga	pga	PROPN
dpc-4793	26	54	)	)	PUNCT
dpc-4793	26	55	,	,	PUNCT
dpc-4793	26	56	and	and	CCONJ
dpc-4793	26	57	total	total	ADJ
dpc-4793	26	58	sign	sign	NOUN
dpc-4793	26	59	score	score	NOUN
dpc-4793	26	60	(	(	PUNCT
dpc-4793	26	61	tss	tss	NOUN
dpc-4793	26	62	)	)	PUNCT
dpc-4793	26	63	,	,	PUNCT
dpc-4793	26	64	and	and	CCONJ
dpc-4793	26	65	adverse	adverse	ADJ
dpc-4793	26	66	events	event	NOUN
dpc-4793	26	67	.	.	PUNCT
dpc-4793	27	1	a	a	DET
dpc-4793	27	2	random	random	ADJ
dpc-4793	27	3	effects	effect	NOUN
dpc-4793	27	4	network	network	NOUN
dpc-4793	27	5	meta	meta	ADJ
dpc-4793	27	6	-	-	PUNCT
dpc-4793	27	7	analysis	analysis	NOUN
dpc-4793	27	8	was	be	AUX
dpc-4793	27	9	performed	perform	VERB
dpc-4793	27	10	where	where	SCONJ
dpc-4793	27	11	possible	possible	ADJ
dpc-4793	27	12	,	,	PUNCT
dpc-4793	27	13	and	and	CCONJ
dpc-4793	27	14	network	network	NOUN
dpc-4793	27	15	plots	plot	NOUN
dpc-4793	27	16	were	be	AUX
dpc-4793	27	17	generated	generate	VERB
dpc-4793	27	18	.	.	PUNCT
dpc-4793	28	1	abstract	abstract	ADJ
dpc-4793	28	2	2	2	NUM
dpc-4793	28	3	review	review	NOUN
dpc-4793	28	4	|	|	ADV
dpc-4793	28	5	dermatol	dermatol	ADJ
dpc-4793	28	6	pract	pract	NOUN
dpc-4793	28	7	concept	concept	NOUN
dpc-4793	28	8	.	.	PUNCT
dpc-4793	29	1	2025;15(2):4793	2025;15(2):4793	NUM
dpc-4793	29	2	introduction	introduction	NOUN
dpc-4793	29	3	up	up	ADP
dpc-4793	29	4	to	to	PART
dpc-4793	29	5	80	80	NUM
dpc-4793	29	6	%	%	NOUN
dpc-4793	29	7	of	of	ADP
dpc-4793	29	8	patients	patient	NOUN
dpc-4793	29	9	with	with	ADP
dpc-4793	29	10	plaque	plaque	NOUN
dpc-4793	29	11	-	-	PUNCT
dpc-4793	29	12	type	type	NOUN
dpc-4793	29	13	psoriasis	psoriasis	NOUN
dpc-4793	29	14	have	have	VERB
dpc-4793	29	15	scalp	scalp	NOUN
dpc-4793	29	16	involvement	involvement	NOUN
dpc-4793	29	17	[	[	X
dpc-4793	29	18	1	1	NUM
dpc-4793	29	19	]	]	PUNCT
dpc-4793	29	20	.	.	PUNCT
dpc-4793	30	1	scalp	scalp	NOUN
dpc-4793	30	2	psoriasis	psoriasis	NOUN
dpc-4793	30	3	can	can	AUX
dpc-4793	30	4	cause	cause	VERB
dpc-4793	30	5	significant	significant	ADJ
dpc-4793	30	6	physical	physical	ADJ
dpc-4793	30	7	and	and	CCONJ
dpc-4793	30	8	social	social	ADJ
dpc-4793	30	9	distress	distress	NOUN
dpc-4793	30	10	,	,	PUNCT
dpc-4793	30	11	with	with	ADP
dpc-4793	30	12	up	up	ADP
dpc-4793	30	13	to	to	PART
dpc-4793	30	14	97	97	NUM
dpc-4793	30	15	%	%	NOUN
dpc-4793	30	16	reporting	reporting	NOUN
dpc-4793	30	17	that	that	SCONJ
dpc-4793	30	18	the	the	DET
dpc-4793	30	19	condition	condition	NOUN
dpc-4793	30	20	interferes	interfere	VERB
dpc-4793	30	21	in	in	ADP
dpc-4793	30	22	their	their	PRON
dpc-4793	30	23	daily	daily	ADJ
dpc-4793	30	24	life	life	NOUN
dpc-4793	30	25	[	[	X
dpc-4793	30	26	2	2	NUM
dpc-4793	30	27	]	]	PUNCT
dpc-4793	30	28	.	.	PUNCT
dpc-4793	31	1	many	many	ADJ
dpc-4793	31	2	individuals	individual	NOUN
dpc-4793	31	3	experience	experience	VERB
dpc-4793	31	4	intense	intense	ADJ
dpc-4793	31	5	pruritus	pruritus	NOUN
dpc-4793	31	6	and	and	CCONJ
dpc-4793	31	7	pain	pain	NOUN
dpc-4793	31	8	associated	associate	VERB
dpc-4793	31	9	with	with	ADP
dpc-4793	31	10	their	their	PRON
dpc-4793	31	11	disease	disease	NOUN
dpc-4793	31	12	,	,	PUNCT
dpc-4793	31	13	and	and	CCONJ
dpc-4793	31	14	the	the	DET
dpc-4793	31	15	shedding	shedding	NOUN
dpc-4793	31	16	of	of	ADP
dpc-4793	31	17	scale	scale	NOUN
dpc-4793	31	18	as	as	ADP
dpc-4793	31	19	dandruff	dandruff	NOUN
dpc-4793	31	20	can	can	AUX
dpc-4793	31	21	cause	cause	VERB
dpc-4793	31	22	significant	significant	ADJ
dpc-4793	31	23	social	social	ADJ
dpc-4793	31	24	embarrassment	embarrassment	NOUN
dpc-4793	31	25	for	for	ADP
dpc-4793	31	26	affected	affect	VERB
dpc-4793	31	27	individuals	individual	NOUN
dpc-4793	31	28	[	[	X
dpc-4793	31	29	3	3	NUM
dpc-4793	31	30	]	]	PUNCT
dpc-4793	31	31	.	.	PUNCT
dpc-4793	32	1	notably	notably	ADV
dpc-4793	32	2	,	,	PUNCT
dpc-4793	32	3	patients	patient	NOUN
dpc-4793	32	4	have	have	AUX
dpc-4793	32	5	reported	report	VERB
dpc-4793	32	6	significant	significant	ADJ
dpc-4793	32	7	psychosocial	psychosocial	ADJ
dpc-4793	32	8	distress	distress	NOUN
dpc-4793	32	9	and	and	CCONJ
dpc-4793	32	10	withdrawal	withdrawal	NOUN
dpc-4793	32	11	from	from	ADP
dpc-4793	32	12	social	social	ADJ
dpc-4793	32	13	activities	activity	NOUN
dpc-4793	32	14	as	as	ADP
dpc-4793	32	15	a	a	DET
dpc-4793	32	16	result	result	NOUN
dpc-4793	32	17	of	of	ADP
dpc-4793	32	18	embarrassment	embarrassment	NOUN
dpc-4793	32	19	from	from	ADP
dpc-4793	32	20	not	not	PART
dpc-4793	32	21	being	be	AUX
dpc-4793	32	22	able	able	ADJ
dpc-4793	32	23	to	to	PART
dpc-4793	32	24	hide	hide	VERB
dpc-4793	32	25	their	their	PRON
dpc-4793	32	26	lesions	lesion	NOUN
dpc-4793	32	27	[	[	X
dpc-4793	32	28	1	1	NUM
dpc-4793	32	29	,	,	PUNCT
dpc-4793	32	30	4	4	NUM
dpc-4793	32	31	-	-	SYM
dpc-4793	32	32	6	6	NUM
dpc-4793	32	33	]	]	PUNCT
dpc-4793	32	34	.	.	PUNCT
dpc-4793	33	1	scalp	scalp	NOUN
dpc-4793	33	2	psoriasis	psoriasis	NOUN
dpc-4793	33	3	is	be	AUX
dpc-4793	33	4	also	also	ADV
dpc-4793	33	5	often	often	ADV
dpc-4793	33	6	refractory	refractory	ADJ
dpc-4793	33	7	to	to	ADP
dpc-4793	33	8	topical	topical	ADJ
dpc-4793	33	9	agents	agent	NOUN
dpc-4793	34	1	[	[	X
dpc-4793	34	2	1	1	NUM
dpc-4793	34	3	,	,	PUNCT
dpc-4793	34	4	7	7	NUM
dpc-4793	34	5	,	,	PUNCT
dpc-4793	34	6	8	8	NUM
dpc-4793	34	7	]	]	PUNCT
dpc-4793	34	8	.	.	PUNCT
dpc-4793	35	1	overall	overall	ADJ
dpc-4793	35	2	,	,	PUNCT
dpc-4793	35	3	scalp	scalp	NOUN
dpc-4793	35	4	psoriasis	psoriasis	NOUN
dpc-4793	35	5	continues	continue	VERB
dpc-4793	35	6	to	to	PART
dpc-4793	35	7	pose	pose	VERB
dpc-4793	35	8	a	a	DET
dpc-4793	35	9	significant	significant	ADJ
dpc-4793	35	10	challenge	challenge	NOUN
dpc-4793	35	11	for	for	ADP
dpc-4793	35	12	dermatologists	dermatologist	NOUN
dpc-4793	35	13	due	due	ADP
dpc-4793	35	14	to	to	ADP
dpc-4793	35	15	the	the	DET
dpc-4793	35	16	lack	lack	NOUN
dpc-4793	35	17	of	of	ADP
dpc-4793	35	18	effective	effective	ADJ
dpc-4793	35	19	therapies	therapy	NOUN
dpc-4793	35	20	and	and	CCONJ
dpc-4793	35	21	the	the	DET
dpc-4793	35	22	severe	severe	ADJ
dpc-4793	35	23	physical	physical	ADJ
dpc-4793	35	24	and	and	CCONJ
dpc-4793	35	25	psychosocial	psychosocial	ADJ
dpc-4793	35	26	impact	impact	NOUN
dpc-4793	35	27	on	on	ADP
dpc-4793	35	28	affected	affected	ADJ
dpc-4793	35	29	patients	patient	NOUN
dpc-4793	35	30	.	.	PUNCT
dpc-4793	36	1	additionally	additionally	ADV
dpc-4793	36	2	,	,	PUNCT
dpc-4793	36	3	outcome	outcome	VERB
dpc-4793	36	4	measures	measure	NOUN
dpc-4793	36	5	to	to	PART
dpc-4793	36	6	quantify	quantify	VERB
dpc-4793	36	7	the	the	DET
dpc-4793	36	8	severity	severity	NOUN
dpc-4793	36	9	of	of	ADP
dpc-4793	36	10	scalp	scalp	NOUN
dpc-4793	36	11	psoriasis	psoriasis	NOUN
dpc-4793	36	12	are	be	AUX
dpc-4793	36	13	heterogeneous	heterogeneous	ADJ
dpc-4793	36	14	and	and	CCONJ
dpc-4793	36	15	have	have	AUX
dpc-4793	36	16	varied	vary	VERB
dpc-4793	36	17	across	across	ADP
dpc-4793	36	18	various	various	ADJ
dpc-4793	36	19	clinical	clinical	ADJ
dpc-4793	36	20	studies	study	NOUN
dpc-4793	36	21	.	.	PUNCT
dpc-4793	37	1	commonly	commonly	ADV
dpc-4793	37	2	-	-	PUNCT
dpc-4793	37	3	used	use	VERB
dpc-4793	37	4	scalp	scalp	NOUN
dpc-4793	37	5	psoriasis	psoriasis	NOUN
dpc-4793	37	6	tools	tool	NOUN
dpc-4793	37	7	include	include	VERB
dpc-4793	37	8	the	the	DET
dpc-4793	37	9	psoriasis	psoriasis	NOUN
dpc-4793	37	10	scalp	scalp	NOUN
dpc-4793	37	11	severity	severity	NOUN
dpc-4793	37	12	index	index	NOUN
dpc-4793	37	13	(	(	PUNCT
dpc-4793	37	14	pssi	pssi	ADJ
dpc-4793	37	15	)	)	PUNCT
dpc-4793	37	16	,	,	PUNCT
dpc-4793	37	17	scalp	scalp	NOUN
dpc-4793	37	18	physician	physician	NOUN
dpc-4793	37	19	global	global	ADJ
dpc-4793	37	20	assessment	assessment	NOUN
dpc-4793	37	21	(	(	PUNCT
dpc-4793	37	22	scpga	scpga	NOUN
dpc-4793	37	23	)	)	PUNCT
dpc-4793	37	24	,	,	PUNCT
dpc-4793	37	25	scalp	scalp	NOUN
dpc-4793	37	26	-	-	PUNCT
dpc-4793	37	27	specific	specific	ADJ
dpc-4793	37	28	investigator	investigator	NOUN
dpc-4793	37	29	or	or	CCONJ
dpc-4793	37	30	physician	physician	NOUN
dpc-4793	37	31	global	global	ADJ
dpc-4793	37	32	assessment	assessment	NOUN
dpc-4793	37	33	(	(	PUNCT
dpc-4793	37	34	iga	iga	PROPN
dpc-4793	37	35	/	/	SYM
dpc-4793	37	36	pga	pga	PROPN
dpc-4793	37	37	)	)	PUNCT
dpc-4793	37	38	,	,	PUNCT
dpc-4793	37	39	and	and	CCONJ
dpc-4793	37	40	total	total	ADJ
dpc-4793	37	41	sign	sign	NOUN
dpc-4793	37	42	score	score	NOUN
dpc-4793	37	43	(	(	PUNCT
dpc-4793	37	44	tss	tss	NOUN
dpc-4793	37	45	)	)	PUNCT
dpc-4793	37	46	.	.	PUNCT
dpc-4793	38	1	the	the	DET
dpc-4793	38	2	pssi	pssi	ADJ
dpc-4793	38	3	score	score	NOUN
dpc-4793	38	4	is	be	AUX
dpc-4793	38	5	calculated	calculate	VERB
dpc-4793	38	6	by	by	ADP
dpc-4793	38	7	assessing	assess	VERB
dpc-4793	38	8	erythema	erythema	ADJ
dpc-4793	38	9	,	,	PUNCT
dpc-4793	38	10	scaliness	scaliness	NOUN
dpc-4793	38	11	,	,	PUNCT
dpc-4793	38	12	induration	induration	NOUN
dpc-4793	38	13	,	,	PUNCT
dpc-4793	38	14	and	and	CCONJ
dpc-4793	38	15	extent	extent	NOUN
dpc-4793	38	16	of	of	ADP
dpc-4793	38	17	scalp	scalp	NOUN
dpc-4793	38	18	psoriasis	psoriasis	NOUN
dpc-4793	38	19	involvement	involvement	NOUN
dpc-4793	38	20	[	[	X
dpc-4793	38	21	5	5	NUM
dpc-4793	38	22	]	]	PUNCT
dpc-4793	38	23	.	.	PUNCT
dpc-4793	39	1	scpga	scpga	PROPN
dpc-4793	39	2	is	be	AUX
dpc-4793	39	3	a	a	DET
dpc-4793	39	4	seven	seven	NUM
dpc-4793	39	5	-	-	PUNCT
dpc-4793	39	6	point	point	NOUN
dpc-4793	39	7	scale	scale	NOUN
dpc-4793	39	8	assessing	assess	VERB
dpc-4793	39	9	plaque	plaque	NOUN
dpc-4793	39	10	elevation	elevation	NOUN
dpc-4793	39	11	,	,	PUNCT
dpc-4793	39	12	scaling	scaling	NOUN
dpc-4793	39	13	,	,	PUNCT
dpc-4793	39	14	and	and	CCONJ
dpc-4793	39	15	erythema	erythema	ADJ
dpc-4793	39	16	[	[	X
dpc-4793	39	17	9	9	NUM
dpc-4793	39	18	]	]	PUNCT
dpc-4793	39	19	.	.	PUNCT
dpc-4793	40	1	the	the	DET
dpc-4793	40	2	tss	tss	NOUN
dpc-4793	40	3	has	have	AUX
dpc-4793	40	4	been	be	AUX
dpc-4793	40	5	used	use	VERB
dpc-4793	40	6	differently	differently	ADV
dpc-4793	40	7	in	in	ADP
dpc-4793	40	8	the	the	DET
dpc-4793	40	9	studies	study	NOUN
dpc-4793	40	10	,	,	PUNCT
dpc-4793	40	11	with	with	ADP
dpc-4793	40	12	some	some	PRON
dpc-4793	40	13	including	include	VERB
dpc-4793	40	14	only	only	ADV
dpc-4793	40	15	erythema	erythema	ADJ
dpc-4793	40	16	,	,	PUNCT
dpc-4793	40	17	scaling	scaling	NOUN
dpc-4793	40	18	,	,	PUNCT
dpc-4793	40	19	and	and	CCONJ
dpc-4793	40	20	thickness	thickness	NOUN
dpc-4793	40	21	,	,	PUNCT
dpc-4793	40	22	and	and	CCONJ
dpc-4793	40	23	others	other	NOUN
dpc-4793	40	24	also	also	ADV
dpc-4793	40	25	including	include	VERB
dpc-4793	40	26	pruritus	pruritus	PROPN
dpc-4793	40	27	[	[	X
dpc-4793	40	28	8	8	NUM
dpc-4793	40	29	]	]	PUNCT
dpc-4793	40	30	.	.	PUNCT
dpc-4793	41	1	instruments	instrument	NOUN
dpc-4793	41	2	that	that	PRON
dpc-4793	41	3	measure	measure	VERB
dpc-4793	41	4	patient	patient	NOUN
dpc-4793	41	5	-	-	PUNCT
dpc-4793	41	6	reported	report	VERB
dpc-4793	41	7	outcomes	outcome	NOUN
dpc-4793	41	8	such	such	ADJ
dpc-4793	41	9	as	as	ADP
dpc-4793	41	10	quality	quality	NOUN
dpc-4793	41	11	of	of	ADP
dpc-4793	41	12	life	life	NOUN
dpc-4793	41	13	and	and	CCONJ
dpc-4793	41	14	symptom	symptom	NOUN
dpc-4793	41	15	burden	burden	NOUN
dpc-4793	41	16	also	also	ADV
dpc-4793	41	17	exist	exist	VERB
dpc-4793	41	18	but	but	CCONJ
dpc-4793	41	19	are	be	AUX
dpc-4793	41	20	less	less	ADV
dpc-4793	41	21	often	often	ADV
dpc-4793	41	22	used	use	VERB
dpc-4793	41	23	.	.	PUNCT
dpc-4793	42	1	these	these	PRON
dpc-4793	42	2	include	include	VERB
dpc-4793	42	3	the	the	DET
dpc-4793	42	4	dermatology	dermatology	NOUN
dpc-4793	42	5	life	life	NOUN
dpc-4793	42	6	quality	quality	NOUN
dpc-4793	42	7	index	index	NOUN
dpc-4793	42	8	(	(	PUNCT
dpc-4793	42	9	dlqi	dlqi	PROPN
dpc-4793	42	10	)	)	PUNCT
dpc-4793	42	11	and	and	CCONJ
dpc-4793	42	12	scalpdex	scalpdex	NOUN
dpc-4793	43	1	[	[	X
dpc-4793	43	2	5	5	NUM
dpc-4793	43	3	]	]	PUNCT
dpc-4793	43	4	.	.	PUNCT
dpc-4793	44	1	previous	previous	ADJ
dpc-4793	44	2	reviews	review	NOUN
dpc-4793	44	3	and	and	CCONJ
dpc-4793	44	4	meta	meta	NOUN
dpc-4793	44	5	-	-	PUNCT
dpc-4793	44	6	analyses	analysis	NOUN
dpc-4793	44	7	on	on	ADP
dpc-4793	44	8	scalp	scalp	NOUN
dpc-4793	44	9	psoriasis	psoriasis	NOUN
dpc-4793	44	10	found	find	VERB
dpc-4793	44	11	a	a	DET
dpc-4793	44	12	therapeutic	therapeutic	ADJ
dpc-4793	44	13	benefit	benefit	NOUN
dpc-4793	44	14	among	among	ADP
dpc-4793	44	15	biologics	biologic	NOUN
dpc-4793	44	16	and	and	CCONJ
dpc-4793	44	17	small	small	ADJ
dpc-4793	44	18	molecule	molecule	NOUN
dpc-4793	44	19	agent	agent	NOUN
dpc-4793	44	20	(	(	PUNCT
dpc-4793	44	21	smas	sma	NOUN
dpc-4793	44	22	)	)	PUNCT
dpc-4793	44	23	treatments	treatment	NOUN
dpc-4793	44	24	compared	compare	VERB
dpc-4793	44	25	to	to	ADP
dpc-4793	44	26	placebo	placebo	NOUN
dpc-4793	44	27	[	[	X
dpc-4793	44	28	4	4	NUM
dpc-4793	44	29	,	,	PUNCT
dpc-4793	44	30	7	7	NUM
dpc-4793	44	31	]	]	PUNCT
dpc-4793	44	32	.	.	PUNCT
dpc-4793	45	1	there	there	PRON
dpc-4793	45	2	is	be	VERB
dpc-4793	45	3	a	a	DET
dpc-4793	45	4	lack	lack	NOUN
dpc-4793	45	5	of	of	ADP
dpc-4793	45	6	consensus	consensus	NOUN
dpc-4793	45	7	on	on	ADP
dpc-4793	45	8	the	the	DET
dpc-4793	45	9	optimal	optimal	ADJ
dpc-4793	45	10	or	or	CCONJ
dpc-4793	45	11	most	most	ADV
dpc-4793	45	12	effective	effective	ADJ
dpc-4793	45	13	treatment	treatment	NOUN
dpc-4793	45	14	for	for	ADP
dpc-4793	45	15	scalp	scalp	NOUN
dpc-4793	45	16	psoriasis	psoriasis	NOUN
dpc-4793	45	17	mostly	mostly	ADV
dpc-4793	45	18	due	due	ADP
dpc-4793	45	19	to	to	ADP
dpc-4793	45	20	the	the	DET
dpc-4793	45	21	limited	limited	ADJ
dpc-4793	45	22	number	number	NOUN
dpc-4793	45	23	of	of	ADP
dpc-4793	45	24	head	head	NOUN
dpc-4793	45	25	-	-	PUNCT
dpc-4793	45	26	to	to	ADP
dpc-4793	45	27	-	-	PUNCT
dpc-4793	45	28	head	head	NOUN
dpc-4793	45	29	trials	trial	NOUN
dpc-4793	45	30	comparing	compare	VERB
dpc-4793	45	31	biologics	biologic	NOUN
dpc-4793	45	32	and	and	CCONJ
dpc-4793	45	33	smas	sma	NOUN
dpc-4793	45	34	.	.	PUNCT
dpc-4793	46	1	we	we	PRON
dpc-4793	46	2	conducted	conduct	VERB
dpc-4793	46	3	a	a	DET
dpc-4793	46	4	systematic	systematic	ADJ
dpc-4793	46	5	review	review	NOUN
dpc-4793	46	6	and	and	CCONJ
dpc-4793	46	7	network	network	NOUN
dpc-4793	46	8	meta	meta	ADJ
dpc-4793	46	9	analysis	analysis	NOUN
dpc-4793	46	10	on	on	ADP
dpc-4793	46	11	systemic	systemic	ADJ
dpc-4793	46	12	therapies	therapy	NOUN
dpc-4793	46	13	for	for	ADP
dpc-4793	46	14	scalp	scalp	NOUN
dpc-4793	46	15	psoriasis	psoriasis	NOUN
dpc-4793	46	16	.	.	PUNCT
dpc-4793	47	1	objectives	objective	VERB
dpc-4793	47	2	the	the	DET
dpc-4793	47	3	objective	objective	NOUN
dpc-4793	47	4	of	of	ADP
dpc-4793	47	5	this	this	DET
dpc-4793	47	6	study	study	NOUN
dpc-4793	47	7	was	be	AUX
dpc-4793	47	8	to	to	PART
dpc-4793	47	9	compare	compare	VERB
dpc-4793	47	10	the	the	DET
dpc-4793	47	11	efficacy	efficacy	NOUN
dpc-4793	47	12	of	of	ADP
dpc-4793	47	13	various	various	ADJ
dpc-4793	47	14	therapies	therapy	NOUN
dpc-4793	47	15	for	for	ADP
dpc-4793	47	16	the	the	DET
dpc-4793	47	17	treatment	treatment	NOUN
dpc-4793	47	18	of	of	ADP
dpc-4793	47	19	scalp	scalp	NOUN
dpc-4793	47	20	psoriasis	psoriasis	NOUN
dpc-4793	47	21	.	.	PUNCT
dpc-4793	48	1	methods	method	NOUN
dpc-4793	48	2	search	search	VERB
dpc-4793	48	3	strategy	strategy	NOUN
dpc-4793	48	4	and	and	CCONJ
dpc-4793	48	5	selection	selection	NOUN
dpc-4793	48	6	criteria	criterion	NOUN
dpc-4793	48	7	a	a	DET
dpc-4793	48	8	systematic	systematic	ADJ
dpc-4793	48	9	review	review	NOUN
dpc-4793	48	10	of	of	ADP
dpc-4793	48	11	the	the	DET
dpc-4793	48	12	literature	literature	NOUN
dpc-4793	48	13	was	be	AUX
dpc-4793	48	14	conducted	conduct	VERB
dpc-4793	48	15	of	of	ADP
dpc-4793	48	16	the	the	DET
dpc-4793	48	17	ovid	ovid	PROPN
dpc-4793	48	18	medline(r	medline(r	PROPN
dpc-4793	48	19	)	)	PUNCT
dpc-4793	48	20	,	,	PUNCT
dpc-4793	48	21	embase	embase	NOUN
dpc-4793	48	22	,	,	PUNCT
dpc-4793	48	23	and	and	CCONJ
dpc-4793	48	24	cochrane	cochrane	PROPN
dpc-4793	48	25	central	central	ADJ
dpc-4793	48	26	register	register	NOUN
dpc-4793	48	27	of	of	ADP
dpc-4793	48	28	controlled	control	VERB
dpc-4793	48	29	trials	trial	NOUN
dpc-4793	48	30	databases	database	NOUN
dpc-4793	48	31	from	from	ADP
dpc-4793	48	32	01	01	NUM
dpc-4793	48	33	january	january	PROPN
dpc-4793	48	34	2000	2000	NUM
dpc-4793	48	35	to	to	ADP
dpc-4793	48	36	05	05	NUM
dpc-4793	48	37	october	october	PROPN
dpc-4793	48	38	2022	2022	NUM
dpc-4793	48	39	.	.	PUNCT
dpc-4793	49	1	all	all	DET
dpc-4793	49	2	full	full	ADJ
dpc-4793	49	3	-	-	PUNCT
dpc-4793	49	4	text	text	NOUN
dpc-4793	49	5	works	work	NOUN
dpc-4793	49	6	published	publish	VERB
dpc-4793	49	7	in	in	ADP
dpc-4793	49	8	english	english	PROPN
dpc-4793	49	9	were	be	AUX
dpc-4793	49	10	included	include	VERB
dpc-4793	49	11	in	in	ADP
dpc-4793	49	12	the	the	DET
dpc-4793	49	13	analysis	analysis	NOUN
dpc-4793	49	14	if	if	SCONJ
dpc-4793	49	15	they	they	PRON
dpc-4793	49	16	answered	answer	VERB
dpc-4793	49	17	the	the	DET
dpc-4793	49	18	research	research	NOUN
dpc-4793	49	19	question	question	NOUN
dpc-4793	49	20	outlined	outline	VERB
dpc-4793	49	21	using	use	VERB
dpc-4793	49	22	the	the	DET
dpc-4793	49	23	population	population	NOUN
dpc-4793	49	24	,	,	PUNCT
dpc-4793	49	25	intervention	intervention	NOUN
dpc-4793	49	26	,	,	PUNCT
dpc-4793	49	27	comparison	comparison	NOUN
dpc-4793	49	28	,	,	PUNCT
dpc-4793	49	29	and	and	CCONJ
dpc-4793	49	30	outcome	outcome	NOUN
dpc-4793	49	31	(	(	PUNCT
dpc-4793	49	32	pico	pico	NOUN
dpc-4793	49	33	)	)	PUNCT
dpc-4793	49	34	method	method	NOUN
dpc-4793	49	35	:	:	PUNCT
dpc-4793	49	36	p	p	X
dpc-4793	49	37	)	)	PUNCT
dpc-4793	49	38	patients	patient	NOUN
dpc-4793	49	39	with	with	ADP
dpc-4793	49	40	any	any	DET
dpc-4793	49	41	severity	severity	NOUN
dpc-4793	49	42	of	of	ADP
dpc-4793	49	43	scalp	scalp	NOUN
dpc-4793	49	44	psoriasis	psoriasis	NOUN
dpc-4793	49	45	;	;	PUNCT
dpc-4793	49	46	i	i	PRON
dpc-4793	49	47	and	and	CCONJ
dpc-4793	49	48	c	c	X
dpc-4793	49	49	)	)	PUNCT
dpc-4793	49	50	any	any	DET
dpc-4793	49	51	therapy	therapy	NOUN
dpc-4793	49	52	type	type	NOUN
dpc-4793	49	53	(	(	PUNCT
dpc-4793	49	54	topical	topical	ADJ
dpc-4793	49	55	agents	agent	NOUN
dpc-4793	49	56	,	,	PUNCT
dpc-4793	49	57	smas	sma	NOUN
dpc-4793	49	58	,	,	PUNCT
dpc-4793	49	59	biologics	biologic	NOUN
dpc-4793	49	60	,	,	PUNCT
dpc-4793	49	61	phototherapy	phototherapy	NOUN
dpc-4793	49	62	,	,	PUNCT
dpc-4793	49	63	and	and	CCONJ
dpc-4793	49	64	other	other	ADJ
dpc-4793	49	65	)	)	PUNCT
dpc-4793	49	66	;	;	PUNCT
dpc-4793	49	67	and	and	CCONJ
dpc-4793	49	68	o	o	X
dpc-4793	49	69	)	)	PUNCT
dpc-4793	49	70	change	change	NOUN
dpc-4793	49	71	in	in	ADP
dpc-4793	49	72	scalp	scalp	NOUN
dpc-4793	49	73	psoriasis	psoriasis	NOUN
dpc-4793	49	74	as	as	SCONJ
dpc-4793	49	75	determined	determine	VERB
dpc-4793	49	76	by	by	ADP
dpc-4793	49	77	improvement	improvement	NOUN
dpc-4793	49	78	and	and	CCONJ
dpc-4793	49	79	changes	change	NOUN
dpc-4793	49	80	in	in	ADP
dpc-4793	49	81	pssi	pssi	ADJ
dpc-4793	49	82	score	score	NOUN
dpc-4793	49	83	,	,	PUNCT
dpc-4793	49	84	iga	iga	PROPN
dpc-4793	49	85	score	score	NOUN
dpc-4793	49	86	,	,	PUNCT
dpc-4793	49	87	scpga	scpga	NOUN
dpc-4793	49	88	,	,	PUNCT
dpc-4793	49	89	modified	modify	VERB
dpc-4793	49	90	psoriasis	psoriasis	NOUN
dpc-4793	49	91	area	area	NOUN
dpc-4793	49	92	and	and	CCONJ
dpc-4793	49	93	severity	severity	NOUN
dpc-4793	49	94	index	index	NOUN
dpc-4793	49	95	(	(	PUNCT
dpc-4793	49	96	mpasi	mpasi	NOUN
dpc-4793	49	97	)	)	PUNCT
dpc-4793	49	98	score	score	NOUN
dpc-4793	49	99	,	,	PUNCT
dpc-4793	49	100	or	or	CCONJ
dpc-4793	49	101	tss	tss	NOUN
dpc-4793	49	102	[	[	X
dpc-4793	49	103	10	10	NUM
dpc-4793	49	104	]	]	PUNCT
dpc-4793	49	105	.	.	PUNCT
dpc-4793	50	1	works	work	NOUN
dpc-4793	50	2	were	be	AUX
dpc-4793	50	3	excluded	exclude	VERB
dpc-4793	50	4	for	for	ADP
dpc-4793	50	5	the	the	DET
dpc-4793	50	6	following	follow	VERB
dpc-4793	50	7	reasons	reason	NOUN
dpc-4793	50	8	:	:	PUNCT
dpc-4793	50	9	only	only	ADV
dpc-4793	50	10	reporting	report	VERB
dpc-4793	50	11	outcomes	outcome	NOUN
dpc-4793	50	12	beyond	beyond	ADP
dpc-4793	50	13	24	24	NUM
dpc-4793	50	14	weeks	week	NOUN
dpc-4793	50	15	from	from	ADP
dpc-4793	50	16	baseline	baseline	PROPN
dpc-4793	50	17	(	(	PUNCT
dpc-4793	50	18	denoted	denote	VERB
dpc-4793	50	19	as	as	ADP
dpc-4793	50	20	“	"	PUNCT
dpc-4793	50	21	remission	remission	NOUN
dpc-4793	50	22	therapy	therapy	NOUN
dpc-4793	50	23	”	"	PUNCT
dpc-4793	50	24	)	)	PUNCT
dpc-4793	50	25	,	,	PUNCT
dpc-4793	50	26	non	non	ADJ
dpc-4793	50	27	-	-	ADJ
dpc-4793	50	28	randomized	randomized	ADJ
dpc-4793	50	29	studies	study	NOUN
dpc-4793	50	30	,	,	PUNCT
dpc-4793	50	31	abstract	abstract	ADJ
dpc-4793	50	32	-	-	PUNCT
dpc-4793	50	33	only	only	ADV
dpc-4793	50	34	studies	study	NOUN
dpc-4793	50	35	,	,	PUNCT
dpc-4793	50	36	non	non	ADJ
dpc-4793	50	37	-	-	ADJ
dpc-4793	50	38	english	english	ADJ
dpc-4793	50	39	language	language	NOUN
dpc-4793	50	40	,	,	PUNCT
dpc-4793	50	41	pediatric	pediatric	ADJ
dpc-4793	50	42	populations	population	NOUN
dpc-4793	50	43	,	,	PUNCT
dpc-4793	50	44	or	or	CCONJ
dpc-4793	50	45	non	non	ADJ
dpc-4793	50	46	-	-	ADJ
dpc-4793	50	47	human	human	ADJ
dpc-4793	50	48	models	model	NOUN
dpc-4793	50	49	.	.	PUNCT
dpc-4793	51	1	in	in	ADP
dpc-4793	51	2	accordance	accordance	NOUN
dpc-4793	51	3	with	with	ADP
dpc-4793	51	4	the	the	DET
dpc-4793	51	5	preferred	preferred	ADJ
dpc-4793	51	6	reporting	reporting	NOUN
dpc-4793	51	7	items	item	NOUN
dpc-4793	51	8	for	for	ADP
dpc-4793	51	9	systematic	systematic	ADJ
dpc-4793	51	10	reviews	review	NOUN
dpc-4793	51	11	and	and	CCONJ
dpc-4793	51	12	meta	meta	NOUN
dpc-4793	51	13	-	-	PUNCT
dpc-4793	51	14	analyses	analysis	NOUN
dpc-4793	51	15	(	(	PUNCT
dpc-4793	51	16	prisma	prisma	NOUN
dpc-4793	51	17	)	)	PUNCT
dpc-4793	51	18	statement	statement	NOUN
dpc-4793	51	19	,	,	PUNCT
dpc-4793	51	20	two	two	NUM
dpc-4793	51	21	authors	author	NOUN
dpc-4793	51	22	(	(	PUNCT
dpc-4793	51	23	tb	tb	NOUN
dpc-4793	51	24	and	and	CCONJ
dpc-4793	51	25	rpl	rpl	NOUN
dpc-4793	51	26	)	)	PUNCT
dpc-4793	51	27	screened	screen	VERB
dpc-4793	51	28	all	all	DET
dpc-4793	51	29	titles	title	NOUN
dpc-4793	51	30	and	and	CCONJ
dpc-4793	51	31	abstracts	abstract	NOUN
dpc-4793	51	32	independently	independently	ADV
dpc-4793	51	33	for	for	ADP
dpc-4793	51	34	eligibility	eligibility	NOUN
dpc-4793	51	35	and	and	CCONJ
dpc-4793	51	36	discussed	discuss	VERB
dpc-4793	51	37	any	any	DET
dpc-4793	51	38	discrepancies	discrepancy	NOUN
dpc-4793	51	39	[	[	X
dpc-4793	51	40	11	11	NUM
dpc-4793	51	41	]	]	PUNCT
dpc-4793	51	42	.	.	PUNCT
dpc-4793	52	1	all	all	DET
dpc-4793	52	2	full	full	ADJ
dpc-4793	52	3	texts	text	NOUN
dpc-4793	52	4	of	of	ADP
dpc-4793	52	5	studies	study	NOUN
dpc-4793	52	6	were	be	AUX
dpc-4793	52	7	then	then	ADV
dpc-4793	52	8	for	for	ADP
dpc-4793	52	9	eligibility	eligibility	NOUN
dpc-4793	52	10	,	,	PUNCT
dpc-4793	52	11	and	and	CCONJ
dpc-4793	52	12	all	all	DET
dpc-4793	52	13	extracted	extract	VERB
dpc-4793	52	14	data	datum	NOUN
dpc-4793	52	15	were	be	AUX
dpc-4793	52	16	cross	cross	ADJ
dpc-4793	52	17	-	-	ADJ
dpc-4793	52	18	referenced	reference	VERB
dpc-4793	52	19	by	by	ADP
dpc-4793	52	20	two	two	NUM
dpc-4793	52	21	reviewers	reviewer	NOUN
dpc-4793	52	22	(	(	PUNCT
dpc-4793	52	23	tb	tb	NOUN
dpc-4793	52	24	and	and	CCONJ
dpc-4793	52	25	rpl	rpl	NOUN
dpc-4793	52	26	)	)	PUNCT
dpc-4793	52	27	to	to	PART
dpc-4793	52	28	ensure	ensure	VERB
dpc-4793	52	29	accuracy	accuracy	NOUN
dpc-4793	52	30	.	.	PUNCT
dpc-4793	53	1	for	for	ADP
dpc-4793	53	2	each	each	DET
dpc-4793	53	3	outcome	outcome	NOUN
dpc-4793	53	4	,	,	PUNCT
dpc-4793	53	5	data	datum	NOUN
dpc-4793	53	6	were	be	AUX
dpc-4793	53	7	only	only	ADV
dpc-4793	53	8	extracted	extract	VERB
dpc-4793	53	9	between	between	ADP
dpc-4793	53	10	baseline	baseline	NOUN
dpc-4793	53	11	and	and	CCONJ
dpc-4793	53	12	the	the	DET
dpc-4793	53	13	24	24	NUM
dpc-4793	53	14	-	-	PUNCT
dpc-4793	53	15	week	week	NOUN
dpc-4793	53	16	time	time	NOUN
dpc-4793	53	17	point	point	NOUN
dpc-4793	53	18	,	,	PUNCT
dpc-4793	53	19	which	which	PRON
dpc-4793	53	20	was	be	AUX
dpc-4793	53	21	denoted	denote	VERB
dpc-4793	53	22	as	as	ADP
dpc-4793	53	23	“	"	PUNCT
dpc-4793	53	24	induction	induction	NOUN
dpc-4793	53	25	therapy	therapy	NOUN
dpc-4793	53	26	.	.	PUNCT
dpc-4793	53	27	”	"	PUNCT
dpc-4793	54	1	data	datum	NOUN
dpc-4793	54	2	collection	collection	NOUN
dpc-4793	54	3	across	across	ADP
dpc-4793	54	4	studies	study	NOUN
dpc-4793	54	5	included	include	VERB
dpc-4793	54	6	,	,	PUNCT
dpc-4793	54	7	data	datum	NOUN
dpc-4793	54	8	were	be	AUX
dpc-4793	54	9	extracted	extract	VERB
dpc-4793	54	10	on	on	ADP
dpc-4793	54	11	demographics	demographic	NOUN
dpc-4793	54	12	,	,	PUNCT
dpc-4793	54	13	sample	sample	NOUN
dpc-4793	54	14	size	size	NOUN
dpc-4793	54	15	,	,	PUNCT
dpc-4793	54	16	publication	publication	NOUN
dpc-4793	54	17	year	year	NOUN
dpc-4793	54	18	,	,	PUNCT
dpc-4793	54	19	treatment	treatment	NOUN
dpc-4793	54	20	characteristics	characteristic	NOUN
dpc-4793	54	21	(	(	PUNCT
dpc-4793	54	22	dosing	dosing	NOUN
dpc-4793	54	23	,	,	PUNCT
dpc-4793	54	24	frequency	frequency	NOUN
dpc-4793	54	25	)	)	PUNCT
dpc-4793	54	26	,	,	PUNCT
dpc-4793	54	27	comparison	comparison	NOUN
dpc-4793	54	28	group	group	NOUN
dpc-4793	54	29	,	,	PUNCT
dpc-4793	54	30	timing	timing	NOUN
dpc-4793	54	31	of	of	ADP
dpc-4793	54	32	outcome	outcome	NOUN
dpc-4793	54	33	assessment	assessment	NOUN
dpc-4793	54	34	,	,	PUNCT
dpc-4793	54	35	key	key	ADJ
dpc-4793	54	36	findings	finding	NOUN
dpc-4793	54	37	,	,	PUNCT
dpc-4793	54	38	and	and	CCONJ
dpc-4793	54	39	others	other	NOUN
dpc-4793	54	40	.	.	PUNCT
dpc-4793	55	1	pssi	pssi	ADJ
dpc-4793	55	2	,	,	PUNCT
dpc-4793	55	3	iga	iga	PROPN
dpc-4793	55	4	/	/	SYM
dpc-4793	55	5	pga	pga	PROPN
dpc-4793	55	6	,	,	PUNCT
dpc-4793	55	7	scpga	scpga	NOUN
dpc-4793	55	8	,	,	PUNCT
dpc-4793	55	9	mpasi	mpasi	NOUN
dpc-4793	55	10	,	,	PUNCT
dpc-4793	55	11	tss	tss	NOUN
dpc-4793	55	12	,	,	PUNCT
dpc-4793	55	13	and	and	CCONJ
dpc-4793	55	14	adverse	adverse	ADJ
dpc-4793	55	15	event	event	NOUN
dpc-4793	55	16	outcome	outcome	NOUN
dpc-4793	55	17	data	datum	NOUN
dpc-4793	55	18	were	be	AUX
dpc-4793	55	19	also	also	ADV
dpc-4793	55	20	results	result	NOUN
dpc-4793	55	21	:	:	PUNCT
dpc-4793	55	22	of	of	ADP
dpc-4793	55	23	1,046	1,046	NUM
dpc-4793	55	24	studies	study	NOUN
dpc-4793	55	25	identified	identify	VERB
dpc-4793	55	26	,	,	PUNCT
dpc-4793	55	27	35	35	NUM
dpc-4793	55	28	met	meet	VERB
dpc-4793	55	29	the	the	DET
dpc-4793	55	30	inclusion	inclusion	NOUN
dpc-4793	55	31	criteria	criterion	NOUN
dpc-4793	55	32	,	,	PUNCT
dpc-4793	55	33	with	with	ADP
dpc-4793	55	34	seven	seven	NUM
dpc-4793	55	35	in	in	ADP
dpc-4793	55	36	the	the	DET
dpc-4793	55	37	pssi	pssi	ADJ
dpc-4793	55	38	analysis	analysis	NOUN
dpc-4793	55	39	and	and	CCONJ
dpc-4793	55	40	16	16	NUM
dpc-4793	55	41	in	in	ADP
dpc-4793	55	42	the	the	DET
dpc-4793	55	43	iga	iga	PROPN
dpc-4793	55	44	analysis	analysis	NOUN
dpc-4793	55	45	.	.	PUNCT
dpc-4793	56	1	all	all	DET
dpc-4793	56	2	interventions	intervention	NOUN
dpc-4793	56	3	led	lead	VERB
dpc-4793	56	4	to	to	ADP
dpc-4793	56	5	an	an	DET
dpc-4793	56	6	improvement	improvement	NOUN
dpc-4793	56	7	in	in	ADP
dpc-4793	56	8	all	all	DET
dpc-4793	56	9	outcomes	outcome	NOUN
dpc-4793	56	10	when	when	SCONJ
dpc-4793	56	11	compared	compare	VERB
dpc-4793	56	12	to	to	ADP
dpc-4793	56	13	placebo	placebo	NOUN
dpc-4793	56	14	in	in	ADP
dpc-4793	56	15	the	the	DET
dpc-4793	56	16	pssi	pssi	ADJ
dpc-4793	56	17	and	and	CCONJ
dpc-4793	56	18	pga	pga	PROPN
dpc-4793	56	19	/	/	SYM
dpc-4793	56	20	iga	iga	PROPN
dpc-4793	56	21	.	.	PUNCT
dpc-4793	57	1	for	for	ADP
dpc-4793	57	2	the	the	DET
dpc-4793	57	3	pssi	pssi	ADJ
dpc-4793	57	4	response	response	NOUN
dpc-4793	57	5	,	,	PUNCT
dpc-4793	57	6	secukinumab	secukinumab	NOUN
dpc-4793	57	7	300	300	NUM
dpc-4793	57	8	mg	mg	NOUN
dpc-4793	57	9	every	every	DET
dpc-4793	57	10	four	four	NUM
dpc-4793	57	11	weeks	week	NOUN
dpc-4793	57	12	(	(	PUNCT
dpc-4793	57	13	q4w	q4w	ADV
dpc-4793	57	14	)	)	PUNCT
dpc-4793	57	15	was	be	AUX
dpc-4793	57	16	the	the	DET
dpc-4793	57	17	most	most	ADV
dpc-4793	57	18	effective	effective	ADJ
dpc-4793	57	19	(	(	PUNCT
dpc-4793	57	20	sucra	sucra	NOUN
dpc-4793	57	21	0.991	0.991	NUM
dpc-4793	57	22	)	)	PUNCT
dpc-4793	57	23	.	.	PUNCT
dpc-4793	58	1	for	for	ADP
dpc-4793	58	2	the	the	DET
dpc-4793	58	3	pga	pga	PROPN
dpc-4793	58	4	/	/	SYM
dpc-4793	58	5	iga	iga	PROPN
dpc-4793	58	6	response	response	NOUN
dpc-4793	58	7	,	,	PUNCT
dpc-4793	58	8	bimekizumab	bimekizumab	X
dpc-4793	58	9	320	320	NUM
dpc-4793	58	10	mg	mg	NOUN
dpc-4793	58	11	q4w	q4w	PROPN
dpc-4793	58	12	was	be	AUX
dpc-4793	58	13	the	the	DET
dpc-4793	58	14	most	most	ADV
dpc-4793	58	15	effective	effective	ADJ
dpc-4793	58	16	(	(	PUNCT
dpc-4793	58	17	sucra	sucra	NOUN
dpc-4793	58	18	0.975	0.975	NUM
dpc-4793	58	19	)	)	PUNCT
dpc-4793	58	20	.	.	PUNCT
dpc-4793	59	1	conclusions	conclusion	NOUN
dpc-4793	59	2	:	:	PUNCT
dpc-4793	59	3	several	several	ADJ
dpc-4793	59	4	systemic	systemic	ADJ
dpc-4793	59	5	therapies	therapy	NOUN
dpc-4793	59	6	are	be	AUX
dpc-4793	59	7	superior	superior	ADJ
dpc-4793	59	8	to	to	PART
dpc-4793	59	9	placebo	placebo	VERB
dpc-4793	59	10	in	in	ADP
dpc-4793	59	11	improving	improve	VERB
dpc-4793	59	12	clinical	clinical	ADJ
dpc-4793	59	13	outcomes	outcome	NOUN
dpc-4793	59	14	,	,	PUNCT
dpc-4793	59	15	with	with	ADP
dpc-4793	59	16	secukinumab	secukinumab	NOUN
dpc-4793	59	17	300	300	NUM
dpc-4793	59	18	mg	mg	NOUN
dpc-4793	59	19	q4w	q4w	PROPN
dpc-4793	59	20	and	and	CCONJ
dpc-4793	59	21	bimekizumab	bimekizumab	NOUN
dpc-4793	59	22	320	320	NUM
dpc-4793	59	23	mg	mg	PROPN
dpc-4793	60	1	q4w	q4w	PROPN
dpc-4793	60	2	deemed	deem	VERB
dpc-4793	60	3	the	the	DET
dpc-4793	60	4	most	most	ADV
dpc-4793	60	5	effective	effective	ADJ
dpc-4793	60	6	among	among	ADP
dpc-4793	60	7	biologic	biologic	ADJ
dpc-4793	60	8	agents	agent	NOUN
dpc-4793	60	9	analyzed	analyze	VERB
dpc-4793	60	10	.	.	PUNCT
dpc-4793	61	1	efforts	effort	NOUN
dpc-4793	61	2	to	to	PART
dpc-4793	61	3	enhance	enhance	VERB
dpc-4793	61	4	research	research	NOUN
dpc-4793	61	5	standardization	standardization	NOUN
dpc-4793	61	6	,	,	PUNCT
dpc-4793	61	7	including	include	VERB
dpc-4793	61	8	head	head	NOUN
dpc-4793	61	9	-	-	PUNCT
dpc-4793	61	10	to	to	ADP
dpc-4793	61	11	-	-	PUNCT
dpc-4793	61	12	head	head	NOUN
dpc-4793	61	13	trials	trial	NOUN
dpc-4793	61	14	with	with	ADP
dpc-4793	61	15	standardized	standardized	ADJ
dpc-4793	61	16	outcome	outcome	NOUN
dpc-4793	61	17	measures	measure	NOUN
dpc-4793	61	18	,	,	PUNCT
dpc-4793	61	19	diverse	diverse	ADJ
dpc-4793	61	20	patient	patient	ADJ
dpc-4793	61	21	recruitment	recruitment	NOUN
dpc-4793	61	22	,	,	PUNCT
dpc-4793	61	23	and	and	CCONJ
dpc-4793	61	24	long	long	ADJ
dpc-4793	61	25	-	-	PUNCT
dpc-4793	61	26	term	term	NOUN
dpc-4793	61	27	follow	follow	NOUN
dpc-4793	61	28	-	-	PUNCT
dpc-4793	61	29	up	up	NOUN
dpc-4793	61	30	,	,	PUNCT
dpc-4793	61	31	are	be	AUX
dpc-4793	61	32	crucial	crucial	ADJ
dpc-4793	61	33	next	next	ADJ
dpc-4793	61	34	steps	step	NOUN
dpc-4793	61	35	in	in	ADP
dpc-4793	61	36	assessing	assess	VERB
dpc-4793	61	37	treatment	treatment	NOUN
dpc-4793	61	38	efficacy	efficacy	NOUN
dpc-4793	61	39	and	and	CCONJ
dpc-4793	61	40	adverse	adverse	ADJ
dpc-4793	61	41	events	event	NOUN
dpc-4793	61	42	.	.	PUNCT
dpc-4793	62	1	review	review	VERB
dpc-4793	62	2	|	|	ADV
dpc-4793	62	3	dermatol	dermatol	ADJ
dpc-4793	62	4	pract	pract	NOUN
dpc-4793	62	5	concept	concept	NOUN
dpc-4793	62	6	.	.	PUNCT
dpc-4793	63	1	2025;15(2):4793	2025;15(2):4793	NUM
dpc-4793	63	2	3	3	NUM
dpc-4793	63	3	extracted	extract	VERB
dpc-4793	63	4	.	.	PUNCT
dpc-4793	64	1	outcomes	outcome	NOUN
dpc-4793	64	2	assessed	assess	VERB
dpc-4793	64	3	at	at	ADP
dpc-4793	64	4	12	12	NUM
dpc-4793	64	5	weeks	week	NOUN
dpc-4793	64	6	were	be	AUX
dpc-4793	64	7	included	include	VERB
dpc-4793	64	8	in	in	ADP
dpc-4793	64	9	the	the	DET
dpc-4793	64	10	analysis	analysis	NOUN
dpc-4793	64	11	.	.	PUNCT
dpc-4793	65	1	for	for	ADP
dpc-4793	65	2	studies	study	NOUN
dpc-4793	65	3	that	that	PRON
dpc-4793	65	4	did	do	AUX
dpc-4793	65	5	not	not	PART
dpc-4793	65	6	report	report	VERB
dpc-4793	65	7	12	12	NUM
dpc-4793	65	8	-	-	PUNCT
dpc-4793	65	9	week	week	NOUN
dpc-4793	65	10	data	datum	NOUN
dpc-4793	65	11	,	,	PUNCT
dpc-4793	65	12	the	the	DET
dpc-4793	65	13	time	time	NOUN
dpc-4793	65	14	point	point	NOUN
dpc-4793	65	15	closest	close	ADJ
dpc-4793	65	16	to	to	ADP
dpc-4793	65	17	12	12	NUM
dpc-4793	65	18	weeks	week	NOUN
dpc-4793	65	19	was	be	AUX
dpc-4793	65	20	included	include	VERB
dpc-4793	65	21	for	for	ADP
dpc-4793	65	22	analysis	analysis	NOUN
dpc-4793	65	23	purposes	purpose	NOUN
dpc-4793	65	24	(	(	PUNCT
dpc-4793	65	25	ranging	range	VERB
dpc-4793	65	26	from	from	ADP
dpc-4793	65	27	four	four	NUM
dpc-4793	65	28	to	to	PART
dpc-4793	65	29	sixteen	sixteen	NUM
dpc-4793	65	30	weeks	week	NOUN
dpc-4793	65	31	)	)	PUNCT
dpc-4793	65	32	.	.	PUNCT
dpc-4793	66	1	the	the	DET
dpc-4793	66	2	risk	risk	NOUN
dpc-4793	66	3	of	of	ADP
dpc-4793	66	4	bias	bias	NOUN
dpc-4793	66	5	of	of	ADP
dpc-4793	66	6	each	each	DET
dpc-4793	66	7	trial	trial	NOUN
dpc-4793	66	8	was	be	AUX
dpc-4793	66	9	also	also	ADV
dpc-4793	66	10	assessed	assess	VERB
dpc-4793	66	11	in	in	ADP
dpc-4793	66	12	accordance	accordance	NOUN
dpc-4793	66	13	with	with	ADP
dpc-4793	66	14	the	the	DET
dpc-4793	66	15	cochrane	cochrane	NOUN
dpc-4793	66	16	risk	risk	NOUN
dpc-4793	66	17	of	of	ADP
dpc-4793	66	18	bias	bias	NOUN
dpc-4793	66	19	tool	tool	NOUN
dpc-4793	66	20	for	for	ADP
dpc-4793	66	21	randomized	randomized	ADJ
dpc-4793	66	22	controlled	control	VERB
dpc-4793	66	23	trials	trial	NOUN
dpc-4793	66	24	(	(	PUNCT
dpc-4793	66	25	rob	rob	PROPN
dpc-4793	66	26	2	2	NUM
dpc-4793	66	27	)	)	PUNCT
dpc-4793	67	1	[	[	X
dpc-4793	67	2	12	12	NUM
dpc-4793	67	3	]	]	PUNCT
dpc-4793	67	4	.	.	PUNCT
dpc-4793	68	1	statistical	statistical	ADJ
dpc-4793	68	2	analysis	analysis	NOUN
dpc-4793	68	3	a	a	DET
dpc-4793	68	4	random	random	ADJ
dpc-4793	68	5	-	-	PUNCT
dpc-4793	68	6	effects	effect	NOUN
dpc-4793	68	7	network	network	NOUN
dpc-4793	68	8	meta	meta	NOUN
dpc-4793	68	9	-	-	PUNCT
dpc-4793	68	10	analysis	analysis	NOUN
dpc-4793	68	11	was	be	AUX
dpc-4793	68	12	performed	perform	VERB
dpc-4793	68	13	using	use	VERB
dpc-4793	68	14	r	r	NOUN
dpc-4793	68	15	statistical	statistical	ADJ
dpc-4793	68	16	software	software	NOUN
dpc-4793	68	17	(	(	PUNCT
dpc-4793	68	18	netmeta	netmeta	NOUN
dpc-4793	68	19	package	package	NOUN
dpc-4793	68	20	)	)	PUNCT
dpc-4793	68	21	.	.	PUNCT
dpc-4793	69	1	within	within	ADP
dpc-4793	69	2	the	the	DET
dpc-4793	69	3	outcome	outcome	NOUN
dpc-4793	69	4	domain	domain	NOUN
dpc-4793	69	5	,	,	PUNCT
dpc-4793	69	6	standardized	standardized	ADJ
dpc-4793	69	7	mean	mean	NOUN
dpc-4793	69	8	differences	difference	NOUN
dpc-4793	69	9	(	(	PUNCT
dpc-4793	69	10	smd	smd	NOUN
dpc-4793	69	11	)	)	PUNCT
dpc-4793	69	12	were	be	AUX
dpc-4793	69	13	employed	employ	VERB
dpc-4793	69	14	to	to	PART
dpc-4793	69	15	combine	combine	VERB
dpc-4793	69	16	different	different	ADJ
dpc-4793	69	17	scales	scale	NOUN
dpc-4793	69	18	to	to	PART
dpc-4793	69	19	allow	allow	VERB
dpc-4793	69	20	for	for	ADP
dpc-4793	69	21	the	the	DET
dpc-4793	69	22	consideration	consideration	NOUN
dpc-4793	69	23	of	of	ADP
dpc-4793	69	24	all	all	DET
dpc-4793	69	25	the	the	DET
dpc-4793	69	26	studies	study	NOUN
dpc-4793	69	27	reporting	report	VERB
dpc-4793	69	28	a	a	DET
dpc-4793	69	29	given	give	VERB
dpc-4793	69	30	outcome	outcome	NOUN
dpc-4793	69	31	.	.	PUNCT
dpc-4793	70	1	studies	study	NOUN
dpc-4793	70	2	of	of	ADP
dpc-4793	70	3	four	four	NUM
dpc-4793	70	4	to	to	PART
dpc-4793	70	5	sixteen	sixteen	NUM
dpc-4793	70	6	weeks	week	NOUN
dpc-4793	70	7	of	of	ADP
dpc-4793	70	8	treatment	treatment	NOUN
dpc-4793	70	9	were	be	AUX
dpc-4793	70	10	pooled	pool	VERB
dpc-4793	70	11	,	,	PUNCT
dpc-4793	70	12	and	and	CCONJ
dpc-4793	70	13	the	the	DET
dpc-4793	70	14	analysis	analysis	NOUN
dpc-4793	70	15	was	be	AUX
dpc-4793	70	16	conducted	conduct	VERB
dpc-4793	70	17	using	use	VERB
dpc-4793	70	18	intention	intention	NOUN
dpc-4793	70	19	-	-	PUNCT
dpc-4793	70	20	to	to	ADP
dpc-4793	70	21	-	-	PUNCT
dpc-4793	70	22	treat	treat	VERB
dpc-4793	70	23	(	(	PUNCT
dpc-4793	70	24	itt	itt	ADJ
dpc-4793	70	25	)	)	PUNCT
dpc-4793	70	26	data	datum	NOUN
dpc-4793	70	27	.	.	PUNCT
dpc-4793	71	1	in	in	ADP
dpc-4793	71	2	these	these	DET
dpc-4793	71	3	analyses	analysis	NOUN
dpc-4793	71	4	,	,	PUNCT
dpc-4793	71	5	dosing	dose	VERB
dpc-4793	71	6	schedules	schedule	NOUN
dpc-4793	71	7	were	be	AUX
dpc-4793	71	8	treated	treat	VERB
dpc-4793	71	9	as	as	ADP
dpc-4793	71	10	their	their	PRON
dpc-4793	71	11	own	own	ADJ
dpc-4793	71	12	network	network	NOUN
dpc-4793	71	13	nodes	node	NOUN
dpc-4793	71	14	(	(	PUNCT
dpc-4793	71	15	i.e.	i.e.	X
dpc-4793	71	16	,	,	PUNCT
dpc-4793	71	17	results	result	NOUN
dpc-4793	71	18	of	of	ADP
dpc-4793	71	19	different	different	ADJ
dpc-4793	71	20	administration	administration	NOUN
dpc-4793	71	21	schedules	schedule	NOUN
dpc-4793	71	22	of	of	ADP
dpc-4793	71	23	medications	medication	NOUN
dpc-4793	71	24	were	be	AUX
dpc-4793	71	25	not	not	PART
dpc-4793	71	26	pooled	pool	VERB
dpc-4793	71	27	)	)	PUNCT
dpc-4793	71	28	.	.	PUNCT
dpc-4793	72	1	network	network	NOUN
dpc-4793	72	2	plots	plot	NOUN
dpc-4793	72	3	were	be	AUX
dpc-4793	72	4	generated	generate	VERB
dpc-4793	72	5	for	for	ADP
dpc-4793	72	6	the	the	DET
dpc-4793	72	7	analysis	analysis	NOUN
dpc-4793	72	8	.	.	PUNCT
dpc-4793	73	1	summary	summary	NOUN
dpc-4793	73	2	results	result	NOUN
dpc-4793	73	3	are	be	AUX
dpc-4793	73	4	presented	present	VERB
dpc-4793	73	5	as	as	ADP
dpc-4793	73	6	smds	smds	NOUN
dpc-4793	73	7	with	with	ADP
dpc-4793	73	8	a	a	DET
dpc-4793	73	9	95	95	NUM
dpc-4793	73	10	%	%	NOUN
dpc-4793	73	11	confidence	confidence	NOUN
dpc-4793	73	12	interval	interval	NOUN
dpc-4793	73	13	(	(	PUNCT
dpc-4793	73	14	ci	ci	NOUN
dpc-4793	73	15	)	)	PUNCT
dpc-4793	73	16	.	.	PUNCT
dpc-4793	74	1	effect	effect	NOUN
dpc-4793	74	2	estimates	estimate	NOUN
dpc-4793	74	3	for	for	ADP
dpc-4793	74	4	all	all	DET
dpc-4793	74	5	pairwise	pairwise	NOUN
dpc-4793	74	6	comparisons	comparison	NOUN
dpc-4793	74	7	in	in	ADP
dpc-4793	74	8	the	the	DET
dpc-4793	74	9	network	network	NOUN
dpc-4793	74	10	were	be	AUX
dpc-4793	74	11	also	also	ADV
dpc-4793	74	12	calculated	calculate	VERB
dpc-4793	74	13	.	.	PUNCT
dpc-4793	75	1	results	result	VERB
dpc-4793	75	2	characteristics	characteristic	NOUN
dpc-4793	75	3	of	of	ADP
dpc-4793	75	4	included	include	VERB
dpc-4793	75	5	studies	study	NOUN
dpc-4793	75	6	through	through	ADP
dpc-4793	75	7	an	an	DET
dpc-4793	75	8	initial	initial	ADJ
dpc-4793	75	9	search	search	NOUN
dpc-4793	75	10	of	of	ADP
dpc-4793	75	11	the	the	DET
dpc-4793	75	12	databases	database	NOUN
dpc-4793	75	13	,	,	PUNCT
dpc-4793	75	14	1,046	1,046	NUM
dpc-4793	75	15	studies	study	NOUN
dpc-4793	75	16	were	be	AUX
dpc-4793	75	17	identified	identify	VERB
dpc-4793	75	18	,	,	PUNCT
dpc-4793	75	19	of	of	ADP
dpc-4793	75	20	which	which	PRON
dpc-4793	75	21	702	702	NUM
dpc-4793	75	22	remained	remain	VERB
dpc-4793	75	23	after	after	SCONJ
dpc-4793	75	24	duplicates	duplicate	NOUN
dpc-4793	75	25	were	be	AUX
dpc-4793	75	26	removed	remove	VERB
dpc-4793	75	27	(	(	PUNCT
dpc-4793	75	28	figure	figure	NOUN
dpc-4793	75	29	1	1	NUM
dpc-4793	75	30	)	)	PUNCT
dpc-4793	75	31	;	;	PUNCT
dpc-4793	75	32	184	184	NUM
dpc-4793	75	33	studies	study	NOUN
dpc-4793	75	34	were	be	AUX
dpc-4793	75	35	assessed	assess	VERB
dpc-4793	75	36	for	for	ADP
dpc-4793	75	37	eligibility	eligibility	NOUN
dpc-4793	75	38	,	,	PUNCT
dpc-4793	75	39	and	and	CCONJ
dpc-4793	75	40	a	a	DET
dpc-4793	75	41	total	total	NOUN
dpc-4793	75	42	of	of	ADP
dpc-4793	75	43	35	35	NUM
dpc-4793	75	44	rcts	rct	NOUN
dpc-4793	75	45	were	be	AUX
dpc-4793	75	46	selected	select	VERB
dpc-4793	75	47	for	for	ADP
dpc-4793	75	48	inclusion	inclusion	NOUN
dpc-4793	75	49	in	in	ADP
dpc-4793	75	50	the	the	DET
dpc-4793	75	51	systematic	systematic	ADJ
dpc-4793	75	52	review	review	NOUN
dpc-4793	75	53	,	,	PUNCT
dpc-4793	75	54	of	of	ADP
dpc-4793	75	55	which	which	PRON
dpc-4793	75	56	19	19	NUM
dpc-4793	75	57	were	be	AUX
dpc-4793	75	58	included	include	VERB
dpc-4793	75	59	in	in	ADP
dpc-4793	75	60	the	the	DET
dpc-4793	75	61	network	network	NOUN
dpc-4793	75	62	meta	meta	NOUN
dpc-4793	75	63	-	-	PUNCT
dpc-4793	75	64	analysis	analysis	NOUN
dpc-4793	76	1	[	[	X
dpc-4793	76	2	9	9	NUM
dpc-4793	76	3	,	,	PUNCT
dpc-4793	76	4	13	13	NUM
dpc-4793	76	5	-	-	SYM
dpc-4793	76	6	46	46	NUM
dpc-4793	76	7	]	]	PUNCT
dpc-4793	76	8	.	.	PUNCT
dpc-4793	77	1	the	the	DET
dpc-4793	77	2	study	study	NOUN
dpc-4793	77	3	characteristics	characteristic	NOUN
dpc-4793	77	4	for	for	ADP
dpc-4793	77	5	all	all	DET
dpc-4793	77	6	included	include	VERB
dpc-4793	77	7	rcts	rct	NOUN
dpc-4793	77	8	are	be	AUX
dpc-4793	77	9	summarized	summarize	VERB
dpc-4793	77	10	in	in	ADP
dpc-4793	77	11	table	table	NOUN
dpc-4793	77	12	s1	s1	NOUN
dpc-4793	77	13	.	.	PUNCT
dpc-4793	78	1	across	across	ADP
dpc-4793	78	2	included	include	VERB
dpc-4793	78	3	studies	study	NOUN
dpc-4793	78	4	,	,	PUNCT
dpc-4793	78	5	there	there	PRON
dpc-4793	78	6	was	be	VERB
dpc-4793	78	7	only	only	ADV
dpc-4793	78	8	sufficient	sufficient	ADJ
dpc-4793	78	9	evidence	evidence	NOUN
dpc-4793	78	10	available	available	ADJ
dpc-4793	78	11	on	on	ADP
dpc-4793	78	12	systemic	systemic	ADJ
dpc-4793	78	13	agents	agent	NOUN
dpc-4793	78	14	to	to	PART
dpc-4793	78	15	include	include	VERB
dpc-4793	78	16	pssi	pssi	ADJ
dpc-4793	78	17	and	and	CCONJ
dpc-4793	78	18	scalp	scalp	NOUN
dpc-4793	78	19	or	or	CCONJ
dpc-4793	78	20	scalp	scalp	NOUN
dpc-4793	78	21	-	-	PUNCT
dpc-4793	78	22	specific	specific	ADJ
dpc-4793	78	23	iga	iga	PROPN
dpc-4793	78	24	outcomes	outcome	NOUN
dpc-4793	78	25	in	in	ADP
dpc-4793	78	26	a	a	DET
dpc-4793	78	27	network	network	NOUN
dpc-4793	78	28	meta	meta	NOUN
dpc-4793	78	29	-	-	PUNCT
dpc-4793	78	30	analysis	analysis	NOUN
dpc-4793	78	31	.	.	PUNCT
dpc-4793	79	1	twenty	twenty	NUM
dpc-4793	79	2	-	-	PUNCT
dpc-4793	79	3	two	two	NUM
dpc-4793	79	4	studies	study	NOUN
dpc-4793	79	5	included	include	VERB
dpc-4793	79	6	a	a	DET
dpc-4793	79	7	biologic	biologic	NOUN
dpc-4793	79	8	as	as	ADP
dpc-4793	79	9	part	part	NOUN
dpc-4793	79	10	of	of	ADP
dpc-4793	79	11	the	the	DET
dpc-4793	79	12	treatment	treatment	NOUN
dpc-4793	79	13	arm	arm	NOUN
dpc-4793	79	14	(	(	PUNCT
dpc-4793	79	15	62.3	62.3	NUM
dpc-4793	79	16	%	%	NOUN
dpc-4793	79	17	)	)	PUNCT
dpc-4793	79	18	,	,	PUNCT
dpc-4793	79	19	with	with	ADP
dpc-4793	79	20	guselkumab	guselkumab	NOUN
dpc-4793	79	21	being	be	AUX
dpc-4793	79	22	the	the	DET
dpc-4793	79	23	most	most	ADV
dpc-4793	79	24	commonly	commonly	ADV
dpc-4793	79	25	used	use	VERB
dpc-4793	79	26	(	(	PUNCT
dpc-4793	79	27	n=4	n=4	ADJ
dpc-4793	79	28	,	,	PUNCT
dpc-4793	79	29	11.4	11.4	NUM
dpc-4793	79	30	%	%	NOUN
dpc-4793	79	31	)	)	PUNCT
dpc-4793	79	32	.	.	PUNCT
dpc-4793	80	1	a	a	DET
dpc-4793	80	2	similar	similar	ADJ
dpc-4793	80	3	number	number	NOUN
dpc-4793	80	4	of	of	ADP
dpc-4793	80	5	studies	study	NOUN
dpc-4793	80	6	had	have	VERB
dpc-4793	80	7	nonsteroidal	nonsteroidal	ADJ
dpc-4793	80	8	topical	topical	ADJ
dpc-4793	80	9	therapy	therapy	NOUN
dpc-4793	80	10	as	as	ADP
dpc-4793	80	11	part	part	NOUN
dpc-4793	80	12	of	of	ADP
dpc-4793	80	13	at	at	ADV
dpc-4793	80	14	least	least	ADV
dpc-4793	80	15	one	one	NUM
dpc-4793	80	16	treatment	treatment	NOUN
dpc-4793	80	17	arm	arm	NOUN
dpc-4793	80	18	(	(	PUNCT
dpc-4793	80	19	n=25	n=25	ADV
dpc-4793	80	20	,	,	PUNCT
dpc-4793	80	21	71.4	71.4	NUM
dpc-4793	80	22	%	%	NOUN
dpc-4793	80	23	)	)	PUNCT
dpc-4793	80	24	.	.	PUNCT
dpc-4793	81	1	fifteen	fifteen	NUM
dpc-4793	81	2	studies	study	NOUN
dpc-4793	81	3	included	include	VERB
dpc-4793	81	4	a	a	DET
dpc-4793	81	5	topical	topical	ADJ
dpc-4793	81	6	corticosteroid	corticosteroid	NOUN
dpc-4793	81	7	as	as	ADP
dpc-4793	81	8	part	part	NOUN
dpc-4793	81	9	of	of	ADP
dpc-4793	81	10	the	the	DET
dpc-4793	81	11	treatment	treatment	NOUN
dpc-4793	81	12	arms	arm	NOUN
dpc-4793	81	13	(	(	PUNCT
dpc-4793	81	14	42.9	42.9	NUM
dpc-4793	81	15	%	%	NOUN
dpc-4793	81	16	)	)	PUNCT
dpc-4793	81	17	,	,	PUNCT
dpc-4793	81	18	with	with	ADP
dpc-4793	81	19	betamethasone	betamethasone	PROPN
dpc-4793	81	20	dipropionate	dipropionate	PROPN
dpc-4793	81	21	used	use	VERB
dpc-4793	81	22	in	in	ADP
dpc-4793	81	23	almost	almost	ADV
dpc-4793	81	24	half	half	NOUN
dpc-4793	81	25	of	of	ADP
dpc-4793	81	26	these	these	DET
dpc-4793	81	27	trials	trial	NOUN
dpc-4793	81	28	(	(	PUNCT
dpc-4793	81	29	n=7	n=7	PROPN
dpc-4793	81	30	,	,	PUNCT
dpc-4793	81	31	20	20	NUM
dpc-4793	81	32	%	%	NOUN
dpc-4793	81	33	)	)	PUNCT
dpc-4793	81	34	.	.	PUNCT
dpc-4793	82	1	placebo	placebo	NOUN
dpc-4793	82	2	was	be	AUX
dpc-4793	82	3	used	use	VERB
dpc-4793	82	4	as	as	ADP
dpc-4793	82	5	the	the	DET
dpc-4793	82	6	control	control	NOUN
dpc-4793	82	7	arm	arm	NOUN
dpc-4793	82	8	in	in	ADP
dpc-4793	82	9	the	the	DET
dpc-4793	82	10	majority	majority	NOUN
dpc-4793	82	11	of	of	ADP
dpc-4793	82	12	the	the	DET
dpc-4793	82	13	studies	study	NOUN
dpc-4793	82	14	(	(	PUNCT
dpc-4793	82	15	n=23	n=23	PROPN
dpc-4793	82	16	,	,	PUNCT
dpc-4793	82	17	65.7	65.7	NUM
dpc-4793	82	18	%	%	NOUN
dpc-4793	82	19	)	)	PUNCT
dpc-4793	82	20	.	.	PUNCT
dpc-4793	83	1	of	of	ADP
dpc-4793	83	2	the	the	DET
dpc-4793	83	3	studies	study	NOUN
dpc-4793	83	4	for	for	ADP
dpc-4793	83	5	which	which	PRON
dpc-4793	83	6	the	the	DET
dpc-4793	83	7	blinding	blind	VERB
dpc-4793	83	8	status	status	NOUN
dpc-4793	83	9	was	be	AUX
dpc-4793	83	10	known	know	VERB
dpc-4793	83	11	,	,	PUNCT
dpc-4793	83	12	the	the	DET
dpc-4793	83	13	majority	majority	NOUN
dpc-4793	83	14	of	of	ADP
dpc-4793	83	15	the	the	DET
dpc-4793	83	16	studies	study	NOUN
dpc-4793	83	17	were	be	AUX
dpc-4793	83	18	double	double	ADJ
dpc-4793	83	19	-	-	PUNCT
dpc-4793	83	20	blinded	blind	VERB
dpc-4793	83	21	(	(	PUNCT
dpc-4793	83	22	n=23	n=23	PROPN
dpc-4793	83	23	,	,	PUNCT
dpc-4793	83	24	65.7	65.7	NUM
dpc-4793	83	25	%	%	NOUN
dpc-4793	83	26	)	)	PUNCT
dpc-4793	83	27	.	.	PUNCT
dpc-4793	84	1	detailed	detailed	ADJ
dpc-4793	84	2	baseline	baseline	ADJ
dpc-4793	84	3	demographic	demographic	ADJ
dpc-4793	84	4	characteristics	characteristic	NOUN
dpc-4793	84	5	for	for	ADP
dpc-4793	84	6	each	each	DET
dpc-4793	84	7	included	include	VERB
dpc-4793	84	8	study	study	NOUN
dpc-4793	84	9	are	be	AUX
dpc-4793	84	10	included	include	VERB
dpc-4793	84	11	in	in	ADP
dpc-4793	84	12	table	table	NOUN
dpc-4793	84	13	1	1	NUM
dpc-4793	84	14	.	.	PUNCT
dpc-4793	84	15	of	of	ADP
dpc-4793	84	16	note	note	NOUN
dpc-4793	84	17	,	,	PUNCT
dpc-4793	84	18	studies	study	NOUN
dpc-4793	84	19	that	that	PRON
dpc-4793	84	20	reported	report	VERB
dpc-4793	84	21	on	on	ADP
dpc-4793	84	22	topical	topical	ADJ
dpc-4793	84	23	therapies	therapy	NOUN
dpc-4793	84	24	only	only	ADV
dpc-4793	84	25	were	be	AUX
dpc-4793	84	26	not	not	PART
dpc-4793	84	27	included	include	VERB
dpc-4793	84	28	in	in	ADP
dpc-4793	84	29	the	the	DET
dpc-4793	84	30	network	network	NOUN
dpc-4793	84	31	meta	meta	ADJ
dpc-4793	84	32	-	-	PUNCT
dpc-4793	84	33	analysis	analysis	NOUN
dpc-4793	84	34	.	.	PUNCT
dpc-4793	85	1	in	in	ADP
dpc-4793	85	2	total	total	ADJ
dpc-4793	85	3	,	,	PUNCT
dpc-4793	85	4	11	11	NUM
dpc-4793	85	5	studies	study	NOUN
dpc-4793	85	6	examined	examine	VERB
dpc-4793	85	7	only	only	ADV
dpc-4793	85	8	these	these	DET
dpc-4793	85	9	agents	agent	NOUN
dpc-4793	85	10	,	,	PUNCT
dpc-4793	85	11	which	which	PRON
dpc-4793	85	12	included	include	VERB
dpc-4793	85	13	betamethasone	betamethasone	PROPN
dpc-4793	85	14	valerate	valerate	NOUN
dpc-4793	85	15	,	,	PUNCT
dpc-4793	85	16	betamethasone	betamethasone	NOUN
dpc-4793	85	17	dipropionate	dipropionate	PROPN
dpc-4793	85	18	,	,	PUNCT
dpc-4793	85	19	calcipotriol	calcipotriol	NOUN
dpc-4793	85	20	,	,	PUNCT
dpc-4793	85	21	calcipotriene	calcipotriene	NOUN
dpc-4793	85	22	,	,	PUNCT
dpc-4793	85	23	and	and	CCONJ
dpc-4793	85	24	combinations	combination	NOUN
dpc-4793	85	25	of	of	ADP
dpc-4793	85	26	these	these	DET
dpc-4793	85	27	therapies	therapy	NOUN
dpc-4793	85	28	[	[	X
dpc-4793	85	29	9	9	NUM
dpc-4793	85	30	,	,	PUNCT
dpc-4793	85	31	23	23	NUM
dpc-4793	85	32	-	-	SYM
dpc-4793	85	33	25	25	NUM
dpc-4793	85	34	,	,	PUNCT
dpc-4793	85	35	27	27	NUM
dpc-4793	85	36	-	-	SYM
dpc-4793	85	37	32	32	NUM
dpc-4793	85	38	,	,	PUNCT
dpc-4793	85	39	40	40	NUM
dpc-4793	85	40	]	]	PUNCT
dpc-4793	85	41	.	.	PUNCT
dpc-4793	86	1	network	network	NOUN
dpc-4793	86	2	meta	meta	ADJ
dpc-4793	86	3	-	-	PUNCT
dpc-4793	86	4	analysis	analysis	NOUN
dpc-4793	86	5	results	result	NOUN
dpc-4793	86	6	pssi	pssi	ADJ
dpc-4793	86	7	response	response	NOUN
dpc-4793	86	8	from	from	ADP
dpc-4793	86	9	all	all	DET
dpc-4793	86	10	studies	study	NOUN
dpc-4793	86	11	measuring	measure	VERB
dpc-4793	86	12	pssi	pssi	ADJ
dpc-4793	86	13	response	response	NOUN
dpc-4793	86	14	as	as	ADP
dpc-4793	86	15	an	an	DET
dpc-4793	86	16	outcome	outcome	NOUN
dpc-4793	86	17	,	,	PUNCT
dpc-4793	86	18	seven	seven	NUM
dpc-4793	86	19	studies	study	NOUN
dpc-4793	86	20	were	be	AUX
dpc-4793	86	21	included	include	VERB
dpc-4793	86	22	in	in	ADP
dpc-4793	86	23	the	the	DET
dpc-4793	86	24	analysis	analysis	NOUN
dpc-4793	86	25	[	[	X
dpc-4793	86	26	13	13	NUM
dpc-4793	86	27	-	-	SYM
dpc-4793	86	28	19	19	NUM
dpc-4793	86	29	]	]	PUNCT
dpc-4793	86	30	.	.	PUNCT
dpc-4793	87	1	one	one	NUM
dpc-4793	87	2	study	study	NOUN
dpc-4793	87	3	was	be	AUX
dpc-4793	87	4	excluded	exclude	VERB
dpc-4793	87	5	due	due	ADP
dpc-4793	87	6	to	to	ADP
dpc-4793	87	7	a	a	DET
dpc-4793	87	8	lack	lack	NOUN
dpc-4793	87	9	of	of	ADP
dpc-4793	87	10	information	information	NOUN
dpc-4793	87	11	on	on	ADP
dpc-4793	87	12	the	the	DET
dpc-4793	87	13	standard	standard	ADJ
dpc-4793	87	14	deviation	deviation	NOUN
dpc-4793	87	15	of	of	ADP
dpc-4793	87	16	the	the	DET
dpc-4793	87	17	mean	mean	ADJ
dpc-4793	87	18	pssi	pssi	NOUN
dpc-4793	88	1	[	[	X
dpc-4793	88	2	20	20	NUM
dpc-4793	88	3	]	]	PUNCT
dpc-4793	88	4	,	,	PUNCT
dpc-4793	88	5	and	and	CCONJ
dpc-4793	88	6	two	two	NUM
dpc-4793	88	7	additional	additional	ADJ
dpc-4793	88	8	studies	study	NOUN
dpc-4793	88	9	were	be	AUX
dpc-4793	88	10	excluded	exclude	VERB
dpc-4793	88	11	for	for	ADP
dpc-4793	88	12	including	include	VERB
dpc-4793	88	13	three	three	NUM
dpc-4793	88	14	treatments	treatment	NOUN
dpc-4793	88	15	that	that	PRON
dpc-4793	88	16	formed	form	VERB
dpc-4793	88	17	a	a	DET
dpc-4793	88	18	separate	separate	ADJ
dpc-4793	88	19	subnetwork	subnetwork	NOUN
dpc-4793	88	20	which	which	PRON
dpc-4793	88	21	was	be	AUX
dpc-4793	88	22	not	not	PART
dpc-4793	88	23	connected	connect	VERB
dpc-4793	88	24	to	to	ADP
dpc-4793	88	25	the	the	DET
dpc-4793	88	26	other	other	ADJ
dpc-4793	88	27	treatments	treatment	NOUN
dpc-4793	88	28	in	in	ADP
dpc-4793	88	29	the	the	DET
dpc-4793	88	30	network	network	NOUN
dpc-4793	88	31	[	[	X
dpc-4793	88	32	21	21	NUM
dpc-4793	88	33	,	,	PUNCT
dpc-4793	88	34	22	22	NUM
dpc-4793	88	35	]	]	PUNCT
dpc-4793	88	36	.	.	PUNCT
dpc-4793	89	1	the	the	DET
dpc-4793	89	2	treatments	treatment	NOUN
dpc-4793	89	3	included	include	VERB
dpc-4793	89	4	in	in	ADP
dpc-4793	89	5	the	the	DET
dpc-4793	89	6	analysis	analysis	NOUN
dpc-4793	89	7	were	be	AUX
dpc-4793	89	8	:	:	PUNCT
dpc-4793	89	9	etanercept	etanercept	VERB
dpc-4793	89	10	50	50	NUM
dpc-4793	89	11	mg	mg	NOUN
dpc-4793	89	12	twice	twice	ADV
dpc-4793	89	13	weekly	weekly	ADJ
dpc-4793	89	14	,	,	PUNCT
dpc-4793	89	15	secukinumab	secukinumab	NOUN
dpc-4793	89	16	300	300	NUM
dpc-4793	89	17	mg	mg	NOUN
dpc-4793	89	18	every	every	DET
dpc-4793	89	19	four	four	NUM
dpc-4793	89	20	weeks	week	NOUN
dpc-4793	89	21	(	(	PUNCT
dpc-4793	89	22	q4w	q4w	NOUN
dpc-4793	89	23	)	)	PUNCT
dpc-4793	89	24	,	,	PUNCT
dpc-4793	89	25	brodalumab	brodalumab	NOUN
dpc-4793	89	26	210	210	NUM
dpc-4793	89	27	mg	mg	NOUN
dpc-4793	89	28	every	every	DET
dpc-4793	89	29	two	two	NUM
dpc-4793	89	30	weeks	week	NOUN
dpc-4793	89	31	(	(	PUNCT
dpc-4793	89	32	q2w	q2w	NOUN
dpc-4793	89	33	)	)	PUNCT
dpc-4793	89	34	,	,	PUNCT
dpc-4793	89	35	ixekizumab	ixekizumab	VERB
dpc-4793	89	36	150	150	NUM
dpc-4793	89	37	mg	mg	NUM
dpc-4793	89	38	q2w	q2w	PROPN
dpc-4793	89	39	,	,	PUNCT
dpc-4793	89	40	ixekizumab	ixekizumab	NOUN
dpc-4793	89	41	160	160	NUM
dpc-4793	89	42	mg	mg	NOUN
dpc-4793	89	43	followed	follow	VERB
dpc-4793	89	44	by	by	ADP
dpc-4793	89	45	80	80	NUM
dpc-4793	89	46	mg	mg	PROPN
dpc-4793	89	47	q2w	q2w	NOUN
dpc-4793	89	48	,	,	PUNCT
dpc-4793	89	49	and	and	CCONJ
dpc-4793	89	50	ixekizumab	ixekizumab	NOUN
dpc-4793	89	51	160	160	NUM
dpc-4793	89	52	mg	mg	NOUN
dpc-4793	89	53	followed	follow	VERB
dpc-4793	89	54	by	by	ADP
dpc-4793	89	55	80	80	NUM
dpc-4793	89	56	mg	mg	PROPN
dpc-4793	89	57	q4w	q4w	PROPN
dpc-4793	89	58	.	.	PUNCT
dpc-4793	90	1	the	the	DET
dpc-4793	90	2	treatment	treatment	NOUN
dpc-4793	90	3	network	network	NOUN
dpc-4793	90	4	formed	form	VERB
dpc-4793	90	5	by	by	ADP
dpc-4793	90	6	the	the	DET
dpc-4793	90	7	included	include	VERB
dpc-4793	90	8	studies	study	NOUN
dpc-4793	90	9	is	be	AUX
dpc-4793	90	10	depicted	depict	VERB
dpc-4793	90	11	in	in	ADP
dpc-4793	90	12	figure	figure	NOUN
dpc-4793	90	13	2a	2a	NUM
dpc-4793	90	14	.	.	PUNCT
dpc-4793	91	1	all	all	DET
dpc-4793	91	2	interventions	intervention	NOUN
dpc-4793	91	3	led	lead	VERB
dpc-4793	91	4	to	to	ADP
dpc-4793	91	5	a	a	DET
dpc-4793	91	6	statistically	statistically	ADV
dpc-4793	91	7	significant	significant	ADJ
dpc-4793	91	8	improvement	improvement	NOUN
dpc-4793	91	9	in	in	ADP
dpc-4793	91	10	pssi	pssi	ADJ
dpc-4793	91	11	response	response	NOUN
dpc-4793	91	12	compared	compare	VERB
dpc-4793	91	13	to	to	ADP
dpc-4793	91	14	placebo	placebo	NOUN
dpc-4793	91	15	,	,	PUNCT
dpc-4793	91	16	indicating	indicate	VERB
dpc-4793	91	17	a	a	DET
dpc-4793	91	18	potentially	potentially	ADV
dpc-4793	91	19	beneficial	beneficial	ADJ
dpc-4793	91	20	effect	effect	NOUN
dpc-4793	91	21	in	in	ADP
dpc-4793	91	22	reducing	reduce	VERB
dpc-4793	91	23	the	the	DET
dpc-4793	91	24	extent	extent	NOUN
dpc-4793	91	25	and	and	CCONJ
dpc-4793	91	26	severity	severity	NOUN
dpc-4793	91	27	of	of	ADP
dpc-4793	91	28	psoriasis	psoriasis	NOUN
dpc-4793	91	29	involvement	involvement	NOUN
dpc-4793	91	30	(	(	PUNCT
dpc-4793	91	31	figure	figure	NOUN
dpc-4793	91	32	2b	2b	NUM
dpc-4793	91	33	and	and	CCONJ
dpc-4793	91	34	table	table	NOUN
dpc-4793	91	35	s1	s1	NOUN
dpc-4793	91	36	)	)	PUNCT
dpc-4793	91	37	.	.	PUNCT
dpc-4793	92	1	when	when	SCONJ
dpc-4793	92	2	compared	compare	VERB
dpc-4793	92	3	to	to	ADP
dpc-4793	92	4	each	each	DET
dpc-4793	92	5	other	other	ADJ
dpc-4793	92	6	,	,	PUNCT
dpc-4793	92	7	secukinumab	secukinumab	NOUN
dpc-4793	92	8	300	300	NUM
dpc-4793	92	9	mg	mg	NOUN
dpc-4793	92	10	q4w	q4w	PROPN
dpc-4793	92	11	was	be	AUX
dpc-4793	92	12	found	find	VERB
dpc-4793	92	13	to	to	PART
dpc-4793	92	14	be	be	AUX
dpc-4793	92	15	the	the	DET
dpc-4793	92	16	safest	safe	ADJ
dpc-4793	92	17	and	and	CCONJ
dpc-4793	92	18	most	most	ADV
dpc-4793	92	19	effective	effective	ADJ
dpc-4793	92	20	(	(	PUNCT
dpc-4793	92	21	sucra	sucra	NOUN
dpc-4793	92	22	0.991	0.991	NUM
dpc-4793	92	23	)	)	PUNCT
dpc-4793	92	24	followed	follow	VERB
dpc-4793	92	25	by	by	ADP
dpc-4793	92	26	ixekizumab	ixekizumab	NOUN
dpc-4793	92	27	160	160	NUM
dpc-4793	92	28	mg	mg	PROPN
dpc-4793	92	29	q2w	q2w	PROPN
dpc-4793	92	30	,	,	PUNCT
dpc-4793	92	31	(	(	PUNCT
dpc-4793	92	32	sucra	sucra	NOUN
dpc-4793	92	33	0.701	0.701	NUM
dpc-4793	92	34	)	)	PUNCT
dpc-4793	92	35	,	,	PUNCT
dpc-4793	92	36	ixekizumab	ixekizumab	VERB
dpc-4793	92	37	150	150	NUM
dpc-4793	92	38	mg	mg	NUM
dpc-4793	92	39	q2w	q2w	NOUN
dpc-4793	92	40	,	,	PUNCT
dpc-4793	92	41	(	(	PUNCT
dpc-4793	92	42	sucra	sucra	NOUN
dpc-4793	92	43	0.671	0.671	NUM
dpc-4793	92	44	)	)	PUNCT
dpc-4793	92	45	,	,	PUNCT
dpc-4793	92	46	ixekizumab	ixekizumab	VERB
dpc-4793	92	47	160	160	NUM
dpc-4793	92	48	mg	mg	NOUN
dpc-4793	92	49	q4w	q4w	PROPN
dpc-4793	92	50	(	(	PUNCT
dpc-4793	92	51	sucra	sucra	PROPN
dpc-4793	92	52	0.605	0.605	NUM
dpc-4793	92	53	)	)	PUNCT
dpc-4793	92	54	,	,	PUNCT
dpc-4793	92	55	brodalumab	brodalumab	NOUN
dpc-4793	92	56	210	210	NUM
dpc-4793	92	57	mg	mg	PROPN
dpc-4793	92	58	q2w	q2w	NOUN
dpc-4793	92	59	,	,	PUNCT
dpc-4793	92	60	(	(	PUNCT
dpc-4793	92	61	sucra	sucra	NOUN
dpc-4793	92	62	0.302	0.302	NUM
dpc-4793	92	63	)	)	PUNCT
dpc-4793	92	64	,	,	PUNCT
dpc-4793	92	65	and	and	CCONJ
dpc-4793	92	66	etanercept	etanercept	VERB
dpc-4793	92	67	50	50	NUM
dpc-4793	92	68	mg	mg	NOUN
dpc-4793	92	69	twice	twice	ADV
dpc-4793	92	70	weekly	weekly	ADJ
dpc-4793	92	71	(	(	PUNCT
dpc-4793	92	72	sucra	sucra	NOUN
dpc-4793	92	73	0.230	0.230	NUM
dpc-4793	92	74	)	)	PUNCT
dpc-4793	92	75	.	.	PUNCT
dpc-4793	93	1	scalp	scalp	NOUN
dpc-4793	93	2	or	or	CCONJ
dpc-4793	93	3	scalp	scalp	NOUN
dpc-4793	93	4	-	-	PUNCT
dpc-4793	93	5	specific	specific	ADJ
dpc-4793	93	6	pga	pga	PROPN
dpc-4793	93	7	/	/	SYM
dpc-4793	93	8	iga	iga	PROPN
dpc-4793	93	9	response	response	NOUN
dpc-4793	93	10	seven	seven	NUM
dpc-4793	93	11	studies	study	NOUN
dpc-4793	93	12	were	be	AUX
dpc-4793	93	13	included	include	VERB
dpc-4793	93	14	in	in	ADP
dpc-4793	93	15	the	the	DET
dpc-4793	93	16	analysis	analysis	NOUN
dpc-4793	93	17	for	for	ADP
dpc-4793	93	18	the	the	DET
dpc-4793	93	19	outcome	outcome	NOUN
dpc-4793	93	20	of	of	ADP
dpc-4793	93	21	the	the	DET
dpc-4793	93	22	iga	iga	PROPN
dpc-4793	93	23	response	response	NOUN
dpc-4793	93	24	[	[	X
dpc-4793	93	25	9	9	NUM
dpc-4793	93	26	,	,	PUNCT
dpc-4793	93	27	13	13	NUM
dpc-4793	93	28	,	,	PUNCT
dpc-4793	93	29	16	16	NUM
dpc-4793	93	30	23	23	NUM
dpc-4793	93	31	-	-	SYM
dpc-4793	93	32	39	39	NUM
dpc-4793	93	33	]	]	PUNCT
dpc-4793	93	34	.	.	PUNCT
dpc-4793	94	1	guselkumab	guselkumab	NOUN
dpc-4793	94	2	50	50	NUM
dpc-4793	94	3	mg	mg	NOUN
dpc-4793	94	4	every	every	DET
dpc-4793	94	5	eight	eight	NUM
dpc-4793	94	6	weeks	week	NOUN
dpc-4793	94	7	(	(	PUNCT
dpc-4793	94	8	q8w	q8w	ADV
dpc-4793	94	9	)	)	PUNCT
dpc-4793	94	10	,	,	PUNCT
dpc-4793	94	11	guselkumab	guselkumab	VERB
dpc-4793	94	12	100	100	NUM
dpc-4793	94	13	mg	mg	ADP
dpc-4793	94	14	q8w	q8w	PROPN
dpc-4793	94	15	,	,	PUNCT
dpc-4793	94	16	adalimumab	adalimumab	VERB
dpc-4793	94	17	80	80	NUM
dpc-4793	94	18	mg	mg	NUM
dpc-4793	94	19	q2w	q2w	NOUN
dpc-4793	94	20	,	,	PUNCT
dpc-4793	94	21	apremilast	apremilast	VERB
dpc-4793	94	22	30	30	NUM
dpc-4793	94	23	mg	mg	NOUN
dpc-4793	94	24	twice	twice	ADV
dpc-4793	94	25	daily	daily	ADV
dpc-4793	94	26	,	,	PUNCT
dpc-4793	94	27	secukinumab	secukinumab	NOUN
dpc-4793	94	28	300	300	NUM
dpc-4793	94	29	mg	mg	NOUN
dpc-4793	94	30	q4w	q4w	PROPN
dpc-4793	94	31	,	,	PUNCT
dpc-4793	94	32	bimekizumab	bimekizumab	X
dpc-4793	94	33	320	320	NUM
dpc-4793	94	34	mg	mg	NOUN
dpc-4793	94	35	q4w	q4w	PROPN
dpc-4793	94	36	,	,	PUNCT
dpc-4793	94	37	and	and	CCONJ
dpc-4793	94	38	ustekinumab	ustekinumab	NOUN
dpc-4793	94	39	90	90	NUM
dpc-4793	94	40	mg	mg	NOUN
dpc-4793	94	41	q12w	q12w	NOUN
dpc-4793	94	42	were	be	AUX
dpc-4793	94	43	the	the	DET
dpc-4793	94	44	treatments	treatment	NOUN
dpc-4793	94	45	included	include	VERB
dpc-4793	94	46	in	in	ADP
dpc-4793	94	47	the	the	DET
dpc-4793	94	48	analysis	analysis	NOUN
dpc-4793	94	49	(	(	PUNCT
dpc-4793	94	50	figure	figure	NOUN
dpc-4793	94	51	3a	3a	NUM
dpc-4793	94	52	)	)	PUNCT
dpc-4793	94	53	.	.	PUNCT
dpc-4793	95	1	in	in	ADP
dpc-4793	95	2	comparison	comparison	NOUN
dpc-4793	95	3	to	to	ADP
dpc-4793	95	4	the	the	DET
dpc-4793	95	5	placebo	placebo	NOUN
dpc-4793	95	6	,	,	PUNCT
dpc-4793	95	7	all	all	DET
dpc-4793	95	8	interventions	intervention	NOUN
dpc-4793	95	9	led	lead	VERB
dpc-4793	95	10	to	to	ADP
dpc-4793	95	11	a	a	DET
dpc-4793	95	12	reduction	reduction	NOUN
dpc-4793	95	13	in	in	ADP
dpc-4793	95	14	iga	iga	PROPN
dpc-4793	95	15	,	,	PUNCT
dpc-4793	95	16	indicating	indicate	VERB
dpc-4793	95	17	a	a	DET
dpc-4793	95	18	potentially	potentially	ADV
dpc-4793	95	19	beneficial	beneficial	ADJ
dpc-4793	95	20	effect	effect	NOUN
dpc-4793	95	21	in	in	ADP
dpc-4793	95	22	improving	improve	VERB
dpc-4793	95	23	symptoms	symptom	NOUN
dpc-4793	95	24	(	(	PUNCT
dpc-4793	95	25	figure	figure	NOUN
dpc-4793	95	26	3b	3b	NOUN
dpc-4793	95	27	and	and	CCONJ
dpc-4793	95	28	table	table	NOUN
dpc-4793	95	29	s1	s1	NOUN
dpc-4793	95	30	)	)	PUNCT
dpc-4793	95	31	.	.	PUNCT
dpc-4793	96	1	aside	aside	ADV
dpc-4793	96	2	from	from	ADP
dpc-4793	96	3	guselkumab	guselkumab	NOUN
dpc-4793	96	4	50	50	NUM
dpc-4793	96	5	mg	mg	NOUN
dpc-4793	96	6	q8w	q8w	PROPN
dpc-4793	96	7	,	,	PUNCT
dpc-4793	96	8	all	all	DET
dpc-4793	96	9	interventions	intervention	NOUN
dpc-4793	96	10	had	have	VERB
dpc-4793	96	11	a	a	DET
dpc-4793	96	12	statistically	statistically	ADV
dpc-4793	96	13	significant	significant	ADJ
dpc-4793	96	14	benefit	benefit	NOUN
dpc-4793	96	15	when	when	SCONJ
dpc-4793	96	16	compared	compare	VERB
dpc-4793	96	17	to	to	ADP
dpc-4793	96	18	placebo	placebo	NOUN
dpc-4793	96	19	.	.	PUNCT
dpc-4793	97	1	according	accord	VERB
dpc-4793	97	2	to	to	ADP
dpc-4793	97	3	the	the	DET
dpc-4793	97	4	sucra	sucra	NOUN
dpc-4793	97	5	analysis	analysis	NOUN
dpc-4793	97	6	,	,	PUNCT
dpc-4793	97	7	bimekizumab	bimekizumab	X
dpc-4793	97	8	320	320	NUM
dpc-4793	97	9	mg	mg	NOUN
dpc-4793	97	10	q4w	q4w	PROPN
dpc-4793	97	11	had	have	VERB
dpc-4793	97	12	the	the	DET
dpc-4793	97	13	highest	high	ADJ
dpc-4793	97	14	likelihood	likelihood	NOUN
dpc-4793	97	15	of	of	ADP
dpc-4793	97	16	improving	improve	VERB
dpc-4793	97	17	iga	iga	PROPN
dpc-4793	97	18	scores	score	NOUN
dpc-4793	97	19	(	(	PUNCT
dpc-4793	97	20	sucra	sucra	PROPN
dpc-4793	97	21	0.975	0.975	NUM
dpc-4793	97	22	)	)	PUNCT
dpc-4793	97	23	,	,	PUNCT
dpc-4793	97	24	followed	follow	VERB
dpc-4793	97	25	by	by	ADP
dpc-4793	97	26	ustekinumab	ustekinumab	NOUN
dpc-4793	97	27	90	90	NUM
dpc-4793	97	28	mg	mg	NOUN
dpc-4793	97	29	q12w	q12w	PROPN
dpc-4793	97	30	(	(	PUNCT
dpc-4793	97	31	sucra	sucra	NOUN
dpc-4793	97	32	0.7050	0.7050	NUM
dpc-4793	97	33	)	)	PUNCT
dpc-4793	97	34	,	,	PUNCT
dpc-4793	97	35	secukinumab	secukinumab	NOUN
dpc-4793	97	36	300	300	NUM
dpc-4793	97	37	mg	mg	NOUN
dpc-4793	97	38	q4w	q4w	PROPN
dpc-4793	97	39	(	(	PUNCT
dpc-4793	97	40	sucra	sucra	PROPN
dpc-4793	97	41	0.6374	0.6374	NUM
dpc-4793	97	42	)	)	PUNCT
dpc-4793	97	43	,	,	PUNCT
dpc-4793	97	44	guselkumab	guselkumab	VERB
dpc-4793	97	45	100	100	NUM
dpc-4793	97	46	mg	mg	ADP
dpc-4793	97	47	q8w	q8w	ADV
dpc-4793	97	48	(	(	PUNCT
dpc-4793	97	49	sucra	sucra	PROPN
dpc-4793	97	50	0.5194	0.5194	NUM
dpc-4793	97	51	)	)	PUNCT
dpc-4793	97	52	,	,	PUNCT
dpc-4793	97	53	apremilast	apremilast	VERB
dpc-4793	97	54	30	30	NUM
dpc-4793	97	55	mg	mg	NOUN
dpc-4793	97	56	twice	twice	ADV
dpc-4793	97	57	daily	daily	ADV
dpc-4793	97	58	(	(	PUNCT
dpc-4793	97	59	sucra	sucra	NOUN
dpc-4793	97	60	0.5071	0.5071	NUM
dpc-4793	97	61	)	)	PUNCT
dpc-4793	97	62	,	,	PUNCT
dpc-4793	97	63	adalimumab	adalimumab	NOUN
dpc-4793	97	64	80	80	NUM
dpc-4793	97	65	mg	mg	NUM
dpc-4793	97	66	q2w	q2w	NOUN
dpc-4793	97	67	,	,	PUNCT
dpc-4793	97	68	(	(	PUNCT
dpc-4793	97	69	sucra	sucra	NOUN
dpc-4793	97	70	0.4384	0.4384	NUM
dpc-4793	97	71	)	)	PUNCT
dpc-4793	97	72	,	,	PUNCT
dpc-4793	97	73	and	and	CCONJ
dpc-4793	97	74	guselkumab	guselkumab	VERB
dpc-4793	97	75	50	50	NUM
dpc-4793	97	76	mg	mg	NOUN
dpc-4793	97	77	q8w	q8w	ADV
dpc-4793	97	78	(	(	PUNCT
dpc-4793	97	79	sucra	sucra	PROPN
dpc-4793	97	80	0.2023	0.2023	NUM
dpc-4793	97	81	)	)	PUNCT
dpc-4793	97	82	.	.	PUNCT
dpc-4793	98	1	risk	risk	NOUN
dpc-4793	98	2	of	of	ADP
dpc-4793	98	3	bias	bias	NOUN
dpc-4793	98	4	assessment	assessment	NOUN
dpc-4793	98	5	the	the	DET
dpc-4793	98	6	risk	risk	NOUN
dpc-4793	98	7	of	of	ADP
dpc-4793	98	8	bias	bias	NOUN
dpc-4793	98	9	assessment	assessment	NOUN
dpc-4793	98	10	for	for	ADP
dpc-4793	98	11	the	the	DET
dpc-4793	98	12	included	include	VERB
dpc-4793	98	13	studies	study	NOUN
dpc-4793	98	14	in	in	ADP
dpc-4793	98	15	the	the	DET
dpc-4793	98	16	network	network	NOUN
dpc-4793	98	17	meta	meta	ADJ
dpc-4793	98	18	-	-	PUNCT
dpc-4793	98	19	analysis	analysis	NOUN
dpc-4793	98	20	revealed	reveal	VERB
dpc-4793	98	21	varying	vary	VERB
dpc-4793	98	22	degrees	degree	NOUN
dpc-4793	98	23	of	of	ADP
dpc-4793	98	24	methodological	methodological	ADJ
dpc-4793	98	25	quality	quality	NOUN
dpc-4793	98	26	across	across	ADP
dpc-4793	98	27	different	different	ADJ
dpc-4793	98	28	trials	trial	NOUN
dpc-4793	98	29	.	.	PUNCT
dpc-4793	99	1	overall	overall	ADV
dpc-4793	99	2	,	,	PUNCT
dpc-4793	99	3	most	most	ADJ
dpc-4793	99	4	studies	study	NOUN
dpc-4793	99	5	exhibited	exhibit	VERB
dpc-4793	99	6	a	a	DET
dpc-4793	99	7	low	low	ADJ
dpc-4793	99	8	risk	risk	NOUN
dpc-4793	99	9	of	of	ADP
dpc-4793	99	10	bias	bias	NOUN
dpc-4793	99	11	in	in	ADP
dpc-4793	99	12	random	random	ADJ
dpc-4793	99	13	sequence	sequence	NOUN
dpc-4793	99	14	generation	generation	NOUN
dpc-4793	99	15	,	,	PUNCT
dpc-4793	99	16	blinding	blind	VERB
dpc-4793	99	17	of	of	ADP
dpc-4793	99	18	participants	participant	NOUN
dpc-4793	99	19	and	and	CCONJ
dpc-4793	99	20	personnel	personnel	NOUN
dpc-4793	99	21	,	,	PUNCT
dpc-4793	99	22	blinding	blind	VERB
dpc-4793	99	23	of	of	ADP
dpc-4793	99	24	outcome	outcome	NOUN
dpc-4793	99	25	4	4	NUM
dpc-4793	99	26	review	review	NOUN
dpc-4793	99	27	|	|	ADV
dpc-4793	99	28	dermatol	dermatol	ADJ
dpc-4793	99	29	pract	pract	NOUN
dpc-4793	99	30	concept	concept	NOUN
dpc-4793	99	31	.	.	PUNCT
dpc-4793	100	1	2025;15(2):4793	2025;15(2):4793	NUM
dpc-4793	100	2	effects	effect	NOUN
dpc-4793	100	3	,	,	PUNCT
dpc-4793	100	4	including	include	VERB
dpc-4793	100	5	skin	skin	NOUN
dpc-4793	100	6	lesions	lesion	NOUN
dpc-4793	100	7	and	and	CCONJ
dpc-4793	100	8	atrophy	atrophy	NOUN
dpc-4793	100	9	,	,	PUNCT
dpc-4793	100	10	highlighting	highlight	VERB
dpc-4793	100	11	a	a	DET
dpc-4793	100	12	need	need	NOUN
dpc-4793	100	13	for	for	ADP
dpc-4793	100	14	newer	new	ADJ
dpc-4793	100	15	,	,	PUNCT
dpc-4793	100	16	systemic	systemic	ADJ
dpc-4793	100	17	therapeutic	therapeutic	ADJ
dpc-4793	100	18	modalities	modality	NOUN
dpc-4793	100	19	[	[	X
dpc-4793	100	20	6	6	NUM
dpc-4793	100	21	,	,	PUNCT
dpc-4793	100	22	47	47	NUM
dpc-4793	100	23	,	,	PUNCT
dpc-4793	100	24	48	48	NUM
dpc-4793	100	25	]	]	PUNCT
dpc-4793	100	26	.	.	PUNCT
dpc-4793	101	1	in	in	ADP
dpc-4793	101	2	this	this	DET
dpc-4793	101	3	analysis	analysis	NOUN
dpc-4793	101	4	,	,	PUNCT
dpc-4793	101	5	all	all	PRON
dpc-4793	101	6	included	include	VERB
dpc-4793	101	7	therapies	therapy	NOUN
dpc-4793	101	8	showed	show	VERB
dpc-4793	101	9	significant	significant	ADJ
dpc-4793	101	10	efficacy	efficacy	NOUN
dpc-4793	101	11	when	when	SCONJ
dpc-4793	101	12	compared	compare	VERB
dpc-4793	101	13	to	to	ADP
dpc-4793	101	14	placebo	placebo	NOUN
dpc-4793	101	15	through	through	ADP
dpc-4793	101	16	various	various	ADJ
dpc-4793	101	17	measures	measure	NOUN
dpc-4793	101	18	,	,	PUNCT
dpc-4793	101	19	including	include	VERB
dpc-4793	101	20	pssi	pssi	ADJ
dpc-4793	101	21	response	response	NOUN
dpc-4793	101	22	and	and	CCONJ
dpc-4793	101	23	iga	iga	PROPN
dpc-4793	101	24	response	response	NOUN
dpc-4793	101	25	.	.	PUNCT
dpc-4793	102	1	when	when	SCONJ
dpc-4793	102	2	all	all	DET
dpc-4793	102	3	interventions	intervention	NOUN
dpc-4793	102	4	were	be	AUX
dpc-4793	102	5	compared	compare	VERB
dpc-4793	102	6	against	against	ADP
dpc-4793	102	7	each	each	DET
dpc-4793	102	8	other	other	ADJ
dpc-4793	102	9	,	,	PUNCT
dpc-4793	102	10	secukinumab	secukinumab	NOUN
dpc-4793	102	11	300	300	NUM
dpc-4793	102	12	mg	mg	NOUN
dpc-4793	102	13	and	and	CCONJ
dpc-4793	102	14	bimekizumab	bimekizumab	NOUN
dpc-4793	102	15	320	320	NUM
dpc-4793	102	16	mg	mg	NUM
dpc-4793	102	17	were	be	AUX
dpc-4793	102	18	found	find	VERB
dpc-4793	102	19	to	to	PART
dpc-4793	102	20	be	be	AUX
dpc-4793	102	21	the	the	DET
dpc-4793	102	22	most	most	ADV
dpc-4793	102	23	effective	effective	ADJ
dpc-4793	102	24	in	in	ADP
dpc-4793	102	25	improving	improve	VERB
dpc-4793	102	26	the	the	DET
dpc-4793	102	27	pssi	pssi	ADJ
dpc-4793	102	28	and	and	CCONJ
dpc-4793	102	29	pga	pga	PROPN
dpc-4793	102	30	/	/	SYM
dpc-4793	102	31	iga	iga	PROPN
dpc-4793	102	32	scores	score	NOUN
dpc-4793	102	33	,	,	PUNCT
dpc-4793	102	34	respectively	respectively	ADV
dpc-4793	102	35	.	.	PUNCT
dpc-4793	103	1	among	among	ADP
dpc-4793	103	2	biologics	biologic	NOUN
dpc-4793	103	3	compared	compare	VERB
dpc-4793	103	4	in	in	ADP
dpc-4793	103	5	the	the	DET
dpc-4793	103	6	pssi	pssi	ADJ
dpc-4793	103	7	and	and	CCONJ
dpc-4793	103	8	iga	iga	PROPN
dpc-4793	103	9	response	response	NOUN
dpc-4793	103	10	analyses	analysis	NOUN
dpc-4793	103	11	,	,	PUNCT
dpc-4793	103	12	biologic	biologic	NOUN
dpc-4793	103	13	agents	agent	NOUN
dpc-4793	103	14	outperformed	outperform	VERB
dpc-4793	103	15	other	other	ADJ
dpc-4793	103	16	small	small	ADJ
dpc-4793	103	17	molecules	molecule	NOUN
dpc-4793	103	18	,	,	PUNCT
dpc-4793	103	19	aside	aside	ADV
dpc-4793	103	20	from	from	ADP
dpc-4793	103	21	a	a	DET
dpc-4793	103	22	50	50	NUM
dpc-4793	103	23	-	-	PUNCT
dpc-4793	103	24	mg	mg	NOUN
dpc-4793	103	25	dosing	dosing	NOUN
dpc-4793	103	26	of	of	ADP
dpc-4793	103	27	guselkumab	guselkumab	NOUN
dpc-4793	103	28	,	,	PUNCT
dpc-4793	103	29	which	which	PRON
dpc-4793	103	30	is	be	AUX
dpc-4793	103	31	assessment	assessment	NOUN
dpc-4793	103	32	,	,	PUNCT
dpc-4793	103	33	and	and	CCONJ
dpc-4793	103	34	incomplete	incomplete	ADJ
dpc-4793	103	35	outcome	outcome	NOUN
dpc-4793	103	36	data	datum	NOUN
dpc-4793	103	37	.	.	PUNCT
dpc-4793	104	1	however	however	ADV
dpc-4793	104	2	,	,	PUNCT
dpc-4793	104	3	there	there	PRON
dpc-4793	104	4	were	be	VERB
dpc-4793	104	5	instances	instance	NOUN
dpc-4793	104	6	of	of	ADP
dpc-4793	104	7	unclear	unclear	ADJ
dpc-4793	104	8	or	or	CCONJ
dpc-4793	104	9	high	high	ADJ
dpc-4793	104	10	risk	risk	NOUN
dpc-4793	104	11	of	of	ADP
dpc-4793	104	12	bias	bias	NOUN
dpc-4793	104	13	in	in	ADP
dpc-4793	104	14	certain	certain	ADJ
dpc-4793	104	15	domains	domain	NOUN
dpc-4793	104	16	,	,	PUNCT
dpc-4793	104	17	particularly	particularly	ADV
dpc-4793	104	18	in	in	ADP
dpc-4793	104	19	the	the	DET
dpc-4793	104	20	allocation	allocation	NOUN
dpc-4793	104	21	concealment	concealment	NOUN
dpc-4793	104	22	,	,	PUNCT
dpc-4793	104	23	selective	selective	ADJ
dpc-4793	104	24	reporting	reporting	NOUN
dpc-4793	104	25	,	,	PUNCT
dpc-4793	104	26	and	and	CCONJ
dpc-4793	104	27	other	other	ADJ
dpc-4793	104	28	biases	bias	NOUN
dpc-4793	104	29	domains	domain	NOUN
dpc-4793	104	30	.	.	PUNCT
dpc-4793	105	1	in	in	ADP
dpc-4793	105	2	total	total	ADJ
dpc-4793	105	3	,	,	PUNCT
dpc-4793	105	4	six	six	NUM
dpc-4793	105	5	out	out	ADP
dpc-4793	105	6	of	of	ADP
dpc-4793	105	7	24	24	NUM
dpc-4793	105	8	studies	study	NOUN
dpc-4793	105	9	had	have	VERB
dpc-4793	105	10	a	a	DET
dpc-4793	105	11	high	high	ADJ
dpc-4793	105	12	risk	risk	NOUN
dpc-4793	105	13	of	of	ADP
dpc-4793	105	14	bias	bias	NOUN
dpc-4793	105	15	in	in	ADP
dpc-4793	105	16	at	at	ADV
dpc-4793	105	17	least	least	ADV
dpc-4793	105	18	one	one	NUM
dpc-4793	105	19	domain	domain	NOUN
dpc-4793	105	20	,	,	PUNCT
dpc-4793	105	21	while	while	SCONJ
dpc-4793	105	22	20	20	NUM
dpc-4793	105	23	studies	study	NOUN
dpc-4793	105	24	had	have	VERB
dpc-4793	105	25	an	an	DET
dpc-4793	105	26	unclear	unclear	ADJ
dpc-4793	105	27	risk	risk	NOUN
dpc-4793	105	28	of	of	ADP
dpc-4793	105	29	bias	bias	NOUN
dpc-4793	105	30	in	in	ADP
dpc-4793	105	31	at	at	ADV
dpc-4793	105	32	least	least	ADV
dpc-4793	105	33	one	one	NUM
dpc-4793	105	34	domain	domain	NOUN
dpc-4793	105	35	.	.	PUNCT
dpc-4793	106	1	conclusions	conclusion	NOUN
dpc-4793	106	2	though	though	SCONJ
dpc-4793	106	3	corticosteroids	corticosteroid	NOUN
dpc-4793	106	4	are	be	AUX
dpc-4793	106	5	commonly	commonly	ADV
dpc-4793	106	6	used	use	VERB
dpc-4793	106	7	in	in	ADP
dpc-4793	106	8	the	the	DET
dpc-4793	106	9	treatment	treatment	NOUN
dpc-4793	106	10	of	of	ADP
dpc-4793	106	11	scalp	scalp	NOUN
dpc-4793	106	12	psoriasis	psoriasis	NOUN
dpc-4793	106	13	,	,	PUNCT
dpc-4793	106	14	they	they	PRON
dpc-4793	106	15	are	be	AUX
dpc-4793	106	16	suboptimal	suboptimal	ADJ
dpc-4793	106	17	in	in	ADP
dpc-4793	106	18	severe	severe	ADJ
dpc-4793	106	19	or	or	CCONJ
dpc-4793	106	20	resistant	resistant	ADJ
dpc-4793	106	21	cases	case	NOUN
dpc-4793	106	22	,	,	PUNCT
dpc-4793	106	23	and	and	CCONJ
dpc-4793	106	24	long	long	ADJ
dpc-4793	106	25	-	-	PUNCT
dpc-4793	106	26	term	term	NOUN
dpc-4793	106	27	use	use	NOUN
dpc-4793	106	28	is	be	AUX
dpc-4793	106	29	associated	associate	VERB
dpc-4793	106	30	with	with	ADP
dpc-4793	106	31	adverse	adverse	ADJ
dpc-4793	106	32	side	side	NOUN
dpc-4793	106	33	figure	figure	NOUN
dpc-4793	106	34	1	1	NUM
dpc-4793	106	35	.	.	PUNCT
dpc-4793	107	1	preferred	preferred	ADJ
dpc-4793	107	2	reporting	reporting	NOUN
dpc-4793	107	3	items	item	NOUN
dpc-4793	107	4	for	for	ADP
dpc-4793	107	5	systematic	systematic	ADJ
dpc-4793	107	6	reviews	review	NOUN
dpc-4793	107	7	and	and	CCONJ
dpc-4793	107	8	meta	meta	NOUN
dpc-4793	107	9	-	-	PUNCT
dpc-4793	107	10	analyses	analysis	NOUN
dpc-4793	107	11	(	(	PUNCT
dpc-4793	107	12	prisma	prisma	NOUN
dpc-4793	107	13	)	)	PUNCT
dpc-4793	107	14	flow	flow	NOUN
dpc-4793	107	15	diagram	diagram	NOUN
dpc-4793	107	16	.	.	PUNCT
dpc-4793	108	1	review	review	VERB
dpc-4793	108	2	|	|	ADV
dpc-4793	108	3	dermatol	dermatol	ADJ
dpc-4793	108	4	pract	pract	NOUN
dpc-4793	108	5	concept	concept	NOUN
dpc-4793	108	6	.	.	PUNCT
dpc-4793	109	1	2025;15(2):4793	2025;15(2):4793	NUM
dpc-4793	109	2	5	5	NUM
dpc-4793	109	3	t	t	PROPN
dpc-4793	109	4	ab	ab	PROPN
dpc-4793	109	5	le	le	PROPN
dpc-4793	109	6	1	1	NUM
dpc-4793	109	7	.	.	PUNCT
dpc-4793	110	1	b	b	X
dpc-4793	110	2	as	as	ADP
dpc-4793	110	3	el	el	PROPN
dpc-4793	110	4	in	in	ADP
dpc-4793	110	5	e	e	PROPN
dpc-4793	110	6	c	c	NOUN
dpc-4793	110	7	ha	ha	INTJ
dpc-4793	110	8	ra	ra	INTJ
dpc-4793	110	9	ct	ct	INTJ
dpc-4793	110	10	er	er	INTJ
dpc-4793	110	11	is	be	AUX
dpc-4793	110	12	ti	ti	X
dpc-4793	110	13	cs	cs	ADJ
dpc-4793	110	14	o	o	PROPN
dpc-4793	110	15	f	f	PROPN
dpc-4793	110	16	in	in	ADP
dpc-4793	110	17	cl	cl	INTJ
dpc-4793	111	1	ud	ud	INTJ
dpc-4793	112	1	ed	ed	PROPN
dpc-4793	112	2	s	s	PROPN
dpc-4793	112	3	tu	tu	X
dpc-4793	112	4	di	di	NOUN
dpc-4793	112	5	es	es	PROPN
dpc-4793	112	6	.	.	PUNCT
dpc-4793	113	1	a	a	DET
dpc-4793	113	2	ut	ut	PROPN
dpc-4793	113	3	ho	ho	PROPN
dpc-4793	113	4	r	r	PROPN
dpc-4793	113	5	a	a	DET
dpc-4793	113	6	rm	rm	NOUN
dpc-4793	113	7	s	s	PROPN
dpc-4793	113	8	c	c	NOUN
dpc-4793	113	9	au	au	NOUN
dpc-4793	113	10	ca	can	AUX
dpc-4793	113	11	si	si	PROPN
dpc-4793	113	12	an	an	DET
dpc-4793	113	13	(	(	PUNCT
dpc-4793	113	14	%	%	NOUN
dpc-4793	113	15	)	)	PUNCT
dpc-4793	113	16	m	m	VERB
dpc-4793	113	17	al	al	PROPN
dpc-4793	113	18	e	e	PROPN
dpc-4793	113	19	(	(	PUNCT
dpc-4793	113	20	%	%	INTJ
dpc-4793	113	21	)	)	PUNCT
dpc-4793	113	22	a	a	DET
dpc-4793	113	23	ge	ge	PROPN
dpc-4793	113	24	[	[	PUNCT
dpc-4793	113	25	m	m	VERB
dpc-4793	113	26	in	in	ADP
dpc-4793	113	27	-m	-m	DET
dpc-4793	113	28	ax	ax	NOUN
dpc-4793	113	29	]	]	PUNCT
dpc-4793	113	30	(	(	PUNCT
dpc-4793	113	31	y	y	PROPN
dpc-4793	113	32	ea	ea	PROPN
dpc-4793	113	33	rs	rs	PROPN
dpc-4793	113	34	)	)	PUNCT
dpc-4793	113	35	m	m	VERB
dpc-4793	113	36	ea	ea	NOUN
dpc-4793	113	37	n	n	NUM
dpc-4793	113	38	b	b	NOUN
dpc-4793	113	39	m	m	VERB
dpc-4793	113	40	i	i	PRON
dpc-4793	113	41	ps	ps	VERB
dpc-4793	113	42	or	or	CCONJ
dpc-4793	113	43	ia	ia	PROPN
dpc-4793	113	44	si	si	X
dpc-4793	113	45	s	s	PROPN
dpc-4793	114	1	d	d	X
dpc-4793	114	2	ur	ur	INTJ
dpc-4793	114	3	at	at	ADP
dpc-4793	114	4	io	io	X
dpc-4793	114	5	n	n	PROPN
dpc-4793	114	6	(	(	PUNCT
dpc-4793	114	7	y	y	PROPN
dpc-4793	114	8	ea	ea	PROPN
dpc-4793	114	9	rs	rs	PROPN
dpc-4793	114	10	)	)	PUNCT
dpc-4793	115	1	sc	sc	PROPN
dpc-4793	115	2	al	al	PROPN
dpc-4793	115	3	p	p	PROPN
dpc-4793	115	4	in	in	ADP
dpc-4793	115	5	vo	vo	X
dpc-4793	115	6	lv	lv	PROPN
dpc-4793	115	7	em	em	PRON
dpc-4793	115	8	en	en	PROPN
dpc-4793	115	9	t	t	PROPN
dpc-4793	115	10	(	(	PUNCT
dpc-4793	115	11	%	%	NOUN
dpc-4793	115	12	)	)	PUNCT
dpc-4793	116	1	ps	ps	INTJ
dpc-4793	117	1	si	si	PROPN
dpc-4793	117	2	t	t	PROPN
dpc-4793	117	3	ss	ss	VERB
dpc-4793	117	4	ig	ig	PROPN
dpc-4793	117	5	a	a	DET
dpc-4793	117	6	/p	/p	PUNCT
dpc-4793	117	7	g	g	PROPN
dpc-4793	117	8	a	a	DET
dpc-4793	117	9	s	s	X
dpc-4793	117	10	co	co	X
dpc-4793	117	11	re	re	NOUN
dpc-4793	117	12	of	of	ADP
dpc-4793	117	13	3	3	NUM
dpc-4793	117	14	-5	-5	NUM
dpc-4793	117	15	(	(	PUNCT
dpc-4793	117	16	%	%	NOUN
dpc-4793	117	17	)	)	PUNCT
dpc-4793	117	18	b	b	PROPN
dpc-4793	117	19	ag	ag	PROPN
dpc-4793	117	20	el	el	PROPN
dpc-4793	117	21	j	j	PROPN
dpc-4793	117	22	[	[	PUNCT
dpc-4793	117	23	13	13	NUM
dpc-4793	117	24	]	]	PUNCT
dpc-4793	117	25	se	se	PROPN
dpc-4793	117	26	cu	cu	PROPN
dpc-4793	118	1	ki	ki	PROPN
dpc-4793	118	2	nu	nu	INTJ
dpc-4793	118	3	m	m	VERB
dpc-4793	118	4	ab	ab	PROPN
dpc-4793	118	5	3	3	NUM
dpc-4793	118	6	00	00	NUM
dpc-4793	118	7	m	m	VERB
dpc-4793	118	8	g	g	PROPN
dpc-4793	118	9	86	86	NUM
dpc-4793	118	10	.3	.3	NUM
dpc-4793	118	11	52	52	NUM
dpc-4793	118	12	.9	.9	NUM
dpc-4793	118	13	42	42	NUM
dpc-4793	118	14	.7	.7	NUM
dpc-4793	119	1	*	*	PUNCT
dpc-4793	119	2	31	31	NUM
dpc-4793	120	1	.2	.2	NUM
dpc-4793	121	1	*	*	PUNCT
dpc-4793	121	2	14	14	NUM
dpc-4793	121	3	.4	.4	NUM
dpc-4793	122	1	*	*	PUNCT
dpc-4793	122	2	61	61	NUM
dpc-4793	122	3	.6	.6	NUM
dpc-4793	122	4	*	*	PUNCT
dpc-4793	123	1	33	33	NUM
dpc-4793	123	2	.4	.4	NUM
dpc-4793	123	3	*	*	PUNCT
dpc-4793	124	1	n	n	PRON
dpc-4793	124	2	r	r	NOUN
dpc-4793	124	3	84	84	NUM
dpc-4793	124	4	.3	.3	NUM
dpc-4793	124	5	,	,	PUNCT
dpc-4793	124	6	7	7	NUM
dpc-4793	124	7	0	0	NUM
dpc-4793	124	8	.	.	NOUN
dpc-4793	125	1	6	6	NUM
dpc-4793	125	2	,	,	PUNCT
dpc-4793	125	3	n	n	PRON
dpc-4793	125	4	r	r	NOUN
dpc-4793	125	5	pl	pl	X
dpc-4793	125	6	ac	ac	PROPN
dpc-4793	125	7	eb	eb	PROPN
dpc-4793	125	8	o	o	PROPN
dpc-4793	126	1	74	74	NUM
dpc-4793	126	2	.5	.5	NUM
dpc-4793	126	3	41	41	NUM
dpc-4793	127	1	.2	.2	NUM
dpc-4793	127	2	41	41	NUM
dpc-4793	127	3	.1	.1	NUM
dpc-4793	127	4	*	*	PUNCT
dpc-4793	127	5	31	31	NUM
dpc-4793	127	6	.9	.9	NUM
dpc-4793	128	1	*	*	PUNCT
dpc-4793	128	2	15	15	NUM
dpc-4793	128	3	.4	.4	NUM
dpc-4793	128	4	*	*	PUNCT
dpc-4793	128	5	59	59	NUM
dpc-4793	128	6	.3	.3	NUM
dpc-4793	128	7	*	*	SYM
dpc-4793	128	8	33	33	NUM
dpc-4793	128	9	*	*	SYM
dpc-4793	128	10	n	n	NUM
dpc-4793	128	11	r	r	NOUN
dpc-4793	128	12	15	15	NUM
dpc-4793	128	13	.7	.7	NUM
dpc-4793	128	14	,	,	PUNCT
dpc-4793	128	15	2	2	NUM
dpc-4793	128	16	9	9	NUM
dpc-4793	128	17	.	.	NOUN
dpc-4793	128	18	4	4	NUM
dpc-4793	128	19	,	,	PUNCT
dpc-4793	128	20	n	n	PRON
dpc-4793	129	1	r	r	NOUN
dpc-4793	129	2	b	b	PROPN
dpc-4793	130	1	uc	uc	INTJ
dpc-4793	130	2	kl	kl	PROPN
dpc-4793	130	3	ey	ey	INTJ
dpc-4793	130	4	c	c	PROPN
dpc-4793	130	5	[	[	PUNCT
dpc-4793	130	6	23	23	NUM
dpc-4793	130	7	]	]	PUNCT
dpc-4793	130	8	c	c	PROPN
dpc-4793	130	9	al	al	PROPN
dpc-4793	130	10	ci	ci	PROPN
dpc-4793	130	11	po	po	PROPN
dpc-4793	130	12	tr	tr	VERB
dpc-4793	130	13	io	io	PROPN
dpc-4793	130	14	l	l	PROPN
dpc-4793	130	15	/	/	SYM
dpc-4793	130	16	e	e	X
dpc-4793	130	17	ne	ne	NOUN
dpc-4793	131	1	+	+	CCONJ
dpc-4793	131	2	b	b	X
dpc-4793	131	3	et	et	NOUN
dpc-4793	131	4	am	be	AUX
dpc-4793	131	5	et	et	NOUN
dpc-4793	131	6	ha	ha	INTJ
dpc-4793	131	7	so	so	ADV
dpc-4793	131	8	ne	ne	PROPN
dpc-4793	131	9	d	d	PROPN
dpc-4793	131	10	ip	ip	PRON
dpc-4793	131	11	ro	ro	X
dpc-4793	131	12	pi	pi	NOUN
dpc-4793	131	13	on	on	ADV
dpc-4793	131	14	at	at	ADP
dpc-4793	131	15	e	e	PROPN
dpc-4793	131	16	97	97	NUM
dpc-4793	131	17	.2	.2	NUM
dpc-4793	131	18	43	43	NUM
dpc-4793	131	19	.5	.5	NUM
dpc-4793	131	20	48	48	NUM
dpc-4793	131	21	.4	.4	NUM
dpc-4793	131	22	*	*	PUNCT
dpc-4793	132	1	n	n	PRON
dpc-4793	132	2	r	r	NOUN
dpc-4793	132	3	16	16	NUM
dpc-4793	132	4	*	*	PUNCT
dpc-4793	132	5	n	n	ADP
dpc-4793	132	6	r	r	NOUN
dpc-4793	132	7	n	n	NOUN
dpc-4793	132	8	r	r	NOUN
dpc-4793	132	9	6	6	NUM
dpc-4793	132	10	.	.	PUNCT
dpc-4793	133	1	79	79	NUM
dpc-4793	133	2	*	*	PUNCT
dpc-4793	133	3	n	n	DET
dpc-4793	133	4	r	r	NOUN
dpc-4793	133	5	b	b	NOUN
dpc-4793	133	6	et	et	NOUN
dpc-4793	133	7	am	be	AUX
dpc-4793	133	8	et	et	NOUN
dpc-4793	133	9	ha	ha	INTJ
dpc-4793	133	10	so	so	ADV
dpc-4793	133	11	ne	ne	PROPN
dpc-4793	133	12	d	d	PROPN
dpc-4793	133	13	ip	ip	PRON
dpc-4793	133	14	ro	ro	X
dpc-4793	133	15	pi	pi	NOUN
dpc-4793	133	16	on	on	ADV
dpc-4793	133	17	at	at	ADP
dpc-4793	133	18	e	e	PROPN
dpc-4793	133	19	98	98	NUM
dpc-4793	133	20	.2	.2	NUM
dpc-4793	133	21	46	46	NUM
dpc-4793	133	22	.4	.4	NUM
dpc-4793	133	23	48	48	NUM
dpc-4793	133	24	.4	.4	NUM
dpc-4793	134	1	*	*	PUNCT
dpc-4793	135	1	n	n	NUM
dpc-4793	135	2	r	r	NOUN
dpc-4793	135	3	13	13	NUM
dpc-4793	135	4	.2	.2	NUM
dpc-4793	135	5	*	*	PUNCT
dpc-4793	135	6	n	n	CCONJ
dpc-4793	135	7	r	r	NOUN
dpc-4793	135	8	n	n	NOUN
dpc-4793	135	9	r	r	NOUN
dpc-4793	135	10	6	6	NUM
dpc-4793	135	11	.	.	PUNCT
dpc-4793	136	1	81	81	NUM
dpc-4793	136	2	*	*	PUNCT
dpc-4793	136	3	n	n	NUM
dpc-4793	136	4	r	r	NOUN
dpc-4793	136	5	e	e	X
dpc-4793	136	6	le	le	X
dpc-4793	136	7	w	w	NOUN
dpc-4793	136	8	sk	sk	INTJ
dpc-4793	136	9	i	i	PROPN
dpc-4793	136	10	b	b	PROPN
dpc-4793	136	11	[	[	PUNCT
dpc-4793	136	12	14	14	NUM
dpc-4793	136	13	]	]	PUNCT
dpc-4793	136	14	b	b	X
dpc-4793	136	15	ro	ro	X
dpc-4793	136	16	da	da	PROPN
dpc-4793	136	17	lu	lu	PROPN
dpc-4793	136	18	m	m	VERB
dpc-4793	136	19	ab	ab	PROPN
dpc-4793	136	20	2	2	NUM
dpc-4793	136	21	10	10	NUM
dpc-4793	136	22	m	m	NOUN
dpc-4793	136	23	g	g	NOUN
dpc-4793	136	24	n	n	ADP
dpc-4793	136	25	r	r	NOUN
dpc-4793	136	26	n	n	ADP
dpc-4793	136	27	r	r	NOUN
dpc-4793	136	28	n	n	ADP
dpc-4793	136	29	r	r	NOUN
dpc-4793	136	30	n	n	NOUN
dpc-4793	136	31	r	r	NOUN
dpc-4793	136	32	20	20	NUM
dpc-4793	136	33	.4	.4	NUM
dpc-4793	136	34	*	*	PUNCT
dpc-4793	136	35	n	n	NUM
dpc-4793	136	36	r	r	NOUN
dpc-4793	136	37	16	16	NUM
dpc-4793	136	38	.7	.7	NUM
dpc-4793	136	39	n	n	CCONJ
dpc-4793	136	40	r	r	NOUN
dpc-4793	136	41	n	n	NOUN
dpc-4793	136	42	r	r	NOUN
dpc-4793	136	43	pl	pl	X
dpc-4793	136	44	ac	ac	PROPN
dpc-4793	136	45	eb	eb	PROPN
dpc-4793	136	46	o	o	PROPN
dpc-4793	136	47	n	n	ADP
dpc-4793	136	48	r	r	NOUN
dpc-4793	136	49	n	n	ADP
dpc-4793	136	50	r	r	NOUN
dpc-4793	136	51	n	n	ADP
dpc-4793	136	52	r	r	NOUN
dpc-4793	136	53	n	n	NOUN
dpc-4793	136	54	r	r	NOUN
dpc-4793	136	55	20	20	NUM
dpc-4793	136	56	.7	.7	NUM
dpc-4793	136	57	*	*	PUNCT
dpc-4793	136	58	n	n	NUM
dpc-4793	136	59	r	r	NOUN
dpc-4793	136	60	20	20	NUM
dpc-4793	136	61	*	*	PUNCT
dpc-4793	136	62	n	n	NUM
dpc-4793	136	63	r	r	NOUN
dpc-4793	136	64	n	n	NOUN
dpc-4793	136	65	r	r	NOUN
dpc-4793	136	66	b	b	PROPN
dpc-4793	136	67	ag	ag	PROPN
dpc-4793	136	68	el	el	PROPN
dpc-4793	136	69	j	j	PROPN
dpc-4793	136	70	[	[	PUNCT
dpc-4793	136	71	15	15	NUM
dpc-4793	136	72	]	]	PUNCT
dpc-4793	136	73	e	e	X
dpc-4793	136	74	ta	ta	PROPN
dpc-4793	136	75	ne	ne	PROPN
dpc-4793	136	76	rc	rc	PROPN
dpc-4793	136	77	ep	ep	PROPN
dpc-4793	136	78	t	t	PROPN
dpc-4793	136	79	50	50	NUM
dpc-4793	136	80	m	m	NOUN
dpc-4793	136	81	g	g	ADP
dpc-4793	136	82	69	69	NUM
dpc-4793	136	83	.5	.5	NUM
dpc-4793	137	1	53	53	NUM
dpc-4793	138	1	.2	.2	NUM
dpc-4793	138	2	39	39	NUM
dpc-4793	138	3	[	[	PUNCT
dpc-4793	138	4	18	18	NUM
dpc-4793	138	5	-7	-7	NOUN
dpc-4793	138	6	1	1	NUM
dpc-4793	138	7	]	]	SYM
dpc-4793	138	8	30	30	NUM
dpc-4793	138	9	.2	.2	NUM
dpc-4793	138	10	17	17	NUM
dpc-4793	138	11	.5	.5	NUM
dpc-4793	138	12	72	72	NUM
dpc-4793	138	13	.5	.5	NUM
dpc-4793	138	14	35	35	NUM
dpc-4793	138	15	n	n	NOUN
dpc-4793	138	16	r	r	NOUN
dpc-4793	138	17	n	n	NOUN
dpc-4793	138	18	r	r	NOUN
dpc-4793	138	19	pl	pl	X
dpc-4793	138	20	ac	ac	PROPN
dpc-4793	138	21	eb	eb	PROPN
dpc-4793	138	22	o	o	PROPN
dpc-4793	139	1	75	75	NUM
dpc-4793	139	2	.8	.8	NUM
dpc-4793	139	3	58	58	NUM
dpc-4793	139	4	.1	.1	NUM
dpc-4793	139	5	42	42	NUM
dpc-4793	139	6	[	[	PUNCT
dpc-4793	139	7	18	18	NUM
dpc-4793	139	8	-7	-7	NOUN
dpc-4793	139	9	0	0	NUM
dpc-4793	139	10	]	]	SYM
dpc-4793	139	11	30	30	NUM
dpc-4793	139	12	.1	.1	NUM
dpc-4793	139	13	11	11	NUM
dpc-4793	139	14	.9	.9	NUM
dpc-4793	139	15	60	60	NUM
dpc-4793	139	16	30	30	NUM
dpc-4793	139	17	n	n	NOUN
dpc-4793	139	18	r	r	NOUN
dpc-4793	139	19	n	n	NOUN
dpc-4793	139	20	r	r	NOUN
dpc-4793	139	21	b	b	PROPN
dpc-4793	139	22	ah	ah	INTJ
dpc-4793	139	23	ra	ra	PROPN
dpc-4793	139	24	in	in	ADP
dpc-4793	139	25	i	i	PRON
dpc-4793	139	26	p	p	X
dpc-4793	139	27	[	[	PUNCT
dpc-4793	139	28	41	41	NUM
dpc-4793	139	29	]	]	PUNCT
dpc-4793	139	30	tu	tu	PROPN
dpc-4793	139	31	rm	rm	PROPN
dpc-4793	139	32	er	er	INTJ
dpc-4793	139	33	ic	ic	PROPN
dpc-4793	139	34	t	t	PROPN
dpc-4793	139	35	on	on	ADP
dpc-4793	139	36	ic	ic	PROPN
dpc-4793	139	37	n	n	CCONJ
dpc-4793	139	38	r	r	NOUN
dpc-4793	139	39	40	40	NUM
dpc-4793	139	40	29	29	NUM
dpc-4793	139	41	[	[	PUNCT
dpc-4793	139	42	27	27	NUM
dpc-4793	139	43	-3	-3	SYM
dpc-4793	139	44	5	5	NUM
dpc-4793	139	45	]	]	PUNCT
dpc-4793	139	46	n	n	ADP
dpc-4793	139	47	r	r	NOUN
dpc-4793	139	48	n	n	ADP
dpc-4793	139	49	r	r	NOUN
dpc-4793	139	50	n	n	ADP
dpc-4793	139	51	r	r	NOUN
dpc-4793	139	52	n	n	ADP
dpc-4793	139	53	r	r	NOUN
dpc-4793	139	54	n	n	ADP
dpc-4793	139	55	r	r	NOUN
dpc-4793	139	56	n	n	NOUN
dpc-4793	139	57	r	r	NOUN
dpc-4793	139	58	pl	pl	X
dpc-4793	139	59	ac	ac	PROPN
dpc-4793	139	60	eb	eb	PROPN
dpc-4793	139	61	o	o	PROPN
dpc-4793	139	62	n	n	CCONJ
dpc-4793	139	63	r	r	NOUN
dpc-4793	139	64	20	20	NUM
dpc-4793	139	65	44	44	NUM
dpc-4793	139	66	[	[	PUNCT
dpc-4793	139	67	29	29	NUM
dpc-4793	139	68	-5	-5	NUM
dpc-4793	139	69	0	0	NUM
dpc-4793	139	70	]	]	PUNCT
dpc-4793	139	71	n	n	CCONJ
dpc-4793	139	72	r	r	NOUN
dpc-4793	139	73	n	n	ADP
dpc-4793	139	74	r	r	NOUN
dpc-4793	139	75	n	n	ADP
dpc-4793	139	76	r	r	NOUN
dpc-4793	139	77	n	n	ADP
dpc-4793	139	78	r	r	NOUN
dpc-4793	139	79	n	n	ADP
dpc-4793	139	80	r	r	NOUN
dpc-4793	139	81	n	n	CCONJ
dpc-4793	139	82	r	r	NOUN
dpc-4793	139	83	fe	fe	X
dpc-4793	139	84	ld	ld	PROPN
dpc-4793	139	85	m	m	VERB
dpc-4793	139	86	an	an	PRON
dpc-4793	139	87	s	s	X
dpc-4793	139	88	r	r	NOUN
dpc-4793	139	89	[	[	PUNCT
dpc-4793	139	90	9	9	NUM
dpc-4793	139	91	]	]	SYM
dpc-4793	139	92	b	b	X
dpc-4793	139	93	et	et	NOUN
dpc-4793	139	94	am	be	AUX
dpc-4793	139	95	et	et	NOUN
dpc-4793	139	96	ha	ha	INTJ
dpc-4793	140	1	so	so	PROPN
dpc-4793	140	2	ne	ne	PROPN
dpc-4793	140	3	va	va	PROPN
dpc-4793	140	4	le	le	X
dpc-4793	140	5	ra	ra	PROPN
dpc-4793	141	1	te	te	PROPN
dpc-4793	141	2	b	b	PROPN
dpc-4793	142	1	i	i	PROPN
dpc-4793	142	2	d	d	PROPN
dpc-4793	142	3	n	n	NOUN
dpc-4793	142	4	r	r	VERB
dpc-4793	142	5	45	45	NUM
dpc-4793	142	6	.5	.5	NUM
dpc-4793	142	7	7	7	NUM
dpc-4793	142	8	50	50	NUM
dpc-4793	142	9	*	*	PUNCT
dpc-4793	143	1	[	[	X
dpc-4793	143	2	1	1	NUM
dpc-4793	143	3	790	790	NUM
dpc-4793	143	4	]	]	PUNCT
dpc-4793	143	5	n	n	CCONJ
dpc-4793	143	6	r	r	NOUN
dpc-4793	143	7	n	n	ADP
dpc-4793	143	8	r	r	NOUN
dpc-4793	143	9	n	n	ADP
dpc-4793	143	10	r	r	NOUN
dpc-4793	143	11	n	n	NOUN
dpc-4793	143	12	r	r	NOUN
dpc-4793	143	13	7	7	NUM
dpc-4793	143	14	.	.	NOUN
dpc-4793	143	15	7	7	NUM
dpc-4793	143	16	*	*	SYM
dpc-4793	143	17	n	n	PRON
dpc-4793	143	18	r	r	NOUN
dpc-4793	143	19	b	b	NOUN
dpc-4793	143	20	et	et	NOUN
dpc-4793	143	21	am	be	AUX
dpc-4793	143	22	et	et	NOUN
dpc-4793	143	23	ha	ha	INTJ
dpc-4793	143	24	so	so	PROPN
dpc-4793	143	25	ne	ne	PROPN
dpc-4793	143	26	va	va	PROPN
dpc-4793	143	27	le	le	X
dpc-4793	143	28	ra	ra	PROPN
dpc-4793	144	1	te	te	INTJ
dpc-4793	144	2	q	q	PROPN
dpc-4793	144	3	d	d	PROPN
dpc-4793	144	4	n	n	CCONJ
dpc-4793	144	5	r	r	NOUN
dpc-4793	144	6	45	45	NUM
dpc-4793	144	7	.5	.5	NUM
dpc-4793	144	8	7	7	NUM
dpc-4793	144	9	50	50	NUM
dpc-4793	144	10	*	*	PUNCT
dpc-4793	145	1	[	[	X
dpc-4793	145	2	1	1	NUM
dpc-4793	145	3	790	790	NUM
dpc-4793	145	4	]	]	PUNCT
dpc-4793	145	5	n	n	CCONJ
dpc-4793	145	6	r	r	NOUN
dpc-4793	145	7	n	n	ADP
dpc-4793	145	8	r	r	NOUN
dpc-4793	145	9	n	n	ADP
dpc-4793	145	10	r	r	NOUN
dpc-4793	145	11	n	n	NOUN
dpc-4793	145	12	r	r	NOUN
dpc-4793	145	13	8	8	NUM
dpc-4793	145	14	.	.	PUNCT
dpc-4793	146	1	1	1	NUM
dpc-4793	146	2	*	*	SYM
dpc-4793	146	3	n	n	NUM
dpc-4793	146	4	r	r	X
dpc-4793	146	5	je	je	X
dpc-4793	146	6	m	m	NOUN
dpc-4793	146	7	ec	ec	PROPN
dpc-4793	146	8	g	g	PROPN
dpc-4793	146	9	b	b	PROPN
dpc-4793	146	10	e	e	X
dpc-4793	146	11	[	[	PUNCT
dpc-4793	146	12	24	24	NUM
dpc-4793	146	13	]	]	PUNCT
dpc-4793	146	14	c	c	PROPN
dpc-4793	146	15	al	al	PROPN
dpc-4793	146	16	ci	ci	PROPN
dpc-4793	146	17	po	po	PROPN
dpc-4793	146	18	tr	tr	VERB
dpc-4793	146	19	io	io	PROPN
dpc-4793	146	20	l	l	PROPN
dpc-4793	146	21	/	/	SYM
dpc-4793	146	22	e	e	X
dpc-4793	146	23	ne	ne	NOUN
dpc-4793	147	1	+	+	CCONJ
dpc-4793	147	2	b	b	X
dpc-4793	147	3	et	et	NOUN
dpc-4793	147	4	am	be	AUX
dpc-4793	147	5	et	et	NOUN
dpc-4793	147	6	ha	ha	INTJ
dpc-4793	147	7	so	so	ADV
dpc-4793	147	8	ne	ne	PROPN
dpc-4793	147	9	d	d	PROPN
dpc-4793	147	10	ip	ip	PRON
dpc-4793	147	11	ro	ro	X
dpc-4793	147	12	pi	pi	NOUN
dpc-4793	147	13	on	on	ADV
dpc-4793	147	14	at	at	ADP
dpc-4793	147	15	e	e	PROPN
dpc-4793	147	16	95	95	NUM
dpc-4793	147	17	.7	.7	NUM
dpc-4793	147	18	47	47	NUM
dpc-4793	147	19	.9	.9	NUM
dpc-4793	148	1	47	47	NUM
dpc-4793	148	2	.9	.9	NUM
dpc-4793	149	1	*	*	PUNCT
dpc-4793	150	1	[	[	X
dpc-4793	150	2	1	1	NUM
dpc-4793	150	3	883	883	NUM
dpc-4793	150	4	]	]	PUNCT
dpc-4793	150	5	n	n	CCONJ
dpc-4793	150	6	r	r	NOUN
dpc-4793	150	7	15	15	NUM
dpc-4793	150	8	.4	.4	NUM
dpc-4793	150	9	*	*	PUNCT
dpc-4793	150	10	n	n	CCONJ
dpc-4793	150	11	r	r	NOUN
dpc-4793	150	12	n	n	NOUN
dpc-4793	150	13	r	r	NOUN
dpc-4793	150	14	6	6	NUM
dpc-4793	150	15	.	.	PUNCT
dpc-4793	151	1	7	7	NUM
dpc-4793	151	2	*	*	SYM
dpc-4793	151	3	56	56	NUM
dpc-4793	151	4	.2	.2	NUM
dpc-4793	151	5	,	,	PUNCT
dpc-4793	151	6	2	2	NUM
dpc-4793	151	7	8	8	NUM
dpc-4793	151	8	.	.	NOUN
dpc-4793	151	9	2	2	NUM
dpc-4793	151	10	,	,	PUNCT
dpc-4793	151	11	6	6	NUM
dpc-4793	151	12	.3	.3	NUM
dpc-4793	151	13	c	c	NOUN
dpc-4793	151	14	al	al	PROPN
dpc-4793	151	15	ci	ci	PROPN
dpc-4793	151	16	po	po	PROPN
dpc-4793	151	17	tr	tr	VERB
dpc-4793	151	18	ie	ie	X
dpc-4793	151	19	ne	ne	X
dpc-4793	151	20	/o	/o	PUNCT
dpc-4793	152	1	l	l	NOUN
dpc-4793	152	2	97	97	NUM
dpc-4793	153	1	.4	.4	NUM
dpc-4793	153	2	44	44	NUM
dpc-4793	153	3	.5	.5	NUM
dpc-4793	153	4	50	50	NUM
dpc-4793	153	5	.1	.1	NUM
dpc-4793	153	6	*	*	PUNCT
dpc-4793	154	1	[	[	X
dpc-4793	154	2	1	1	NUM
dpc-4793	154	3	791	791	NUM
dpc-4793	154	4	]	]	PUNCT
dpc-4793	154	5	n	n	CCONJ
dpc-4793	154	6	r	r	NOUN
dpc-4793	154	7	16	16	NUM
dpc-4793	154	8	.7	.7	NUM
dpc-4793	154	9	*	*	PUNCT
dpc-4793	154	10	n	n	CCONJ
dpc-4793	154	11	r	r	NOUN
dpc-4793	154	12	n	n	NOUN
dpc-4793	154	13	r	r	NOUN
dpc-4793	154	14	6	6	NUM
dpc-4793	154	15	.	.	NOUN
dpc-4793	154	16	8	8	NUM
dpc-4793	154	17	*	*	SYM
dpc-4793	154	18	57	57	NUM
dpc-4793	154	19	.4	.4	NUM
dpc-4793	154	20	,	,	PUNCT
dpc-4793	154	21	3	3	NUM
dpc-4793	154	22	2	2	NUM
dpc-4793	154	23	,	,	PUNCT
dpc-4793	154	24	4	4	NUM
dpc-4793	154	25	.8	.8	NUM
dpc-4793	154	26	b	b	X
dpc-4793	154	27	et	et	NOUN
dpc-4793	154	28	am	be	AUX
dpc-4793	154	29	et	et	NOUN
dpc-4793	154	30	ha	ha	INTJ
dpc-4793	154	31	so	so	ADV
dpc-4793	154	32	ne	ne	PROPN
dpc-4793	154	33	d	d	PROPN
dpc-4793	154	34	ip	ip	PRON
dpc-4793	154	35	ro	ro	X
dpc-4793	154	36	pi	pi	NOUN
dpc-4793	154	37	on	on	ADV
dpc-4793	154	38	at	at	ADP
dpc-4793	154	39	e	e	PROPN
dpc-4793	154	40	q	q	PROPN
dpc-4793	154	41	d	d	PROPN
dpc-4793	154	42	96	96	NUM
dpc-4793	154	43	.8	.8	NUM
dpc-4793	154	44	41	41	NUM
dpc-4793	154	45	.9	.9	NUM
dpc-4793	154	46	49	49	NUM
dpc-4793	154	47	.5	.5	NUM
dpc-4793	155	1	*	*	PUNCT
dpc-4793	155	2	[	[	PUNCT
dpc-4793	155	3	18	18	NUM
dpc-4793	155	4	-9	-9	NOUN
dpc-4793	155	5	1	1	NUM
dpc-4793	155	6	]	]	PUNCT
dpc-4793	155	7	n	n	PRON
dpc-4793	155	8	r	r	NOUN
dpc-4793	155	9	17	17	NUM
dpc-4793	155	10	.4	.4	NUM
dpc-4793	155	11	*	*	PUNCT
dpc-4793	155	12	n	n	CCONJ
dpc-4793	155	13	r	r	NOUN
dpc-4793	155	14	n	n	NOUN
dpc-4793	155	15	r	r	NOUN
dpc-4793	155	16	6	6	NUM
dpc-4793	155	17	.	.	PUNCT
dpc-4793	156	1	9	9	NUM
dpc-4793	156	2	*	*	SYM
dpc-4793	156	3	57	57	NUM
dpc-4793	156	4	,	,	PUNCT
dpc-4793	156	5	3	3	NUM
dpc-4793	156	6	2	2	NUM
dpc-4793	156	7	.	.	NOUN
dpc-4793	156	8	9	9	NUM
dpc-4793	156	9	,	,	PUNCT
dpc-4793	156	10	5	5	NUM
dpc-4793	156	11	.6	.6	NUM
dpc-4793	156	12	pl	pl	PROPN
dpc-4793	156	13	ac	ac	PROPN
dpc-4793	156	14	eb	eb	PROPN
dpc-4793	156	15	o	o	PROPN
dpc-4793	156	16	94	94	NUM
dpc-4793	157	1	.9	.9	NUM
dpc-4793	157	2	44	44	NUM
dpc-4793	158	1	.9	.9	NUM
dpc-4793	158	2	49	49	NUM
dpc-4793	159	1	.6	.6	NUM
dpc-4793	159	2	*	*	PUNCT
dpc-4793	160	1	[	[	X
dpc-4793	160	2	1	1	NUM
dpc-4793	160	3	897	897	NUM
dpc-4793	160	4	]	]	PUNCT
dpc-4793	160	5	n	n	CCONJ
dpc-4793	160	6	r	r	NOUN
dpc-4793	160	7	16	16	NUM
dpc-4793	160	8	.3	.3	NUM
dpc-4793	160	9	*	*	PUNCT
dpc-4793	160	10	n	n	CCONJ
dpc-4793	160	11	r	r	NOUN
dpc-4793	160	12	n	n	NOUN
dpc-4793	160	13	r	r	NOUN
dpc-4793	160	14	7	7	NUM
dpc-4793	160	15	*	*	SYM
dpc-4793	160	16	50	50	NUM
dpc-4793	160	17	.7	.7	NOUN
dpc-4793	160	18	,	,	PUNCT
dpc-4793	160	19	3	3	NUM
dpc-4793	160	20	6	6	NUM
dpc-4793	160	21	,	,	PUNCT
dpc-4793	160	22	5	5	NUM
dpc-4793	160	23	.9	.9	NUM
dpc-4793	160	24	ju	ju	PROPN
dpc-4793	161	1	ry	ry	NOUN
dpc-4793	161	2	c	c	PROPN
dpc-4793	161	3	s	s	X
dpc-4793	162	1	[	[	X
dpc-4793	162	2	4	4	NUM
dpc-4793	162	3	2	2	NUM
dpc-4793	162	4	]	]	PUNCT
dpc-4793	162	5	it	it	PRON
dpc-4793	162	6	ra	ra	INTJ
dpc-4793	162	7	co	co	VERB
dpc-4793	162	8	na	na	PROPN
dpc-4793	162	9	zo	zo	PROPN
dpc-4793	162	10	le	le	X
dpc-4793	162	11	n	n	PROPN
dpc-4793	162	12	r	r	NOUN
dpc-4793	162	13	42	42	NUM
dpc-4793	162	14	.8	.8	NUM
dpc-4793	162	15	5	5	NUM
dpc-4793	162	16	47	47	NUM
dpc-4793	162	17	n	n	NOUN
dpc-4793	162	18	r	r	NOUN
dpc-4793	162	19	n	n	ADP
dpc-4793	162	20	r	r	NOUN
dpc-4793	162	21	n	n	ADP
dpc-4793	162	22	r	r	NOUN
dpc-4793	162	23	n	n	ADP
dpc-4793	162	24	r	r	NOUN
dpc-4793	162	25	n	n	ADP
dpc-4793	162	26	r	r	NOUN
dpc-4793	162	27	n	n	NOUN
dpc-4793	162	28	r	r	NOUN
dpc-4793	162	29	pl	pl	X
dpc-4793	162	30	ac	ac	PROPN
dpc-4793	162	31	eb	eb	PROPN
dpc-4793	162	32	o	o	PROPN
dpc-4793	162	33	n	n	CCONJ
dpc-4793	162	34	r	r	NOUN
dpc-4793	162	35	42	42	NUM
dpc-4793	162	36	.8	.8	NUM
dpc-4793	162	37	5	5	NUM
dpc-4793	162	38	47	47	NUM
dpc-4793	162	39	n	n	NOUN
dpc-4793	162	40	r	r	NOUN
dpc-4793	162	41	n	n	ADP
dpc-4793	162	42	r	r	NOUN
dpc-4793	162	43	n	n	ADP
dpc-4793	162	44	r	r	NOUN
dpc-4793	162	45	n	n	ADP
dpc-4793	162	46	r	r	NOUN
dpc-4793	162	47	n	n	ADP
dpc-4793	162	48	r	r	NOUN
dpc-4793	162	49	n	n	NOUN
dpc-4793	162	50	r	r	NOUN
dpc-4793	162	51	k	k	X
dpc-4793	162	52	ra	ra	PROPN
dpc-4793	162	53	gb	gb	ADP
dpc-4793	162	54	al	al	PROPN
dpc-4793	162	55	le	le	PROPN
dpc-4793	162	56	k	k	PROPN
dpc-4793	163	1	[	[	PUNCT
dpc-4793	163	2	25	25	NUM
dpc-4793	163	3	]	]	PUNCT
dpc-4793	163	4	c	c	PROPN
dpc-4793	163	5	al	al	PROPN
dpc-4793	163	6	ci	ci	PROPN
dpc-4793	163	7	po	po	PROPN
dpc-4793	163	8	tr	tr	VERB
dpc-4793	163	9	io	io	PROPN
dpc-4793	163	10	l	l	PROPN
dpc-4793	163	11	/	/	SYM
dpc-4793	163	12	e	e	X
dpc-4793	163	13	ne	ne	NOUN
dpc-4793	164	1	+	+	CCONJ
dpc-4793	164	2	b	b	X
dpc-4793	164	3	et	et	NOUN
dpc-4793	164	4	am	be	AUX
dpc-4793	164	5	et	et	NOUN
dpc-4793	164	6	ha	ha	INTJ
dpc-4793	164	7	so	so	ADV
dpc-4793	164	8	ne	ne	PROPN
dpc-4793	164	9	d	d	PROPN
dpc-4793	164	10	ip	ip	PRON
dpc-4793	164	11	ro	ro	X
dpc-4793	164	12	pi	pi	NOUN
dpc-4793	164	13	on	on	ADV
dpc-4793	164	14	at	at	ADP
dpc-4793	164	15	e	e	PROPN
dpc-4793	164	16	99	99	NUM
dpc-4793	164	17	43	43	NUM
dpc-4793	164	18	.5	.5	NUM
dpc-4793	164	19	50	50	NUM
dpc-4793	165	1	.8	.8	NUM
dpc-4793	165	2	*	*	PUNCT
dpc-4793	166	1	[	[	X
dpc-4793	166	2	1	1	NUM
dpc-4793	166	3	891	891	NUM
dpc-4793	166	4	]	]	PUNCT
dpc-4793	166	5	n	n	CCONJ
dpc-4793	166	6	r	r	NOUN
dpc-4793	166	7	18	18	NUM
dpc-4793	166	8	.4	.4	NUM
dpc-4793	166	9	*	*	PUNCT
dpc-4793	166	10	n	n	CCONJ
dpc-4793	166	11	r	r	NOUN
dpc-4793	166	12	n	n	NOUN
dpc-4793	166	13	r	r	NOUN
dpc-4793	166	14	7	7	NUM
dpc-4793	166	15	.	.	NOUN
dpc-4793	166	16	4	4	NUM
dpc-4793	166	17	*	*	SYM
dpc-4793	166	18	54	54	NUM
dpc-4793	166	19	.6	.6	NUM
dpc-4793	166	20	,	,	PUNCT
dpc-4793	166	21	3	3	NUM
dpc-4793	166	22	7	7	NUM
dpc-4793	166	23	.	.	NOUN
dpc-4793	166	24	7	7	NUM
dpc-4793	166	25	,	,	PUNCT
dpc-4793	166	26	7	7	NUM
dpc-4793	166	27	.7	.7	NUM
dpc-4793	166	28	c	c	NOUN
dpc-4793	166	29	al	al	PROPN
dpc-4793	166	30	ci	ci	PROPN
dpc-4793	166	31	po	po	PROPN
dpc-4793	166	32	tr	tr	VERB
dpc-4793	166	33	ie	ie	X
dpc-4793	166	34	ne	ne	X
dpc-4793	166	35	/o	/o	PUNCT
dpc-4793	166	36	l	l	NOUN
dpc-4793	167	1	99	99	NUM
dpc-4793	168	1	41	41	NUM
dpc-4793	168	2	.9	.9	NUM
dpc-4793	168	3	51	51	NUM
dpc-4793	169	1	.4	.4	NUM
dpc-4793	170	1	*	*	PUNCT
dpc-4793	171	1	[	[	X
dpc-4793	171	2	2	2	NUM
dpc-4793	171	3	485	485	NUM
dpc-4793	171	4	]	]	PUNCT
dpc-4793	171	5	n	n	CCONJ
dpc-4793	171	6	r	r	NOUN
dpc-4793	171	7	19	19	NUM
dpc-4793	171	8	.3	.3	NUM
dpc-4793	171	9	*	*	PUNCT
dpc-4793	171	10	n	n	CCONJ
dpc-4793	171	11	r	r	NOUN
dpc-4793	171	12	n	n	NOUN
dpc-4793	171	13	r	r	NOUN
dpc-4793	171	14	7	7	NUM
dpc-4793	171	15	.	.	NOUN
dpc-4793	172	1	1	1	NUM
dpc-4793	172	2	*	*	SYM
dpc-4793	172	3	61	61	NUM
dpc-4793	172	4	,	,	PUNCT
dpc-4793	172	5	3	3	NUM
dpc-4793	172	6	2	2	NUM
dpc-4793	172	7	.	.	NOUN
dpc-4793	172	8	4	4	NUM
dpc-4793	172	9	,	,	PUNCT
dpc-4793	172	10	6	6	NUM
dpc-4793	172	11	.7	.7	NUM
dpc-4793	172	12	l	l	NOUN
dpc-4793	172	13	iu	iu	ADP
dpc-4793	172	14	l	l	NOUN
dpc-4793	172	15	[	[	PUNCT
dpc-4793	172	16	26	26	NUM
dpc-4793	172	17	]	]	PUNCT
dpc-4793	172	18	c	c	PROPN
dpc-4793	172	19	al	al	PROPN
dpc-4793	172	20	ci	ci	PROPN
dpc-4793	172	21	po	po	PROPN
dpc-4793	172	22	tr	tr	VERB
dpc-4793	172	23	io	io	PROPN
dpc-4793	172	24	l	l	PROPN
dpc-4793	172	25	/	/	SYM
dpc-4793	172	26	e	e	X
dpc-4793	172	27	ne	ne	NOUN
dpc-4793	172	28	+	+	CCONJ
dpc-4793	172	29	b	b	X
dpc-4793	172	30	et	et	NOUN
dpc-4793	172	31	am	be	AUX
dpc-4793	172	32	et	et	NOUN
dpc-4793	172	33	ha	ha	INTJ
dpc-4793	172	34	so	so	ADV
dpc-4793	172	35	ne	ne	PROPN
dpc-4793	172	36	d	d	PROPN
dpc-4793	172	37	ip	ip	PRON
dpc-4793	172	38	ro	ro	X
dpc-4793	172	39	pi	pi	NOUN
dpc-4793	172	40	on	on	ADV
dpc-4793	172	41	at	at	ADP
dpc-4793	172	42	e	e	X
dpc-4793	172	43	0	0	NUM
dpc-4793	172	44	67	67	NUM
dpc-4793	172	45	.6	.6	NUM
dpc-4793	172	46	40	40	NUM
dpc-4793	172	47	.9	.9	NUM
dpc-4793	173	1	*	*	PUNCT
dpc-4793	174	1	[	[	X
dpc-4793	174	2	1	1	NUM
dpc-4793	174	3	881	881	NUM
dpc-4793	174	4	]	]	SYM
dpc-4793	174	5	24	24	NUM
dpc-4793	174	6	.0	.0	NUM
dpc-4793	174	7	5	5	NUM
dpc-4793	174	8	*	*	SYM
dpc-4793	174	9	8	8	NUM
dpc-4793	174	10	.	.	NOUN
dpc-4793	174	11	27	27	NUM
dpc-4793	174	12	8	8	NUM
dpc-4793	174	13	*	*	SYM
dpc-4793	174	14	n	n	ADP
dpc-4793	174	15	r	r	NOUN
dpc-4793	174	16	n	n	NOUN
dpc-4793	174	17	r	r	NOUN
dpc-4793	174	18	n	n	NOUN
dpc-4793	174	19	r	r	NOUN
dpc-4793	174	20	56	56	NUM
dpc-4793	174	21	.7	.7	NUM
dpc-4793	174	22	,	,	PUNCT
dpc-4793	174	23	2	2	NUM
dpc-4793	174	24	7	7	NUM
dpc-4793	174	25	.	.	NOUN
dpc-4793	174	26	1	1	NUM
dpc-4793	174	27	,	,	PUNCT
dpc-4793	174	28	1	1	NUM
dpc-4793	174	29	.8	.8	NUM
dpc-4793	174	30	c	c	PROPN
dpc-4793	174	31	al	al	PROPN
dpc-4793	174	32	ci	ci	PROPN
dpc-4793	174	33	po	po	PROPN
dpc-4793	174	34	tr	tr	VERB
dpc-4793	174	35	ie	ie	X
dpc-4793	174	36	ne	ne	X
dpc-4793	174	37	/o	/o	PUNCT
dpc-4793	175	1	l	l	NOUN
dpc-4793	175	2	0	0	NUM
dpc-4793	176	1	66	66	NUM
dpc-4793	176	2	.1	.1	NUM
dpc-4793	176	3	39	39	NUM
dpc-4793	177	1	.9	.9	NUM
dpc-4793	178	1	*	*	PUNCT
dpc-4793	179	1	[	[	X
dpc-4793	179	2	1	1	NUM
dpc-4793	179	3	876	876	NUM
dpc-4793	179	4	]	]	SYM
dpc-4793	179	5	24	24	NUM
dpc-4793	179	6	.0	.0	NUM
dpc-4793	179	7	5	5	NUM
dpc-4793	179	8	*	*	SYM
dpc-4793	179	9	7	7	NUM
dpc-4793	179	10	.	.	NUM
dpc-4793	179	11	51	51	NUM
dpc-4793	180	1	7	7	NUM
dpc-4793	180	2	*	*	SYM
dpc-4793	180	3	n	n	ADP
dpc-4793	180	4	r	r	NOUN
dpc-4793	180	5	n	n	NOUN
dpc-4793	180	6	r	r	NOUN
dpc-4793	180	7	n	n	NOUN
dpc-4793	180	8	r	r	NOUN
dpc-4793	180	9	56	56	NUM
dpc-4793	180	10	,	,	PUNCT
dpc-4793	180	11	2	2	NUM
dpc-4793	180	12	3	3	NUM
dpc-4793	180	13	.	.	NOUN
dpc-4793	180	14	6	6	NUM
dpc-4793	180	15	,	,	PUNCT
dpc-4793	180	16	1	1	NUM
dpc-4793	180	17	t	t	PROPN
dpc-4793	180	18	ab	ab	PROPN
dpc-4793	180	19	le	le	X
dpc-4793	180	20	1	1	NUM
dpc-4793	180	21	co	co	VERB
dpc-4793	180	22	nt	not	PART
dpc-4793	180	23	in	in	ADP
dpc-4793	180	24	ue	ue	PROPN
dpc-4793	180	25	s	s	PROPN
dpc-4793	180	26	6	6	NUM
dpc-4793	180	27	review	review	NOUN
dpc-4793	180	28	|	|	ADV
dpc-4793	180	29	dermatol	dermatol	ADJ
dpc-4793	180	30	pract	pract	NOUN
dpc-4793	180	31	concept	concept	NOUN
dpc-4793	180	32	.	.	PUNCT
dpc-4793	181	1	2025;15(2):4793	2025;15(2):4793	NUM
dpc-4793	181	2	a	a	DET
dpc-4793	181	3	ut	ut	PROPN
dpc-4793	181	4	ho	ho	PROPN
dpc-4793	181	5	r	r	PROPN
dpc-4793	181	6	a	a	DET
dpc-4793	181	7	rm	rm	NOUN
dpc-4793	181	8	s	s	PROPN
dpc-4793	181	9	c	c	NOUN
dpc-4793	181	10	au	au	NOUN
dpc-4793	181	11	ca	can	AUX
dpc-4793	181	12	si	si	PROPN
dpc-4793	181	13	an	an	DET
dpc-4793	181	14	(	(	PUNCT
dpc-4793	181	15	%	%	NOUN
dpc-4793	181	16	)	)	PUNCT
dpc-4793	181	17	m	m	VERB
dpc-4793	181	18	al	al	PROPN
dpc-4793	181	19	e	e	PROPN
dpc-4793	181	20	(	(	PUNCT
dpc-4793	181	21	%	%	INTJ
dpc-4793	181	22	)	)	PUNCT
dpc-4793	181	23	a	a	DET
dpc-4793	181	24	ge	ge	PROPN
dpc-4793	181	25	[	[	PUNCT
dpc-4793	181	26	m	m	VERB
dpc-4793	181	27	in	in	ADP
dpc-4793	181	28	-m	-m	DET
dpc-4793	181	29	ax	ax	NOUN
dpc-4793	181	30	]	]	PUNCT
dpc-4793	181	31	(	(	PUNCT
dpc-4793	181	32	y	y	PROPN
dpc-4793	181	33	ea	ea	PROPN
dpc-4793	181	34	rs	rs	PROPN
dpc-4793	181	35	)	)	PUNCT
dpc-4793	182	1	m	m	VERB
dpc-4793	182	2	ea	ea	NOUN
dpc-4793	183	1	n	n	NUM
dpc-4793	183	2	b	b	NOUN
dpc-4793	183	3	m	m	VERB
dpc-4793	183	4	i	i	PRON
dpc-4793	183	5	ps	ps	VERB
dpc-4793	183	6	or	or	CCONJ
dpc-4793	183	7	ia	ia	PROPN
dpc-4793	184	1	si	si	X
dpc-4793	184	2	s	s	PROPN
dpc-4793	184	3	d	d	X
dpc-4793	184	4	ur	ur	INTJ
dpc-4793	184	5	at	at	ADP
dpc-4793	184	6	io	io	X
dpc-4793	184	7	n	n	PROPN
dpc-4793	184	8	(	(	PUNCT
dpc-4793	184	9	y	y	PROPN
dpc-4793	184	10	ea	ea	PROPN
dpc-4793	184	11	rs	rs	PROPN
dpc-4793	184	12	)	)	PUNCT
dpc-4793	184	13	sc	sc	PROPN
dpc-4793	184	14	al	al	PROPN
dpc-4793	184	15	p	p	PROPN
dpc-4793	184	16	in	in	ADP
dpc-4793	184	17	vo	vo	X
dpc-4793	184	18	lv	lv	PROPN
dpc-4793	184	19	em	em	PRON
dpc-4793	184	20	en	en	PROPN
dpc-4793	184	21	t	t	PROPN
dpc-4793	184	22	(	(	PUNCT
dpc-4793	184	23	%	%	NOUN
dpc-4793	184	24	)	)	PUNCT
dpc-4793	184	25	ps	ps	INTJ
dpc-4793	184	26	si	si	PROPN
dpc-4793	184	27	t	t	PROPN
dpc-4793	184	28	ss	ss	VERB
dpc-4793	184	29	ig	ig	PROPN
dpc-4793	184	30	a	a	PRON
dpc-4793	184	31	/p	/p	PUNCT
dpc-4793	184	32	g	g	PROPN
dpc-4793	184	33	a	a	DET
dpc-4793	184	34	s	s	X
dpc-4793	184	35	co	co	X
dpc-4793	184	36	re	re	NOUN
dpc-4793	184	37	of	of	ADP
dpc-4793	184	38	3	3	NUM
dpc-4793	184	39	-5	-5	NUM
dpc-4793	184	40	(	(	PUNCT
dpc-4793	184	41	%	%	INTJ
dpc-4793	184	42	)	)	PUNCT
dpc-4793	184	43	m	m	VERB
dpc-4793	184	44	a	a	DET
dpc-4793	184	45	l	l	NOUN
dpc-4793	184	46	[	[	PUNCT
dpc-4793	184	47	27	27	NUM
dpc-4793	184	48	]	]	PUNCT
dpc-4793	184	49	c	c	PROPN
dpc-4793	184	50	al	al	PROPN
dpc-4793	184	51	ci	ci	PROPN
dpc-4793	184	52	po	po	PROPN
dpc-4793	184	53	tr	tr	VERB
dpc-4793	184	54	io	io	PROPN
dpc-4793	184	55	l	l	PROPN
dpc-4793	184	56	/	/	SYM
dpc-4793	184	57	e	e	X
dpc-4793	184	58	ne	ne	NOUN
dpc-4793	185	1	+	+	CCONJ
dpc-4793	185	2	b	b	X
dpc-4793	185	3	et	et	NOUN
dpc-4793	185	4	am	be	AUX
dpc-4793	185	5	et	et	NOUN
dpc-4793	185	6	ha	ha	INTJ
dpc-4793	185	7	so	so	ADV
dpc-4793	185	8	ne	ne	PROPN
dpc-4793	185	9	d	d	PROPN
dpc-4793	185	10	ip	ip	PRON
dpc-4793	185	11	ro	ro	X
dpc-4793	185	12	pi	pi	NOUN
dpc-4793	185	13	on	on	ADV
dpc-4793	185	14	at	at	ADP
dpc-4793	185	15	e	e	PROPN
dpc-4793	185	16	n	n	ADP
dpc-4793	185	17	r	r	NOUN
dpc-4793	185	18	60	60	NUM
dpc-4793	185	19	.8	.8	NUM
dpc-4793	185	20	39	39	NUM
dpc-4793	185	21	.9	.9	NUM
dpc-4793	186	1	*	*	PUNCT
dpc-4793	186	2	n	n	NUM
dpc-4793	186	3	r	r	NOUN
dpc-4793	186	4	7	7	NUM
dpc-4793	186	5	.	.	NOUN
dpc-4793	186	6	4	4	NUM
dpc-4793	186	7	*	*	SYM
dpc-4793	186	8	54	54	NUM
dpc-4793	186	9	.1	.1	NUM
dpc-4793	186	10	*	*	PUNCT
dpc-4793	187	1	n	n	CCONJ
dpc-4793	187	2	r	r	NOUN
dpc-4793	187	3	6	6	NUM
dpc-4793	187	4	.	.	NOUN
dpc-4793	187	5	8	8	NUM
dpc-4793	187	6	*	*	SYM
dpc-4793	187	7	69	69	NUM
dpc-4793	187	8	.2	.2	NUM
dpc-4793	187	9	,	,	PUNCT
dpc-4793	187	10	2	2	NUM
dpc-4793	187	11	4	4	NUM
dpc-4793	187	12	.	.	NOUN
dpc-4793	187	13	4	4	NUM
dpc-4793	187	14	,	,	PUNCT
dpc-4793	187	15	6	6	NUM
dpc-4793	187	16	.7	.7	NUM
dpc-4793	187	17	c	c	NOUN
dpc-4793	187	18	al	al	PROPN
dpc-4793	187	19	ci	ci	PROPN
dpc-4793	187	20	po	po	PROPN
dpc-4793	187	21	tr	tr	VERB
dpc-4793	187	22	ie	ie	X
dpc-4793	187	23	ne	ne	X
dpc-4793	187	24	/o	/o	PUNCT
dpc-4793	188	1	l	l	NOUN
dpc-4793	188	2	n	n	CCONJ
dpc-4793	188	3	r	r	NOUN
dpc-4793	188	4	55	55	NUM
dpc-4793	188	5	.6	.6	NUM
dpc-4793	188	6	38	38	NUM
dpc-4793	188	7	.7	.7	NUM
dpc-4793	188	8	*	*	PUNCT
dpc-4793	189	1	n	n	CCONJ
dpc-4793	189	2	r	r	NOUN
dpc-4793	189	3	7	7	NUM
dpc-4793	189	4	.	.	NOUN
dpc-4793	190	1	5	5	NUM
dpc-4793	190	2	*	*	SYM
dpc-4793	190	3	48	48	NUM
dpc-4793	191	1	.6	.6	NUM
dpc-4793	191	2	*	*	PUNCT
dpc-4793	191	3	n	n	CCONJ
dpc-4793	191	4	r	r	NOUN
dpc-4793	191	5	6	6	NUM
dpc-4793	191	6	.	.	PUNCT
dpc-4793	191	7	9	9	NUM
dpc-4793	191	8	*	*	SYM
dpc-4793	191	9	70	70	NUM
dpc-4793	191	10	.2	.2	NUM
dpc-4793	191	11	,	,	PUNCT
dpc-4793	191	12	2	2	NUM
dpc-4793	191	13	5	5	NUM
dpc-4793	191	14	.	.	NOUN
dpc-4793	191	15	8	8	NUM
dpc-4793	191	16	,	,	PUNCT
dpc-4793	191	17	4	4	NUM
dpc-4793	191	18	o	o	NOUN
dpc-4793	191	19	ku	ku	PROPN
dpc-4793	191	20	bo	bo	PROPN
dpc-4793	191	21	y	y	PROPN
dpc-4793	191	22	[	[	PUNCT
dpc-4793	191	23	40	40	NUM
dpc-4793	191	24	]	]	SYM
dpc-4793	191	25	b	b	X
dpc-4793	191	26	et	et	NOUN
dpc-4793	191	27	am	be	AUX
dpc-4793	191	28	et	et	NOUN
dpc-4793	191	29	ha	ha	INTJ
dpc-4793	192	1	so	so	ADV
dpc-4793	192	2	ne	ne	INTJ
dpc-4793	192	3	bu	bu	PROPN
dpc-4793	192	4	ty	ty	INTJ
dpc-4793	193	1	ra	ra	INTJ
dpc-4793	194	1	te	te	INTJ
dpc-4793	194	2	p	p	X
dpc-4793	194	3	ro	ro	ADJ
dpc-4793	194	4	pi	pi	NOUN
dpc-4793	194	5	on	on	ADV
dpc-4793	194	6	at	at	ADP
dpc-4793	194	7	e	e	PROPN
dpc-4793	194	8	+	+	NOUN
dpc-4793	194	9	m	m	VERB
dpc-4793	194	10	ax	ax	NOUN
dpc-4793	194	11	ac	ac	PROPN
dpc-4793	194	12	al	al	PROPN
dpc-4793	194	13	ci	ci	PROPN
dpc-4793	194	14	to	to	ADP
dpc-4793	194	15	l	l	PROPN
dpc-4793	194	16	(	(	PUNCT
dpc-4793	194	17	8	8	NUM
dpc-4793	194	18	 	 	SPACE
dpc-4793	194	19	w	w	PROPN
dpc-4793	194	20	ee	ee	PROPN
dpc-4793	194	21	ks	ks	PROPN
dpc-4793	194	22	)	)	PUNCT
dpc-4793	195	1	n	n	CCONJ
dpc-4793	195	2	r	r	NOUN
dpc-4793	195	3	87	87	NUM
dpc-4793	195	4	.5	.5	NUM
dpc-4793	195	5	49	49	NUM
dpc-4793	196	1	.6	.6	NUM
dpc-4793	196	2	*	*	PUNCT
dpc-4793	197	1	[	[	X
dpc-4793	197	2	2	2	NUM
dpc-4793	197	3	478	478	NUM
dpc-4793	197	4	]	]	PUNCT
dpc-4793	197	5	n	n	CCONJ
dpc-4793	197	6	r	r	NOUN
dpc-4793	197	7	14	14	NUM
dpc-4793	197	8	.1	.1	NUM
dpc-4793	197	9	*	*	PUNCT
dpc-4793	198	1	n	n	CCONJ
dpc-4793	198	2	r	r	NOUN
dpc-4793	198	3	n	n	NOUN
dpc-4793	198	4	r	r	NOUN
dpc-4793	198	5	5	5	NUM
dpc-4793	198	6	.	.	NOUN
dpc-4793	199	1	6	6	NUM
dpc-4793	199	2	*	*	NOUN
dpc-4793	199	3	n	n	PRON
dpc-4793	199	4	r	r	NOUN
dpc-4793	199	5	b	b	NOUN
dpc-4793	199	6	et	et	NOUN
dpc-4793	199	7	am	be	AUX
dpc-4793	199	8	et	et	NOUN
dpc-4793	199	9	ha	ha	INTJ
dpc-4793	200	1	so	so	ADV
dpc-4793	200	2	ne	ne	INTJ
dpc-4793	200	3	bu	bu	PROPN
dpc-4793	200	4	ty	ty	INTJ
dpc-4793	201	1	ra	ra	INTJ
dpc-4793	202	1	te	te	INTJ
dpc-4793	202	2	p	p	X
dpc-4793	202	3	ro	ro	ADJ
dpc-4793	202	4	pi	pi	NOUN
dpc-4793	202	5	on	on	ADV
dpc-4793	202	6	at	at	ADP
dpc-4793	202	7	e	e	PROPN
dpc-4793	202	8	+	+	NOUN
dpc-4793	202	9	m	m	VERB
dpc-4793	202	10	ax	ax	NOUN
dpc-4793	202	11	ac	ac	PROPN
dpc-4793	202	12	al	al	PROPN
dpc-4793	202	13	ci	ci	PROPN
dpc-4793	202	14	to	to	ADP
dpc-4793	202	15	l	l	PROPN
dpc-4793	202	16	(	(	PUNCT
dpc-4793	202	17	4	4	NUM
dpc-4793	202	18	w	w	PROPN
dpc-4793	202	19	ee	ee	PROPN
dpc-4793	202	20	ks	ks	PROPN
dpc-4793	202	21	)	)	PUNCT
dpc-4793	202	22	n	n	CCONJ
dpc-4793	202	23	r	r	NOUN
dpc-4793	202	24	80	80	NUM
dpc-4793	202	25	46	46	NUM
dpc-4793	202	26	.1	.1	NUM
dpc-4793	202	27	*	*	PUNCT
dpc-4793	203	1	[	[	X
dpc-4793	203	2	2	2	NUM
dpc-4793	203	3	676	676	NUM
dpc-4793	203	4	]	]	PUNCT
dpc-4793	203	5	n	n	CCONJ
dpc-4793	203	6	r	r	NOUN
dpc-4793	203	7	7	7	NUM
dpc-4793	203	8	.	.	PUNCT
dpc-4793	203	9	3	3	NUM
dpc-4793	203	10	*	*	SYM
dpc-4793	203	11	n	n	NUM
dpc-4793	203	12	r	r	NOUN
dpc-4793	203	13	n	n	NOUN
dpc-4793	203	14	r	r	NOUN
dpc-4793	203	15	5	5	NUM
dpc-4793	203	16	.	.	NOUN
dpc-4793	203	17	4	4	NUM
dpc-4793	203	18	*	*	NOUN
dpc-4793	203	19	n	n	NUM
dpc-4793	203	20	r	r	PROPN
dpc-4793	203	21	va	va	PROPN
dpc-4793	203	22	n	n	CCONJ
dpc-4793	203	23	de	de	PROPN
dpc-4793	203	24	k	k	PROPN
dpc-4793	204	1	er	er	INTJ
dpc-4793	204	2	kh	kh	PROPN
dpc-4793	204	3	of	of	ADP
dpc-4793	204	4	p	p	PROPN
dpc-4793	204	5	c	c	PROPN
dpc-4793	205	1	[	[	X
dpc-4793	205	2	2	2	NUM
dpc-4793	205	3	8	8	NUM
dpc-4793	205	4	]	]	PUNCT
dpc-4793	205	5	c	c	PROPN
dpc-4793	205	6	al	al	PROPN
dpc-4793	205	7	ci	ci	PROPN
dpc-4793	205	8	po	po	PROPN
dpc-4793	205	9	tr	tr	VERB
dpc-4793	205	10	io	io	PROPN
dpc-4793	205	11	l	l	PROPN
dpc-4793	205	12	/	/	SYM
dpc-4793	205	13	e	e	X
dpc-4793	205	14	ne	ne	NOUN
dpc-4793	206	1	+	+	CCONJ
dpc-4793	206	2	b	b	X
dpc-4793	206	3	et	et	NOUN
dpc-4793	206	4	am	be	AUX
dpc-4793	206	5	et	et	NOUN
dpc-4793	206	6	ha	ha	INTJ
dpc-4793	206	7	so	so	ADV
dpc-4793	206	8	ne	ne	PROPN
dpc-4793	206	9	d	d	PROPN
dpc-4793	206	10	ip	ip	PRON
dpc-4793	206	11	ro	ro	X
dpc-4793	206	12	pi	pi	NOUN
dpc-4793	206	13	on	on	ADV
dpc-4793	206	14	at	at	ADP
dpc-4793	206	15	e	e	PROPN
dpc-4793	206	16	98	98	NUM
dpc-4793	206	17	.4	.4	NUM
dpc-4793	206	18	41	41	NUM
dpc-4793	206	19	.9	.9	NUM
dpc-4793	206	20	48	48	NUM
dpc-4793	206	21	.5	.5	NUM
dpc-4793	207	1	*	*	PUNCT
dpc-4793	208	1	[	[	X
dpc-4793	208	2	1	1	NUM
dpc-4793	208	3	892	892	NUM
dpc-4793	208	4	]	]	PUNCT
dpc-4793	208	5	n	n	CCONJ
dpc-4793	208	6	r	r	NOUN
dpc-4793	208	7	15	15	NUM
dpc-4793	208	8	.7	.7	NUM
dpc-4793	208	9	*	*	PUNCT
dpc-4793	208	10	n	n	CCONJ
dpc-4793	208	11	r	r	NOUN
dpc-4793	208	12	n	n	NOUN
dpc-4793	208	13	r	r	NOUN
dpc-4793	208	14	6	6	NUM
dpc-4793	208	15	.	.	NOUN
dpc-4793	208	16	8	8	NUM
dpc-4793	208	17	*	*	SYM
dpc-4793	208	18	54	54	NUM
dpc-4793	208	19	.8	.8	NUM
dpc-4793	208	20	,	,	PUNCT
dpc-4793	208	21	2	2	NUM
dpc-4793	208	22	9	9	NUM
dpc-4793	208	23	.	.	NOUN
dpc-4793	208	24	9	9	NUM
dpc-4793	208	25	,	,	PUNCT
dpc-4793	208	26	5	5	NUM
dpc-4793	208	27	.5	.5	NUM
dpc-4793	208	28	b	b	X
dpc-4793	208	29	et	et	NOUN
dpc-4793	208	30	am	be	AUX
dpc-4793	208	31	et	et	NOUN
dpc-4793	208	32	ha	ha	INTJ
dpc-4793	208	33	so	so	ADV
dpc-4793	208	34	ne	ne	PROPN
dpc-4793	208	35	d	d	PROPN
dpc-4793	208	36	ip	ip	PRON
dpc-4793	208	37	ro	ro	X
dpc-4793	208	38	pi	pi	NOUN
dpc-4793	208	39	on	on	ADV
dpc-4793	208	40	at	at	ADP
dpc-4793	208	41	e	e	PROPN
dpc-4793	208	42	q	q	PROPN
dpc-4793	208	43	d	d	PROPN
dpc-4793	208	44	96	96	NUM
dpc-4793	208	45	.8	.8	NUM
dpc-4793	208	46	46	46	NUM
dpc-4793	209	1	.2	.2	NUM
dpc-4793	209	2	47	47	NUM
dpc-4793	210	1	.9	.9	NUM
dpc-4793	211	1	*	*	PUNCT
dpc-4793	212	1	[	[	X
dpc-4793	212	2	1	1	NUM
dpc-4793	212	3	885	885	NUM
dpc-4793	212	4	]	]	PUNCT
dpc-4793	212	5	n	n	CCONJ
dpc-4793	212	6	r	r	NOUN
dpc-4793	212	7	16	16	NUM
dpc-4793	212	8	.1	.1	NUM
dpc-4793	212	9	*	*	PUNCT
dpc-4793	213	1	n	n	CCONJ
dpc-4793	213	2	r	r	NOUN
dpc-4793	213	3	n	n	NOUN
dpc-4793	213	4	r	r	NOUN
dpc-4793	213	5	6	6	NUM
dpc-4793	213	6	.	.	PUNCT
dpc-4793	213	7	9	9	NUM
dpc-4793	213	8	*	*	SYM
dpc-4793	213	9	53	53	NUM
dpc-4793	213	10	.6	.6	NUM
dpc-4793	213	11	,	,	PUNCT
dpc-4793	213	12	3	3	NUM
dpc-4793	213	13	3	3	NUM
dpc-4793	213	14	.	.	NOUN
dpc-4793	213	15	6	6	NUM
dpc-4793	213	16	,	,	PUNCT
dpc-4793	213	17	4	4	NUM
dpc-4793	213	18	.8	.8	NUM
dpc-4793	213	19	c	c	PROPN
dpc-4793	213	20	al	al	PROPN
dpc-4793	213	21	ci	ci	PROPN
dpc-4793	213	22	po	po	PROPN
dpc-4793	213	23	tr	tr	VERB
dpc-4793	213	24	ie	ie	X
dpc-4793	213	25	ne	ne	X
dpc-4793	213	26	/o	/o	PUNCT
dpc-4793	213	27	l	l	NOUN
dpc-4793	214	1	95	95	NUM
dpc-4793	214	2	.8	.8	NUM
dpc-4793	214	3	47	47	NUM
dpc-4793	215	1	.9	.9	NUM
dpc-4793	215	2	48	48	NUM
dpc-4793	216	1	.7	.7	NUM
dpc-4793	216	2	*	*	PUNCT
dpc-4793	217	1	[	[	X
dpc-4793	217	2	1	1	NUM
dpc-4793	217	3	888	888	NUM
dpc-4793	217	4	]	]	PUNCT
dpc-4793	217	5	n	n	CCONJ
dpc-4793	217	6	r	r	NOUN
dpc-4793	217	7	15	15	NUM
dpc-4793	217	8	.8	.8	NUM
dpc-4793	217	9	*	*	PUNCT
dpc-4793	217	10	n	n	CCONJ
dpc-4793	217	11	r	r	NOUN
dpc-4793	217	12	n	n	NOUN
dpc-4793	217	13	r	r	NOUN
dpc-4793	217	14	6	6	NUM
dpc-4793	217	15	.	.	NOUN
dpc-4793	217	16	8	8	NUM
dpc-4793	217	17	*	*	SYM
dpc-4793	217	18	51	51	NUM
dpc-4793	217	19	.4	.4	NUM
dpc-4793	217	20	,	,	PUNCT
dpc-4793	217	21	3	3	NUM
dpc-4793	217	22	2	2	NUM
dpc-4793	217	23	.	.	NOUN
dpc-4793	217	24	9	9	NUM
dpc-4793	217	25	,	,	PUNCT
dpc-4793	217	26	3	3	NUM
dpc-4793	217	27	.5	.5	NUM
dpc-4793	218	1	pa	pa	NOUN
dpc-4793	218	2	te	te	PROPN
dpc-4793	218	3	l	l	PROPN
dpc-4793	219	1	d	d	X
dpc-4793	219	2	s	s	X
dpc-4793	220	1	[	[	X
dpc-4793	220	2	2	2	NUM
dpc-4793	220	3	9	9	NUM
dpc-4793	220	4	]	]	PUNCT
dpc-4793	220	5	c	c	PROPN
dpc-4793	220	6	al	al	PROPN
dpc-4793	220	7	ci	ci	PROPN
dpc-4793	220	8	po	po	PROPN
dpc-4793	220	9	tr	tr	VERB
dpc-4793	220	10	io	io	PROPN
dpc-4793	220	11	l	l	PROPN
dpc-4793	220	12	/	/	SYM
dpc-4793	220	13	e	e	X
dpc-4793	220	14	ne	ne	NOUN
dpc-4793	221	1	+	+	CCONJ
dpc-4793	221	2	b	b	X
dpc-4793	221	3	et	et	NOUN
dpc-4793	221	4	am	be	AUX
dpc-4793	221	5	et	et	NOUN
dpc-4793	221	6	ha	ha	INTJ
dpc-4793	221	7	so	so	ADV
dpc-4793	221	8	ne	ne	PROPN
dpc-4793	221	9	d	d	PROPN
dpc-4793	221	10	ip	ip	PRON
dpc-4793	221	11	ro	ro	X
dpc-4793	221	12	pi	pi	NOUN
dpc-4793	221	13	on	on	ADV
dpc-4793	221	14	at	at	ADP
dpc-4793	221	15	e	e	PROPN
dpc-4793	221	16	93	93	NUM
dpc-4793	221	17	53	53	NUM
dpc-4793	221	18	47	47	NUM
dpc-4793	221	19	.4	.4	NUM
dpc-4793	222	1	*	*	PUNCT
dpc-4793	223	1	[	[	X
dpc-4793	223	2	2	2	NUM
dpc-4793	223	3	081	081	NUM
dpc-4793	223	4	]	]	PUNCT
dpc-4793	223	5	n	n	CCONJ
dpc-4793	223	6	r	r	NOUN
dpc-4793	223	7	14	14	NUM
dpc-4793	223	8	.6	.6	NUM
dpc-4793	223	9	*	*	PUNCT
dpc-4793	223	10	n	n	CCONJ
dpc-4793	223	11	r	r	NOUN
dpc-4793	223	12	n	n	NOUN
dpc-4793	223	13	r	r	NOUN
dpc-4793	223	14	n	n	NOUN
dpc-4793	223	15	r	r	NOUN
dpc-4793	223	16	65	65	NUM
dpc-4793	223	17	,	,	PUNCT
dpc-4793	223	18	1	1	NUM
dpc-4793	223	19	7	7	NUM
dpc-4793	223	20	,	,	PUNCT
dpc-4793	223	21	n	n	PRON
dpc-4793	223	22	r	r	NOUN
dpc-4793	223	23	c	c	PROPN
dpc-4793	223	24	al	al	PROPN
dpc-4793	223	25	ci	ci	PROPN
dpc-4793	223	26	po	po	PROPN
dpc-4793	223	27	tr	tr	VERB
dpc-4793	223	28	ie	ie	X
dpc-4793	223	29	ne	ne	X
dpc-4793	223	30	/o	/o	PUNCT
dpc-4793	224	1	l	l	NOUN
dpc-4793	224	2	91	91	NUM
dpc-4793	225	1	.1	.1	NUM
dpc-4793	225	2	60	60	NUM
dpc-4793	225	3	.4	.4	NUM
dpc-4793	225	4	50	50	NUM
dpc-4793	226	1	.7	.7	NUM
dpc-4793	226	2	*	*	PUNCT
dpc-4793	227	1	[	[	X
dpc-4793	227	2	2	2	NUM
dpc-4793	227	3	185	185	NUM
dpc-4793	227	4	]	]	PUNCT
dpc-4793	227	5	n	n	CCONJ
dpc-4793	227	6	r	r	NOUN
dpc-4793	227	7	18	18	NUM
dpc-4793	227	8	.4	.4	NUM
dpc-4793	227	9	*	*	PUNCT
dpc-4793	227	10	n	n	CCONJ
dpc-4793	227	11	r	r	NOUN
dpc-4793	227	12	n	n	NOUN
dpc-4793	227	13	r	r	NOUN
dpc-4793	227	14	n	n	NOUN
dpc-4793	227	15	r	r	NOUN
dpc-4793	227	16	62	62	NUM
dpc-4793	227	17	.4	.4	NUM
dpc-4793	227	18	,	,	PUNCT
dpc-4793	227	19	1	1	NUM
dpc-4793	227	20	4	4	NUM
dpc-4793	227	21	.	.	NOUN
dpc-4793	227	22	9	9	NUM
dpc-4793	227	23	,	,	PUNCT
dpc-4793	227	24	n	n	NOUN
dpc-4793	227	25	r	r	NOUN
dpc-4793	227	26	b	b	PROPN
dpc-4793	227	27	et	et	NOUN
dpc-4793	227	28	am	be	AUX
dpc-4793	227	29	et	et	NOUN
dpc-4793	227	30	ha	ha	INTJ
dpc-4793	227	31	so	so	ADV
dpc-4793	227	32	ne	ne	PROPN
dpc-4793	227	33	d	d	PROPN
dpc-4793	227	34	ip	ip	PRON
dpc-4793	227	35	ro	ro	X
dpc-4793	227	36	pi	pi	NOUN
dpc-4793	227	37	on	on	ADV
dpc-4793	227	38	at	at	ADP
dpc-4793	227	39	e	e	PROPN
dpc-4793	227	40	q	q	PROPN
dpc-4793	227	41	d	d	X
dpc-4793	227	42	82	82	NUM
dpc-4793	228	1	.2	.2	NUM
dpc-4793	228	2	55	55	NUM
dpc-4793	228	3	.4	.4	NUM
dpc-4793	228	4	49	49	NUM
dpc-4793	228	5	*	*	PUNCT
dpc-4793	229	1	[	[	X
dpc-4793	229	2	2	2	NUM
dpc-4793	229	3	085	085	NUM
dpc-4793	229	4	]	]	PUNCT
dpc-4793	229	5	n	n	CCONJ
dpc-4793	229	6	r	r	NOUN
dpc-4793	229	7	16	16	NUM
dpc-4793	229	8	.2	.2	NUM
dpc-4793	229	9	*	*	PUNCT
dpc-4793	229	10	n	n	CCONJ
dpc-4793	229	11	r	r	NOUN
dpc-4793	229	12	n	n	NOUN
dpc-4793	229	13	r	r	NOUN
dpc-4793	229	14	n	n	NOUN
dpc-4793	229	15	r	r	NOUN
dpc-4793	229	16	71	71	NUM
dpc-4793	229	17	.3	.3	NUM
dpc-4793	229	18	,	,	PUNCT
dpc-4793	229	19	9	9	NUM
dpc-4793	229	20	.9	.9	NUM
dpc-4793	229	21	,	,	PUNCT
dpc-4793	229	22	n	n	NOUN
dpc-4793	229	23	r	r	NOUN
dpc-4793	229	24	r	r	NOUN
dpc-4793	229	25	at	at	ADP
dpc-4793	229	26	ta	ta	PROPN
dpc-4793	229	27	na	na	INTJ
dpc-4793	229	28	ka	ka	PROPN
dpc-4793	229	29	em	em	PROPN
dpc-4793	229	30	ak	ak	PROPN
dpc-4793	229	31	or	or	CCONJ
dpc-4793	229	32	n	n	PRON
dpc-4793	229	33	p	p	X
dpc-4793	230	1	[	[	X
dpc-4793	230	2	2	2	NUM
dpc-4793	230	3	1	1	NUM
dpc-4793	230	4	]	]	PUNCT
dpc-4793	230	5	e	e	X
dpc-4793	230	6	xc	xc	PROPN
dpc-4793	231	1	i	i	PRON
dpc-4793	231	2	m	m	VERB
dpc-4793	231	3	er	er	INTJ
dpc-4793	231	4	la	la	ADV
dpc-4793	231	5	m	m	PROPN
dpc-4793	231	6	p	p	NOUN
dpc-4793	232	1	+	+	NUM
dpc-4793	232	2	10	10	NUM
dpc-4793	232	3	%	%	NOUN
dpc-4793	233	1	l	l	NOUN
dpc-4793	233	2	c	c	NOUN
dpc-4793	234	1	d	d	X
dpc-4793	234	2	c	c	X
dpc-4793	234	3	re	re	VERB
dpc-4793	234	4	am	be	AUX
dpc-4793	234	5	n	n	ADV
dpc-4793	234	6	r	r	NOUN
dpc-4793	234	7	46	46	NUM
dpc-4793	234	8	.7	.7	NUM
dpc-4793	234	9	35	35	NUM
dpc-4793	234	10	.5	.5	NUM
dpc-4793	234	11	3	3	NUM
dpc-4793	234	12	*	*	SYM
dpc-4793	234	13	27	27	NUM
dpc-4793	234	14	.1	.1	NUM
dpc-4793	234	15	5	5	NUM
dpc-4793	234	16	*	*	SYM
dpc-4793	234	17	n	n	NUM
dpc-4793	234	18	r	r	NOUN
dpc-4793	234	19	n	n	NOUN
dpc-4793	234	20	r	r	NOUN
dpc-4793	234	21	12	12	NUM
dpc-4793	234	22	n	n	NOUN
dpc-4793	234	23	r	r	NOUN
dpc-4793	234	24	n	n	NOUN
dpc-4793	234	25	r	r	NOUN
dpc-4793	234	26	e	e	NOUN
dpc-4793	234	27	xc	xc	PROPN
dpc-4793	235	1	i	i	PRON
dpc-4793	235	2	m	m	VERB
dpc-4793	235	3	er	er	INTJ
dpc-4793	235	4	la	la	ADV
dpc-4793	235	5	m	m	PROPN
dpc-4793	235	6	p	p	NOUN
dpc-4793	236	1	n	n	PRON
dpc-4793	236	2	r	r	NOUN
dpc-4793	236	3	40	40	NUM
dpc-4793	236	4	47	47	NUM
dpc-4793	237	1	*	*	SYM
dpc-4793	237	2	29	29	NUM
dpc-4793	237	3	.1	.1	NUM
dpc-4793	237	4	*	*	PUNCT
dpc-4793	238	1	n	n	CCONJ
dpc-4793	238	2	r	r	NOUN
dpc-4793	238	3	n	n	NOUN
dpc-4793	238	4	r	r	NOUN
dpc-4793	238	5	18	18	NUM
dpc-4793	238	6	n	n	NOUN
dpc-4793	238	7	r	r	NOUN
dpc-4793	238	8	n	n	NOUN
dpc-4793	238	9	r	r	NOUN
dpc-4793	238	10	r	r	NOUN
dpc-4793	238	11	ei	ei	NOUN
dpc-4793	238	12	ch	ch	NOUN
dpc-4793	238	13	k	k	PROPN
dpc-4793	238	14	[	[	PUNCT
dpc-4793	238	15	16	16	NUM
dpc-4793	238	16	]	]	PUNCT
dpc-4793	238	17	e	e	X
dpc-4793	238	18	ta	ta	PROPN
dpc-4793	238	19	ne	ne	PROPN
dpc-4793	238	20	rc	rc	PROPN
dpc-4793	238	21	ep	ep	PROPN
dpc-4793	238	22	t	t	PROPN
dpc-4793	238	23	50	50	NUM
dpc-4793	238	24	m	m	NOUN
dpc-4793	238	25	g	g	ADP
dpc-4793	238	26	92	92	NUM
dpc-4793	238	27	.4	.4	NUM
dpc-4793	238	28	68	68	NUM
dpc-4793	238	29	.7	.7	NUM
dpc-4793	238	30	45	45	NUM
dpc-4793	238	31	.4	.4	NUM
dpc-4793	238	32	*	*	PUNCT
dpc-4793	239	1	n	n	NUM
dpc-4793	239	2	r	r	NOUN
dpc-4793	239	3	18	18	NUM
dpc-4793	239	4	.6	.6	NUM
dpc-4793	239	5	*	*	PUNCT
dpc-4793	239	6	n	n	NUM
dpc-4793	239	7	r	r	NOUN
dpc-4793	239	8	19	19	NUM
dpc-4793	239	9	.9	.9	NUM
dpc-4793	239	10	*	*	PUNCT
dpc-4793	239	11	n	n	CCONJ
dpc-4793	239	12	r	r	NOUN
dpc-4793	239	13	n	n	NOUN
dpc-4793	239	14	r	r	NOUN
dpc-4793	239	15	ix	ix	INTJ
dpc-4793	240	1	ek	ek	INTJ
dpc-4793	241	1	iz	iz	INTJ
dpc-4793	241	2	um	um	INTJ
dpc-4793	241	3	ab	ab	PROPN
dpc-4793	241	4	q	q	PROPN
dpc-4793	241	5	2w	2w	NUM
dpc-4793	241	6	93	93	NUM
dpc-4793	241	7	.2	.2	NUM
dpc-4793	241	8	65	65	NUM
dpc-4793	241	9	.3	.3	NUM
dpc-4793	241	10	44	44	NUM
dpc-4793	241	11	.8	.8	NUM
dpc-4793	241	12	*	*	PUNCT
dpc-4793	242	1	n	n	CCONJ
dpc-4793	242	2	r	r	NOUN
dpc-4793	242	3	18	18	NUM
dpc-4793	242	4	.7	.7	NUM
dpc-4793	242	5	*	*	PUNCT
dpc-4793	242	6	n	n	NUM
dpc-4793	242	7	r	r	NOUN
dpc-4793	242	8	20	20	NUM
dpc-4793	242	9	.3	.3	NUM
dpc-4793	242	10	*	*	PUNCT
dpc-4793	242	11	n	n	CCONJ
dpc-4793	242	12	r	r	NOUN
dpc-4793	242	13	n	n	NOUN
dpc-4793	242	14	r	r	NOUN
dpc-4793	242	15	ix	ix	INTJ
dpc-4793	243	1	ek	ek	INTJ
dpc-4793	244	1	iz	iz	INTJ
dpc-4793	244	2	um	um	INTJ
dpc-4793	244	3	ab	ab	PROPN
dpc-4793	244	4	q	q	PROPN
dpc-4793	244	5	4w	4w	NUM
dpc-4793	244	6	92	92	NUM
dpc-4793	244	7	.2	.2	NUM
dpc-4793	244	8	67	67	NUM
dpc-4793	244	9	.9	.9	NUM
dpc-4793	244	10	45	45	NUM
dpc-4793	245	1	.2	.2	NUM
dpc-4793	245	2	*	*	PUNCT
dpc-4793	246	1	n	n	NUM
dpc-4793	246	2	r	r	NOUN
dpc-4793	246	3	18	18	NUM
dpc-4793	246	4	.7	.7	NUM
dpc-4793	246	5	*	*	PUNCT
dpc-4793	246	6	n	n	CCONJ
dpc-4793	246	7	r	r	NOUN
dpc-4793	246	8	20	20	NUM
dpc-4793	246	9	.1	.1	NUM
dpc-4793	246	10	*	*	PUNCT
dpc-4793	247	1	n	n	CCONJ
dpc-4793	247	2	r	r	NOUN
dpc-4793	248	1	n	n	NOUN
dpc-4793	248	2	r	r	NOUN
dpc-4793	248	3	pl	pl	X
dpc-4793	248	4	ac	ac	PROPN
dpc-4793	248	5	eb	eb	PROPN
dpc-4793	248	6	o	o	PROPN
dpc-4793	248	7	91	91	NUM
dpc-4793	249	1	.4	.4	NUM
dpc-4793	249	2	71	71	NUM
dpc-4793	250	1	.2	.2	NUM
dpc-4793	250	2	46	46	NUM
dpc-4793	250	3	*	*	PUNCT
dpc-4793	251	1	n	n	NUM
dpc-4793	251	2	r	r	NOUN
dpc-4793	251	3	18	18	NUM
dpc-4793	251	4	.8	.8	NUM
dpc-4793	251	5	*	*	PUNCT
dpc-4793	251	6	n	n	NUM
dpc-4793	251	7	r	r	NOUN
dpc-4793	251	8	20	20	NUM
dpc-4793	251	9	.8	.8	NUM
dpc-4793	251	10	*	*	PUNCT
dpc-4793	251	11	n	n	CCONJ
dpc-4793	251	12	r	r	NOUN
dpc-4793	251	13	n	n	NOUN
dpc-4793	251	14	r	r	NOUN
dpc-4793	251	15	r	r	NOUN
dpc-4793	251	16	ey	ey	PRON
dpc-4793	251	17	ga	ga	NOUN
dpc-4793	251	18	gn	gn	PROPN
dpc-4793	251	19	e	e	PROPN
dpc-4793	251	20	p	p	X
dpc-4793	252	1	[	[	X
dpc-4793	252	2	3	3	NUM
dpc-4793	252	3	0	0	NUM
dpc-4793	252	4	]	]	PUNCT
dpc-4793	252	5	c	c	X
dpc-4793	252	6	lo	lo	PROPN
dpc-4793	252	7	be	be	VERB
dpc-4793	252	8	ta	ta	PART
dpc-4793	252	9	so	so	ADV
dpc-4793	252	10	l	l	NOUN
dpc-4793	252	11	pr	pr	NOUN
dpc-4793	252	12	op	op	NOUN
dpc-4793	252	13	io	io	VERB
dpc-4793	252	14	na	na	ADP
dpc-4793	252	15	te	te	PROPN
dpc-4793	252	16	s	s	VERB
dpc-4793	252	17	ha	ha	INTJ
dpc-4793	252	18	m	m	INTJ
dpc-4793	252	19	po	po	NOUN
dpc-4793	252	20	o	o	NOUN
dpc-4793	252	21	n	n	CCONJ
dpc-4793	252	22	r	r	NOUN
dpc-4793	252	23	49	49	NUM
dpc-4793	252	24	44	44	NUM
dpc-4793	252	25	.9	.9	NUM
dpc-4793	253	1	*	*	PUNCT
dpc-4793	253	2	n	n	CCONJ
dpc-4793	253	3	r	r	NOUN
dpc-4793	253	4	n	n	NOUN
dpc-4793	253	5	r	r	NOUN
dpc-4793	253	6	46	46	NUM
dpc-4793	253	7	*	*	SYM
dpc-4793	253	8	n	n	NUM
dpc-4793	253	9	r	r	NOUN
dpc-4793	253	10	4	4	NUM
dpc-4793	253	11	.	.	PUNCT
dpc-4793	254	1	86	86	NUM
dpc-4793	254	2	*	*	SYM
dpc-4793	254	3	n	n	PRON
dpc-4793	254	4	r	r	NOUN
dpc-4793	254	5	c	c	NOUN
dpc-4793	254	6	al	al	PROPN
dpc-4793	254	7	ci	ci	PROPN
dpc-4793	254	8	po	po	PROPN
dpc-4793	254	9	tr	tr	VERB
dpc-4793	254	10	ie	ie	X
dpc-4793	254	11	ne	ne	X
dpc-4793	254	12	/o	/o	PUNCT
dpc-4793	255	1	l	l	NOUN
dpc-4793	255	2	n	n	CCONJ
dpc-4793	255	3	r	r	NOUN
dpc-4793	255	4	45	45	NUM
dpc-4793	255	5	45	45	NUM
dpc-4793	255	6	.7	.7	NUM
dpc-4793	255	7	*	*	PUNCT
dpc-4793	255	8	n	n	CCONJ
dpc-4793	255	9	r	r	NOUN
dpc-4793	255	10	n	n	NOUN
dpc-4793	255	11	r	r	NOUN
dpc-4793	255	12	44	44	NUM
dpc-4793	255	13	*	*	PUNCT
dpc-4793	255	14	n	n	NUM
dpc-4793	255	15	r	r	NOUN
dpc-4793	255	16	4	4	NUM
dpc-4793	255	17	.	.	NOUN
dpc-4793	255	18	95	95	NUM
dpc-4793	255	19	*	*	PUNCT
dpc-4793	255	20	n	n	NUM
dpc-4793	255	21	r	r	NOUN
dpc-4793	255	22	r	r	NOUN
dpc-4793	256	1	ic	ic	NOUN
dpc-4793	256	2	h	h	NOUN
dpc-4793	256	3	p	p	NOUN
dpc-4793	257	1	[	[	X
dpc-4793	257	2	4	4	NUM
dpc-4793	257	3	3	3	NUM
dpc-4793	257	4	]	]	PUNCT
dpc-4793	257	5	a	a	DET
dpc-4793	257	6	pr	pr	NOUN
dpc-4793	257	7	em	em	PRON
dpc-4793	257	8	ila	ila	PROPN
dpc-4793	257	9	st	st	PROPN
dpc-4793	258	1	3	3	NUM
dpc-4793	258	2	0	0	NUM
dpc-4793	258	3	m	m	NOUN
dpc-4793	258	4	g	g	NOUN
dpc-4793	258	5	n	n	CCONJ
dpc-4793	258	6	r	r	NOUN
dpc-4793	258	7	65	65	NUM
dpc-4793	258	8	.2	.2	NUM
dpc-4793	258	9	44	44	NUM
dpc-4793	258	10	.9	.9	NUM
dpc-4793	258	11	*	*	PUNCT
dpc-4793	259	1	n	n	NUM
dpc-4793	259	2	r	r	NOUN
dpc-4793	259	3	19	19	NUM
dpc-4793	259	4	.1	.1	NUM
dpc-4793	259	5	4	4	NUM
dpc-4793	259	6	*	*	SYM
dpc-4793	259	7	n	n	ADP
dpc-4793	259	8	r	r	NOUN
dpc-4793	259	9	n	n	NOUN
dpc-4793	259	10	r	r	NOUN
dpc-4793	259	11	n	n	NOUN
dpc-4793	259	12	r	r	NOUN
dpc-4793	259	13	64	64	NUM
dpc-4793	259	14	.7	.7	NUM
dpc-4793	259	15	,	,	PUNCT
dpc-4793	259	16	3	3	NUM
dpc-4793	259	17	5	5	NUM
dpc-4793	259	18	.	.	NOUN
dpc-4793	259	19	3	3	NUM
dpc-4793	259	20	,	,	PUNCT
dpc-4793	259	21	n	n	PRON
dpc-4793	259	22	r	r	NOUN
dpc-4793	259	23	pl	pl	X
dpc-4793	259	24	ac	ac	PROPN
dpc-4793	259	25	eb	eb	PROPN
dpc-4793	259	26	o	o	PROPN
dpc-4793	259	27	n	n	CCONJ
dpc-4793	259	28	r	r	NOUN
dpc-4793	259	29	65	65	NUM
dpc-4793	259	30	.1	.1	NUM
dpc-4793	259	31	45	45	NUM
dpc-4793	259	32	.1	.1	NUM
dpc-4793	259	33	*	*	PUNCT
dpc-4793	260	1	n	n	X
dpc-4793	260	2	r	r	NOUN
dpc-4793	260	3	17	17	NUM
dpc-4793	260	4	.4	.4	NUM
dpc-4793	260	5	1	1	NUM
dpc-4793	260	6	*	*	SYM
dpc-4793	260	7	n	n	ADP
dpc-4793	260	8	r	r	NOUN
dpc-4793	260	9	n	n	NOUN
dpc-4793	260	10	r	r	NOUN
dpc-4793	260	11	n	n	NOUN
dpc-4793	260	12	r	r	NOUN
dpc-4793	260	13	62	62	NUM
dpc-4793	260	14	.4	.4	NUM
dpc-4793	260	15	,	,	PUNCT
dpc-4793	260	16	3	3	NUM
dpc-4793	260	17	7	7	NUM
dpc-4793	260	18	.	.	NOUN
dpc-4793	260	19	6	6	NUM
dpc-4793	260	20	,	,	PUNCT
dpc-4793	260	21	n	n	PRON
dpc-4793	260	22	r	r	NOUN
dpc-4793	260	23	a	a	DET
dpc-4793	260	24	pr	pr	NOUN
dpc-4793	260	25	em	em	PRON
dpc-4793	260	26	ila	ila	PROPN
dpc-4793	260	27	st	st	PROPN
dpc-4793	261	1	3	3	NUM
dpc-4793	261	2	0	0	NUM
dpc-4793	261	3	m	m	VERB
dpc-4793	261	4	g	g	NOUN
dpc-4793	261	5	n	n	CCONJ
dpc-4793	261	6	r	r	NOUN
dpc-4793	261	7	58	58	NUM
dpc-4793	261	8	.5	.5	NUM
dpc-4793	261	9	44	44	NUM
dpc-4793	261	10	.7	.7	NUM
dpc-4793	261	11	*	*	PUNCT
dpc-4793	262	1	n	n	CCONJ
dpc-4793	262	2	r	r	NOUN
dpc-4793	262	3	17	17	NUM
dpc-4793	262	4	.7	.7	NUM
dpc-4793	262	5	8	8	NUM
dpc-4793	262	6	*	*	SYM
dpc-4793	262	7	n	n	ADP
dpc-4793	262	8	r	r	NOUN
dpc-4793	262	9	n	n	NOUN
dpc-4793	262	10	r	r	NOUN
dpc-4793	262	11	n	n	NOUN
dpc-4793	262	12	r	r	NOUN
dpc-4793	262	13	68	68	NUM
dpc-4793	262	14	.8	.8	NUM
dpc-4793	262	15	,	,	PUNCT
dpc-4793	262	16	3	3	NUM
dpc-4793	262	17	1	1	NUM
dpc-4793	262	18	.	.	NOUN
dpc-4793	262	19	3	3	NUM
dpc-4793	262	20	,	,	PUNCT
dpc-4793	262	21	n	n	PRON
dpc-4793	262	22	r	r	NOUN
dpc-4793	262	23	pl	pl	X
dpc-4793	262	24	ac	ac	PROPN
dpc-4793	262	25	eb	eb	PROPN
dpc-4793	262	26	o	o	PROPN
dpc-4793	262	27	n	n	CCONJ
dpc-4793	262	28	r	r	NOUN
dpc-4793	262	29	75	75	NUM
dpc-4793	262	30	.3	.3	NUM
dpc-4793	262	31	44	44	NUM
dpc-4793	262	32	.1	.1	NUM
dpc-4793	262	33	*	*	PUNCT
dpc-4793	263	1	n	n	X
dpc-4793	263	2	r	r	NOUN
dpc-4793	263	3	17	17	NUM
dpc-4793	263	4	.5	.5	NUM
dpc-4793	263	5	2	2	NUM
dpc-4793	263	6	*	*	SYM
dpc-4793	263	7	n	n	ADP
dpc-4793	263	8	r	r	NOUN
dpc-4793	263	9	n	n	NOUN
dpc-4793	263	10	r	r	NOUN
dpc-4793	263	11	n	n	NOUN
dpc-4793	263	12	r	r	NOUN
dpc-4793	263	13	58	58	NUM
dpc-4793	263	14	.1	.1	NUM
dpc-4793	263	15	,	,	PUNCT
dpc-4793	263	16	4	4	NUM
dpc-4793	263	17	1	1	NUM
dpc-4793	263	18	.	.	NOUN
dpc-4793	263	19	9	9	NUM
dpc-4793	263	20	,	,	PUNCT
dpc-4793	263	21	n	n	PRON
dpc-4793	263	22	r	r	PROPN
dpc-4793	263	23	sa	sa	PROPN
dpc-4793	263	24	ra	ra	PROPN
dpc-4793	263	25	ce	ce	PROPN
dpc-4793	263	26	no	no	DET
dpc-4793	263	27	r	r	NOUN
dpc-4793	263	28	[	[	PUNCT
dpc-4793	263	29	31	31	NUM
dpc-4793	263	30	]	]	PUNCT
dpc-4793	263	31	c	c	PROPN
dpc-4793	263	32	al	al	PROPN
dpc-4793	263	33	ci	ci	PROPN
dpc-4793	263	34	po	po	PROPN
dpc-4793	263	35	tr	tr	VERB
dpc-4793	263	36	io	io	PROPN
dpc-4793	263	37	l	l	PROPN
dpc-4793	263	38	/	/	SYM
dpc-4793	263	39	e	e	X
dpc-4793	263	40	ne	ne	NOUN
dpc-4793	264	1	+	+	CCONJ
dpc-4793	264	2	b	b	X
dpc-4793	264	3	et	et	NOUN
dpc-4793	264	4	am	be	AUX
dpc-4793	264	5	et	et	NOUN
dpc-4793	264	6	ha	ha	INTJ
dpc-4793	264	7	so	so	ADV
dpc-4793	264	8	ne	ne	PROPN
dpc-4793	264	9	d	d	PROPN
dpc-4793	264	10	ip	ip	PRON
dpc-4793	264	11	ro	ro	X
dpc-4793	264	12	pi	pi	NOUN
dpc-4793	264	13	on	on	ADV
dpc-4793	264	14	at	at	ADP
dpc-4793	264	15	e	e	PROPN
dpc-4793	264	16	n	n	ADP
dpc-4793	264	17	r	r	NOUN
dpc-4793	264	18	51	51	NUM
dpc-4793	264	19	44	44	NUM
dpc-4793	264	20	.1	.1	NUM
dpc-4793	264	21	*	*	PUNCT
dpc-4793	265	1	[	[	X
dpc-4793	265	2	1	1	NUM
dpc-4793	265	3	885	885	NUM
dpc-4793	265	4	]	]	PUNCT
dpc-4793	265	5	n	n	CCONJ
dpc-4793	265	6	r	r	NOUN
dpc-4793	265	7	n	n	NOUN
dpc-4793	265	8	r	r	NOUN
dpc-4793	265	9	37	37	NUM
dpc-4793	265	10	.3	.3	NUM
dpc-4793	265	11	*	*	PUNCT
dpc-4793	265	12	n	n	PRON
dpc-4793	265	13	r	r	NOUN
dpc-4793	265	14	6	6	NUM
dpc-4793	265	15	.	.	NOUN
dpc-4793	266	1	9	9	NUM
dpc-4793	266	2	*	*	SYM
dpc-4793	266	3	n	n	NOUN
dpc-4793	266	4	r	r	NOUN
dpc-4793	266	5	c	c	NOUN
dpc-4793	266	6	al	al	PROPN
dpc-4793	266	7	ci	ci	PROPN
dpc-4793	266	8	po	po	PROPN
dpc-4793	266	9	tr	tr	VERB
dpc-4793	266	10	io	io	PROPN
dpc-4793	266	11	l	l	PROPN
dpc-4793	266	12	/	/	SYM
dpc-4793	266	13	e	e	X
dpc-4793	266	14	ne	ne	NOUN
dpc-4793	267	1	+	+	CCONJ
dpc-4793	267	2	b	b	X
dpc-4793	267	3	et	et	NOUN
dpc-4793	267	4	am	be	AUX
dpc-4793	267	5	et	et	NOUN
dpc-4793	267	6	ha	ha	INTJ
dpc-4793	267	7	so	so	ADV
dpc-4793	267	8	ne	ne	PROPN
dpc-4793	267	9	d	d	PROPN
dpc-4793	267	10	ip	ip	PRON
dpc-4793	267	11	ro	ro	X
dpc-4793	267	12	pi	pi	NOUN
dpc-4793	267	13	on	on	ADV
dpc-4793	267	14	at	at	ADP
dpc-4793	267	15	e	e	PROPN
dpc-4793	267	16	n	n	ADP
dpc-4793	267	17	r	r	NOUN
dpc-4793	267	18	59	59	NUM
dpc-4793	267	19	.2	.2	NUM
dpc-4793	267	20	45	45	NUM
dpc-4793	268	1	.7	.7	NUM
dpc-4793	268	2	*	*	PUNCT
dpc-4793	269	1	[	[	X
dpc-4793	269	2	1	1	NUM
dpc-4793	269	3	884	884	NUM
dpc-4793	269	4	]	]	PUNCT
dpc-4793	269	5	n	n	CCONJ
dpc-4793	269	6	r	r	NOUN
dpc-4793	269	7	n	n	NOUN
dpc-4793	269	8	r	r	NOUN
dpc-4793	269	9	36	36	NUM
dpc-4793	269	10	.8	.8	NUM
dpc-4793	269	11	*	*	PUNCT
dpc-4793	269	12	n	n	CCONJ
dpc-4793	269	13	r	r	NOUN
dpc-4793	269	14	6	6	NUM
dpc-4793	269	15	.	.	NOUN
dpc-4793	269	16	8	8	NUM
dpc-4793	269	17	*	*	SYM
dpc-4793	269	18	n	n	PRON
dpc-4793	269	19	r	r	NOUN
dpc-4793	269	20	ty	ty	INTJ
dpc-4793	269	21	ri	ri	PROPN
dpc-4793	269	22	ng	ng	PROPN
dpc-4793	269	23	s	s	X
dpc-4793	270	1	[	[	PUNCT
dpc-4793	270	2	32	32	NUM
dpc-4793	270	3	]	]	PUNCT
dpc-4793	270	4	c	c	PROPN
dpc-4793	270	5	al	al	PROPN
dpc-4793	270	6	ci	ci	PROPN
dpc-4793	270	7	po	po	PROPN
dpc-4793	270	8	tr	tr	VERB
dpc-4793	270	9	io	io	PROPN
dpc-4793	270	10	l	l	PROPN
dpc-4793	270	11	/	/	SYM
dpc-4793	270	12	e	e	X
dpc-4793	270	13	ne	ne	NOUN
dpc-4793	271	1	+	+	CCONJ
dpc-4793	271	2	b	b	X
dpc-4793	271	3	et	et	NOUN
dpc-4793	271	4	am	be	AUX
dpc-4793	271	5	et	et	NOUN
dpc-4793	271	6	ha	ha	INTJ
dpc-4793	271	7	so	so	ADV
dpc-4793	271	8	ne	ne	PROPN
dpc-4793	271	9	d	d	PROPN
dpc-4793	271	10	ip	ip	PRON
dpc-4793	271	11	ro	ro	X
dpc-4793	271	12	pi	pi	NOUN
dpc-4793	271	13	on	on	ADV
dpc-4793	271	14	at	at	ADP
dpc-4793	271	15	e	e	X
dpc-4793	271	16	0	0	NUM
dpc-4793	271	17	62	62	NUM
dpc-4793	271	18	.2	.2	NUM
dpc-4793	271	19	44	44	NUM
dpc-4793	271	20	.4	.4	NUM
dpc-4793	272	1	*	*	PUNCT
dpc-4793	273	1	[	[	X
dpc-4793	273	2	1	1	NUM
dpc-4793	273	3	875	875	NUM
dpc-4793	273	4	]	]	PUNCT
dpc-4793	273	5	n	n	CCONJ
dpc-4793	273	6	r	r	NOUN
dpc-4793	273	7	10	10	NUM
dpc-4793	273	8	.5	.5	NUM
dpc-4793	273	9	*	*	PUNCT
dpc-4793	273	10	n	n	NUM
dpc-4793	273	11	r	r	NOUN
dpc-4793	273	12	n	n	NOUN
dpc-4793	273	13	r	r	NOUN
dpc-4793	273	14	6	6	NUM
dpc-4793	273	15	.	.	PUNCT
dpc-4793	273	16	3	3	NUM
dpc-4793	273	17	*	*	SYM
dpc-4793	273	18	81	81	NUM
dpc-4793	273	19	.5	.5	NUM
dpc-4793	273	20	,	,	PUNCT
dpc-4793	273	21	n	n	CCONJ
dpc-4793	273	22	r	r	NOUN
dpc-4793	273	23	,	,	PUNCT
dpc-4793	273	24	n	n	CCONJ
dpc-4793	273	25	r	r	NOUN
dpc-4793	273	26	pl	pl	X
dpc-4793	273	27	ac	ac	PROPN
dpc-4793	273	28	eb	eb	PROPN
dpc-4793	273	29	o	o	PROPN
dpc-4793	273	30	0	0	NUM
dpc-4793	273	31	66	66	NUM
dpc-4793	273	32	.7	.7	NUM
dpc-4793	273	33	45	45	NUM
dpc-4793	273	34	.8	.8	NUM
dpc-4793	273	35	*	*	PUNCT
dpc-4793	274	1	[	[	X
dpc-4793	274	2	2	2	NUM
dpc-4793	274	3	276	276	NUM
dpc-4793	274	4	]	]	PUNCT
dpc-4793	274	5	n	n	CCONJ
dpc-4793	274	6	r	r	NOUN
dpc-4793	274	7	11	11	NUM
dpc-4793	274	8	.8	.8	NUM
dpc-4793	274	9	*	*	PUNCT
dpc-4793	275	1	n	n	CCONJ
dpc-4793	275	2	r	r	NOUN
dpc-4793	275	3	n	n	NOUN
dpc-4793	275	4	r	r	NOUN
dpc-4793	275	5	6	6	NUM
dpc-4793	275	6	.	.	NOUN
dpc-4793	276	1	2	2	NUM
dpc-4793	276	2	*	*	SYM
dpc-4793	276	3	76	76	NUM
dpc-4793	277	1	.2	.2	NUM
dpc-4793	277	2	,	,	PUNCT
dpc-4793	277	3	n	n	CCONJ
dpc-4793	277	4	r	r	NOUN
dpc-4793	277	5	,	,	PUNCT
dpc-4793	277	6	n	n	NOUN
dpc-4793	277	7	r	r	NOUN
dpc-4793	277	8	v	v	NOUN
dpc-4793	277	9	an	an	DET
dpc-4793	277	10	v	v	NOUN
dpc-4793	277	11	oo	oo	INTJ
dpc-4793	277	12	rh	rh	PROPN
dpc-4793	277	13	ee	ee	ADP
dpc-4793	277	14	s	s	PROPN
dpc-4793	277	15	s	s	X
dpc-4793	277	16	[	[	X
dpc-4793	277	17	3	3	NUM
dpc-4793	277	18	3	3	NUM
dpc-4793	277	19	]	]	PUNCT
dpc-4793	277	20	a	a	DET
dpc-4793	277	21	pr	pr	NOUN
dpc-4793	278	1	em	em	PRON
dpc-4793	278	2	ila	ila	PROPN
dpc-4793	278	3	st	st	PROPN
dpc-4793	279	1	3	3	NUM
dpc-4793	279	2	0	0	NUM
dpc-4793	279	3	m	m	VERB
dpc-4793	279	4	g	g	NOUN
dpc-4793	279	5	76	76	NUM
dpc-4793	279	6	.6	.6	NUM
dpc-4793	279	7	62	62	NUM
dpc-4793	279	8	.2	.2	NUM
dpc-4793	279	9	47	47	NUM
dpc-4793	279	10	*	*	SYM
dpc-4793	279	11	30	30	NUM
dpc-4793	279	12	.7	.7	PROPN
dpc-4793	279	13	*	*	PUNCT
dpc-4793	279	14	15	15	NUM
dpc-4793	279	15	.7	.7	PROPN
dpc-4793	279	16	*	*	PUNCT
dpc-4793	279	17	61	61	NUM
dpc-4793	280	1	.9	.9	NUM
dpc-4793	280	2	*	*	PUNCT
dpc-4793	281	1	n	n	CCONJ
dpc-4793	281	2	r	r	NOUN
dpc-4793	281	3	n	n	NOUN
dpc-4793	281	4	r	r	NOUN
dpc-4793	281	5	76	76	NUM
dpc-4793	281	6	.1	.1	NUM
dpc-4793	281	7	,	,	PUNCT
dpc-4793	281	8	2	2	NUM
dpc-4793	281	9	3	3	NUM
dpc-4793	281	10	.	.	NOUN
dpc-4793	281	11	9	9	NUM
dpc-4793	281	12	,	,	PUNCT
dpc-4793	281	13	n	n	PRON
dpc-4793	281	14	r	r	NOUN
dpc-4793	281	15	pl	pl	X
dpc-4793	281	16	ac	ac	PROPN
dpc-4793	281	17	eb	eb	PROPN
dpc-4793	281	18	o	o	PROPN
dpc-4793	282	1	73	73	NUM
dpc-4793	282	2	.5	.5	NUM
dpc-4793	282	3	60	60	NUM
dpc-4793	282	4	.8	.8	NUM
dpc-4793	282	5	46	46	NUM
dpc-4793	282	6	.7	.7	PROPN
dpc-4793	282	7	*	*	PUNCT
dpc-4793	283	1	31	31	NUM
dpc-4793	283	2	.7	.7	PUNCT
dpc-4793	283	3	*	*	PUNCT
dpc-4793	283	4	14	14	NUM
dpc-4793	283	5	.8	.8	NUM
dpc-4793	284	1	*	*	PUNCT
dpc-4793	285	1	58	58	NUM
dpc-4793	286	1	.2	.2	NUM
dpc-4793	286	2	*	*	PUNCT
dpc-4793	287	1	n	n	CCONJ
dpc-4793	287	2	r	r	NOUN
dpc-4793	287	3	n	n	NOUN
dpc-4793	287	4	r	r	NOUN
dpc-4793	287	5	74	74	NUM
dpc-4793	287	6	.5	.5	NUM
dpc-4793	287	7	,	,	PUNCT
dpc-4793	287	8	2	2	NUM
dpc-4793	287	9	5	5	NUM
dpc-4793	287	10	.	.	NOUN
dpc-4793	287	11	5	5	NUM
dpc-4793	287	12	,	,	PUNCT
dpc-4793	287	13	n	n	PRON
dpc-4793	287	14	r	r	NOUN
dpc-4793	287	15	z	z	NOUN
dpc-4793	287	16	ho	ho	PROPN
dpc-4793	287	17	u	u	X
dpc-4793	287	18	j	j	PROPN
dpc-4793	288	1	[	[	X
dpc-4793	288	2	2	2	NUM
dpc-4793	288	3	2	2	NUM
dpc-4793	288	4	]	]	SYM
dpc-4793	288	5	u	u	NOUN
dpc-4793	288	6	v	v	ADP
dpc-4793	288	7	a	a	DET
dpc-4793	288	8	1	1	NUM
dpc-4793	288	9	ph	ph	NOUN
dpc-4793	288	10	ot	ot	NOUN
dpc-4793	288	11	ot	ot	INTJ
dpc-4793	288	12	he	he	PRON
dpc-4793	288	13	ra	ra	INTJ
dpc-4793	288	14	py	py	INTJ
dpc-4793	288	15	n	n	CCONJ
dpc-4793	288	16	r	r	NOUN
dpc-4793	288	17	61	61	NUM
dpc-4793	288	18	.7	.7	NUM
dpc-4793	288	19	6	6	NUM
dpc-4793	288	20	32	32	NUM
dpc-4793	288	21	.7	.7	NUM
dpc-4793	288	22	*	*	PUNCT
dpc-4793	289	1	[	[	X
dpc-4793	289	2	2	2	NUM
dpc-4793	289	3	153	153	NUM
dpc-4793	289	4	]	]	PUNCT
dpc-4793	289	5	n	n	CCONJ
dpc-4793	289	6	r	r	NOUN
dpc-4793	289	7	3	3	NUM
dpc-4793	289	8	.	.	PUNCT
dpc-4793	289	9	02	02	NUM
dpc-4793	290	1	*	*	PUNCT
dpc-4793	290	2	n	n	NUM
dpc-4793	290	3	r	r	NOUN
dpc-4793	290	4	15	15	NUM
dpc-4793	290	5	.2	.2	NUM
dpc-4793	290	6	8	8	NUM
dpc-4793	290	7	*	*	SYM
dpc-4793	290	8	n	n	ADP
dpc-4793	290	9	r	r	NOUN
dpc-4793	290	10	n	n	ADP
dpc-4793	290	11	r	r	NOUN
dpc-4793	290	12	n	n	PROPN
dpc-4793	290	13	ar	ar	PROPN
dpc-4793	290	14	ro	ro	PROPN
dpc-4793	290	15	w	w	PROPN
dpc-4793	290	16	b	b	PROPN
dpc-4793	290	17	an	an	DET
dpc-4793	290	18	d	d	X
dpc-4793	290	19	u	u	PROPN
dpc-4793	290	20	v	v	PROPN
dpc-4793	290	21	b	b	NOUN
dpc-4793	290	22	ph	ph	NOUN
dpc-4793	291	1	ot	ot	INTJ
dpc-4793	291	2	ot	ot	INTJ
dpc-4793	291	3	he	he	PRON
dpc-4793	291	4	ra	ra	INTJ
dpc-4793	291	5	py	py	INTJ
dpc-4793	291	6	n	n	CCONJ
dpc-4793	291	7	r	r	NOUN
dpc-4793	291	8	61	61	NUM
dpc-4793	291	9	.7	.7	NUM
dpc-4793	291	10	6	6	NUM
dpc-4793	291	11	32	32	NUM
dpc-4793	291	12	.7	.7	NUM
dpc-4793	291	13	*	*	PUNCT
dpc-4793	292	1	[	[	X
dpc-4793	292	2	2	2	NUM
dpc-4793	292	3	153	153	NUM
dpc-4793	292	4	]	]	PUNCT
dpc-4793	292	5	n	n	CCONJ
dpc-4793	292	6	r	r	NOUN
dpc-4793	292	7	3	3	NUM
dpc-4793	292	8	.	.	PUNCT
dpc-4793	292	9	02	02	NUM
dpc-4793	293	1	*	*	PUNCT
dpc-4793	293	2	n	n	NUM
dpc-4793	293	3	r	r	NOUN
dpc-4793	293	4	15	15	NUM
dpc-4793	293	5	.5	.5	NUM
dpc-4793	293	6	*	*	PUNCT
dpc-4793	294	1	n	n	NUM
dpc-4793	294	2	r	r	NOUN
dpc-4793	294	3	n	n	NOUN
dpc-4793	294	4	r	r	NOUN
dpc-4793	294	5	t	t	NOUN
dpc-4793	294	6	ha	ha	INTJ
dpc-4793	294	7	çi	çi	PROPN
dpc-4793	295	1	d	d	X
dpc-4793	295	2	[	[	PUNCT
dpc-4793	295	3	20	20	NUM
dpc-4793	295	4	]	]	X
dpc-4793	295	5	r	r	NOUN
dpc-4793	295	6	is	be	AUX
dpc-4793	295	7	an	an	DET
dpc-4793	295	8	ki	ki	PROPN
dpc-4793	295	9	zu	zu	PROPN
dpc-4793	295	10	m	m	VERB
dpc-4793	295	11	ab	ab	PROPN
dpc-4793	295	12	1	1	NUM
dpc-4793	295	13	50	50	NUM
dpc-4793	295	14	m	m	NOUN
dpc-4793	295	15	g	g	NOUN
dpc-4793	295	16	n	n	ADP
dpc-4793	295	17	r	r	NOUN
dpc-4793	295	18	n	n	NOUN
dpc-4793	295	19	r	r	NOUN
dpc-4793	295	20	42	42	NUM
dpc-4793	295	21	*	*	PUNCT
dpc-4793	296	1	[	[	X
dpc-4793	296	2	1	1	NUM
dpc-4793	296	3	873	873	NUM
dpc-4793	296	4	]	]	PUNCT
dpc-4793	296	5	n	n	CCONJ
dpc-4793	296	6	r	r	NOUN
dpc-4793	296	7	n	n	NOUN
dpc-4793	296	8	r	r	NOUN
dpc-4793	296	9	n	n	NOUN
dpc-4793	296	10	r	r	NOUN
dpc-4793	296	11	23	23	NUM
dpc-4793	296	12	.1	.1	NUM
dpc-4793	296	13	*	*	PUNCT
dpc-4793	297	1	n	n	CCONJ
dpc-4793	297	2	r	r	NOUN
dpc-4793	297	3	n	n	CCONJ
dpc-4793	297	4	r	r	NOUN
dpc-4793	297	5	fu	fu	NOUN
dpc-4793	297	6	m	m	PROPN
dpc-4793	297	7	ar	ar	PROPN
dpc-4793	297	8	ic	ic	PROPN
dpc-4793	297	9	a	a	DET
dpc-4793	297	10	ci	ci	PROPN
dpc-4793	297	11	d	d	X
dpc-4793	297	12	es	es	X
dpc-4793	297	13	te	te	PROPN
dpc-4793	297	14	rs	rs	NOUN
dpc-4793	297	15	n	n	CCONJ
dpc-4793	297	16	r	r	NOUN
dpc-4793	297	17	n	n	NOUN
dpc-4793	297	18	r	r	NOUN
dpc-4793	297	19	42	42	NUM
dpc-4793	297	20	.5	.5	NUM
dpc-4793	297	21	*	*	PUNCT
dpc-4793	298	1	[	[	X
dpc-4793	298	2	1	1	NUM
dpc-4793	298	3	969	969	NUM
dpc-4793	298	4	]	]	PUNCT
dpc-4793	298	5	n	n	CCONJ
dpc-4793	298	6	r	r	NOUN
dpc-4793	298	7	n	n	NOUN
dpc-4793	298	8	r	r	NOUN
dpc-4793	298	9	n	n	NOUN
dpc-4793	298	10	r	r	NOUN
dpc-4793	298	11	20	20	NUM
dpc-4793	298	12	.2	.2	NUM
dpc-4793	298	13	*	*	PUNCT
dpc-4793	299	1	n	n	CCONJ
dpc-4793	299	2	r	r	NOUN
dpc-4793	299	3	n	n	NOUN
dpc-4793	299	4	r	r	NOUN
dpc-4793	299	5	b	b	PROPN
dpc-4793	299	6	la	la	PROPN
dpc-4793	299	7	uv	uv	PROPN
dpc-4793	299	8	el	el	PROPN
dpc-4793	299	9	t	t	PROPN
dpc-4793	299	10	a	a	PRON
dpc-4793	299	11	[	[	PUNCT
dpc-4793	299	12	44	44	NUM
dpc-4793	299	13	]	]	PUNCT
dpc-4793	299	14	 	 	SPACE
dpc-4793	299	15	p	p	PROPN
dpc-4793	299	16	la	la	PROPN
dpc-4793	299	17	ce	ce	PROPN
dpc-4793	299	18	bo	bo	PROPN
dpc-4793	299	19	n	n	PROPN
dpc-4793	299	20	r	r	NOUN
dpc-4793	299	21	n	n	ADP
dpc-4793	299	22	r	r	NOUN
dpc-4793	299	23	n	n	ADP
dpc-4793	299	24	r	r	NOUN
dpc-4793	299	25	n	n	ADP
dpc-4793	299	26	r	r	NOUN
dpc-4793	299	27	n	n	ADP
dpc-4793	299	28	r	r	NOUN
dpc-4793	299	29	n	n	ADP
dpc-4793	299	30	r	r	NOUN
dpc-4793	299	31	n	n	ADP
dpc-4793	299	32	r	r	NOUN
dpc-4793	299	33	n	n	NOUN
dpc-4793	299	34	r	r	NOUN
dpc-4793	299	35	59	59	NUM
dpc-4793	299	36	.3	.3	NUM
dpc-4793	299	37	,	,	PUNCT
dpc-4793	299	38	1	1	NUM
dpc-4793	299	39	6	6	NUM
dpc-4793	299	40	.	.	NOUN
dpc-4793	299	41	7	7	NUM
dpc-4793	299	42	,	,	PUNCT
dpc-4793	299	43	n	n	PRON
dpc-4793	299	44	r	r	NOUN
dpc-4793	299	45	g	g	PROPN
dpc-4793	299	46	us	us	PROPN
dpc-4793	300	1	el	el	PROPN
dpc-4793	300	2	ku	ku	PROPN
dpc-4793	300	3	m	m	PROPN
dpc-4793	300	4	ab	ab	PROPN
dpc-4793	300	5	1	1	NUM
dpc-4793	300	6	00	00	NUM
dpc-4793	300	7	m	m	VERB
dpc-4793	300	8	g	g	NOUN
dpc-4793	300	9	n	n	ADP
dpc-4793	300	10	r	r	NOUN
dpc-4793	300	11	n	n	ADP
dpc-4793	300	12	r	r	NOUN
dpc-4793	300	13	n	n	ADP
dpc-4793	300	14	r	r	NOUN
dpc-4793	300	15	n	n	ADP
dpc-4793	300	16	r	r	NOUN
dpc-4793	300	17	n	n	ADP
dpc-4793	300	18	r	r	NOUN
dpc-4793	300	19	n	n	ADP
dpc-4793	300	20	r	r	NOUN
dpc-4793	300	21	n	n	ADP
dpc-4793	300	22	r	r	NOUN
dpc-4793	300	23	n	n	NOUN
dpc-4793	300	24	r	r	NOUN
dpc-4793	300	25	58	58	NUM
dpc-4793	300	26	.8	.8	NUM
dpc-4793	300	27	,	,	PUNCT
dpc-4793	300	28	1	1	NUM
dpc-4793	300	29	9	9	NUM
dpc-4793	300	30	.	.	NOUN
dpc-4793	300	31	6	6	NUM
dpc-4793	300	32	,	,	PUNCT
dpc-4793	300	33	n	n	PRON
dpc-4793	300	34	r	r	NOUN
dpc-4793	300	35	a	a	DET
dpc-4793	300	36	da	da	PROPN
dpc-4793	300	37	lim	lim	PROPN
dpc-4793	300	38	um	um	INTJ
dpc-4793	300	39	ab	ab	PROPN
dpc-4793	300	40	8	8	NUM
dpc-4793	300	41	0	0	NUM
dpc-4793	300	42	m	m	VERB
dpc-4793	300	43	g	g	NOUN
dpc-4793	300	44	n	n	ADP
dpc-4793	300	45	r	r	NOUN
dpc-4793	300	46	n	n	ADP
dpc-4793	300	47	r	r	NOUN
dpc-4793	300	48	n	n	ADP
dpc-4793	300	49	r	r	NOUN
dpc-4793	300	50	n	n	ADP
dpc-4793	300	51	r	r	NOUN
dpc-4793	300	52	n	n	ADP
dpc-4793	300	53	r	r	NOUN
dpc-4793	300	54	n	n	ADP
dpc-4793	300	55	r	r	NOUN
dpc-4793	300	56	n	n	ADP
dpc-4793	300	57	r	r	NOUN
dpc-4793	300	58	n	n	NOUN
dpc-4793	300	59	r	r	NOUN
dpc-4793	300	60	59	59	NUM
dpc-4793	300	61	.3	.3	NUM
dpc-4793	300	62	,	,	PUNCT
dpc-4793	300	63	1	1	NUM
dpc-4793	300	64	9	9	NUM
dpc-4793	300	65	.	.	NOUN
dpc-4793	300	66	3	3	NUM
dpc-4793	300	67	,	,	PUNCT
dpc-4793	300	68	n	n	NOUN
dpc-4793	300	69	r	r	NOUN
dpc-4793	300	70	r	r	NOUN
dpc-4793	300	71	ei	ei	NOUN
dpc-4793	300	72	ch	ch	NOUN
dpc-4793	300	73	k	k	PROPN
dpc-4793	300	74	[	[	PUNCT
dpc-4793	300	75	34	34	NUM
dpc-4793	300	76	]	]	PUNCT
dpc-4793	300	77	pl	pl	PROPN
dpc-4793	300	78	ac	ac	PROPN
dpc-4793	300	79	eb	eb	PROPN
dpc-4793	300	80	o	o	PROPN
dpc-4793	300	81	n	n	ADP
dpc-4793	300	82	r	r	NOUN
dpc-4793	300	83	n	n	ADP
dpc-4793	300	84	r	r	NOUN
dpc-4793	300	85	n	n	ADP
dpc-4793	300	86	r	r	NOUN
dpc-4793	300	87	n	n	ADP
dpc-4793	300	88	r	r	NOUN
dpc-4793	300	89	n	n	ADP
dpc-4793	300	90	r	r	NOUN
dpc-4793	300	91	n	n	ADP
dpc-4793	300	92	r	r	NOUN
dpc-4793	300	93	n	n	ADP
dpc-4793	300	94	r	r	NOUN
dpc-4793	300	95	n	n	ADP
dpc-4793	300	96	r	r	NOUN
dpc-4793	300	97	n	n	NOUN
dpc-4793	300	98	r	r	NOUN
dpc-4793	300	99	g	g	PROPN
dpc-4793	300	100	us	us	PROPN
dpc-4793	301	1	el	el	PROPN
dpc-4793	301	2	ku	ku	PROPN
dpc-4793	301	3	m	m	PROPN
dpc-4793	301	4	ab	ab	PROPN
dpc-4793	301	5	1	1	NUM
dpc-4793	301	6	00	00	NUM
dpc-4793	301	7	m	m	VERB
dpc-4793	301	8	g	g	NOUN
dpc-4793	301	9	n	n	ADP
dpc-4793	301	10	r	r	NOUN
dpc-4793	301	11	n	n	ADP
dpc-4793	301	12	r	r	NOUN
dpc-4793	301	13	n	n	ADP
dpc-4793	301	14	r	r	NOUN
dpc-4793	301	15	n	n	ADP
dpc-4793	301	16	r	r	NOUN
dpc-4793	301	17	n	n	ADP
dpc-4793	301	18	r	r	NOUN
dpc-4793	301	19	n	n	ADP
dpc-4793	301	20	r	r	NOUN
dpc-4793	301	21	n	n	ADP
dpc-4793	301	22	r	r	NOUN
dpc-4793	301	23	n	n	ADP
dpc-4793	301	24	r	r	NOUN
dpc-4793	301	25	n	n	NOUN
dpc-4793	301	26	r	r	NOUN
dpc-4793	301	27	a	a	DET
dpc-4793	301	28	da	da	NOUN
dpc-4793	301	29	lim	lim	PROPN
dpc-4793	301	30	um	um	INTJ
dpc-4793	301	31	ab	ab	PROPN
dpc-4793	301	32	8	8	NUM
dpc-4793	301	33	0	0	NUM
dpc-4793	301	34	m	m	VERB
dpc-4793	301	35	g	g	NOUN
dpc-4793	301	36	n	n	ADP
dpc-4793	301	37	r	r	NOUN
dpc-4793	301	38	n	n	ADP
dpc-4793	301	39	r	r	NOUN
dpc-4793	301	40	n	n	ADP
dpc-4793	301	41	r	r	NOUN
dpc-4793	301	42	n	n	ADP
dpc-4793	301	43	r	r	NOUN
dpc-4793	301	44	n	n	ADP
dpc-4793	301	45	r	r	NOUN
dpc-4793	301	46	n	n	ADP
dpc-4793	301	47	r	r	NOUN
dpc-4793	301	48	n	n	ADP
dpc-4793	301	49	r	r	NOUN
dpc-4793	301	50	n	n	ADP
dpc-4793	301	51	r	r	NOUN
dpc-4793	301	52	n	n	NOUN
dpc-4793	301	53	r	r	NOUN
dpc-4793	301	54	o	o	NOUN
dpc-4793	302	1	ht	ht	INTJ
dpc-4793	302	2	su	su	INTJ
dpc-4793	303	1	ki	ki	PROPN
dpc-4793	303	2	m	m	PROPN
dpc-4793	303	3	[	[	PUNCT
dpc-4793	303	4	35	35	NUM
dpc-4793	303	5	]	]	PUNCT
dpc-4793	303	6	pl	pl	X
dpc-4793	303	7	ac	ac	PROPN
dpc-4793	303	8	eb	eb	PROPN
dpc-4793	303	9	o	o	PROPN
dpc-4793	304	1	n	n	ADP
dpc-4793	304	2	r	r	NOUN
dpc-4793	304	3	n	n	ADP
dpc-4793	304	4	r	r	NOUN
dpc-4793	304	5	n	n	ADP
dpc-4793	304	6	r	r	NOUN
dpc-4793	304	7	n	n	ADP
dpc-4793	304	8	r	r	NOUN
dpc-4793	304	9	n	n	ADP
dpc-4793	304	10	r	r	NOUN
dpc-4793	304	11	n	n	ADP
dpc-4793	304	12	r	r	NOUN
dpc-4793	304	13	n	n	ADP
dpc-4793	304	14	r	r	NOUN
dpc-4793	304	15	n	n	ADP
dpc-4793	304	16	r	r	NOUN
dpc-4793	304	17	n	n	NOUN
dpc-4793	304	18	r	r	NOUN
dpc-4793	304	19	g	g	PROPN
dpc-4793	304	20	us	us	PROPN
dpc-4793	304	21	el	el	PROPN
dpc-4793	304	22	ku	ku	PROPN
dpc-4793	304	23	m	m	PROPN
dpc-4793	304	24	ab	ab	PROPN
dpc-4793	305	1	5	5	NUM
dpc-4793	305	2	0	0	NUM
dpc-4793	305	3	m	m	VERB
dpc-4793	305	4	g	g	NOUN
dpc-4793	305	5	n	n	ADP
dpc-4793	305	6	r	r	NOUN
dpc-4793	305	7	n	n	ADP
dpc-4793	305	8	r	r	NOUN
dpc-4793	305	9	n	n	ADP
dpc-4793	305	10	r	r	NOUN
dpc-4793	305	11	n	n	ADP
dpc-4793	305	12	r	r	NOUN
dpc-4793	305	13	n	n	ADP
dpc-4793	305	14	r	r	NOUN
dpc-4793	305	15	n	n	ADP
dpc-4793	305	16	r	r	NOUN
dpc-4793	305	17	n	n	ADP
dpc-4793	305	18	r	r	NOUN
dpc-4793	305	19	n	n	ADP
dpc-4793	305	20	r	r	NOUN
dpc-4793	305	21	n	n	NOUN
dpc-4793	305	22	r	r	NOUN
dpc-4793	305	23	g	g	PROPN
dpc-4793	305	24	us	us	PROPN
dpc-4793	305	25	el	el	PROPN
dpc-4793	305	26	ku	ku	PROPN
dpc-4793	305	27	m	m	PROPN
dpc-4793	305	28	ab	ab	PROPN
dpc-4793	305	29	1	1	NUM
dpc-4793	305	30	00	00	NUM
dpc-4793	305	31	m	m	VERB
dpc-4793	305	32	g	g	NOUN
dpc-4793	305	33	n	n	ADP
dpc-4793	305	34	r	r	NOUN
dpc-4793	305	35	n	n	ADP
dpc-4793	305	36	r	r	NOUN
dpc-4793	305	37	n	n	ADP
dpc-4793	305	38	r	r	NOUN
dpc-4793	305	39	n	n	ADP
dpc-4793	305	40	r	r	NOUN
dpc-4793	305	41	n	n	ADP
dpc-4793	305	42	r	r	NOUN
dpc-4793	305	43	n	n	ADP
dpc-4793	305	44	r	r	NOUN
dpc-4793	305	45	n	n	ADP
dpc-4793	305	46	r	r	NOUN
dpc-4793	305	47	n	n	ADP
dpc-4793	305	48	r	r	NOUN
dpc-4793	305	49	n	n	NOUN
dpc-4793	305	50	r	r	NOUN
dpc-4793	305	51	t	t	NOUN
dpc-4793	305	52	ha	ha	INTJ
dpc-4793	305	53	çi	çi	PROPN
dpc-4793	306	1	d	d	X
dpc-4793	306	2	[	[	PUNCT
dpc-4793	306	3	36	36	NUM
dpc-4793	306	4	]	]	PUNCT
dpc-4793	306	5	g	g	PROPN
dpc-4793	306	6	us	us	PROPN
dpc-4793	307	1	el	el	PROPN
dpc-4793	307	2	ku	ku	PROPN
dpc-4793	307	3	m	m	PROPN
dpc-4793	307	4	ab	ab	PROPN
dpc-4793	307	5	1	1	NUM
dpc-4793	307	6	00	00	NUM
dpc-4793	307	7	m	m	VERB
dpc-4793	307	8	g	g	NOUN
dpc-4793	307	9	n	n	ADP
dpc-4793	307	10	r	r	NOUN
dpc-4793	307	11	n	n	ADP
dpc-4793	307	12	r	r	NOUN
dpc-4793	307	13	n	n	ADP
dpc-4793	307	14	r	r	NOUN
dpc-4793	307	15	n	n	ADP
dpc-4793	307	16	r	r	NOUN
dpc-4793	307	17	n	n	ADP
dpc-4793	307	18	r	r	NOUN
dpc-4793	307	19	n	n	ADP
dpc-4793	307	20	r	r	NOUN
dpc-4793	307	21	n	n	ADP
dpc-4793	307	22	r	r	NOUN
dpc-4793	307	23	n	n	ADP
dpc-4793	307	24	r	r	NOUN
dpc-4793	307	25	n	n	CCONJ
dpc-4793	307	26	r	r	NOUN
dpc-4793	307	27	fu	fu	NOUN
dpc-4793	307	28	m	m	PROPN
dpc-4793	307	29	ar	ar	PROPN
dpc-4793	307	30	ic	ic	PROPN
dpc-4793	307	31	a	a	DET
dpc-4793	307	32	ci	ci	PROPN
dpc-4793	307	33	d	d	X
dpc-4793	307	34	es	es	X
dpc-4793	307	35	te	te	PROPN
dpc-4793	307	36	rs	rs	NOUN
dpc-4793	307	37	n	n	CCONJ
dpc-4793	307	38	r	r	NOUN
dpc-4793	307	39	n	n	ADP
dpc-4793	307	40	r	r	NOUN
dpc-4793	307	41	n	n	ADP
dpc-4793	307	42	r	r	NOUN
dpc-4793	307	43	n	n	ADP
dpc-4793	307	44	r	r	NOUN
dpc-4793	307	45	n	n	ADP
dpc-4793	307	46	r	r	NOUN
dpc-4793	307	47	n	n	ADP
dpc-4793	307	48	r	r	NOUN
dpc-4793	307	49	n	n	ADP
dpc-4793	307	50	r	r	NOUN
dpc-4793	307	51	n	n	ADP
dpc-4793	307	52	r	r	NOUN
dpc-4793	307	53	n	n	NOUN
dpc-4793	307	54	r	r	NOUN
dpc-4793	307	55	se	se	NOUN
dpc-4793	307	56	o	o	X
dpc-4793	307	57	sj	sj	INTJ
dpc-4793	307	58	[	[	PUNCT
dpc-4793	307	59	17	17	NUM
dpc-4793	307	60	]	]	PUNCT
dpc-4793	307	61	pl	pl	PROPN
dpc-4793	307	62	ac	ac	PROPN
dpc-4793	307	63	eb	eb	PROPN
dpc-4793	307	64	o	o	PROPN
dpc-4793	307	65	n	n	ADP
dpc-4793	307	66	r	r	NOUN
dpc-4793	307	67	n	n	ADP
dpc-4793	307	68	r	r	NOUN
dpc-4793	307	69	n	n	ADP
dpc-4793	307	70	r	r	NOUN
dpc-4793	307	71	n	n	ADP
dpc-4793	307	72	r	r	NOUN
dpc-4793	307	73	n	n	ADP
dpc-4793	307	74	r	r	NOUN
dpc-4793	307	75	n	n	NOUN
dpc-4793	307	76	r	r	NOUN
dpc-4793	307	77	28	28	NUM
dpc-4793	307	78	*	*	PUNCT
dpc-4793	307	79	n	n	ADP
dpc-4793	307	80	r	r	NOUN
dpc-4793	307	81	n	n	NOUN
dpc-4793	307	82	r	r	NOUN
dpc-4793	307	83	b	b	X
dpc-4793	307	84	ro	ro	X
dpc-4793	307	85	da	da	PROPN
dpc-4793	307	86	lu	lu	PROPN
dpc-4793	307	87	m	m	VERB
dpc-4793	307	88	ab	ab	PROPN
dpc-4793	307	89	2	2	NUM
dpc-4793	307	90	10	10	NUM
dpc-4793	307	91	m	m	NOUN
dpc-4793	307	92	g	g	NOUN
dpc-4793	307	93	n	n	ADP
dpc-4793	307	94	r	r	NOUN
dpc-4793	307	95	n	n	ADP
dpc-4793	307	96	r	r	NOUN
dpc-4793	307	97	n	n	ADP
dpc-4793	307	98	r	r	NOUN
dpc-4793	307	99	n	n	ADP
dpc-4793	307	100	r	r	NOUN
dpc-4793	307	101	n	n	ADP
dpc-4793	307	102	r	r	NOUN
dpc-4793	307	103	n	n	NOUN
dpc-4793	307	104	r	r	NOUN
dpc-4793	307	105	24	24	NUM
dpc-4793	307	106	.6	.6	NUM
dpc-4793	307	107	*	*	PUNCT
dpc-4793	307	108	n	n	CCONJ
dpc-4793	307	109	r	r	NOUN
dpc-4793	307	110	n	n	NOUN
dpc-4793	307	111	r	r	NOUN
dpc-4793	307	112	t	t	X
dpc-4793	307	113	ab	ab	X
dpc-4793	307	114	le	le	PROPN
dpc-4793	307	115	1	1	NUM
dpc-4793	307	116	.	.	PUNCT
dpc-4793	308	1	b	b	X
dpc-4793	308	2	as	as	ADP
dpc-4793	308	3	el	el	PROPN
dpc-4793	308	4	in	in	ADP
dpc-4793	308	5	e	e	PROPN
dpc-4793	308	6	c	c	NOUN
dpc-4793	308	7	ha	ha	INTJ
dpc-4793	308	8	ra	ra	INTJ
dpc-4793	308	9	ct	ct	INTJ
dpc-4793	308	10	er	er	INTJ
dpc-4793	308	11	is	be	AUX
dpc-4793	308	12	ti	ti	X
dpc-4793	308	13	cs	cs	ADJ
dpc-4793	308	14	o	o	PROPN
dpc-4793	308	15	f	f	PROPN
dpc-4793	308	16	in	in	ADP
dpc-4793	308	17	cl	cl	INTJ
dpc-4793	309	1	ud	ud	INTJ
dpc-4793	310	1	ed	ed	PROPN
dpc-4793	310	2	s	s	PROPN
dpc-4793	310	3	tu	tu	X
dpc-4793	310	4	di	di	NOUN
dpc-4793	310	5	es	es	PROPN
dpc-4793	310	6	.	.	PUNCT
dpc-4793	311	1	(	(	PUNCT
dpc-4793	311	2	co	co	X
dpc-4793	311	3	nt	not	PART
dpc-4793	311	4	in	in	ADP
dpc-4793	311	5	ue	ue	PROPN
dpc-4793	311	6	d	d	PROPN
dpc-4793	311	7	)	)	PUNCT
dpc-4793	311	8	review	review	NOUN
dpc-4793	311	9	|	|	ADV
dpc-4793	311	10	dermatol	dermatol	ADJ
dpc-4793	311	11	pract	pract	NOUN
dpc-4793	311	12	concept	concept	NOUN
dpc-4793	311	13	.	.	PUNCT
dpc-4793	312	1	2025;15(2):4793	2025;15(2):4793	NUM
dpc-4793	312	2	7	7	NUM
dpc-4793	312	3	a	a	DET
dpc-4793	312	4	ut	ut	PROPN
dpc-4793	312	5	ho	ho	PROPN
dpc-4793	312	6	r	r	PROPN
dpc-4793	312	7	a	a	DET
dpc-4793	312	8	rm	rm	NOUN
dpc-4793	312	9	s	s	PROPN
dpc-4793	312	10	c	c	NOUN
dpc-4793	312	11	au	au	NOUN
dpc-4793	312	12	ca	can	AUX
dpc-4793	312	13	si	si	PROPN
dpc-4793	312	14	an	an	DET
dpc-4793	312	15	(	(	PUNCT
dpc-4793	312	16	%	%	NOUN
dpc-4793	312	17	)	)	PUNCT
dpc-4793	312	18	m	m	VERB
dpc-4793	312	19	al	al	PROPN
dpc-4793	312	20	e	e	PROPN
dpc-4793	312	21	(	(	PUNCT
dpc-4793	312	22	%	%	INTJ
dpc-4793	312	23	)	)	PUNCT
dpc-4793	312	24	a	a	DET
dpc-4793	312	25	ge	ge	PROPN
dpc-4793	312	26	[	[	PUNCT
dpc-4793	312	27	m	m	VERB
dpc-4793	312	28	in	in	ADP
dpc-4793	312	29	-m	-m	DET
dpc-4793	312	30	ax	ax	NOUN
dpc-4793	312	31	]	]	PUNCT
dpc-4793	312	32	(	(	PUNCT
dpc-4793	312	33	y	y	PROPN
dpc-4793	312	34	ea	ea	PROPN
dpc-4793	312	35	rs	rs	PROPN
dpc-4793	312	36	)	)	PUNCT
dpc-4793	312	37	m	m	VERB
dpc-4793	312	38	ea	ea	NOUN
dpc-4793	312	39	n	n	NUM
dpc-4793	312	40	b	b	NOUN
dpc-4793	312	41	m	m	VERB
dpc-4793	312	42	i	i	PRON
dpc-4793	312	43	ps	ps	VERB
dpc-4793	312	44	or	or	CCONJ
dpc-4793	312	45	ia	ia	PROPN
dpc-4793	312	46	si	si	X
dpc-4793	312	47	s	s	PROPN
dpc-4793	312	48	d	d	X
dpc-4793	312	49	ur	ur	INTJ
dpc-4793	312	50	at	at	ADP
dpc-4793	312	51	io	io	X
dpc-4793	312	52	n	n	PROPN
dpc-4793	312	53	(	(	PUNCT
dpc-4793	312	54	y	y	PROPN
dpc-4793	312	55	ea	ea	PROPN
dpc-4793	312	56	rs	rs	PROPN
dpc-4793	312	57	)	)	PUNCT
dpc-4793	312	58	sc	sc	PROPN
dpc-4793	312	59	al	al	PROPN
dpc-4793	312	60	p	p	PROPN
dpc-4793	312	61	in	in	ADP
dpc-4793	312	62	vo	vo	X
dpc-4793	312	63	lv	lv	PROPN
dpc-4793	312	64	em	em	PRON
dpc-4793	312	65	en	en	PROPN
dpc-4793	312	66	t	t	PROPN
dpc-4793	312	67	(	(	PUNCT
dpc-4793	312	68	%	%	NOUN
dpc-4793	312	69	)	)	PUNCT
dpc-4793	312	70	ps	ps	INTJ
dpc-4793	313	1	si	si	PROPN
dpc-4793	313	2	t	t	PROPN
dpc-4793	313	3	ss	ss	VERB
dpc-4793	313	4	ig	ig	PROPN
dpc-4793	313	5	a	a	PRON
dpc-4793	313	6	/p	/p	PUNCT
dpc-4793	313	7	g	g	PROPN
dpc-4793	313	8	a	a	DET
dpc-4793	313	9	s	s	X
dpc-4793	313	10	co	co	X
dpc-4793	313	11	re	re	NOUN
dpc-4793	313	12	of	of	ADP
dpc-4793	313	13	3	3	NUM
dpc-4793	313	14	-5	-5	NUM
dpc-4793	313	15	(	(	PUNCT
dpc-4793	313	16	%	%	INTJ
dpc-4793	313	17	)	)	PUNCT
dpc-4793	313	18	m	m	VERB
dpc-4793	313	19	a	a	DET
dpc-4793	313	20	l	l	NOUN
dpc-4793	313	21	[	[	PUNCT
dpc-4793	313	22	27	27	NUM
dpc-4793	313	23	]	]	PUNCT
dpc-4793	313	24	c	c	PROPN
dpc-4793	313	25	al	al	PROPN
dpc-4793	313	26	ci	ci	PROPN
dpc-4793	313	27	po	po	PROPN
dpc-4793	313	28	tr	tr	VERB
dpc-4793	313	29	io	io	PROPN
dpc-4793	313	30	l	l	PROPN
dpc-4793	313	31	/	/	SYM
dpc-4793	313	32	e	e	X
dpc-4793	313	33	ne	ne	NOUN
dpc-4793	314	1	+	+	CCONJ
dpc-4793	314	2	b	b	X
dpc-4793	314	3	et	et	NOUN
dpc-4793	314	4	am	be	AUX
dpc-4793	314	5	et	et	NOUN
dpc-4793	314	6	ha	ha	INTJ
dpc-4793	314	7	so	so	ADV
dpc-4793	314	8	ne	ne	PROPN
dpc-4793	314	9	d	d	PROPN
dpc-4793	314	10	ip	ip	PRON
dpc-4793	314	11	ro	ro	X
dpc-4793	314	12	pi	pi	NOUN
dpc-4793	314	13	on	on	ADV
dpc-4793	314	14	at	at	ADP
dpc-4793	314	15	e	e	PROPN
dpc-4793	314	16	n	n	ADP
dpc-4793	314	17	r	r	NOUN
dpc-4793	314	18	60	60	NUM
dpc-4793	314	19	.8	.8	NUM
dpc-4793	314	20	39	39	NUM
dpc-4793	314	21	.9	.9	NUM
dpc-4793	315	1	*	*	PUNCT
dpc-4793	315	2	n	n	NUM
dpc-4793	315	3	r	r	NOUN
dpc-4793	315	4	7	7	NUM
dpc-4793	315	5	.	.	NOUN
dpc-4793	315	6	4	4	NUM
dpc-4793	315	7	*	*	SYM
dpc-4793	315	8	54	54	NUM
dpc-4793	315	9	.1	.1	NUM
dpc-4793	315	10	*	*	PUNCT
dpc-4793	316	1	n	n	CCONJ
dpc-4793	316	2	r	r	NOUN
dpc-4793	316	3	6	6	NUM
dpc-4793	316	4	.	.	NOUN
dpc-4793	316	5	8	8	NUM
dpc-4793	316	6	*	*	SYM
dpc-4793	316	7	69	69	NUM
dpc-4793	316	8	.2	.2	NUM
dpc-4793	316	9	,	,	PUNCT
dpc-4793	316	10	2	2	NUM
dpc-4793	316	11	4	4	NUM
dpc-4793	316	12	.	.	NOUN
dpc-4793	316	13	4	4	NUM
dpc-4793	316	14	,	,	PUNCT
dpc-4793	316	15	6	6	NUM
dpc-4793	316	16	.7	.7	NUM
dpc-4793	316	17	c	c	NOUN
dpc-4793	316	18	al	al	PROPN
dpc-4793	316	19	ci	ci	PROPN
dpc-4793	316	20	po	po	PROPN
dpc-4793	316	21	tr	tr	VERB
dpc-4793	316	22	ie	ie	X
dpc-4793	316	23	ne	ne	X
dpc-4793	316	24	/o	/o	PUNCT
dpc-4793	317	1	l	l	NOUN
dpc-4793	317	2	n	n	CCONJ
dpc-4793	317	3	r	r	NOUN
dpc-4793	317	4	55	55	NUM
dpc-4793	317	5	.6	.6	NUM
dpc-4793	317	6	38	38	NUM
dpc-4793	317	7	.7	.7	NUM
dpc-4793	317	8	*	*	PUNCT
dpc-4793	318	1	n	n	CCONJ
dpc-4793	318	2	r	r	NOUN
dpc-4793	318	3	7	7	NUM
dpc-4793	318	4	.	.	NOUN
dpc-4793	319	1	5	5	NUM
dpc-4793	319	2	*	*	SYM
dpc-4793	319	3	48	48	NUM
dpc-4793	320	1	.6	.6	NUM
dpc-4793	320	2	*	*	PUNCT
dpc-4793	320	3	n	n	CCONJ
dpc-4793	320	4	r	r	NOUN
dpc-4793	320	5	6	6	NUM
dpc-4793	320	6	.	.	PUNCT
dpc-4793	320	7	9	9	NUM
dpc-4793	320	8	*	*	SYM
dpc-4793	320	9	70	70	NUM
dpc-4793	320	10	.2	.2	NUM
dpc-4793	320	11	,	,	PUNCT
dpc-4793	320	12	2	2	NUM
dpc-4793	320	13	5	5	NUM
dpc-4793	320	14	.	.	NOUN
dpc-4793	320	15	8	8	NUM
dpc-4793	320	16	,	,	PUNCT
dpc-4793	320	17	4	4	NUM
dpc-4793	320	18	o	o	NOUN
dpc-4793	320	19	ku	ku	PROPN
dpc-4793	320	20	bo	bo	PROPN
dpc-4793	320	21	y	y	PROPN
dpc-4793	320	22	[	[	PUNCT
dpc-4793	320	23	40	40	NUM
dpc-4793	320	24	]	]	SYM
dpc-4793	320	25	b	b	X
dpc-4793	320	26	et	et	NOUN
dpc-4793	320	27	am	be	AUX
dpc-4793	320	28	et	et	NOUN
dpc-4793	320	29	ha	ha	INTJ
dpc-4793	321	1	so	so	ADV
dpc-4793	321	2	ne	ne	INTJ
dpc-4793	321	3	bu	bu	PROPN
dpc-4793	321	4	ty	ty	INTJ
dpc-4793	322	1	ra	ra	INTJ
dpc-4793	323	1	te	te	INTJ
dpc-4793	323	2	p	p	X
dpc-4793	323	3	ro	ro	ADJ
dpc-4793	323	4	pi	pi	NOUN
dpc-4793	323	5	on	on	ADV
dpc-4793	323	6	at	at	ADP
dpc-4793	323	7	e	e	PROPN
dpc-4793	323	8	+	+	NOUN
dpc-4793	323	9	m	m	VERB
dpc-4793	323	10	ax	ax	NOUN
dpc-4793	323	11	ac	ac	PROPN
dpc-4793	323	12	al	al	PROPN
dpc-4793	323	13	ci	ci	PROPN
dpc-4793	323	14	to	to	ADP
dpc-4793	323	15	l	l	PROPN
dpc-4793	323	16	(	(	PUNCT
dpc-4793	323	17	8	8	NUM
dpc-4793	323	18	 	 	SPACE
dpc-4793	323	19	w	w	PROPN
dpc-4793	323	20	ee	ee	PROPN
dpc-4793	323	21	ks	ks	PROPN
dpc-4793	323	22	)	)	PUNCT
dpc-4793	324	1	n	n	CCONJ
dpc-4793	324	2	r	r	NOUN
dpc-4793	324	3	87	87	NUM
dpc-4793	324	4	.5	.5	NUM
dpc-4793	324	5	49	49	NUM
dpc-4793	325	1	.6	.6	NUM
dpc-4793	325	2	*	*	PUNCT
dpc-4793	326	1	[	[	X
dpc-4793	326	2	2	2	NUM
dpc-4793	326	3	478	478	NUM
dpc-4793	326	4	]	]	PUNCT
dpc-4793	326	5	n	n	CCONJ
dpc-4793	326	6	r	r	NOUN
dpc-4793	326	7	14	14	NUM
dpc-4793	326	8	.1	.1	NUM
dpc-4793	326	9	*	*	PUNCT
dpc-4793	327	1	n	n	CCONJ
dpc-4793	327	2	r	r	NOUN
dpc-4793	327	3	n	n	NOUN
dpc-4793	327	4	r	r	NOUN
dpc-4793	327	5	5	5	NUM
dpc-4793	327	6	.	.	NOUN
dpc-4793	328	1	6	6	NUM
dpc-4793	328	2	*	*	NOUN
dpc-4793	328	3	n	n	PRON
dpc-4793	328	4	r	r	NOUN
dpc-4793	328	5	b	b	NOUN
dpc-4793	328	6	et	et	NOUN
dpc-4793	328	7	am	be	AUX
dpc-4793	328	8	et	et	NOUN
dpc-4793	328	9	ha	ha	INTJ
dpc-4793	329	1	so	so	ADV
dpc-4793	329	2	ne	ne	INTJ
dpc-4793	329	3	bu	bu	PROPN
dpc-4793	329	4	ty	ty	INTJ
dpc-4793	330	1	ra	ra	INTJ
dpc-4793	331	1	te	te	INTJ
dpc-4793	331	2	p	p	X
dpc-4793	331	3	ro	ro	ADJ
dpc-4793	331	4	pi	pi	NOUN
dpc-4793	331	5	on	on	ADV
dpc-4793	331	6	at	at	ADP
dpc-4793	331	7	e	e	PROPN
dpc-4793	331	8	+	+	NOUN
dpc-4793	331	9	m	m	VERB
dpc-4793	331	10	ax	ax	NOUN
dpc-4793	331	11	ac	ac	PROPN
dpc-4793	331	12	al	al	PROPN
dpc-4793	331	13	ci	ci	PROPN
dpc-4793	331	14	to	to	ADP
dpc-4793	331	15	l	l	PROPN
dpc-4793	331	16	(	(	PUNCT
dpc-4793	331	17	4	4	NUM
dpc-4793	331	18	w	w	PROPN
dpc-4793	331	19	ee	ee	PROPN
dpc-4793	331	20	ks	ks	PROPN
dpc-4793	331	21	)	)	PUNCT
dpc-4793	331	22	n	n	CCONJ
dpc-4793	331	23	r	r	NOUN
dpc-4793	331	24	80	80	NUM
dpc-4793	331	25	46	46	NUM
dpc-4793	331	26	.1	.1	NUM
dpc-4793	331	27	*	*	PUNCT
dpc-4793	332	1	[	[	X
dpc-4793	332	2	2	2	NUM
dpc-4793	332	3	676	676	NUM
dpc-4793	332	4	]	]	PUNCT
dpc-4793	332	5	n	n	CCONJ
dpc-4793	332	6	r	r	NOUN
dpc-4793	332	7	7	7	NUM
dpc-4793	332	8	.	.	PUNCT
dpc-4793	332	9	3	3	NUM
dpc-4793	332	10	*	*	SYM
dpc-4793	332	11	n	n	NUM
dpc-4793	332	12	r	r	NOUN
dpc-4793	332	13	n	n	NOUN
dpc-4793	332	14	r	r	NOUN
dpc-4793	332	15	5	5	NUM
dpc-4793	332	16	.	.	NOUN
dpc-4793	332	17	4	4	NUM
dpc-4793	332	18	*	*	NOUN
dpc-4793	332	19	n	n	NUM
dpc-4793	332	20	r	r	PROPN
dpc-4793	332	21	va	va	PROPN
dpc-4793	332	22	n	n	CCONJ
dpc-4793	332	23	de	de	PROPN
dpc-4793	332	24	k	k	PROPN
dpc-4793	333	1	er	er	INTJ
dpc-4793	333	2	kh	kh	PROPN
dpc-4793	333	3	of	of	ADP
dpc-4793	333	4	p	p	PROPN
dpc-4793	333	5	c	c	PROPN
dpc-4793	334	1	[	[	X
dpc-4793	334	2	2	2	NUM
dpc-4793	334	3	8	8	NUM
dpc-4793	334	4	]	]	PUNCT
dpc-4793	334	5	c	c	PROPN
dpc-4793	334	6	al	al	PROPN
dpc-4793	334	7	ci	ci	PROPN
dpc-4793	334	8	po	po	PROPN
dpc-4793	334	9	tr	tr	VERB
dpc-4793	334	10	io	io	PROPN
dpc-4793	334	11	l	l	PROPN
dpc-4793	334	12	/	/	SYM
dpc-4793	334	13	e	e	X
dpc-4793	334	14	ne	ne	NOUN
dpc-4793	335	1	+	+	CCONJ
dpc-4793	335	2	b	b	X
dpc-4793	335	3	et	et	NOUN
dpc-4793	335	4	am	be	AUX
dpc-4793	335	5	et	et	NOUN
dpc-4793	335	6	ha	ha	INTJ
dpc-4793	335	7	so	so	ADV
dpc-4793	335	8	ne	ne	PROPN
dpc-4793	335	9	d	d	PROPN
dpc-4793	335	10	ip	ip	PRON
dpc-4793	335	11	ro	ro	X
dpc-4793	335	12	pi	pi	NOUN
dpc-4793	335	13	on	on	ADV
dpc-4793	335	14	at	at	ADP
dpc-4793	335	15	e	e	PROPN
dpc-4793	335	16	98	98	NUM
dpc-4793	335	17	.4	.4	NUM
dpc-4793	335	18	41	41	NUM
dpc-4793	335	19	.9	.9	NUM
dpc-4793	335	20	48	48	NUM
dpc-4793	335	21	.5	.5	NUM
dpc-4793	336	1	*	*	PUNCT
dpc-4793	337	1	[	[	X
dpc-4793	337	2	1	1	NUM
dpc-4793	337	3	892	892	NUM
dpc-4793	337	4	]	]	PUNCT
dpc-4793	337	5	n	n	CCONJ
dpc-4793	337	6	r	r	NOUN
dpc-4793	337	7	15	15	NUM
dpc-4793	337	8	.7	.7	NUM
dpc-4793	337	9	*	*	PUNCT
dpc-4793	337	10	n	n	CCONJ
dpc-4793	337	11	r	r	NOUN
dpc-4793	337	12	n	n	NOUN
dpc-4793	337	13	r	r	NOUN
dpc-4793	337	14	6	6	NUM
dpc-4793	337	15	.	.	NOUN
dpc-4793	337	16	8	8	NUM
dpc-4793	337	17	*	*	SYM
dpc-4793	337	18	54	54	NUM
dpc-4793	337	19	.8	.8	NUM
dpc-4793	337	20	,	,	PUNCT
dpc-4793	337	21	2	2	NUM
dpc-4793	337	22	9	9	NUM
dpc-4793	337	23	.	.	NOUN
dpc-4793	337	24	9	9	NUM
dpc-4793	337	25	,	,	PUNCT
dpc-4793	337	26	5	5	NUM
dpc-4793	337	27	.5	.5	NUM
dpc-4793	337	28	b	b	X
dpc-4793	337	29	et	et	NOUN
dpc-4793	337	30	am	be	AUX
dpc-4793	337	31	et	et	NOUN
dpc-4793	337	32	ha	ha	INTJ
dpc-4793	337	33	so	so	ADV
dpc-4793	337	34	ne	ne	PROPN
dpc-4793	337	35	d	d	PROPN
dpc-4793	337	36	ip	ip	PRON
dpc-4793	337	37	ro	ro	X
dpc-4793	337	38	pi	pi	NOUN
dpc-4793	337	39	on	on	ADV
dpc-4793	337	40	at	at	ADP
dpc-4793	337	41	e	e	PROPN
dpc-4793	337	42	q	q	PROPN
dpc-4793	337	43	d	d	PROPN
dpc-4793	337	44	96	96	NUM
dpc-4793	337	45	.8	.8	NUM
dpc-4793	337	46	46	46	NUM
dpc-4793	338	1	.2	.2	NUM
dpc-4793	338	2	47	47	NUM
dpc-4793	339	1	.9	.9	NUM
dpc-4793	340	1	*	*	PUNCT
dpc-4793	341	1	[	[	X
dpc-4793	341	2	1	1	NUM
dpc-4793	341	3	885	885	NUM
dpc-4793	341	4	]	]	PUNCT
dpc-4793	341	5	n	n	CCONJ
dpc-4793	341	6	r	r	NOUN
dpc-4793	341	7	16	16	NUM
dpc-4793	341	8	.1	.1	NUM
dpc-4793	341	9	*	*	PUNCT
dpc-4793	342	1	n	n	CCONJ
dpc-4793	342	2	r	r	NOUN
dpc-4793	342	3	n	n	NOUN
dpc-4793	342	4	r	r	NOUN
dpc-4793	342	5	6	6	NUM
dpc-4793	342	6	.	.	PUNCT
dpc-4793	342	7	9	9	NUM
dpc-4793	342	8	*	*	SYM
dpc-4793	342	9	53	53	NUM
dpc-4793	342	10	.6	.6	NUM
dpc-4793	342	11	,	,	PUNCT
dpc-4793	342	12	3	3	NUM
dpc-4793	342	13	3	3	NUM
dpc-4793	342	14	.	.	NOUN
dpc-4793	342	15	6	6	NUM
dpc-4793	342	16	,	,	PUNCT
dpc-4793	342	17	4	4	NUM
dpc-4793	342	18	.8	.8	NUM
dpc-4793	342	19	c	c	PROPN
dpc-4793	342	20	al	al	PROPN
dpc-4793	342	21	ci	ci	PROPN
dpc-4793	342	22	po	po	PROPN
dpc-4793	342	23	tr	tr	VERB
dpc-4793	342	24	ie	ie	X
dpc-4793	342	25	ne	ne	X
dpc-4793	342	26	/o	/o	PUNCT
dpc-4793	342	27	l	l	NOUN
dpc-4793	343	1	95	95	NUM
dpc-4793	343	2	.8	.8	NUM
dpc-4793	343	3	47	47	NUM
dpc-4793	344	1	.9	.9	NUM
dpc-4793	344	2	48	48	NUM
dpc-4793	345	1	.7	.7	NUM
dpc-4793	345	2	*	*	PUNCT
dpc-4793	346	1	[	[	X
dpc-4793	346	2	1	1	NUM
dpc-4793	346	3	888	888	NUM
dpc-4793	346	4	]	]	PUNCT
dpc-4793	346	5	n	n	CCONJ
dpc-4793	346	6	r	r	NOUN
dpc-4793	346	7	15	15	NUM
dpc-4793	346	8	.8	.8	NUM
dpc-4793	346	9	*	*	PUNCT
dpc-4793	346	10	n	n	CCONJ
dpc-4793	346	11	r	r	NOUN
dpc-4793	346	12	n	n	NOUN
dpc-4793	346	13	r	r	NOUN
dpc-4793	346	14	6	6	NUM
dpc-4793	346	15	.	.	NOUN
dpc-4793	346	16	8	8	NUM
dpc-4793	346	17	*	*	SYM
dpc-4793	346	18	51	51	NUM
dpc-4793	346	19	.4	.4	NUM
dpc-4793	346	20	,	,	PUNCT
dpc-4793	346	21	3	3	NUM
dpc-4793	346	22	2	2	NUM
dpc-4793	346	23	.	.	NOUN
dpc-4793	346	24	9	9	NUM
dpc-4793	346	25	,	,	PUNCT
dpc-4793	346	26	3	3	NUM
dpc-4793	346	27	.5	.5	NUM
dpc-4793	347	1	pa	pa	NOUN
dpc-4793	347	2	te	te	PROPN
dpc-4793	347	3	l	l	PROPN
dpc-4793	348	1	d	d	X
dpc-4793	348	2	s	s	X
dpc-4793	349	1	[	[	X
dpc-4793	349	2	2	2	NUM
dpc-4793	349	3	9	9	NUM
dpc-4793	349	4	]	]	PUNCT
dpc-4793	349	5	c	c	PROPN
dpc-4793	349	6	al	al	PROPN
dpc-4793	349	7	ci	ci	PROPN
dpc-4793	349	8	po	po	PROPN
dpc-4793	349	9	tr	tr	VERB
dpc-4793	349	10	io	io	PROPN
dpc-4793	349	11	l	l	PROPN
dpc-4793	349	12	/	/	SYM
dpc-4793	349	13	e	e	X
dpc-4793	349	14	ne	ne	NOUN
dpc-4793	350	1	+	+	CCONJ
dpc-4793	350	2	b	b	X
dpc-4793	350	3	et	et	NOUN
dpc-4793	350	4	am	be	AUX
dpc-4793	350	5	et	et	NOUN
dpc-4793	350	6	ha	ha	INTJ
dpc-4793	350	7	so	so	ADV
dpc-4793	350	8	ne	ne	PROPN
dpc-4793	350	9	d	d	PROPN
dpc-4793	350	10	ip	ip	PRON
dpc-4793	350	11	ro	ro	X
dpc-4793	350	12	pi	pi	NOUN
dpc-4793	350	13	on	on	ADV
dpc-4793	350	14	at	at	ADP
dpc-4793	350	15	e	e	PROPN
dpc-4793	350	16	93	93	NUM
dpc-4793	350	17	53	53	NUM
dpc-4793	350	18	47	47	NUM
dpc-4793	350	19	.4	.4	NUM
dpc-4793	351	1	*	*	PUNCT
dpc-4793	352	1	[	[	X
dpc-4793	352	2	2	2	NUM
dpc-4793	352	3	081	081	NUM
dpc-4793	352	4	]	]	PUNCT
dpc-4793	352	5	n	n	CCONJ
dpc-4793	352	6	r	r	NOUN
dpc-4793	352	7	14	14	NUM
dpc-4793	352	8	.6	.6	NUM
dpc-4793	352	9	*	*	PUNCT
dpc-4793	352	10	n	n	CCONJ
dpc-4793	352	11	r	r	NOUN
dpc-4793	352	12	n	n	NOUN
dpc-4793	352	13	r	r	NOUN
dpc-4793	352	14	n	n	NOUN
dpc-4793	352	15	r	r	NOUN
dpc-4793	352	16	65	65	NUM
dpc-4793	352	17	,	,	PUNCT
dpc-4793	352	18	1	1	NUM
dpc-4793	352	19	7	7	NUM
dpc-4793	352	20	,	,	PUNCT
dpc-4793	352	21	n	n	PRON
dpc-4793	352	22	r	r	NOUN
dpc-4793	352	23	c	c	PROPN
dpc-4793	352	24	al	al	PROPN
dpc-4793	352	25	ci	ci	PROPN
dpc-4793	352	26	po	po	PROPN
dpc-4793	352	27	tr	tr	VERB
dpc-4793	352	28	ie	ie	X
dpc-4793	352	29	ne	ne	X
dpc-4793	352	30	/o	/o	PUNCT
dpc-4793	353	1	l	l	NOUN
dpc-4793	353	2	91	91	NUM
dpc-4793	354	1	.1	.1	NUM
dpc-4793	354	2	60	60	NUM
dpc-4793	354	3	.4	.4	NUM
dpc-4793	354	4	50	50	NUM
dpc-4793	355	1	.7	.7	NUM
dpc-4793	355	2	*	*	PUNCT
dpc-4793	356	1	[	[	X
dpc-4793	356	2	2	2	NUM
dpc-4793	356	3	185	185	NUM
dpc-4793	356	4	]	]	PUNCT
dpc-4793	356	5	n	n	CCONJ
dpc-4793	356	6	r	r	NOUN
dpc-4793	356	7	18	18	NUM
dpc-4793	356	8	.4	.4	NUM
dpc-4793	356	9	*	*	PUNCT
dpc-4793	356	10	n	n	CCONJ
dpc-4793	356	11	r	r	NOUN
dpc-4793	356	12	n	n	NOUN
dpc-4793	356	13	r	r	NOUN
dpc-4793	356	14	n	n	NOUN
dpc-4793	356	15	r	r	NOUN
dpc-4793	356	16	62	62	NUM
dpc-4793	356	17	.4	.4	NUM
dpc-4793	356	18	,	,	PUNCT
dpc-4793	356	19	1	1	NUM
dpc-4793	356	20	4	4	NUM
dpc-4793	356	21	.	.	NOUN
dpc-4793	356	22	9	9	NUM
dpc-4793	356	23	,	,	PUNCT
dpc-4793	356	24	n	n	NOUN
dpc-4793	356	25	r	r	NOUN
dpc-4793	356	26	b	b	PROPN
dpc-4793	356	27	et	et	NOUN
dpc-4793	356	28	am	be	AUX
dpc-4793	356	29	et	et	NOUN
dpc-4793	356	30	ha	ha	INTJ
dpc-4793	356	31	so	so	ADV
dpc-4793	356	32	ne	ne	PROPN
dpc-4793	356	33	d	d	PROPN
dpc-4793	356	34	ip	ip	PRON
dpc-4793	356	35	ro	ro	X
dpc-4793	356	36	pi	pi	NOUN
dpc-4793	356	37	on	on	ADV
dpc-4793	356	38	at	at	ADP
dpc-4793	356	39	e	e	PROPN
dpc-4793	356	40	q	q	PROPN
dpc-4793	356	41	d	d	X
dpc-4793	356	42	82	82	NUM
dpc-4793	357	1	.2	.2	NUM
dpc-4793	357	2	55	55	NUM
dpc-4793	357	3	.4	.4	NUM
dpc-4793	357	4	49	49	NUM
dpc-4793	357	5	*	*	PUNCT
dpc-4793	358	1	[	[	X
dpc-4793	358	2	2	2	NUM
dpc-4793	358	3	085	085	NUM
dpc-4793	358	4	]	]	PUNCT
dpc-4793	358	5	n	n	CCONJ
dpc-4793	358	6	r	r	NOUN
dpc-4793	358	7	16	16	NUM
dpc-4793	358	8	.2	.2	NUM
dpc-4793	358	9	*	*	PUNCT
dpc-4793	358	10	n	n	CCONJ
dpc-4793	358	11	r	r	NOUN
dpc-4793	358	12	n	n	NOUN
dpc-4793	358	13	r	r	NOUN
dpc-4793	358	14	n	n	NOUN
dpc-4793	358	15	r	r	NOUN
dpc-4793	358	16	71	71	NUM
dpc-4793	358	17	.3	.3	NUM
dpc-4793	358	18	,	,	PUNCT
dpc-4793	358	19	9	9	NUM
dpc-4793	358	20	.9	.9	NUM
dpc-4793	358	21	,	,	PUNCT
dpc-4793	358	22	n	n	NOUN
dpc-4793	358	23	r	r	NOUN
dpc-4793	358	24	r	r	NOUN
dpc-4793	358	25	at	at	ADP
dpc-4793	358	26	ta	ta	PROPN
dpc-4793	358	27	na	na	INTJ
dpc-4793	358	28	ka	ka	PROPN
dpc-4793	358	29	em	em	PROPN
dpc-4793	358	30	ak	ak	PROPN
dpc-4793	358	31	or	or	CCONJ
dpc-4793	358	32	n	n	PRON
dpc-4793	358	33	p	p	X
dpc-4793	359	1	[	[	X
dpc-4793	359	2	2	2	NUM
dpc-4793	359	3	1	1	NUM
dpc-4793	359	4	]	]	PUNCT
dpc-4793	359	5	e	e	X
dpc-4793	359	6	xc	xc	PROPN
dpc-4793	360	1	i	i	PRON
dpc-4793	360	2	m	m	VERB
dpc-4793	360	3	er	er	INTJ
dpc-4793	360	4	la	la	ADV
dpc-4793	360	5	m	m	PROPN
dpc-4793	360	6	p	p	NOUN
dpc-4793	361	1	+	+	NUM
dpc-4793	361	2	10	10	NUM
dpc-4793	361	3	%	%	NOUN
dpc-4793	362	1	l	l	NOUN
dpc-4793	362	2	c	c	NOUN
dpc-4793	363	1	d	d	X
dpc-4793	363	2	c	c	X
dpc-4793	363	3	re	re	VERB
dpc-4793	363	4	am	be	AUX
dpc-4793	363	5	n	n	ADV
dpc-4793	363	6	r	r	NOUN
dpc-4793	363	7	46	46	NUM
dpc-4793	363	8	.7	.7	NUM
dpc-4793	363	9	35	35	NUM
dpc-4793	363	10	.5	.5	NUM
dpc-4793	363	11	3	3	NUM
dpc-4793	363	12	*	*	SYM
dpc-4793	363	13	27	27	NUM
dpc-4793	363	14	.1	.1	NUM
dpc-4793	363	15	5	5	NUM
dpc-4793	363	16	*	*	SYM
dpc-4793	363	17	n	n	NUM
dpc-4793	363	18	r	r	NOUN
dpc-4793	363	19	n	n	NOUN
dpc-4793	363	20	r	r	NOUN
dpc-4793	363	21	12	12	NUM
dpc-4793	363	22	n	n	NOUN
dpc-4793	363	23	r	r	NOUN
dpc-4793	363	24	n	n	NOUN
dpc-4793	363	25	r	r	NOUN
dpc-4793	363	26	e	e	NOUN
dpc-4793	363	27	xc	xc	PROPN
dpc-4793	364	1	i	i	PRON
dpc-4793	364	2	m	m	VERB
dpc-4793	364	3	er	er	INTJ
dpc-4793	364	4	la	la	ADV
dpc-4793	364	5	m	m	PROPN
dpc-4793	364	6	p	p	NOUN
dpc-4793	365	1	n	n	PRON
dpc-4793	365	2	r	r	NOUN
dpc-4793	365	3	40	40	NUM
dpc-4793	365	4	47	47	NUM
dpc-4793	366	1	*	*	SYM
dpc-4793	366	2	29	29	NUM
dpc-4793	366	3	.1	.1	NUM
dpc-4793	366	4	*	*	PUNCT
dpc-4793	367	1	n	n	CCONJ
dpc-4793	367	2	r	r	NOUN
dpc-4793	367	3	n	n	NOUN
dpc-4793	367	4	r	r	NOUN
dpc-4793	367	5	18	18	NUM
dpc-4793	367	6	n	n	NOUN
dpc-4793	367	7	r	r	NOUN
dpc-4793	367	8	n	n	NOUN
dpc-4793	367	9	r	r	NOUN
dpc-4793	367	10	r	r	NOUN
dpc-4793	367	11	ei	ei	NOUN
dpc-4793	367	12	ch	ch	NOUN
dpc-4793	367	13	k	k	PROPN
dpc-4793	367	14	[	[	PUNCT
dpc-4793	367	15	16	16	NUM
dpc-4793	367	16	]	]	PUNCT
dpc-4793	367	17	e	e	X
dpc-4793	367	18	ta	ta	PROPN
dpc-4793	367	19	ne	ne	PROPN
dpc-4793	367	20	rc	rc	PROPN
dpc-4793	367	21	ep	ep	PROPN
dpc-4793	367	22	t	t	PROPN
dpc-4793	367	23	50	50	NUM
dpc-4793	367	24	m	m	NOUN
dpc-4793	367	25	g	g	ADP
dpc-4793	367	26	92	92	NUM
dpc-4793	367	27	.4	.4	NUM
dpc-4793	367	28	68	68	NUM
dpc-4793	367	29	.7	.7	NUM
dpc-4793	367	30	45	45	NUM
dpc-4793	367	31	.4	.4	NUM
dpc-4793	367	32	*	*	PUNCT
dpc-4793	368	1	n	n	NUM
dpc-4793	368	2	r	r	NOUN
dpc-4793	368	3	18	18	NUM
dpc-4793	368	4	.6	.6	NUM
dpc-4793	368	5	*	*	PUNCT
dpc-4793	368	6	n	n	NUM
dpc-4793	368	7	r	r	NOUN
dpc-4793	368	8	19	19	NUM
dpc-4793	368	9	.9	.9	NUM
dpc-4793	368	10	*	*	PUNCT
dpc-4793	368	11	n	n	CCONJ
dpc-4793	368	12	r	r	NOUN
dpc-4793	368	13	n	n	NOUN
dpc-4793	368	14	r	r	NOUN
dpc-4793	368	15	ix	ix	INTJ
dpc-4793	369	1	ek	ek	INTJ
dpc-4793	370	1	iz	iz	INTJ
dpc-4793	370	2	um	um	INTJ
dpc-4793	370	3	ab	ab	PROPN
dpc-4793	370	4	q	q	PROPN
dpc-4793	370	5	2w	2w	NUM
dpc-4793	370	6	93	93	NUM
dpc-4793	370	7	.2	.2	NUM
dpc-4793	370	8	65	65	NUM
dpc-4793	370	9	.3	.3	NUM
dpc-4793	370	10	44	44	NUM
dpc-4793	370	11	.8	.8	NUM
dpc-4793	370	12	*	*	PUNCT
dpc-4793	371	1	n	n	CCONJ
dpc-4793	371	2	r	r	NOUN
dpc-4793	371	3	18	18	NUM
dpc-4793	371	4	.7	.7	NUM
dpc-4793	371	5	*	*	PUNCT
dpc-4793	371	6	n	n	NUM
dpc-4793	371	7	r	r	NOUN
dpc-4793	371	8	20	20	NUM
dpc-4793	371	9	.3	.3	NUM
dpc-4793	371	10	*	*	PUNCT
dpc-4793	371	11	n	n	CCONJ
dpc-4793	371	12	r	r	NOUN
dpc-4793	371	13	n	n	NOUN
dpc-4793	371	14	r	r	NOUN
dpc-4793	371	15	ix	ix	INTJ
dpc-4793	372	1	ek	ek	INTJ
dpc-4793	373	1	iz	iz	INTJ
dpc-4793	373	2	um	um	INTJ
dpc-4793	373	3	ab	ab	PROPN
dpc-4793	373	4	q	q	PROPN
dpc-4793	373	5	4w	4w	NUM
dpc-4793	373	6	92	92	NUM
dpc-4793	373	7	.2	.2	NUM
dpc-4793	373	8	67	67	NUM
dpc-4793	373	9	.9	.9	NUM
dpc-4793	373	10	45	45	NUM
dpc-4793	374	1	.2	.2	NUM
dpc-4793	374	2	*	*	PUNCT
dpc-4793	375	1	n	n	NUM
dpc-4793	375	2	r	r	NOUN
dpc-4793	375	3	18	18	NUM
dpc-4793	375	4	.7	.7	NUM
dpc-4793	375	5	*	*	PUNCT
dpc-4793	375	6	n	n	CCONJ
dpc-4793	375	7	r	r	NOUN
dpc-4793	375	8	20	20	NUM
dpc-4793	375	9	.1	.1	NUM
dpc-4793	375	10	*	*	PUNCT
dpc-4793	376	1	n	n	CCONJ
dpc-4793	376	2	r	r	NOUN
dpc-4793	377	1	n	n	NOUN
dpc-4793	377	2	r	r	NOUN
dpc-4793	377	3	pl	pl	X
dpc-4793	377	4	ac	ac	PROPN
dpc-4793	377	5	eb	eb	PROPN
dpc-4793	377	6	o	o	PROPN
dpc-4793	377	7	91	91	NUM
dpc-4793	378	1	.4	.4	NUM
dpc-4793	378	2	71	71	NUM
dpc-4793	379	1	.2	.2	NUM
dpc-4793	379	2	46	46	NUM
dpc-4793	379	3	*	*	PUNCT
dpc-4793	380	1	n	n	NUM
dpc-4793	380	2	r	r	NOUN
dpc-4793	380	3	18	18	NUM
dpc-4793	380	4	.8	.8	NUM
dpc-4793	380	5	*	*	PUNCT
dpc-4793	380	6	n	n	NUM
dpc-4793	380	7	r	r	NOUN
dpc-4793	380	8	20	20	NUM
dpc-4793	380	9	.8	.8	NUM
dpc-4793	380	10	*	*	PUNCT
dpc-4793	380	11	n	n	CCONJ
dpc-4793	380	12	r	r	NOUN
dpc-4793	380	13	n	n	NOUN
dpc-4793	380	14	r	r	NOUN
dpc-4793	380	15	r	r	NOUN
dpc-4793	380	16	ey	ey	PRON
dpc-4793	380	17	ga	ga	NOUN
dpc-4793	380	18	gn	gn	PROPN
dpc-4793	380	19	e	e	PROPN
dpc-4793	380	20	p	p	X
dpc-4793	381	1	[	[	X
dpc-4793	381	2	3	3	NUM
dpc-4793	381	3	0	0	NUM
dpc-4793	381	4	]	]	PUNCT
dpc-4793	381	5	c	c	X
dpc-4793	381	6	lo	lo	PROPN
dpc-4793	381	7	be	be	VERB
dpc-4793	381	8	ta	ta	PART
dpc-4793	381	9	so	so	ADV
dpc-4793	381	10	l	l	NOUN
dpc-4793	381	11	pr	pr	NOUN
dpc-4793	381	12	op	op	NOUN
dpc-4793	381	13	io	io	VERB
dpc-4793	381	14	na	na	ADP
dpc-4793	381	15	te	te	PROPN
dpc-4793	381	16	s	s	VERB
dpc-4793	381	17	ha	ha	INTJ
dpc-4793	381	18	m	m	INTJ
dpc-4793	381	19	po	po	NOUN
dpc-4793	381	20	o	o	NOUN
dpc-4793	381	21	n	n	CCONJ
dpc-4793	381	22	r	r	NOUN
dpc-4793	381	23	49	49	NUM
dpc-4793	381	24	44	44	NUM
dpc-4793	381	25	.9	.9	NUM
dpc-4793	382	1	*	*	PUNCT
dpc-4793	382	2	n	n	CCONJ
dpc-4793	382	3	r	r	NOUN
dpc-4793	382	4	n	n	NOUN
dpc-4793	382	5	r	r	NOUN
dpc-4793	382	6	46	46	NUM
dpc-4793	382	7	*	*	SYM
dpc-4793	382	8	n	n	NUM
dpc-4793	382	9	r	r	NOUN
dpc-4793	382	10	4	4	NUM
dpc-4793	382	11	.	.	PUNCT
dpc-4793	383	1	86	86	NUM
dpc-4793	383	2	*	*	SYM
dpc-4793	383	3	n	n	PRON
dpc-4793	383	4	r	r	NOUN
dpc-4793	383	5	c	c	NOUN
dpc-4793	383	6	al	al	PROPN
dpc-4793	383	7	ci	ci	PROPN
dpc-4793	383	8	po	po	PROPN
dpc-4793	383	9	tr	tr	VERB
dpc-4793	383	10	ie	ie	X
dpc-4793	383	11	ne	ne	X
dpc-4793	383	12	/o	/o	PUNCT
dpc-4793	384	1	l	l	NOUN
dpc-4793	384	2	n	n	CCONJ
dpc-4793	384	3	r	r	NOUN
dpc-4793	384	4	45	45	NUM
dpc-4793	384	5	45	45	NUM
dpc-4793	384	6	.7	.7	NUM
dpc-4793	384	7	*	*	PUNCT
dpc-4793	384	8	n	n	CCONJ
dpc-4793	384	9	r	r	NOUN
dpc-4793	384	10	n	n	NOUN
dpc-4793	384	11	r	r	NOUN
dpc-4793	384	12	44	44	NUM
dpc-4793	384	13	*	*	PUNCT
dpc-4793	384	14	n	n	NUM
dpc-4793	384	15	r	r	NOUN
dpc-4793	384	16	4	4	NUM
dpc-4793	384	17	.	.	NOUN
dpc-4793	384	18	95	95	NUM
dpc-4793	384	19	*	*	PUNCT
dpc-4793	384	20	n	n	NUM
dpc-4793	384	21	r	r	NOUN
dpc-4793	384	22	r	r	NOUN
dpc-4793	385	1	ic	ic	NOUN
dpc-4793	385	2	h	h	NOUN
dpc-4793	385	3	p	p	NOUN
dpc-4793	386	1	[	[	X
dpc-4793	386	2	4	4	NUM
dpc-4793	386	3	3	3	NUM
dpc-4793	386	4	]	]	PUNCT
dpc-4793	386	5	a	a	DET
dpc-4793	386	6	pr	pr	NOUN
dpc-4793	386	7	em	em	PRON
dpc-4793	386	8	ila	ila	PROPN
dpc-4793	386	9	st	st	PROPN
dpc-4793	387	1	3	3	NUM
dpc-4793	387	2	0	0	NUM
dpc-4793	387	3	m	m	NOUN
dpc-4793	387	4	g	g	NOUN
dpc-4793	387	5	n	n	CCONJ
dpc-4793	387	6	r	r	NOUN
dpc-4793	387	7	65	65	NUM
dpc-4793	387	8	.2	.2	NUM
dpc-4793	387	9	44	44	NUM
dpc-4793	387	10	.9	.9	NUM
dpc-4793	387	11	*	*	PUNCT
dpc-4793	388	1	n	n	NUM
dpc-4793	388	2	r	r	NOUN
dpc-4793	388	3	19	19	NUM
dpc-4793	388	4	.1	.1	NUM
dpc-4793	388	5	4	4	NUM
dpc-4793	388	6	*	*	SYM
dpc-4793	388	7	n	n	ADP
dpc-4793	388	8	r	r	NOUN
dpc-4793	388	9	n	n	NOUN
dpc-4793	388	10	r	r	NOUN
dpc-4793	388	11	n	n	NOUN
dpc-4793	388	12	r	r	NOUN
dpc-4793	388	13	64	64	NUM
dpc-4793	388	14	.7	.7	NUM
dpc-4793	388	15	,	,	PUNCT
dpc-4793	388	16	3	3	NUM
dpc-4793	388	17	5	5	NUM
dpc-4793	388	18	.	.	NOUN
dpc-4793	388	19	3	3	NUM
dpc-4793	388	20	,	,	PUNCT
dpc-4793	388	21	n	n	PRON
dpc-4793	388	22	r	r	NOUN
dpc-4793	388	23	pl	pl	X
dpc-4793	388	24	ac	ac	PROPN
dpc-4793	388	25	eb	eb	PROPN
dpc-4793	388	26	o	o	PROPN
dpc-4793	388	27	n	n	CCONJ
dpc-4793	388	28	r	r	NOUN
dpc-4793	388	29	65	65	NUM
dpc-4793	388	30	.1	.1	NUM
dpc-4793	388	31	45	45	NUM
dpc-4793	388	32	.1	.1	NUM
dpc-4793	388	33	*	*	PUNCT
dpc-4793	389	1	n	n	X
dpc-4793	389	2	r	r	NOUN
dpc-4793	389	3	17	17	NUM
dpc-4793	389	4	.4	.4	NUM
dpc-4793	389	5	1	1	NUM
dpc-4793	389	6	*	*	SYM
dpc-4793	389	7	n	n	ADP
dpc-4793	389	8	r	r	NOUN
dpc-4793	389	9	n	n	NOUN
dpc-4793	389	10	r	r	NOUN
dpc-4793	389	11	n	n	NOUN
dpc-4793	389	12	r	r	NOUN
dpc-4793	389	13	62	62	NUM
dpc-4793	389	14	.4	.4	NUM
dpc-4793	389	15	,	,	PUNCT
dpc-4793	389	16	3	3	NUM
dpc-4793	389	17	7	7	NUM
dpc-4793	389	18	.	.	NOUN
dpc-4793	389	19	6	6	NUM
dpc-4793	389	20	,	,	PUNCT
dpc-4793	389	21	n	n	PRON
dpc-4793	389	22	r	r	NOUN
dpc-4793	389	23	a	a	DET
dpc-4793	389	24	pr	pr	NOUN
dpc-4793	389	25	em	em	PRON
dpc-4793	389	26	ila	ila	PROPN
dpc-4793	389	27	st	st	PROPN
dpc-4793	390	1	3	3	NUM
dpc-4793	390	2	0	0	NUM
dpc-4793	390	3	m	m	VERB
dpc-4793	390	4	g	g	NOUN
dpc-4793	390	5	n	n	CCONJ
dpc-4793	390	6	r	r	NOUN
dpc-4793	390	7	58	58	NUM
dpc-4793	390	8	.5	.5	NUM
dpc-4793	390	9	44	44	NUM
dpc-4793	390	10	.7	.7	NUM
dpc-4793	390	11	*	*	PUNCT
dpc-4793	391	1	n	n	CCONJ
dpc-4793	391	2	r	r	NOUN
dpc-4793	391	3	17	17	NUM
dpc-4793	391	4	.7	.7	NUM
dpc-4793	391	5	8	8	NUM
dpc-4793	391	6	*	*	SYM
dpc-4793	391	7	n	n	ADP
dpc-4793	391	8	r	r	NOUN
dpc-4793	391	9	n	n	NOUN
dpc-4793	391	10	r	r	NOUN
dpc-4793	391	11	n	n	NOUN
dpc-4793	391	12	r	r	NOUN
dpc-4793	391	13	68	68	NUM
dpc-4793	391	14	.8	.8	NUM
dpc-4793	391	15	,	,	PUNCT
dpc-4793	391	16	3	3	NUM
dpc-4793	391	17	1	1	NUM
dpc-4793	391	18	.	.	NOUN
dpc-4793	391	19	3	3	NUM
dpc-4793	391	20	,	,	PUNCT
dpc-4793	391	21	n	n	PRON
dpc-4793	391	22	r	r	NOUN
dpc-4793	391	23	pl	pl	X
dpc-4793	391	24	ac	ac	PROPN
dpc-4793	391	25	eb	eb	PROPN
dpc-4793	391	26	o	o	PROPN
dpc-4793	391	27	n	n	CCONJ
dpc-4793	391	28	r	r	NOUN
dpc-4793	391	29	75	75	NUM
dpc-4793	391	30	.3	.3	NUM
dpc-4793	391	31	44	44	NUM
dpc-4793	391	32	.1	.1	NUM
dpc-4793	391	33	*	*	PUNCT
dpc-4793	392	1	n	n	X
dpc-4793	392	2	r	r	NOUN
dpc-4793	392	3	17	17	NUM
dpc-4793	392	4	.5	.5	NUM
dpc-4793	392	5	2	2	NUM
dpc-4793	392	6	*	*	SYM
dpc-4793	392	7	n	n	ADP
dpc-4793	392	8	r	r	NOUN
dpc-4793	392	9	n	n	NOUN
dpc-4793	392	10	r	r	NOUN
dpc-4793	392	11	n	n	NOUN
dpc-4793	392	12	r	r	NOUN
dpc-4793	392	13	58	58	NUM
dpc-4793	392	14	.1	.1	NUM
dpc-4793	392	15	,	,	PUNCT
dpc-4793	392	16	4	4	NUM
dpc-4793	392	17	1	1	NUM
dpc-4793	392	18	.	.	NOUN
dpc-4793	392	19	9	9	NUM
dpc-4793	392	20	,	,	PUNCT
dpc-4793	392	21	n	n	PRON
dpc-4793	392	22	r	r	PROPN
dpc-4793	392	23	sa	sa	PROPN
dpc-4793	392	24	ra	ra	PROPN
dpc-4793	392	25	ce	ce	PROPN
dpc-4793	392	26	no	no	DET
dpc-4793	392	27	r	r	NOUN
dpc-4793	392	28	[	[	PUNCT
dpc-4793	392	29	31	31	NUM
dpc-4793	392	30	]	]	PUNCT
dpc-4793	392	31	c	c	PROPN
dpc-4793	392	32	al	al	PROPN
dpc-4793	392	33	ci	ci	PROPN
dpc-4793	392	34	po	po	PROPN
dpc-4793	392	35	tr	tr	VERB
dpc-4793	392	36	io	io	PROPN
dpc-4793	392	37	l	l	PROPN
dpc-4793	392	38	/	/	SYM
dpc-4793	392	39	e	e	X
dpc-4793	392	40	ne	ne	NOUN
dpc-4793	393	1	+	+	CCONJ
dpc-4793	393	2	b	b	X
dpc-4793	393	3	et	et	NOUN
dpc-4793	393	4	am	be	AUX
dpc-4793	393	5	et	et	NOUN
dpc-4793	393	6	ha	ha	INTJ
dpc-4793	393	7	so	so	ADV
dpc-4793	393	8	ne	ne	PROPN
dpc-4793	393	9	d	d	PROPN
dpc-4793	393	10	ip	ip	PRON
dpc-4793	393	11	ro	ro	X
dpc-4793	393	12	pi	pi	NOUN
dpc-4793	393	13	on	on	ADV
dpc-4793	393	14	at	at	ADP
dpc-4793	393	15	e	e	PROPN
dpc-4793	393	16	n	n	ADP
dpc-4793	393	17	r	r	NOUN
dpc-4793	393	18	51	51	NUM
dpc-4793	393	19	44	44	NUM
dpc-4793	393	20	.1	.1	NUM
dpc-4793	393	21	*	*	PUNCT
dpc-4793	394	1	[	[	X
dpc-4793	394	2	1	1	NUM
dpc-4793	394	3	885	885	NUM
dpc-4793	394	4	]	]	PUNCT
dpc-4793	394	5	n	n	CCONJ
dpc-4793	394	6	r	r	NOUN
dpc-4793	394	7	n	n	NOUN
dpc-4793	394	8	r	r	NOUN
dpc-4793	394	9	37	37	NUM
dpc-4793	394	10	.3	.3	NUM
dpc-4793	394	11	*	*	PUNCT
dpc-4793	394	12	n	n	PRON
dpc-4793	394	13	r	r	NOUN
dpc-4793	394	14	6	6	NUM
dpc-4793	394	15	.	.	NOUN
dpc-4793	395	1	9	9	NUM
dpc-4793	395	2	*	*	SYM
dpc-4793	395	3	n	n	NOUN
dpc-4793	395	4	r	r	NOUN
dpc-4793	395	5	c	c	NOUN
dpc-4793	395	6	al	al	PROPN
dpc-4793	395	7	ci	ci	PROPN
dpc-4793	395	8	po	po	PROPN
dpc-4793	395	9	tr	tr	VERB
dpc-4793	395	10	io	io	PROPN
dpc-4793	395	11	l	l	PROPN
dpc-4793	395	12	/	/	SYM
dpc-4793	395	13	e	e	X
dpc-4793	395	14	ne	ne	NOUN
dpc-4793	396	1	+	+	CCONJ
dpc-4793	396	2	b	b	X
dpc-4793	396	3	et	et	NOUN
dpc-4793	396	4	am	be	AUX
dpc-4793	396	5	et	et	NOUN
dpc-4793	396	6	ha	ha	INTJ
dpc-4793	396	7	so	so	ADV
dpc-4793	396	8	ne	ne	PROPN
dpc-4793	396	9	d	d	PROPN
dpc-4793	396	10	ip	ip	PRON
dpc-4793	396	11	ro	ro	X
dpc-4793	396	12	pi	pi	NOUN
dpc-4793	396	13	on	on	ADV
dpc-4793	396	14	at	at	ADP
dpc-4793	396	15	e	e	PROPN
dpc-4793	396	16	n	n	ADP
dpc-4793	396	17	r	r	NOUN
dpc-4793	396	18	59	59	NUM
dpc-4793	396	19	.2	.2	NUM
dpc-4793	396	20	45	45	NUM
dpc-4793	397	1	.7	.7	NUM
dpc-4793	397	2	*	*	PUNCT
dpc-4793	398	1	[	[	X
dpc-4793	398	2	1	1	NUM
dpc-4793	398	3	884	884	NUM
dpc-4793	398	4	]	]	PUNCT
dpc-4793	398	5	n	n	CCONJ
dpc-4793	398	6	r	r	NOUN
dpc-4793	398	7	n	n	NOUN
dpc-4793	398	8	r	r	NOUN
dpc-4793	398	9	36	36	NUM
dpc-4793	398	10	.8	.8	NUM
dpc-4793	398	11	*	*	PUNCT
dpc-4793	398	12	n	n	CCONJ
dpc-4793	398	13	r	r	NOUN
dpc-4793	398	14	6	6	NUM
dpc-4793	398	15	.	.	NOUN
dpc-4793	398	16	8	8	NUM
dpc-4793	398	17	*	*	SYM
dpc-4793	398	18	n	n	PRON
dpc-4793	398	19	r	r	NOUN
dpc-4793	398	20	ty	ty	INTJ
dpc-4793	398	21	ri	ri	PROPN
dpc-4793	398	22	ng	ng	PROPN
dpc-4793	398	23	s	s	X
dpc-4793	399	1	[	[	PUNCT
dpc-4793	399	2	32	32	NUM
dpc-4793	399	3	]	]	PUNCT
dpc-4793	399	4	c	c	PROPN
dpc-4793	399	5	al	al	PROPN
dpc-4793	399	6	ci	ci	PROPN
dpc-4793	399	7	po	po	PROPN
dpc-4793	399	8	tr	tr	VERB
dpc-4793	399	9	io	io	PROPN
dpc-4793	399	10	l	l	PROPN
dpc-4793	399	11	/	/	SYM
dpc-4793	399	12	e	e	X
dpc-4793	399	13	ne	ne	NOUN
dpc-4793	400	1	+	+	CCONJ
dpc-4793	400	2	b	b	X
dpc-4793	400	3	et	et	NOUN
dpc-4793	400	4	am	be	AUX
dpc-4793	400	5	et	et	NOUN
dpc-4793	400	6	ha	ha	INTJ
dpc-4793	400	7	so	so	ADV
dpc-4793	400	8	ne	ne	PROPN
dpc-4793	400	9	d	d	PROPN
dpc-4793	400	10	ip	ip	PRON
dpc-4793	400	11	ro	ro	X
dpc-4793	400	12	pi	pi	NOUN
dpc-4793	400	13	on	on	ADV
dpc-4793	400	14	at	at	ADP
dpc-4793	400	15	e	e	X
dpc-4793	400	16	0	0	NUM
dpc-4793	400	17	62	62	NUM
dpc-4793	400	18	.2	.2	NUM
dpc-4793	400	19	44	44	NUM
dpc-4793	400	20	.4	.4	NUM
dpc-4793	401	1	*	*	PUNCT
dpc-4793	402	1	[	[	X
dpc-4793	402	2	1	1	NUM
dpc-4793	402	3	875	875	NUM
dpc-4793	402	4	]	]	PUNCT
dpc-4793	402	5	n	n	CCONJ
dpc-4793	402	6	r	r	NOUN
dpc-4793	402	7	10	10	NUM
dpc-4793	402	8	.5	.5	NUM
dpc-4793	402	9	*	*	PUNCT
dpc-4793	402	10	n	n	NUM
dpc-4793	402	11	r	r	NOUN
dpc-4793	402	12	n	n	NOUN
dpc-4793	402	13	r	r	NOUN
dpc-4793	402	14	6	6	NUM
dpc-4793	402	15	.	.	PUNCT
dpc-4793	402	16	3	3	NUM
dpc-4793	402	17	*	*	SYM
dpc-4793	402	18	81	81	NUM
dpc-4793	402	19	.5	.5	NUM
dpc-4793	402	20	,	,	PUNCT
dpc-4793	402	21	n	n	CCONJ
dpc-4793	402	22	r	r	NOUN
dpc-4793	402	23	,	,	PUNCT
dpc-4793	402	24	n	n	CCONJ
dpc-4793	402	25	r	r	NOUN
dpc-4793	402	26	pl	pl	X
dpc-4793	402	27	ac	ac	PROPN
dpc-4793	402	28	eb	eb	PROPN
dpc-4793	402	29	o	o	PROPN
dpc-4793	402	30	0	0	NUM
dpc-4793	402	31	66	66	NUM
dpc-4793	402	32	.7	.7	NUM
dpc-4793	402	33	45	45	NUM
dpc-4793	402	34	.8	.8	NUM
dpc-4793	402	35	*	*	PUNCT
dpc-4793	403	1	[	[	X
dpc-4793	403	2	2	2	NUM
dpc-4793	403	3	276	276	NUM
dpc-4793	403	4	]	]	PUNCT
dpc-4793	403	5	n	n	CCONJ
dpc-4793	403	6	r	r	NOUN
dpc-4793	403	7	11	11	NUM
dpc-4793	403	8	.8	.8	NUM
dpc-4793	403	9	*	*	PUNCT
dpc-4793	404	1	n	n	CCONJ
dpc-4793	404	2	r	r	NOUN
dpc-4793	404	3	n	n	NOUN
dpc-4793	404	4	r	r	NOUN
dpc-4793	404	5	6	6	NUM
dpc-4793	404	6	.	.	NOUN
dpc-4793	405	1	2	2	NUM
dpc-4793	405	2	*	*	SYM
dpc-4793	405	3	76	76	NUM
dpc-4793	406	1	.2	.2	NUM
dpc-4793	406	2	,	,	PUNCT
dpc-4793	406	3	n	n	CCONJ
dpc-4793	406	4	r	r	NOUN
dpc-4793	406	5	,	,	PUNCT
dpc-4793	406	6	n	n	NOUN
dpc-4793	406	7	r	r	NOUN
dpc-4793	406	8	v	v	NOUN
dpc-4793	406	9	an	an	DET
dpc-4793	406	10	v	v	NOUN
dpc-4793	406	11	oo	oo	INTJ
dpc-4793	406	12	rh	rh	PROPN
dpc-4793	406	13	ee	ee	ADP
dpc-4793	406	14	s	s	PROPN
dpc-4793	406	15	s	s	X
dpc-4793	406	16	[	[	X
dpc-4793	406	17	3	3	NUM
dpc-4793	406	18	3	3	NUM
dpc-4793	406	19	]	]	PUNCT
dpc-4793	406	20	a	a	DET
dpc-4793	406	21	pr	pr	NOUN
dpc-4793	407	1	em	em	PRON
dpc-4793	407	2	ila	ila	PROPN
dpc-4793	407	3	st	st	PROPN
dpc-4793	408	1	3	3	NUM
dpc-4793	408	2	0	0	NUM
dpc-4793	408	3	m	m	VERB
dpc-4793	408	4	g	g	NOUN
dpc-4793	408	5	76	76	NUM
dpc-4793	408	6	.6	.6	NUM
dpc-4793	408	7	62	62	NUM
dpc-4793	408	8	.2	.2	NUM
dpc-4793	408	9	47	47	NUM
dpc-4793	408	10	*	*	SYM
dpc-4793	408	11	30	30	NUM
dpc-4793	408	12	.7	.7	PROPN
dpc-4793	408	13	*	*	PUNCT
dpc-4793	408	14	15	15	NUM
dpc-4793	408	15	.7	.7	PROPN
dpc-4793	408	16	*	*	PUNCT
dpc-4793	408	17	61	61	NUM
dpc-4793	409	1	.9	.9	NUM
dpc-4793	409	2	*	*	PUNCT
dpc-4793	410	1	n	n	CCONJ
dpc-4793	410	2	r	r	NOUN
dpc-4793	410	3	n	n	NOUN
dpc-4793	410	4	r	r	NOUN
dpc-4793	410	5	76	76	NUM
dpc-4793	410	6	.1	.1	NUM
dpc-4793	410	7	,	,	PUNCT
dpc-4793	410	8	2	2	NUM
dpc-4793	410	9	3	3	NUM
dpc-4793	410	10	.	.	NOUN
dpc-4793	410	11	9	9	NUM
dpc-4793	410	12	,	,	PUNCT
dpc-4793	410	13	n	n	PRON
dpc-4793	410	14	r	r	NOUN
dpc-4793	410	15	pl	pl	X
dpc-4793	410	16	ac	ac	PROPN
dpc-4793	410	17	eb	eb	PROPN
dpc-4793	410	18	o	o	PROPN
dpc-4793	411	1	73	73	NUM
dpc-4793	411	2	.5	.5	NUM
dpc-4793	411	3	60	60	NUM
dpc-4793	411	4	.8	.8	NUM
dpc-4793	411	5	46	46	NUM
dpc-4793	411	6	.7	.7	PROPN
dpc-4793	411	7	*	*	PUNCT
dpc-4793	412	1	31	31	NUM
dpc-4793	412	2	.7	.7	PUNCT
dpc-4793	412	3	*	*	PUNCT
dpc-4793	412	4	14	14	NUM
dpc-4793	412	5	.8	.8	NUM
dpc-4793	413	1	*	*	PUNCT
dpc-4793	414	1	58	58	NUM
dpc-4793	415	1	.2	.2	NUM
dpc-4793	415	2	*	*	PUNCT
dpc-4793	416	1	n	n	CCONJ
dpc-4793	416	2	r	r	NOUN
dpc-4793	416	3	n	n	NOUN
dpc-4793	416	4	r	r	NOUN
dpc-4793	416	5	74	74	NUM
dpc-4793	416	6	.5	.5	NUM
dpc-4793	416	7	,	,	PUNCT
dpc-4793	416	8	2	2	NUM
dpc-4793	416	9	5	5	NUM
dpc-4793	416	10	.	.	NOUN
dpc-4793	416	11	5	5	NUM
dpc-4793	416	12	,	,	PUNCT
dpc-4793	416	13	n	n	PRON
dpc-4793	416	14	r	r	NOUN
dpc-4793	416	15	z	z	NOUN
dpc-4793	416	16	ho	ho	PROPN
dpc-4793	416	17	u	u	X
dpc-4793	416	18	j	j	PROPN
dpc-4793	417	1	[	[	X
dpc-4793	417	2	2	2	NUM
dpc-4793	417	3	2	2	NUM
dpc-4793	417	4	]	]	SYM
dpc-4793	417	5	u	u	NOUN
dpc-4793	417	6	v	v	ADP
dpc-4793	417	7	a	a	DET
dpc-4793	417	8	1	1	NUM
dpc-4793	417	9	ph	ph	NOUN
dpc-4793	417	10	ot	ot	NOUN
dpc-4793	417	11	ot	ot	INTJ
dpc-4793	417	12	he	he	PRON
dpc-4793	417	13	ra	ra	INTJ
dpc-4793	417	14	py	py	INTJ
dpc-4793	417	15	n	n	CCONJ
dpc-4793	417	16	r	r	NOUN
dpc-4793	417	17	61	61	NUM
dpc-4793	417	18	.7	.7	NUM
dpc-4793	417	19	6	6	NUM
dpc-4793	417	20	32	32	NUM
dpc-4793	417	21	.7	.7	NUM
dpc-4793	417	22	*	*	PUNCT
dpc-4793	418	1	[	[	X
dpc-4793	418	2	2	2	NUM
dpc-4793	418	3	153	153	NUM
dpc-4793	418	4	]	]	PUNCT
dpc-4793	418	5	n	n	CCONJ
dpc-4793	418	6	r	r	NOUN
dpc-4793	418	7	3	3	NUM
dpc-4793	418	8	.	.	PUNCT
dpc-4793	418	9	02	02	NUM
dpc-4793	419	1	*	*	PUNCT
dpc-4793	419	2	n	n	NUM
dpc-4793	419	3	r	r	NOUN
dpc-4793	419	4	15	15	NUM
dpc-4793	419	5	.2	.2	NUM
dpc-4793	419	6	8	8	NUM
dpc-4793	419	7	*	*	SYM
dpc-4793	419	8	n	n	ADP
dpc-4793	419	9	r	r	NOUN
dpc-4793	419	10	n	n	ADP
dpc-4793	419	11	r	r	NOUN
dpc-4793	419	12	n	n	PROPN
dpc-4793	419	13	ar	ar	PROPN
dpc-4793	419	14	ro	ro	PROPN
dpc-4793	419	15	w	w	PROPN
dpc-4793	419	16	b	b	PROPN
dpc-4793	419	17	an	an	DET
dpc-4793	419	18	d	d	X
dpc-4793	419	19	u	u	PROPN
dpc-4793	419	20	v	v	PROPN
dpc-4793	419	21	b	b	NOUN
dpc-4793	419	22	ph	ph	NOUN
dpc-4793	420	1	ot	ot	INTJ
dpc-4793	420	2	ot	ot	INTJ
dpc-4793	420	3	he	he	PRON
dpc-4793	420	4	ra	ra	INTJ
dpc-4793	420	5	py	py	INTJ
dpc-4793	420	6	n	n	CCONJ
dpc-4793	420	7	r	r	NOUN
dpc-4793	420	8	61	61	NUM
dpc-4793	420	9	.7	.7	NUM
dpc-4793	420	10	6	6	NUM
dpc-4793	420	11	32	32	NUM
dpc-4793	420	12	.7	.7	NUM
dpc-4793	420	13	*	*	PUNCT
dpc-4793	421	1	[	[	X
dpc-4793	421	2	2	2	NUM
dpc-4793	421	3	153	153	NUM
dpc-4793	421	4	]	]	PUNCT
dpc-4793	421	5	n	n	CCONJ
dpc-4793	421	6	r	r	NOUN
dpc-4793	421	7	3	3	NUM
dpc-4793	421	8	.	.	PUNCT
dpc-4793	421	9	02	02	NUM
dpc-4793	422	1	*	*	PUNCT
dpc-4793	422	2	n	n	NUM
dpc-4793	422	3	r	r	NOUN
dpc-4793	422	4	15	15	NUM
dpc-4793	422	5	.5	.5	NUM
dpc-4793	422	6	*	*	PUNCT
dpc-4793	423	1	n	n	NUM
dpc-4793	423	2	r	r	NOUN
dpc-4793	423	3	n	n	NOUN
dpc-4793	423	4	r	r	NOUN
dpc-4793	423	5	t	t	NOUN
dpc-4793	423	6	ha	ha	INTJ
dpc-4793	423	7	çi	çi	PROPN
dpc-4793	424	1	d	d	X
dpc-4793	424	2	[	[	PUNCT
dpc-4793	424	3	20	20	NUM
dpc-4793	424	4	]	]	X
dpc-4793	424	5	r	r	NOUN
dpc-4793	424	6	is	be	AUX
dpc-4793	424	7	an	an	DET
dpc-4793	424	8	ki	ki	PROPN
dpc-4793	424	9	zu	zu	PROPN
dpc-4793	424	10	m	m	VERB
dpc-4793	424	11	ab	ab	PROPN
dpc-4793	424	12	1	1	NUM
dpc-4793	424	13	50	50	NUM
dpc-4793	424	14	m	m	NOUN
dpc-4793	424	15	g	g	NOUN
dpc-4793	424	16	n	n	ADP
dpc-4793	424	17	r	r	NOUN
dpc-4793	424	18	n	n	NOUN
dpc-4793	424	19	r	r	NOUN
dpc-4793	424	20	42	42	NUM
dpc-4793	424	21	*	*	PUNCT
dpc-4793	425	1	[	[	X
dpc-4793	425	2	1	1	NUM
dpc-4793	425	3	873	873	NUM
dpc-4793	425	4	]	]	PUNCT
dpc-4793	425	5	n	n	CCONJ
dpc-4793	425	6	r	r	NOUN
dpc-4793	425	7	n	n	NOUN
dpc-4793	425	8	r	r	NOUN
dpc-4793	425	9	n	n	NOUN
dpc-4793	425	10	r	r	NOUN
dpc-4793	425	11	23	23	NUM
dpc-4793	425	12	.1	.1	NUM
dpc-4793	425	13	*	*	PUNCT
dpc-4793	426	1	n	n	CCONJ
dpc-4793	426	2	r	r	NOUN
dpc-4793	426	3	n	n	CCONJ
dpc-4793	426	4	r	r	NOUN
dpc-4793	426	5	fu	fu	NOUN
dpc-4793	426	6	m	m	PROPN
dpc-4793	426	7	ar	ar	PROPN
dpc-4793	426	8	ic	ic	PROPN
dpc-4793	426	9	a	a	DET
dpc-4793	426	10	ci	ci	PROPN
dpc-4793	426	11	d	d	X
dpc-4793	426	12	es	es	X
dpc-4793	426	13	te	te	PROPN
dpc-4793	426	14	rs	rs	NOUN
dpc-4793	426	15	n	n	CCONJ
dpc-4793	426	16	r	r	NOUN
dpc-4793	426	17	n	n	NOUN
dpc-4793	426	18	r	r	NOUN
dpc-4793	426	19	42	42	NUM
dpc-4793	426	20	.5	.5	NUM
dpc-4793	426	21	*	*	PUNCT
dpc-4793	427	1	[	[	X
dpc-4793	427	2	1	1	NUM
dpc-4793	427	3	969	969	NUM
dpc-4793	427	4	]	]	PUNCT
dpc-4793	427	5	n	n	CCONJ
dpc-4793	427	6	r	r	NOUN
dpc-4793	427	7	n	n	NOUN
dpc-4793	427	8	r	r	NOUN
dpc-4793	427	9	n	n	NOUN
dpc-4793	427	10	r	r	NOUN
dpc-4793	427	11	20	20	NUM
dpc-4793	427	12	.2	.2	NUM
dpc-4793	427	13	*	*	PUNCT
dpc-4793	428	1	n	n	CCONJ
dpc-4793	428	2	r	r	NOUN
dpc-4793	428	3	n	n	NOUN
dpc-4793	428	4	r	r	NOUN
dpc-4793	428	5	b	b	PROPN
dpc-4793	428	6	la	la	PROPN
dpc-4793	428	7	uv	uv	PROPN
dpc-4793	428	8	el	el	PROPN
dpc-4793	428	9	t	t	PROPN
dpc-4793	428	10	a	a	PRON
dpc-4793	428	11	[	[	PUNCT
dpc-4793	428	12	44	44	NUM
dpc-4793	428	13	]	]	PUNCT
dpc-4793	428	14	 	 	SPACE
dpc-4793	428	15	p	p	PROPN
dpc-4793	428	16	la	la	PROPN
dpc-4793	428	17	ce	ce	PROPN
dpc-4793	428	18	bo	bo	PROPN
dpc-4793	428	19	n	n	PROPN
dpc-4793	428	20	r	r	NOUN
dpc-4793	428	21	n	n	ADP
dpc-4793	428	22	r	r	NOUN
dpc-4793	428	23	n	n	ADP
dpc-4793	428	24	r	r	NOUN
dpc-4793	428	25	n	n	ADP
dpc-4793	428	26	r	r	NOUN
dpc-4793	428	27	n	n	ADP
dpc-4793	428	28	r	r	NOUN
dpc-4793	428	29	n	n	ADP
dpc-4793	428	30	r	r	NOUN
dpc-4793	428	31	n	n	ADP
dpc-4793	428	32	r	r	NOUN
dpc-4793	428	33	n	n	NOUN
dpc-4793	428	34	r	r	NOUN
dpc-4793	428	35	59	59	NUM
dpc-4793	428	36	.3	.3	NUM
dpc-4793	428	37	,	,	PUNCT
dpc-4793	428	38	1	1	NUM
dpc-4793	428	39	6	6	NUM
dpc-4793	428	40	.	.	NOUN
dpc-4793	428	41	7	7	NUM
dpc-4793	428	42	,	,	PUNCT
dpc-4793	428	43	n	n	PRON
dpc-4793	428	44	r	r	NOUN
dpc-4793	428	45	g	g	PROPN
dpc-4793	428	46	us	us	PROPN
dpc-4793	429	1	el	el	PROPN
dpc-4793	429	2	ku	ku	PROPN
dpc-4793	429	3	m	m	PROPN
dpc-4793	429	4	ab	ab	PROPN
dpc-4793	429	5	1	1	NUM
dpc-4793	429	6	00	00	NUM
dpc-4793	429	7	m	m	VERB
dpc-4793	429	8	g	g	NOUN
dpc-4793	429	9	n	n	ADP
dpc-4793	429	10	r	r	NOUN
dpc-4793	429	11	n	n	ADP
dpc-4793	429	12	r	r	NOUN
dpc-4793	429	13	n	n	ADP
dpc-4793	429	14	r	r	NOUN
dpc-4793	429	15	n	n	ADP
dpc-4793	429	16	r	r	NOUN
dpc-4793	429	17	n	n	ADP
dpc-4793	429	18	r	r	NOUN
dpc-4793	429	19	n	n	ADP
dpc-4793	429	20	r	r	NOUN
dpc-4793	429	21	n	n	ADP
dpc-4793	429	22	r	r	NOUN
dpc-4793	429	23	n	n	NOUN
dpc-4793	429	24	r	r	NOUN
dpc-4793	429	25	58	58	NUM
dpc-4793	429	26	.8	.8	NUM
dpc-4793	429	27	,	,	PUNCT
dpc-4793	429	28	1	1	NUM
dpc-4793	429	29	9	9	NUM
dpc-4793	429	30	.	.	NOUN
dpc-4793	429	31	6	6	NUM
dpc-4793	429	32	,	,	PUNCT
dpc-4793	429	33	n	n	PRON
dpc-4793	429	34	r	r	NOUN
dpc-4793	429	35	a	a	DET
dpc-4793	429	36	da	da	PROPN
dpc-4793	429	37	lim	lim	PROPN
dpc-4793	429	38	um	um	INTJ
dpc-4793	429	39	ab	ab	PROPN
dpc-4793	429	40	8	8	NUM
dpc-4793	429	41	0	0	NUM
dpc-4793	429	42	m	m	VERB
dpc-4793	429	43	g	g	NOUN
dpc-4793	429	44	n	n	ADP
dpc-4793	429	45	r	r	NOUN
dpc-4793	429	46	n	n	ADP
dpc-4793	429	47	r	r	NOUN
dpc-4793	429	48	n	n	ADP
dpc-4793	429	49	r	r	NOUN
dpc-4793	429	50	n	n	ADP
dpc-4793	429	51	r	r	NOUN
dpc-4793	429	52	n	n	ADP
dpc-4793	429	53	r	r	NOUN
dpc-4793	429	54	n	n	ADP
dpc-4793	429	55	r	r	NOUN
dpc-4793	429	56	n	n	ADP
dpc-4793	429	57	r	r	NOUN
dpc-4793	429	58	n	n	NOUN
dpc-4793	429	59	r	r	NOUN
dpc-4793	429	60	59	59	NUM
dpc-4793	429	61	.3	.3	NUM
dpc-4793	429	62	,	,	PUNCT
dpc-4793	429	63	1	1	NUM
dpc-4793	429	64	9	9	NUM
dpc-4793	429	65	.	.	NOUN
dpc-4793	429	66	3	3	NUM
dpc-4793	429	67	,	,	PUNCT
dpc-4793	429	68	n	n	NOUN
dpc-4793	429	69	r	r	NOUN
dpc-4793	429	70	r	r	NOUN
dpc-4793	429	71	ei	ei	NOUN
dpc-4793	429	72	ch	ch	NOUN
dpc-4793	429	73	k	k	PROPN
dpc-4793	429	74	[	[	PUNCT
dpc-4793	429	75	34	34	NUM
dpc-4793	429	76	]	]	PUNCT
dpc-4793	429	77	pl	pl	PROPN
dpc-4793	429	78	ac	ac	PROPN
dpc-4793	429	79	eb	eb	PROPN
dpc-4793	429	80	o	o	PROPN
dpc-4793	429	81	n	n	ADP
dpc-4793	429	82	r	r	NOUN
dpc-4793	429	83	n	n	ADP
dpc-4793	429	84	r	r	NOUN
dpc-4793	429	85	n	n	ADP
dpc-4793	429	86	r	r	NOUN
dpc-4793	429	87	n	n	ADP
dpc-4793	429	88	r	r	NOUN
dpc-4793	429	89	n	n	ADP
dpc-4793	429	90	r	r	NOUN
dpc-4793	429	91	n	n	ADP
dpc-4793	429	92	r	r	NOUN
dpc-4793	429	93	n	n	ADP
dpc-4793	429	94	r	r	NOUN
dpc-4793	429	95	n	n	ADP
dpc-4793	429	96	r	r	NOUN
dpc-4793	429	97	n	n	NOUN
dpc-4793	429	98	r	r	NOUN
dpc-4793	429	99	g	g	PROPN
dpc-4793	429	100	us	us	PROPN
dpc-4793	430	1	el	el	PROPN
dpc-4793	430	2	ku	ku	PROPN
dpc-4793	430	3	m	m	PROPN
dpc-4793	430	4	ab	ab	PROPN
dpc-4793	430	5	1	1	NUM
dpc-4793	430	6	00	00	NUM
dpc-4793	430	7	m	m	VERB
dpc-4793	430	8	g	g	NOUN
dpc-4793	430	9	n	n	ADP
dpc-4793	430	10	r	r	NOUN
dpc-4793	430	11	n	n	ADP
dpc-4793	430	12	r	r	NOUN
dpc-4793	430	13	n	n	ADP
dpc-4793	430	14	r	r	NOUN
dpc-4793	430	15	n	n	ADP
dpc-4793	430	16	r	r	NOUN
dpc-4793	430	17	n	n	ADP
dpc-4793	430	18	r	r	NOUN
dpc-4793	430	19	n	n	ADP
dpc-4793	430	20	r	r	NOUN
dpc-4793	430	21	n	n	ADP
dpc-4793	430	22	r	r	NOUN
dpc-4793	430	23	n	n	ADP
dpc-4793	430	24	r	r	NOUN
dpc-4793	430	25	n	n	NOUN
dpc-4793	430	26	r	r	NOUN
dpc-4793	430	27	a	a	DET
dpc-4793	430	28	da	da	NOUN
dpc-4793	430	29	lim	lim	PROPN
dpc-4793	430	30	um	um	INTJ
dpc-4793	430	31	ab	ab	PROPN
dpc-4793	430	32	8	8	NUM
dpc-4793	430	33	0	0	NUM
dpc-4793	430	34	m	m	VERB
dpc-4793	430	35	g	g	NOUN
dpc-4793	430	36	n	n	ADP
dpc-4793	430	37	r	r	NOUN
dpc-4793	430	38	n	n	ADP
dpc-4793	430	39	r	r	NOUN
dpc-4793	430	40	n	n	ADP
dpc-4793	430	41	r	r	NOUN
dpc-4793	430	42	n	n	ADP
dpc-4793	430	43	r	r	NOUN
dpc-4793	430	44	n	n	ADP
dpc-4793	430	45	r	r	NOUN
dpc-4793	430	46	n	n	ADP
dpc-4793	430	47	r	r	NOUN
dpc-4793	430	48	n	n	ADP
dpc-4793	430	49	r	r	NOUN
dpc-4793	430	50	n	n	ADP
dpc-4793	430	51	r	r	NOUN
dpc-4793	430	52	n	n	NOUN
dpc-4793	430	53	r	r	NOUN
dpc-4793	430	54	o	o	NOUN
dpc-4793	431	1	ht	ht	INTJ
dpc-4793	431	2	su	su	INTJ
dpc-4793	432	1	ki	ki	PROPN
dpc-4793	432	2	m	m	PROPN
dpc-4793	432	3	[	[	PUNCT
dpc-4793	432	4	35	35	NUM
dpc-4793	432	5	]	]	PUNCT
dpc-4793	432	6	pl	pl	X
dpc-4793	432	7	ac	ac	PROPN
dpc-4793	432	8	eb	eb	PROPN
dpc-4793	432	9	o	o	PROPN
dpc-4793	433	1	n	n	ADP
dpc-4793	433	2	r	r	NOUN
dpc-4793	433	3	n	n	ADP
dpc-4793	433	4	r	r	NOUN
dpc-4793	433	5	n	n	ADP
dpc-4793	433	6	r	r	NOUN
dpc-4793	433	7	n	n	ADP
dpc-4793	433	8	r	r	NOUN
dpc-4793	433	9	n	n	ADP
dpc-4793	433	10	r	r	NOUN
dpc-4793	433	11	n	n	ADP
dpc-4793	433	12	r	r	NOUN
dpc-4793	433	13	n	n	ADP
dpc-4793	433	14	r	r	NOUN
dpc-4793	433	15	n	n	ADP
dpc-4793	433	16	r	r	NOUN
dpc-4793	433	17	n	n	NOUN
dpc-4793	433	18	r	r	NOUN
dpc-4793	433	19	g	g	PROPN
dpc-4793	433	20	us	us	PROPN
dpc-4793	433	21	el	el	PROPN
dpc-4793	433	22	ku	ku	PROPN
dpc-4793	433	23	m	m	PROPN
dpc-4793	433	24	ab	ab	PROPN
dpc-4793	434	1	5	5	NUM
dpc-4793	434	2	0	0	NUM
dpc-4793	434	3	m	m	VERB
dpc-4793	434	4	g	g	NOUN
dpc-4793	434	5	n	n	ADP
dpc-4793	434	6	r	r	NOUN
dpc-4793	434	7	n	n	ADP
dpc-4793	434	8	r	r	NOUN
dpc-4793	434	9	n	n	ADP
dpc-4793	434	10	r	r	NOUN
dpc-4793	434	11	n	n	ADP
dpc-4793	434	12	r	r	NOUN
dpc-4793	434	13	n	n	ADP
dpc-4793	434	14	r	r	NOUN
dpc-4793	434	15	n	n	ADP
dpc-4793	434	16	r	r	NOUN
dpc-4793	434	17	n	n	ADP
dpc-4793	434	18	r	r	NOUN
dpc-4793	434	19	n	n	ADP
dpc-4793	434	20	r	r	NOUN
dpc-4793	434	21	n	n	NOUN
dpc-4793	434	22	r	r	NOUN
dpc-4793	434	23	g	g	PROPN
dpc-4793	434	24	us	us	PROPN
dpc-4793	434	25	el	el	PROPN
dpc-4793	434	26	ku	ku	PROPN
dpc-4793	434	27	m	m	PROPN
dpc-4793	434	28	ab	ab	PROPN
dpc-4793	434	29	1	1	NUM
dpc-4793	434	30	00	00	NUM
dpc-4793	434	31	m	m	VERB
dpc-4793	434	32	g	g	NOUN
dpc-4793	434	33	n	n	ADP
dpc-4793	434	34	r	r	NOUN
dpc-4793	434	35	n	n	ADP
dpc-4793	434	36	r	r	NOUN
dpc-4793	434	37	n	n	ADP
dpc-4793	434	38	r	r	NOUN
dpc-4793	434	39	n	n	ADP
dpc-4793	434	40	r	r	NOUN
dpc-4793	434	41	n	n	ADP
dpc-4793	434	42	r	r	NOUN
dpc-4793	434	43	n	n	ADP
dpc-4793	434	44	r	r	NOUN
dpc-4793	434	45	n	n	ADP
dpc-4793	434	46	r	r	NOUN
dpc-4793	434	47	n	n	ADP
dpc-4793	434	48	r	r	NOUN
dpc-4793	434	49	n	n	NOUN
dpc-4793	434	50	r	r	NOUN
dpc-4793	434	51	t	t	NOUN
dpc-4793	434	52	ha	ha	INTJ
dpc-4793	434	53	çi	çi	PROPN
dpc-4793	435	1	d	d	X
dpc-4793	435	2	[	[	PUNCT
dpc-4793	435	3	36	36	NUM
dpc-4793	435	4	]	]	PUNCT
dpc-4793	435	5	g	g	PROPN
dpc-4793	435	6	us	us	PROPN
dpc-4793	436	1	el	el	PROPN
dpc-4793	436	2	ku	ku	PROPN
dpc-4793	436	3	m	m	PROPN
dpc-4793	436	4	ab	ab	PROPN
dpc-4793	436	5	1	1	NUM
dpc-4793	436	6	00	00	NUM
dpc-4793	436	7	m	m	VERB
dpc-4793	436	8	g	g	NOUN
dpc-4793	436	9	n	n	ADP
dpc-4793	436	10	r	r	NOUN
dpc-4793	436	11	n	n	ADP
dpc-4793	436	12	r	r	NOUN
dpc-4793	436	13	n	n	ADP
dpc-4793	436	14	r	r	NOUN
dpc-4793	436	15	n	n	ADP
dpc-4793	436	16	r	r	NOUN
dpc-4793	436	17	n	n	ADP
dpc-4793	436	18	r	r	NOUN
dpc-4793	436	19	n	n	ADP
dpc-4793	436	20	r	r	NOUN
dpc-4793	436	21	n	n	ADP
dpc-4793	436	22	r	r	NOUN
dpc-4793	436	23	n	n	ADP
dpc-4793	436	24	r	r	NOUN
dpc-4793	436	25	n	n	CCONJ
dpc-4793	436	26	r	r	NOUN
dpc-4793	436	27	fu	fu	NOUN
dpc-4793	436	28	m	m	PROPN
dpc-4793	436	29	ar	ar	PROPN
dpc-4793	436	30	ic	ic	PROPN
dpc-4793	436	31	a	a	DET
dpc-4793	436	32	ci	ci	PROPN
dpc-4793	436	33	d	d	X
dpc-4793	436	34	es	es	X
dpc-4793	436	35	te	te	PROPN
dpc-4793	436	36	rs	rs	NOUN
dpc-4793	436	37	n	n	CCONJ
dpc-4793	436	38	r	r	NOUN
dpc-4793	436	39	n	n	ADP
dpc-4793	436	40	r	r	NOUN
dpc-4793	436	41	n	n	ADP
dpc-4793	436	42	r	r	NOUN
dpc-4793	436	43	n	n	ADP
dpc-4793	436	44	r	r	NOUN
dpc-4793	436	45	n	n	ADP
dpc-4793	436	46	r	r	NOUN
dpc-4793	436	47	n	n	ADP
dpc-4793	436	48	r	r	NOUN
dpc-4793	436	49	n	n	ADP
dpc-4793	436	50	r	r	NOUN
dpc-4793	436	51	n	n	ADP
dpc-4793	436	52	r	r	NOUN
dpc-4793	436	53	n	n	NOUN
dpc-4793	436	54	r	r	NOUN
dpc-4793	436	55	se	se	NOUN
dpc-4793	436	56	o	o	X
dpc-4793	436	57	sj	sj	INTJ
dpc-4793	436	58	[	[	PUNCT
dpc-4793	436	59	17	17	NUM
dpc-4793	436	60	]	]	PUNCT
dpc-4793	436	61	pl	pl	PROPN
dpc-4793	436	62	ac	ac	PROPN
dpc-4793	436	63	eb	eb	PROPN
dpc-4793	436	64	o	o	PROPN
dpc-4793	436	65	n	n	ADP
dpc-4793	436	66	r	r	NOUN
dpc-4793	436	67	n	n	ADP
dpc-4793	436	68	r	r	NOUN
dpc-4793	436	69	n	n	ADP
dpc-4793	436	70	r	r	NOUN
dpc-4793	436	71	n	n	ADP
dpc-4793	436	72	r	r	NOUN
dpc-4793	436	73	n	n	ADP
dpc-4793	436	74	r	r	NOUN
dpc-4793	436	75	n	n	NOUN
dpc-4793	436	76	r	r	NOUN
dpc-4793	436	77	28	28	NUM
dpc-4793	436	78	*	*	PUNCT
dpc-4793	436	79	n	n	ADP
dpc-4793	436	80	r	r	NOUN
dpc-4793	436	81	n	n	NOUN
dpc-4793	436	82	r	r	NOUN
dpc-4793	436	83	b	b	X
dpc-4793	436	84	ro	ro	X
dpc-4793	436	85	da	da	PROPN
dpc-4793	436	86	lu	lu	PROPN
dpc-4793	436	87	m	m	VERB
dpc-4793	436	88	ab	ab	PROPN
dpc-4793	436	89	2	2	NUM
dpc-4793	436	90	10	10	NUM
dpc-4793	436	91	m	m	NOUN
dpc-4793	436	92	g	g	NOUN
dpc-4793	436	93	n	n	ADP
dpc-4793	436	94	r	r	NOUN
dpc-4793	436	95	n	n	ADP
dpc-4793	436	96	r	r	NOUN
dpc-4793	436	97	n	n	ADP
dpc-4793	436	98	r	r	NOUN
dpc-4793	436	99	n	n	ADP
dpc-4793	436	100	r	r	NOUN
dpc-4793	436	101	n	n	ADP
dpc-4793	436	102	r	r	NOUN
dpc-4793	436	103	n	n	NOUN
dpc-4793	436	104	r	r	NOUN
dpc-4793	436	105	24	24	NUM
dpc-4793	436	106	.6	.6	NUM
dpc-4793	436	107	*	*	PUNCT
dpc-4793	436	108	n	n	CCONJ
dpc-4793	436	109	r	r	NOUN
dpc-4793	436	110	n	n	NOUN
dpc-4793	436	111	r	r	NOUN
dpc-4793	436	112	t	t	X
dpc-4793	436	113	ab	ab	X
dpc-4793	436	114	le	le	X
dpc-4793	436	115	1	1	NUM
dpc-4793	436	116	co	co	VERB
dpc-4793	436	117	nt	not	PART
dpc-4793	436	118	in	in	ADP
dpc-4793	436	119	ue	ue	PROPN
dpc-4793	436	120	s	s	PROPN
dpc-4793	436	121	8	8	NUM
dpc-4793	436	122	review	review	NOUN
dpc-4793	436	123	|	|	ADV
dpc-4793	436	124	dermatol	dermatol	ADJ
dpc-4793	436	125	pract	pract	NOUN
dpc-4793	436	126	concept	concept	NOUN
dpc-4793	436	127	.	.	PUNCT
dpc-4793	437	1	2025;15(2):4793	2025;15(2):4793	NUM
dpc-4793	437	2	a	a	DET
dpc-4793	437	3	ut	ut	PROPN
dpc-4793	437	4	ho	ho	PROPN
dpc-4793	437	5	r	r	PROPN
dpc-4793	437	6	a	a	DET
dpc-4793	437	7	rm	rm	NOUN
dpc-4793	437	8	s	s	PROPN
dpc-4793	437	9	c	c	NOUN
dpc-4793	437	10	au	au	NOUN
dpc-4793	437	11	ca	can	AUX
dpc-4793	437	12	si	si	PROPN
dpc-4793	437	13	an	an	DET
dpc-4793	437	14	(	(	PUNCT
dpc-4793	437	15	%	%	NOUN
dpc-4793	437	16	)	)	PUNCT
dpc-4793	437	17	m	m	VERB
dpc-4793	437	18	al	al	PROPN
dpc-4793	437	19	e	e	PROPN
dpc-4793	437	20	(	(	PUNCT
dpc-4793	437	21	%	%	INTJ
dpc-4793	437	22	)	)	PUNCT
dpc-4793	437	23	a	a	DET
dpc-4793	437	24	ge	ge	PROPN
dpc-4793	437	25	[	[	PUNCT
dpc-4793	437	26	m	m	VERB
dpc-4793	437	27	in	in	ADP
dpc-4793	437	28	-m	-m	DET
dpc-4793	437	29	ax	ax	NOUN
dpc-4793	437	30	]	]	PUNCT
dpc-4793	437	31	(	(	PUNCT
dpc-4793	437	32	y	y	PROPN
dpc-4793	437	33	ea	ea	PROPN
dpc-4793	437	34	rs	rs	PROPN
dpc-4793	437	35	)	)	PUNCT
dpc-4793	438	1	m	m	VERB
dpc-4793	438	2	ea	ea	NOUN
dpc-4793	439	1	n	n	NUM
dpc-4793	439	2	b	b	NOUN
dpc-4793	439	3	m	m	VERB
dpc-4793	439	4	i	i	PRON
dpc-4793	439	5	ps	ps	VERB
dpc-4793	439	6	or	or	CCONJ
dpc-4793	439	7	ia	ia	PROPN
dpc-4793	440	1	si	si	X
dpc-4793	440	2	s	s	PROPN
dpc-4793	440	3	d	d	X
dpc-4793	440	4	ur	ur	INTJ
dpc-4793	440	5	at	at	ADP
dpc-4793	440	6	io	io	X
dpc-4793	440	7	n	n	PROPN
dpc-4793	440	8	(	(	PUNCT
dpc-4793	440	9	y	y	PROPN
dpc-4793	440	10	ea	ea	PROPN
dpc-4793	440	11	rs	rs	PROPN
dpc-4793	440	12	)	)	PUNCT
dpc-4793	440	13	sc	sc	PROPN
dpc-4793	440	14	al	al	PROPN
dpc-4793	440	15	p	p	PROPN
dpc-4793	440	16	in	in	ADP
dpc-4793	440	17	vo	vo	X
dpc-4793	440	18	lv	lv	PROPN
dpc-4793	440	19	em	em	PRON
dpc-4793	440	20	en	en	PROPN
dpc-4793	440	21	t	t	PROPN
dpc-4793	440	22	(	(	PUNCT
dpc-4793	440	23	%	%	NOUN
dpc-4793	440	24	)	)	PUNCT
dpc-4793	440	25	ps	ps	INTJ
dpc-4793	440	26	si	si	PROPN
dpc-4793	440	27	t	t	PROPN
dpc-4793	440	28	ss	ss	VERB
dpc-4793	440	29	ig	ig	PROPN
dpc-4793	440	30	a	a	PRON
dpc-4793	440	31	/p	/p	PUNCT
dpc-4793	440	32	g	g	PROPN
dpc-4793	440	33	a	a	DET
dpc-4793	440	34	s	s	X
dpc-4793	440	35	co	co	X
dpc-4793	440	36	re	re	NOUN
dpc-4793	440	37	of	of	ADP
dpc-4793	440	38	3	3	NUM
dpc-4793	440	39	-5	-5	NUM
dpc-4793	440	40	(	(	PUNCT
dpc-4793	440	41	%	%	NOUN
dpc-4793	440	42	)	)	PUNCT
dpc-4793	440	43	n	n	CCONJ
dpc-4793	440	44	ak	ak	PROPN
dpc-4793	440	45	ag	ag	PROPN
dpc-4793	440	46	aw	aw	INTJ
dpc-4793	440	47	a	a	DET
dpc-4793	440	48	h	h	NOUN
dpc-4793	440	49	[	[	PUNCT
dpc-4793	440	50	18	18	NUM
dpc-4793	440	51	]	]	PUNCT
dpc-4793	440	52	pl	pl	X
dpc-4793	440	53	ac	ac	PROPN
dpc-4793	440	54	eb	eb	PROPN
dpc-4793	440	55	o	o	PROPN
dpc-4793	440	56	n	n	ADP
dpc-4793	440	57	r	r	NOUN
dpc-4793	440	58	n	n	ADP
dpc-4793	440	59	r	r	NOUN
dpc-4793	440	60	n	n	ADP
dpc-4793	440	61	r	r	NOUN
dpc-4793	440	62	n	n	ADP
dpc-4793	440	63	r	r	NOUN
dpc-4793	440	64	n	n	ADP
dpc-4793	440	65	r	r	NOUN
dpc-4793	440	66	n	n	NOUN
dpc-4793	440	67	r	r	NOUN
dpc-4793	440	68	26	26	NUM
dpc-4793	440	69	.2	.2	NUM
dpc-4793	440	70	*	*	PUNCT
dpc-4793	440	71	n	n	CCONJ
dpc-4793	440	72	r	r	NOUN
dpc-4793	440	73	n	n	NOUN
dpc-4793	440	74	r	r	NOUN
dpc-4793	440	75	b	b	X
dpc-4793	440	76	ro	ro	X
dpc-4793	440	77	da	da	PROPN
dpc-4793	440	78	lu	lu	PROPN
dpc-4793	440	79	m	m	PROPN
dpc-4793	440	80	ab	ab	PROPN
dpc-4793	440	81	7	7	NUM
dpc-4793	440	82	0	0	NUM
dpc-4793	440	83	m	m	VERB
dpc-4793	440	84	g	g	NOUN
dpc-4793	440	85	n	n	ADP
dpc-4793	440	86	r	r	NOUN
dpc-4793	440	87	n	n	ADP
dpc-4793	440	88	r	r	NOUN
dpc-4793	440	89	n	n	ADP
dpc-4793	440	90	r	r	NOUN
dpc-4793	440	91	n	n	ADP
dpc-4793	440	92	r	r	NOUN
dpc-4793	440	93	n	n	ADP
dpc-4793	440	94	r	r	NOUN
dpc-4793	440	95	n	n	NOUN
dpc-4793	440	96	r	r	NOUN
dpc-4793	440	97	25	25	NUM
dpc-4793	440	98	.8	.8	NUM
dpc-4793	440	99	*	*	PUNCT
dpc-4793	440	100	n	n	CCONJ
dpc-4793	440	101	r	r	NOUN
dpc-4793	440	102	n	n	NOUN
dpc-4793	440	103	r	r	NOUN
dpc-4793	440	104	b	b	X
dpc-4793	440	105	ro	ro	X
dpc-4793	440	106	da	da	PROPN
dpc-4793	440	107	lu	lu	PROPN
dpc-4793	441	1	m	m	VERB
dpc-4793	442	1	ab	ab	PROPN
dpc-4793	442	2	1	1	NUM
dpc-4793	442	3	40	40	NUM
dpc-4793	442	4	m	m	NOUN
dpc-4793	442	5	g	g	NOUN
dpc-4793	442	6	n	n	ADP
dpc-4793	442	7	r	r	NOUN
dpc-4793	442	8	n	n	ADP
dpc-4793	442	9	r	r	NOUN
dpc-4793	442	10	n	n	ADP
dpc-4793	442	11	r	r	NOUN
dpc-4793	442	12	n	n	ADP
dpc-4793	442	13	r	r	NOUN
dpc-4793	442	14	n	n	ADP
dpc-4793	442	15	r	r	NOUN
dpc-4793	442	16	n	n	NOUN
dpc-4793	442	17	r	r	NOUN
dpc-4793	442	18	26	26	NUM
dpc-4793	442	19	.5	.5	NUM
dpc-4793	442	20	*	*	PUNCT
dpc-4793	442	21	n	n	NUM
dpc-4793	442	22	r	r	NOUN
dpc-4793	442	23	n	n	NOUN
dpc-4793	442	24	r	r	NOUN
dpc-4793	442	25	b	b	X
dpc-4793	442	26	ro	ro	X
dpc-4793	442	27	da	da	PROPN
dpc-4793	442	28	lu	lu	PROPN
dpc-4793	442	29	m	m	VERB
dpc-4793	442	30	ab	ab	PROPN
dpc-4793	442	31	2	2	NUM
dpc-4793	442	32	10	10	NUM
dpc-4793	442	33	m	m	NOUN
dpc-4793	442	34	g	g	NOUN
dpc-4793	442	35	n	n	ADP
dpc-4793	442	36	r	r	NOUN
dpc-4793	442	37	n	n	ADP
dpc-4793	442	38	r	r	NOUN
dpc-4793	442	39	n	n	ADP
dpc-4793	442	40	r	r	NOUN
dpc-4793	442	41	n	n	ADP
dpc-4793	442	42	r	r	NOUN
dpc-4793	442	43	n	n	ADP
dpc-4793	442	44	r	r	NOUN
dpc-4793	442	45	n	n	NOUN
dpc-4793	442	46	r	r	NOUN
dpc-4793	442	47	24	24	NUM
dpc-4793	442	48	.3	.3	NUM
dpc-4793	442	49	*	*	PUNCT
dpc-4793	442	50	n	n	CCONJ
dpc-4793	442	51	r	r	NOUN
dpc-4793	442	52	n	n	NOUN
dpc-4793	442	53	r	r	NOUN
dpc-4793	442	54	r	r	NOUN
dpc-4793	442	55	ei	ei	NOUN
dpc-4793	442	56	ch	ch	NOUN
dpc-4793	442	57	k	k	PROPN
dpc-4793	442	58	[	[	PUNCT
dpc-4793	442	59	37	37	NUM
dpc-4793	442	60	]	]	SYM
dpc-4793	442	61	b	b	NOUN
dpc-4793	443	1	i	i	PRON
dpc-4793	443	2	m	m	VERB
dpc-4793	443	3	ek	ek	INTJ
dpc-4793	443	4	iz	iz	INTJ
dpc-4793	443	5	um	um	INTJ
dpc-4793	443	6	ab	ab	PROPN
dpc-4793	443	7	n	n	CCONJ
dpc-4793	443	8	r	r	NOUN
dpc-4793	443	9	n	n	ADP
dpc-4793	443	10	r	r	NOUN
dpc-4793	443	11	n	n	ADP
dpc-4793	443	12	r	r	NOUN
dpc-4793	443	13	n	n	ADP
dpc-4793	443	14	r	r	NOUN
dpc-4793	443	15	n	n	ADP
dpc-4793	443	16	r	r	NOUN
dpc-4793	443	17	n	n	ADP
dpc-4793	443	18	r	r	NOUN
dpc-4793	443	19	n	n	ADP
dpc-4793	443	20	r	r	NOUN
dpc-4793	443	21	n	n	ADP
dpc-4793	443	22	r	r	NOUN
dpc-4793	443	23	n	n	NOUN
dpc-4793	443	24	r	r	NOUN
dpc-4793	443	25	u	u	X
dpc-4793	443	26	st	st	PROPN
dpc-4793	443	27	ek	ek	PROPN
dpc-4793	443	28	in	in	ADP
dpc-4793	443	29	um	um	INTJ
dpc-4793	443	30	ab	ab	PROPN
dpc-4793	443	31	4	4	NUM
dpc-4793	443	32	5	5	NUM
dpc-4793	443	33	or	or	CCONJ
dpc-4793	443	34	90	90	NUM
dpc-4793	443	35	m	m	NOUN
dpc-4793	443	36	g	g	NOUN
dpc-4793	443	37	n	n	ADP
dpc-4793	443	38	r	r	NOUN
dpc-4793	443	39	n	n	ADP
dpc-4793	443	40	r	r	NOUN
dpc-4793	443	41	n	n	ADP
dpc-4793	443	42	r	r	NOUN
dpc-4793	443	43	n	n	ADP
dpc-4793	443	44	r	r	NOUN
dpc-4793	443	45	n	n	ADP
dpc-4793	443	46	r	r	NOUN
dpc-4793	443	47	n	n	ADP
dpc-4793	443	48	r	r	NOUN
dpc-4793	443	49	n	n	ADP
dpc-4793	443	50	r	r	NOUN
dpc-4793	443	51	n	n	ADP
dpc-4793	443	52	r	r	NOUN
dpc-4793	444	1	n	n	NOUN
dpc-4793	444	2	r	r	NOUN
dpc-4793	444	3	pl	pl	X
dpc-4793	444	4	ac	ac	PROPN
dpc-4793	444	5	eb	eb	PROPN
dpc-4793	444	6	o	o	PROPN
dpc-4793	444	7	n	n	ADP
dpc-4793	444	8	r	r	NOUN
dpc-4793	444	9	n	n	ADP
dpc-4793	444	10	r	r	NOUN
dpc-4793	444	11	n	n	ADP
dpc-4793	444	12	r	r	NOUN
dpc-4793	444	13	n	n	ADP
dpc-4793	444	14	r	r	NOUN
dpc-4793	444	15	n	n	ADP
dpc-4793	444	16	r	r	NOUN
dpc-4793	444	17	n	n	ADP
dpc-4793	444	18	r	r	NOUN
dpc-4793	444	19	n	n	ADP
dpc-4793	444	20	r	r	NOUN
dpc-4793	444	21	n	n	ADP
dpc-4793	444	22	r	r	NOUN
dpc-4793	444	23	n	n	NOUN
dpc-4793	444	24	r	r	NOUN
dpc-4793	444	25	g	g	NOUN
dpc-4793	444	26	or	or	CCONJ
dpc-4793	444	27	do	do	VERB
dpc-4793	444	28	n	n	CCONJ
dpc-4793	444	29	k	k	PROPN
dpc-4793	444	30	b	b	PROPN
dpc-4793	444	31	[	[	PUNCT
dpc-4793	444	32	38	38	NUM
dpc-4793	444	33	]	]	PUNCT
dpc-4793	444	34	b	b	NOUN
dpc-4793	445	1	i	i	PRON
dpc-4793	445	2	m	m	VERB
dpc-4793	445	3	ek	ek	INTJ
dpc-4793	446	1	iz	iz	INTJ
dpc-4793	446	2	um	um	INTJ
dpc-4793	446	3	ab	ab	PROPN
dpc-4793	446	4	3	3	NUM
dpc-4793	446	5	20	20	NUM
dpc-4793	446	6	m	m	NOUN
dpc-4793	446	7	g	g	NOUN
dpc-4793	446	8	n	n	ADP
dpc-4793	446	9	r	r	NOUN
dpc-4793	446	10	n	n	ADP
dpc-4793	446	11	r	r	NOUN
dpc-4793	446	12	n	n	ADP
dpc-4793	446	13	r	r	NOUN
dpc-4793	446	14	n	n	ADP
dpc-4793	446	15	r	r	NOUN
dpc-4793	446	16	n	n	ADP
dpc-4793	446	17	r	r	NOUN
dpc-4793	446	18	n	n	ADP
dpc-4793	446	19	r	r	NOUN
dpc-4793	446	20	n	n	ADP
dpc-4793	446	21	r	r	NOUN
dpc-4793	446	22	n	n	ADP
dpc-4793	446	23	r	r	NOUN
dpc-4793	446	24	n	n	NOUN
dpc-4793	446	25	r	r	NOUN
dpc-4793	446	26	pl	pl	X
dpc-4793	446	27	ac	ac	PROPN
dpc-4793	446	28	eb	eb	PROPN
dpc-4793	446	29	o	o	PROPN
dpc-4793	446	30	n	n	ADP
dpc-4793	446	31	r	r	NOUN
dpc-4793	446	32	n	n	ADP
dpc-4793	446	33	r	r	NOUN
dpc-4793	446	34	n	n	ADP
dpc-4793	446	35	r	r	NOUN
dpc-4793	446	36	n	n	ADP
dpc-4793	446	37	r	r	NOUN
dpc-4793	446	38	n	n	ADP
dpc-4793	446	39	r	r	NOUN
dpc-4793	446	40	n	n	ADP
dpc-4793	446	41	r	r	NOUN
dpc-4793	446	42	n	n	ADP
dpc-4793	446	43	r	r	NOUN
dpc-4793	446	44	n	n	ADP
dpc-4793	446	45	r	r	NOUN
dpc-4793	446	46	n	n	NOUN
dpc-4793	446	47	r	r	NOUN
dpc-4793	446	48	l	l	NOUN
dpc-4793	446	49	an	an	DET
dpc-4793	446	50	gl	gl	NOUN
dpc-4793	446	51	ey	ey	PRON
dpc-4793	446	52	r	r	NOUN
dpc-4793	446	53	g	g	PROPN
dpc-4793	446	54	[	[	PUNCT
dpc-4793	446	55	19	19	NUM
dpc-4793	446	56	]	]	PUNCT
dpc-4793	446	57	ix	ix	ADP
dpc-4793	446	58	ek	ek	INTJ
dpc-4793	447	1	iz	iz	INTJ
dpc-4793	447	2	um	um	INTJ
dpc-4793	447	3	ab	ab	PROPN
dpc-4793	447	4	1	1	NUM
dpc-4793	447	5	0	0	NUM
dpc-4793	447	6	m	m	VERB
dpc-4793	447	7	g	g	NOUN
dpc-4793	447	8	n	n	ADP
dpc-4793	447	9	r	r	NOUN
dpc-4793	447	10	n	n	ADP
dpc-4793	447	11	r	r	NOUN
dpc-4793	447	12	n	n	ADP
dpc-4793	447	13	r	r	NOUN
dpc-4793	447	14	n	n	ADP
dpc-4793	447	15	r	r	NOUN
dpc-4793	447	16	n	n	ADP
dpc-4793	447	17	r	r	NOUN
dpc-4793	447	18	n	n	NOUN
dpc-4793	447	19	r	r	NOUN
dpc-4793	447	20	19	19	NUM
dpc-4793	447	21	.5	.5	NUM
dpc-4793	447	22	*	*	PUNCT
dpc-4793	447	23	n	n	NUM
dpc-4793	447	24	r	r	NOUN
dpc-4793	447	25	n	n	NOUN
dpc-4793	447	26	r	r	NOUN
dpc-4793	447	27	ix	ix	INTJ
dpc-4793	448	1	ek	ek	INTJ
dpc-4793	449	1	iz	iz	INTJ
dpc-4793	449	2	um	um	INTJ
dpc-4793	449	3	ab	ab	PROPN
dpc-4793	449	4	2	2	NUM
dpc-4793	449	5	5	5	NUM
dpc-4793	449	6	m	m	NOUN
dpc-4793	449	7	g	g	NOUN
dpc-4793	449	8	n	n	ADP
dpc-4793	449	9	r	r	NOUN
dpc-4793	449	10	n	n	ADP
dpc-4793	449	11	r	r	NOUN
dpc-4793	449	12	n	n	ADP
dpc-4793	449	13	r	r	NOUN
dpc-4793	449	14	n	n	ADP
dpc-4793	449	15	r	r	NOUN
dpc-4793	449	16	n	n	ADP
dpc-4793	449	17	r	r	NOUN
dpc-4793	449	18	n	n	NOUN
dpc-4793	449	19	r	r	NOUN
dpc-4793	449	20	20	20	NUM
dpc-4793	449	21	.5	.5	NUM
dpc-4793	449	22	*	*	PUNCT
dpc-4793	449	23	n	n	NUM
dpc-4793	449	24	r	r	NOUN
dpc-4793	449	25	n	n	NOUN
dpc-4793	449	26	r	r	NOUN
dpc-4793	449	27	ix	ix	INTJ
dpc-4793	450	1	ek	ek	INTJ
dpc-4793	451	1	iz	iz	INTJ
dpc-4793	451	2	um	um	INTJ
dpc-4793	451	3	ab	ab	PROPN
dpc-4793	451	4	7	7	NUM
dpc-4793	451	5	5	5	NUM
dpc-4793	451	6	m	m	NOUN
dpc-4793	451	7	g	g	NOUN
dpc-4793	451	8	n	n	ADP
dpc-4793	451	9	r	r	NOUN
dpc-4793	451	10	n	n	ADP
dpc-4793	451	11	r	r	NOUN
dpc-4793	451	12	n	n	ADP
dpc-4793	451	13	r	r	NOUN
dpc-4793	451	14	n	n	ADP
dpc-4793	451	15	r	r	NOUN
dpc-4793	451	16	n	n	ADP
dpc-4793	451	17	r	r	NOUN
dpc-4793	451	18	n	n	NOUN
dpc-4793	451	19	r	r	NOUN
dpc-4793	451	20	13	13	NUM
dpc-4793	451	21	.8	.8	NUM
dpc-4793	451	22	*	*	PUNCT
dpc-4793	451	23	n	n	CCONJ
dpc-4793	451	24	r	r	NOUN
dpc-4793	452	1	n	n	NOUN
dpc-4793	452	2	r	r	NOUN
dpc-4793	452	3	ix	ix	INTJ
dpc-4793	452	4	ek	ek	INTJ
dpc-4793	453	1	iz	iz	INTJ
dpc-4793	453	2	um	um	INTJ
dpc-4793	453	3	ab	ab	PROPN
dpc-4793	453	4	1	1	NUM
dpc-4793	453	5	50	50	NUM
dpc-4793	453	6	m	m	NOUN
dpc-4793	453	7	g	g	NOUN
dpc-4793	453	8	n	n	ADP
dpc-4793	453	9	r	r	NOUN
dpc-4793	453	10	n	n	ADP
dpc-4793	453	11	r	r	NOUN
dpc-4793	453	12	n	n	ADP
dpc-4793	453	13	r	r	NOUN
dpc-4793	453	14	n	n	ADP
dpc-4793	453	15	r	r	NOUN
dpc-4793	453	16	n	n	ADP
dpc-4793	453	17	r	r	NOUN
dpc-4793	453	18	n	n	NOUN
dpc-4793	453	19	r	r	NOUN
dpc-4793	453	20	20	20	NUM
dpc-4793	453	21	.1	.1	NUM
dpc-4793	453	22	*	*	PUNCT
dpc-4793	454	1	n	n	CCONJ
dpc-4793	454	2	r	r	NOUN
dpc-4793	455	1	n	n	NOUN
dpc-4793	455	2	r	r	NOUN
dpc-4793	455	3	pl	pl	X
dpc-4793	455	4	ac	ac	PROPN
dpc-4793	455	5	eb	eb	PROPN
dpc-4793	455	6	o	o	PROPN
dpc-4793	455	7	n	n	ADP
dpc-4793	455	8	r	r	NOUN
dpc-4793	455	9	n	n	ADP
dpc-4793	455	10	r	r	NOUN
dpc-4793	455	11	n	n	ADP
dpc-4793	455	12	r	r	NOUN
dpc-4793	455	13	n	n	ADP
dpc-4793	455	14	r	r	NOUN
dpc-4793	455	15	n	n	ADP
dpc-4793	455	16	r	r	NOUN
dpc-4793	455	17	n	n	NOUN
dpc-4793	455	18	r	r	NOUN
dpc-4793	455	19	18	18	NUM
dpc-4793	455	20	.8	.8	NUM
dpc-4793	455	21	*	*	PUNCT
dpc-4793	455	22	n	n	CCONJ
dpc-4793	456	1	r	r	NOUN
dpc-4793	456	2	n	n	NOUN
dpc-4793	456	3	r	r	NOUN
dpc-4793	456	4	l	l	NOUN
dpc-4793	456	5	eb	eb	PROPN
dpc-4793	456	6	w	w	PROPN
dpc-4793	457	1	oh	oh	INTJ
dpc-4793	457	2	l	l	NOUN
dpc-4793	457	3	m	m	VERB
dpc-4793	457	4	g	g	NOUN
dpc-4793	457	5	[	[	PUNCT
dpc-4793	457	6	39	39	NUM
dpc-4793	457	7	]	]	PUNCT
dpc-4793	457	8	c	c	PROPN
dpc-4793	457	9	al	al	PROPN
dpc-4793	457	10	ci	ci	PROPN
dpc-4793	457	11	po	po	PROPN
dpc-4793	457	12	tr	tr	VERB
dpc-4793	457	13	io	io	PROPN
dpc-4793	457	14	l	l	PROPN
dpc-4793	457	15	/	/	SYM
dpc-4793	457	16	e	e	X
dpc-4793	457	17	ne	ne	NOUN
dpc-4793	458	1	+	+	CCONJ
dpc-4793	458	2	b	b	X
dpc-4793	458	3	et	et	NOUN
dpc-4793	458	4	am	be	AUX
dpc-4793	458	5	et	et	NOUN
dpc-4793	458	6	ha	ha	INTJ
dpc-4793	458	7	so	so	ADV
dpc-4793	458	8	ne	ne	PROPN
dpc-4793	458	9	d	d	PROPN
dpc-4793	458	10	ip	ip	PRON
dpc-4793	458	11	ro	ro	X
dpc-4793	458	12	pi	pi	NOUN
dpc-4793	458	13	on	on	ADV
dpc-4793	458	14	at	at	ADP
dpc-4793	458	15	e	e	PROPN
dpc-4793	458	16	n	n	ADP
dpc-4793	458	17	r	r	NOUN
dpc-4793	458	18	n	n	ADP
dpc-4793	458	19	r	r	NOUN
dpc-4793	458	20	n	n	ADP
dpc-4793	458	21	r	r	NOUN
dpc-4793	458	22	n	n	ADP
dpc-4793	458	23	r	r	NOUN
dpc-4793	458	24	n	n	ADP
dpc-4793	458	25	r	r	NOUN
dpc-4793	458	26	n	n	ADP
dpc-4793	458	27	r	r	NOUN
dpc-4793	458	28	n	n	ADP
dpc-4793	458	29	r	r	NOUN
dpc-4793	458	30	n	n	ADP
dpc-4793	458	31	r	r	NOUN
dpc-4793	458	32	n	n	NOUN
dpc-4793	458	33	r	r	NOUN
dpc-4793	458	34	c	c	NOUN
dpc-4793	458	35	al	al	PROPN
dpc-4793	458	36	ci	ci	PROPN
dpc-4793	458	37	po	po	PROPN
dpc-4793	458	38	tr	tr	VERB
dpc-4793	458	39	ie	ie	X
dpc-4793	458	40	ne	ne	X
dpc-4793	458	41	/o	/o	PUNCT
dpc-4793	459	1	l	l	NOUN
dpc-4793	459	2	n	n	CCONJ
dpc-4793	459	3	r	r	NOUN
dpc-4793	459	4	n	n	ADP
dpc-4793	459	5	r	r	NOUN
dpc-4793	459	6	n	n	ADP
dpc-4793	459	7	r	r	NOUN
dpc-4793	459	8	n	n	ADP
dpc-4793	459	9	r	r	NOUN
dpc-4793	459	10	n	n	ADP
dpc-4793	459	11	r	r	NOUN
dpc-4793	459	12	n	n	ADP
dpc-4793	459	13	r	r	NOUN
dpc-4793	459	14	n	n	ADP
dpc-4793	459	15	r	r	NOUN
dpc-4793	459	16	n	n	ADP
dpc-4793	459	17	r	r	NOUN
dpc-4793	459	18	n	n	NOUN
dpc-4793	459	19	r	r	NOUN
dpc-4793	459	20	b	b	NOUN
dpc-4793	459	21	et	et	NOUN
dpc-4793	459	22	am	be	AUX
dpc-4793	459	23	et	et	NOUN
dpc-4793	459	24	ha	ha	INTJ
dpc-4793	459	25	so	so	ADV
dpc-4793	459	26	ne	ne	PROPN
dpc-4793	459	27	d	d	PROPN
dpc-4793	459	28	ip	ip	PRON
dpc-4793	459	29	ro	ro	X
dpc-4793	459	30	pi	pi	NOUN
dpc-4793	459	31	on	on	ADV
dpc-4793	459	32	at	at	ADP
dpc-4793	459	33	e	e	PROPN
dpc-4793	459	34	q	q	PROPN
dpc-4793	459	35	d	d	PROPN
dpc-4793	459	36	n	n	CCONJ
dpc-4793	459	37	r	r	NOUN
dpc-4793	459	38	n	n	ADP
dpc-4793	459	39	r	r	NOUN
dpc-4793	459	40	n	n	ADP
dpc-4793	459	41	r	r	NOUN
dpc-4793	459	42	n	n	ADP
dpc-4793	459	43	r	r	NOUN
dpc-4793	459	44	n	n	ADP
dpc-4793	459	45	r	r	NOUN
dpc-4793	459	46	n	n	ADP
dpc-4793	459	47	r	r	NOUN
dpc-4793	459	48	n	n	ADP
dpc-4793	459	49	r	r	NOUN
dpc-4793	459	50	n	n	ADP
dpc-4793	459	51	r	r	NOUN
dpc-4793	459	52	n	n	NOUN
dpc-4793	459	53	r	r	NOUN
dpc-4793	459	54	b	b	NOUN
dpc-4793	459	55	er	er	INTJ
dpc-4793	459	56	gs	gs	INTJ
dpc-4793	459	57	tr	tr	VERB
dpc-4793	459	58	om	om	PROPN
dpc-4793	459	59	k	k	PROPN
dpc-4793	459	60	b	b	PROPN
dpc-4793	459	61	[	[	PUNCT
dpc-4793	459	62	45	45	NUM
dpc-4793	459	63	]	]	PUNCT
dpc-4793	459	64	c	c	X
dpc-4793	459	65	lo	lo	PROPN
dpc-4793	459	66	be	be	VERB
dpc-4793	459	67	ta	ta	X
dpc-4793	460	1	so	so	ADV
dpc-4793	460	2	l	l	PROPN
dpc-4793	460	3	p	p	X
dpc-4793	461	1	ro	ro	ADJ
dpc-4793	461	2	pi	pi	NOUN
dpc-4793	461	3	on	on	ADV
dpc-4793	461	4	at	at	ADP
dpc-4793	461	5	e	e	NOUN
dpc-4793	461	6	fo	fo	ADP
dpc-4793	461	7	am	be	AUX
dpc-4793	461	8	n	n	PRON
dpc-4793	461	9	r	r	NOUN
dpc-4793	461	10	n	n	ADP
dpc-4793	461	11	r	r	NOUN
dpc-4793	461	12	n	n	ADP
dpc-4793	461	13	r	r	NOUN
dpc-4793	461	14	n	n	ADP
dpc-4793	461	15	r	r	NOUN
dpc-4793	461	16	n	n	ADP
dpc-4793	461	17	r	r	NOUN
dpc-4793	461	18	n	n	ADP
dpc-4793	461	19	r	r	NOUN
dpc-4793	461	20	n	n	ADP
dpc-4793	461	21	r	r	NOUN
dpc-4793	461	22	n	n	ADP
dpc-4793	461	23	r	r	NOUN
dpc-4793	461	24	n	n	NOUN
dpc-4793	461	25	r	r	NOUN
dpc-4793	461	26	c	c	NOUN
dpc-4793	461	27	lo	lo	NOUN
dpc-4793	461	28	be	be	VERB
dpc-4793	462	1	ta	ta	PART
dpc-4793	462	2	so	so	ADV
dpc-4793	462	3	l	l	NOUN
dpc-4793	462	4	pr	pr	NOUN
dpc-4793	463	1	op	op	NOUN
dpc-4793	463	2	io	io	VERB
dpc-4793	463	3	na	na	ADP
dpc-4793	463	4	te	te	PROPN
dpc-4793	463	5	s	s	VERB
dpc-4793	463	6	ol	ol	PROPN
dpc-4793	463	7	ut	ut	PROPN
dpc-4793	463	8	io	io	PROPN
dpc-4793	463	9	n	n	CCONJ
dpc-4793	463	10	n	n	ADP
dpc-4793	463	11	r	r	NOUN
dpc-4793	463	12	n	n	ADP
dpc-4793	463	13	r	r	NOUN
dpc-4793	463	14	n	n	ADP
dpc-4793	463	15	r	r	NOUN
dpc-4793	463	16	n	n	ADP
dpc-4793	463	17	r	r	NOUN
dpc-4793	463	18	n	n	ADP
dpc-4793	463	19	r	r	NOUN
dpc-4793	463	20	n	n	ADP
dpc-4793	463	21	r	r	NOUN
dpc-4793	463	22	n	n	ADP
dpc-4793	463	23	r	r	NOUN
dpc-4793	463	24	n	n	ADP
dpc-4793	463	25	r	r	NOUN
dpc-4793	463	26	n	n	NOUN
dpc-4793	463	27	r	r	NOUN
dpc-4793	463	28	st	st	PROPN
dpc-4793	463	29	ei	ei	PROPN
dpc-4793	463	30	n	n	CCONJ
dpc-4793	463	31	g	g	NOUN
dpc-4793	463	32	ol	ol	PROPN
dpc-4793	463	33	d	d	X
dpc-4793	463	34	l	l	X
dpc-4793	463	35	[	[	PUNCT
dpc-4793	463	36	46	46	NUM
dpc-4793	463	37	]	]	PUNCT
dpc-4793	463	38	a	a	DET
dpc-4793	463	39	pr	pr	NOUN
dpc-4793	464	1	em	em	PRON
dpc-4793	464	2	ila	ila	PROPN
dpc-4793	464	3	st	st	PROPN
dpc-4793	465	1	3	3	NUM
dpc-4793	465	2	0	0	NUM
dpc-4793	465	3	m	m	VERB
dpc-4793	465	4	g	g	NOUN
dpc-4793	465	5	n	n	ADP
dpc-4793	465	6	r	r	NOUN
dpc-4793	465	7	n	n	ADP
dpc-4793	465	8	r	r	NOUN
dpc-4793	465	9	n	n	ADP
dpc-4793	465	10	r	r	NOUN
dpc-4793	465	11	n	n	ADP
dpc-4793	465	12	r	r	NOUN
dpc-4793	465	13	n	n	ADP
dpc-4793	465	14	r	r	NOUN
dpc-4793	465	15	n	n	ADP
dpc-4793	465	16	r	r	NOUN
dpc-4793	465	17	n	n	ADP
dpc-4793	465	18	r	r	NOUN
dpc-4793	465	19	n	n	ADP
dpc-4793	465	20	r	r	NOUN
dpc-4793	465	21	n	n	NOUN
dpc-4793	465	22	r	r	NOUN
dpc-4793	465	23	pl	pl	X
dpc-4793	465	24	ac	ac	PROPN
dpc-4793	465	25	eb	eb	PROPN
dpc-4793	465	26	o	o	PROPN
dpc-4793	465	27	n	n	ADP
dpc-4793	465	28	r	r	NOUN
dpc-4793	465	29	n	n	ADP
dpc-4793	465	30	r	r	NOUN
dpc-4793	465	31	n	n	ADP
dpc-4793	465	32	r	r	NOUN
dpc-4793	465	33	n	n	ADP
dpc-4793	465	34	r	r	NOUN
dpc-4793	465	35	n	n	ADP
dpc-4793	465	36	r	r	NOUN
dpc-4793	465	37	n	n	ADP
dpc-4793	465	38	r	r	NOUN
dpc-4793	465	39	n	n	ADP
dpc-4793	465	40	r	r	NOUN
dpc-4793	465	41	n	n	ADP
dpc-4793	465	42	r	r	NOUN
dpc-4793	465	43	n	n	NOUN
dpc-4793	465	44	r	r	NOUN
dpc-4793	465	45	a	a	DET
dpc-4793	465	46	bb	bb	NOUN
dpc-4793	465	47	re	re	ADJ
dpc-4793	465	48	vi	vi	PROPN
dpc-4793	465	49	at	at	ADP
dpc-4793	465	50	io	io	X
dpc-4793	465	51	ns	ns	NUM
dpc-4793	465	52	:	:	PUNCT
dpc-4793	465	53	b	b	X
dpc-4793	465	54	i	i	NOUN
dpc-4793	465	55	d	d	PROPN
dpc-4793	465	56	:	:	PUNCT
dpc-4793	466	1	t	t	PROPN
dpc-4793	466	2	w	w	NOUN
dpc-4793	466	3	ic	ic	PROPN
dpc-4793	466	4	e	e	PROPN
dpc-4793	466	5	a	a	DET
dpc-4793	466	6	da	da	PROPN
dpc-4793	466	7	y	y	PROPN
dpc-4793	466	8	;	;	PUNCT
dpc-4793	466	9	c	c	PROPN
dpc-4793	466	10	al	al	PROPN
dpc-4793	466	11	ci	ci	PROPN
dpc-4793	466	12	po	po	PROPN
dpc-4793	466	13	tr	tr	VERB
dpc-4793	466	14	io	io	PROPN
dpc-4793	466	15	l	l	PROPN
dpc-4793	466	16	/	/	SYM
dpc-4793	466	17	e	e	X
dpc-4793	466	18	ne	ne	X
dpc-4793	466	19	:	:	PUNCT
dpc-4793	467	1	c	c	X
dpc-4793	467	2	om	om	PROPN
dpc-4793	467	3	bi	bi	NOUN
dpc-4793	467	4	na	na	X
dpc-4793	467	5	ti	ti	PROPN
dpc-4793	467	6	on	on	ADP
dpc-4793	467	7	t	t	PROPN
dpc-4793	467	8	he	he	PRON
dpc-4793	468	1	ra	ra	INTJ
dpc-4793	469	1	py	py	INTJ
dpc-4793	470	1	o	o	INTJ
dpc-4793	470	2	f	f	NOUN
dpc-4793	470	3	ca	can	AUX
dpc-4793	470	4	lc	lc	PROPN
dpc-4793	470	5	ip	ip	PRON
dpc-4793	470	6	ot	ot	INTJ
dpc-4793	470	7	ri	ri	PROPN
dpc-4793	470	8	ol	ol	PROPN
dpc-4793	470	9	a	a	DET
dpc-4793	470	10	nd	nd	NOUN
dpc-4793	470	11	c	c	PROPN
dpc-4793	470	12	al	al	PROPN
dpc-4793	470	13	ci	ci	PROPN
dpc-4793	470	14	po	po	PROPN
dpc-4793	470	15	tr	tr	VERB
dpc-4793	470	16	ie	ie	PROPN
dpc-4793	470	17	ne	ne	PROPN
dpc-4793	470	18	;	;	PUNCT
dpc-4793	470	19	c	c	PROPN
dpc-4793	470	20	al	al	PROPN
dpc-4793	470	21	ci	ci	PROPN
dpc-4793	470	22	po	po	PROPN
dpc-4793	470	23	tr	tr	VERB
dpc-4793	470	24	ie	ie	PROPN
dpc-4793	470	25	ne	ne	X
dpc-4793	470	26	/o	/o	PUNCT
dpc-4793	471	1	l	l	NOUN
dpc-4793	471	2	:	:	PUNCT
dpc-4793	471	3	co	co	VERB
dpc-4793	471	4	m	m	PROPN
dpc-4793	471	5	bi	bi	ADJ
dpc-4793	471	6	na	na	ADP
dpc-4793	471	7	ti	ti	PROPN
dpc-4793	471	8	on	on	ADP
dpc-4793	471	9	t	t	PROPN
dpc-4793	471	10	he	he	PRON
dpc-4793	472	1	ra	ra	INTJ
dpc-4793	473	1	py	py	INTJ
dpc-4793	474	1	o	o	INTJ
dpc-4793	474	2	f	f	NOUN
dpc-4793	474	3	ca	can	AUX
dpc-4793	474	4	lc	lc	PROPN
dpc-4793	474	5	ip	ip	NOUN
dpc-4793	474	6	ot	ot	INTJ
dpc-4793	474	7	ri	ri	PROPN
dpc-4793	474	8	en	en	X
dpc-4793	474	9	e	e	PROPN
dpc-4793	474	10	an	an	DET
dpc-4793	474	11	d	d	PROPN
dpc-4793	474	12	ca	can	AUX
dpc-4793	474	13	lc	lc	NOUN
dpc-4793	474	14	ip	ip	NOUN
dpc-4793	474	15	ot	ot	INTJ
dpc-4793	474	16	ri	ri	NOUN
dpc-4793	474	17	ol	ol	PROPN
dpc-4793	474	18	;	;	PUNCT
dpc-4793	475	1	q	q	PROPN
dpc-4793	475	2	d	d	NOUN
dpc-4793	475	3	;	;	PUNCT
dpc-4793	475	4	o	o	PROPN
dpc-4793	475	5	nc	nc	PROPN
dpc-4793	475	6	e	e	PROPN
dpc-4793	475	7	da	da	PROPN
dpc-4793	475	8	ily	ily	ADV
dpc-4793	475	9	,	,	PUNCT
dpc-4793	475	10	*	*	PUNCT
dpc-4793	475	11	in	in	ADP
dpc-4793	475	12	di	di	X
dpc-4793	475	13	ca	can	AUX
dpc-4793	475	14	te	te	PROPN
dpc-4793	475	15	s	s	X
dpc-4793	475	16	th	th	X
dpc-4793	475	17	is	be	AUX
dpc-4793	475	18	va	va	PROPN
dpc-4793	475	19	lu	lu	PROPN
dpc-4793	475	20	e	e	PROPN
dpc-4793	475	21	is	be	AUX
dpc-4793	475	22	a	a	DET
dpc-4793	475	23	m	m	NOUN
dpc-4793	475	24	ea	ea	NOUN
dpc-4793	475	25	n	n	CCONJ
dpc-4793	475	26	,	,	PUNCT
dpc-4793	475	27	in	in	ADP
dpc-4793	475	28	di	di	X
dpc-4793	475	29	ca	can	AUX
dpc-4793	475	30	te	te	PROPN
dpc-4793	475	31	s	s	X
dpc-4793	475	32	th	th	X
dpc-4793	475	33	is	be	AUX
dpc-4793	476	1	v	v	PROPN
dpc-4793	476	2	al	al	PROPN
dpc-4793	476	3	ue	ue	PROPN
dpc-4793	476	4	is	be	AUX
dpc-4793	476	5	a	a	DET
dpc-4793	476	6	m	m	NOUN
dpc-4793	476	7	ed	ed	NOUN
dpc-4793	476	8	ia	ia	PROPN
dpc-4793	476	9	n	n	ADP
dpc-4793	476	10	t	t	X
dpc-4793	476	11	ab	ab	X
dpc-4793	476	12	le	le	PROPN
dpc-4793	476	13	1	1	NUM
dpc-4793	476	14	.	.	PUNCT
dpc-4793	477	1	b	b	X
dpc-4793	477	2	as	as	ADP
dpc-4793	477	3	el	el	PROPN
dpc-4793	477	4	in	in	ADP
dpc-4793	477	5	e	e	PROPN
dpc-4793	477	6	c	c	NOUN
dpc-4793	477	7	ha	ha	INTJ
dpc-4793	477	8	ra	ra	INTJ
dpc-4793	477	9	ct	ct	INTJ
dpc-4793	477	10	er	er	INTJ
dpc-4793	477	11	is	be	AUX
dpc-4793	477	12	ti	ti	X
dpc-4793	477	13	cs	cs	ADJ
dpc-4793	477	14	o	o	PROPN
dpc-4793	477	15	f	f	PROPN
dpc-4793	477	16	in	in	ADP
dpc-4793	477	17	cl	cl	INTJ
dpc-4793	478	1	ud	ud	INTJ
dpc-4793	479	1	ed	ed	PROPN
dpc-4793	479	2	s	s	PROPN
dpc-4793	479	3	tu	tu	X
dpc-4793	479	4	di	di	NOUN
dpc-4793	479	5	es	es	PROPN
dpc-4793	479	6	.	.	PUNCT
dpc-4793	480	1	(	(	PUNCT
dpc-4793	480	2	co	co	X
dpc-4793	480	3	nt	not	PART
dpc-4793	480	4	in	in	ADP
dpc-4793	480	5	ue	ue	PROPN
dpc-4793	480	6	d	d	PROPN
dpc-4793	480	7	)	)	PUNCT
dpc-4793	480	8	review	review	NOUN
dpc-4793	480	9	|	|	ADV
dpc-4793	480	10	dermatol	dermatol	ADJ
dpc-4793	480	11	pract	pract	NOUN
dpc-4793	480	12	concept	concept	NOUN
dpc-4793	480	13	.	.	PUNCT
dpc-4793	481	1	2025;15(2):4793	2025;15(2):4793	NUM
dpc-4793	481	2	9	9	NUM
dpc-4793	481	3	30	30	NUM
dpc-4793	481	4	mg	mg	NOUN
dpc-4793	481	5	twice	twice	ADV
dpc-4793	481	6	daily	daily	ADV
dpc-4793	481	7	and	and	CCONJ
dpc-4793	481	8	adalimumab	adalimumab	NOUN
dpc-4793	481	9	80	80	NUM
dpc-4793	481	10	mg	mg	NUM
dpc-4793	481	11	q2w	q2w	PROPN
dpc-4793	481	12	.	.	PUNCT
dpc-4793	482	1	this	this	PRON
dpc-4793	482	2	is	be	AUX
dpc-4793	482	3	consistent	consistent	ADJ
dpc-4793	482	4	with	with	ADP
dpc-4793	482	5	previous	previous	ADJ
dpc-4793	482	6	head	head	NOUN
dpc-4793	482	7	-	-	PUNCT
dpc-4793	482	8	to	to	ADP
dpc-4793	482	9	-	-	PUNCT
dpc-4793	482	10	head	head	NOUN
dpc-4793	482	11	comparative	comparative	ADJ
dpc-4793	482	12	studies	study	NOUN
dpc-4793	482	13	[	[	X
dpc-4793	482	14	49	49	NUM
dpc-4793	482	15	]	]	PUNCT
dpc-4793	482	16	.	.	PUNCT
dpc-4793	483	1	these	these	DET
dpc-4793	483	2	results	result	NOUN
dpc-4793	483	3	,	,	PUNCT
dpc-4793	483	4	consistent	consistent	ADJ
dpc-4793	483	5	with	with	ADP
dpc-4793	483	6	previous	previous	ADJ
dpc-4793	483	7	research	research	NOUN
dpc-4793	483	8	,	,	PUNCT
dpc-4793	483	9	indicate	indicate	VERB
dpc-4793	483	10	that	that	SCONJ
dpc-4793	483	11	the	the	DET
dpc-4793	483	12	use	use	NOUN
dpc-4793	483	13	of	of	ADP
dpc-4793	483	14	newer	new	ADJ
dpc-4793	483	15	biologics	biologic	NOUN
dpc-4793	483	16	may	may	AUX
dpc-4793	483	17	be	be	AUX
dpc-4793	483	18	linked	link	VERB
dpc-4793	483	19	to	to	ADP
dpc-4793	483	20	better	well	ADJ
dpc-4793	483	21	clinical	clinical	ADJ
dpc-4793	483	22	performance	performance	NOUN
dpc-4793	483	23	and	and	CCONJ
dpc-4793	483	24	control	control	NOUN
dpc-4793	483	25	of	of	ADP
dpc-4793	483	26	scalp	scalp	NOUN
dpc-4793	483	27	psoriasis	psoriasis	NOUN
dpc-4793	483	28	symptoms	symptom	NOUN
dpc-4793	483	29	,	,	PUNCT
dpc-4793	483	30	thus	thus	ADV
dpc-4793	483	31	improving	improve	VERB
dpc-4793	483	32	quality	quality	NOUN
dpc-4793	483	33	of	of	ADP
dpc-4793	483	34	life	life	NOUN
dpc-4793	483	35	[	[	X
dpc-4793	483	36	47	47	NUM
dpc-4793	483	37	]	]	PUNCT
dpc-4793	483	38	.	.	PUNCT
dpc-4793	484	1	scalp	scalp	NOUN
dpc-4793	484	2	psoriasis	psoriasis	NOUN
dpc-4793	484	3	treatment	treatment	NOUN
dpc-4793	484	4	is	be	AUX
dpc-4793	484	5	greatly	greatly	ADV
dpc-4793	484	6	expanding	expand	VERB
dpc-4793	484	7	,	,	PUNCT
dpc-4793	484	8	including	include	VERB
dpc-4793	484	9	over	over	ADP
dpc-4793	484	10	10	10	NUM
dpc-4793	484	11	different	different	ADJ
dpc-4793	484	12	biologic	biologic	NOUN
dpc-4793	484	13	drugs	drug	NOUN
dpc-4793	484	14	and	and	CCONJ
dpc-4793	484	15	one	one	NUM
dpc-4793	484	16	small	small	ADJ
dpc-4793	484	17	molecule	molecule	NOUN
dpc-4793	484	18	.	.	PUNCT
dpc-4793	485	1	scalp	scalp	NOUN
dpc-4793	485	2	psoriatic	psoriatic	ADJ
dpc-4793	485	3	plaques	plaque	NOUN
dpc-4793	485	4	are	be	AUX
dpc-4793	485	5	particularly	particularly	ADV
dpc-4793	485	6	refractory	refractory	NOUN
dpc-4793	485	7	to	to	ADP
dpc-4793	485	8	topical	topical	NOUN
dpc-4793	485	9	not	not	PART
dpc-4793	485	10	used	use	VERB
dpc-4793	485	11	in	in	ADP
dpc-4793	485	12	real	real	ADJ
dpc-4793	485	13	life	life	NOUN
dpc-4793	485	14	.	.	PUNCT
dpc-4793	486	1	in	in	ADP
dpc-4793	486	2	the	the	DET
dpc-4793	486	3	pssi	pssi	ADJ
dpc-4793	486	4	analysis	analysis	NOUN
dpc-4793	486	5	,	,	PUNCT
dpc-4793	486	6	the	the	DET
dpc-4793	486	7	biologic	biologic	NOUN
dpc-4793	486	8	agents	agent	NOUN
dpc-4793	486	9	(	(	PUNCT
dpc-4793	486	10	secukinumab	secukinumab	NOUN
dpc-4793	486	11	300	300	NUM
dpc-4793	486	12	mg	mg	NOUN
dpc-4793	486	13	q4w	q4w	PROPN
dpc-4793	486	14	,	,	PUNCT
dpc-4793	486	15	brodalumab	brodalumab	NOUN
dpc-4793	486	16	210	210	NUM
dpc-4793	486	17	mg	mg	ADP
dpc-4793	486	18	q2w	q2w	NOUN
dpc-4793	486	19	,	,	PUNCT
dpc-4793	486	20	and	and	CCONJ
dpc-4793	486	21	ixekizumab	ixekizumab	VERB
dpc-4793	486	22	150/160	150/160	PROPN
dpc-4793	486	23	mg	mg	PROPN
dpc-4793	486	24	q2	q2	PROPN
dpc-4793	486	25	-	-	PUNCT
dpc-4793	486	26	4w	4w	NOUN
dpc-4793	486	27	)	)	PUNCT
dpc-4793	486	28	had	have	VERB
dpc-4793	486	29	a	a	DET
dpc-4793	486	30	higher	high	ADJ
dpc-4793	486	31	likelihood	likelihood	NOUN
dpc-4793	486	32	of	of	ADP
dpc-4793	486	33	being	be	AUX
dpc-4793	486	34	more	more	ADV
dpc-4793	486	35	effective	effective	ADJ
dpc-4793	486	36	than	than	SCONJ
dpc-4793	486	37	etanercept	etanercept	VERB
dpc-4793	486	38	50	50	NUM
dpc-4793	486	39	twice	twice	ADV
dpc-4793	486	40	weekly	weekly	ADJ
dpc-4793	486	41	,	,	PUNCT
dpc-4793	486	42	which	which	PRON
dpc-4793	486	43	is	be	AUX
dpc-4793	486	44	consistent	consistent	ADJ
dpc-4793	486	45	with	with	ADP
dpc-4793	486	46	previous	previous	ADJ
dpc-4793	486	47	studies	study	NOUN
dpc-4793	486	48	[	[	X
dpc-4793	486	49	7	7	NUM
dpc-4793	486	50	,	,	PUNCT
dpc-4793	486	51	16	16	NUM
dpc-4793	486	52	]	]	PUNCT
dpc-4793	486	53	.	.	PUNCT
dpc-4793	487	1	in	in	ADP
dpc-4793	487	2	the	the	DET
dpc-4793	487	3	iga	iga	PROPN
dpc-4793	487	4	response	response	NOUN
dpc-4793	487	5	analysis	analysis	NOUN
dpc-4793	487	6	,	,	PUNCT
dpc-4793	487	7	bimekizumab	bimekizumab	X
dpc-4793	487	8	320	320	NUM
dpc-4793	487	9	mg	mg	PROPN
dpc-4793	487	10	q4w	q4w	PROPN
dpc-4793	487	11	,	,	PUNCT
dpc-4793	487	12	ustekinumab	ustekinumab	NOUN
dpc-4793	487	13	,	,	PUNCT
dpc-4793	487	14	secukinumab	secukinumab	NOUN
dpc-4793	487	15	300	300	NUM
dpc-4793	487	16	mg	mg	NOUN
dpc-4793	487	17	q4w	q4w	PROPN
dpc-4793	487	18	,	,	PUNCT
dpc-4793	487	19	and	and	CCONJ
dpc-4793	487	20	the	the	DET
dpc-4793	487	21	100	100	NUM
dpc-4793	487	22	mg	mg	NOUN
dpc-4793	487	23	dosing	dose	VERB
dpc-4793	487	24	of	of	ADP
dpc-4793	487	25	guselkumab	guselkumab	NOUN
dpc-4793	487	26	q8w	q8w	PRON
dpc-4793	487	27	were	be	AUX
dpc-4793	487	28	deemed	deem	VERB
dpc-4793	487	29	to	to	PART
dpc-4793	487	30	be	be	AUX
dpc-4793	487	31	more	more	ADV
dpc-4793	487	32	effective	effective	ADJ
dpc-4793	487	33	than	than	ADP
dpc-4793	487	34	other	other	ADJ
dpc-4793	487	35	biologic	biologic	NOUN
dpc-4793	487	36	and	and	CCONJ
dpc-4793	487	37	small	small	ADJ
dpc-4793	487	38	molecule	molecule	NOUN
dpc-4793	487	39	therapies	therapy	NOUN
dpc-4793	487	40	,	,	PUNCT
dpc-4793	487	41	including	include	VERB
dpc-4793	487	42	apremilast	apremilast	ADJ
dpc-4793	487	43	figure	figure	NOUN
dpc-4793	487	44	2	2	NUM
dpc-4793	487	45	.	.	PUNCT
dpc-4793	488	1	(	(	PUNCT
dpc-4793	488	2	a	a	X
dpc-4793	488	3	)	)	PUNCT
dpc-4793	488	4	network	network	NOUN
dpc-4793	488	5	plot	plot	NOUN
dpc-4793	488	6	of	of	ADP
dpc-4793	488	7	studies	study	NOUN
dpc-4793	488	8	reporting	report	VERB
dpc-4793	488	9	the	the	DET
dpc-4793	488	10	pssi	pssi	ADJ
dpc-4793	488	11	response	response	NOUN
dpc-4793	488	12	.	.	PUNCT
dpc-4793	489	1	(	(	PUNCT
dpc-4793	489	2	b	b	X
dpc-4793	489	3	)	)	PUNCT
dpc-4793	489	4	forest	forest	NOUN
dpc-4793	489	5	plot	plot	NOUN
dpc-4793	489	6	of	of	ADP
dpc-4793	489	7	network	network	NOUN
dpc-4793	489	8	meta	meta	ADJ
dpc-4793	489	9	-	-	PUNCT
dpc-4793	489	10	analysis	analysis	NOUN
dpc-4793	489	11	results	result	NOUN
dpc-4793	489	12	for	for	ADP
dpc-4793	489	13	studies	study	NOUN
dpc-4793	489	14	reporting	report	VERB
dpc-4793	489	15	the	the	DET
dpc-4793	489	16	pssi	pssi	ADJ
dpc-4793	489	17	response	response	NOUN
dpc-4793	489	18	.	.	PUNCT
dpc-4793	490	1	(	(	PUNCT
dpc-4793	490	2	pssi	pssi	ADJ
dpc-4793	490	3	=	=	NOUN
dpc-4793	490	4	psoriasis	psoriasis	NOUN
dpc-4793	490	5	scalp	scalp	NOUN
dpc-4793	490	6	severity	severity	NOUN
dpc-4793	490	7	index	index	NOUN
dpc-4793	490	8	.	.	PUNCT
dpc-4793	490	9	)	)	PUNCT
dpc-4793	491	1	figure	figure	NOUN
dpc-4793	491	2	3	3	NUM
dpc-4793	491	3	.	.	PUNCT
dpc-4793	492	1	(	(	PUNCT
dpc-4793	492	2	a	a	X
dpc-4793	492	3	)	)	PUNCT
dpc-4793	492	4	network	network	NOUN
dpc-4793	492	5	plot	plot	NOUN
dpc-4793	492	6	of	of	ADP
dpc-4793	492	7	studies	study	NOUN
dpc-4793	492	8	reporting	report	VERB
dpc-4793	492	9	the	the	DET
dpc-4793	492	10	iga	iga	PROPN
dpc-4793	492	11	response	response	NOUN
dpc-4793	492	12	.	.	PUNCT
dpc-4793	493	1	(	(	PUNCT
dpc-4793	493	2	b	b	X
dpc-4793	493	3	)	)	PUNCT
dpc-4793	493	4	forest	forest	NOUN
dpc-4793	493	5	plot	plot	NOUN
dpc-4793	493	6	of	of	ADP
dpc-4793	493	7	network	network	NOUN
dpc-4793	493	8	meta	meta	ADJ
dpc-4793	493	9	-	-	PUNCT
dpc-4793	493	10	analysis	analysis	NOUN
dpc-4793	493	11	results	result	NOUN
dpc-4793	493	12	for	for	ADP
dpc-4793	493	13	studies	study	NOUN
dpc-4793	493	14	reporting	report	VERB
dpc-4793	493	15	the	the	DET
dpc-4793	493	16	iga	iga	PROPN
dpc-4793	493	17	response	response	NOUN
dpc-4793	493	18	.	.	PUNCT
dpc-4793	494	1	(	(	PUNCT
dpc-4793	494	2	iga	iga	PROPN
dpc-4793	494	3	=	=	SYM
dpc-4793	494	4	scalp	scalp	NOUN
dpc-4793	494	5	-	-	PUNCT
dpc-4793	494	6	specific	specific	ADJ
dpc-4793	494	7	investigator	investigator	NOUN
dpc-4793	494	8	global	global	ADJ
dpc-4793	494	9	assessment	assessment	NOUN
dpc-4793	494	10	)	)	PUNCT
dpc-4793	494	11	.	.	PUNCT
dpc-4793	495	1	10	10	NUM
dpc-4793	495	2	review	review	NOUN
dpc-4793	495	3	|	|	ADV
dpc-4793	495	4	dermatol	dermatol	ADJ
dpc-4793	495	5	pract	pract	NOUN
dpc-4793	495	6	concept	concept	NOUN
dpc-4793	495	7	.	.	PUNCT
dpc-4793	496	1	2025;15(2):4793	2025;15(2):4793	NUM
dpc-4793	496	2	in	in	ADP
dpc-4793	496	3	summary	summary	NOUN
dpc-4793	496	4	,	,	PUNCT
dpc-4793	496	5	this	this	DET
dpc-4793	496	6	systematic	systematic	ADJ
dpc-4793	496	7	review	review	NOUN
dpc-4793	496	8	and	and	CCONJ
dpc-4793	496	9	network	network	NOUN
dpc-4793	496	10	meta	meta	NOUN
dpc-4793	496	11	analysis	analysis	NOUN
dpc-4793	496	12	offer	offer	VERB
dpc-4793	496	13	new	new	ADJ
dpc-4793	496	14	insights	insight	NOUN
dpc-4793	496	15	into	into	ADP
dpc-4793	496	16	the	the	DET
dpc-4793	496	17	range	range	NOUN
dpc-4793	496	18	of	of	ADP
dpc-4793	496	19	treatments	treatment	NOUN
dpc-4793	496	20	for	for	ADP
dpc-4793	496	21	scalp	scalp	NOUN
dpc-4793	496	22	psoriasis	psoriasis	NOUN
dpc-4793	496	23	.	.	PUNCT
dpc-4793	497	1	there	there	PRON
dpc-4793	497	2	is	be	VERB
dpc-4793	497	3	a	a	DET
dpc-4793	497	4	critical	critical	ADJ
dpc-4793	497	5	need	need	NOUN
dpc-4793	497	6	for	for	ADP
dpc-4793	497	7	effective	effective	ADJ
dpc-4793	497	8	therapies	therapy	NOUN
dpc-4793	497	9	for	for	ADP
dpc-4793	497	10	scalp	scalp	NOUN
dpc-4793	497	11	psoriasis	psoriasis	NOUN
dpc-4793	497	12	given	give	VERB
dpc-4793	497	13	its	its	PRON
dpc-4793	497	14	significant	significant	ADJ
dpc-4793	497	15	impact	impact	NOUN
dpc-4793	497	16	on	on	ADP
dpc-4793	497	17	patients	patient	NOUN
dpc-4793	497	18	’	'	PUNCT
dpc-4793	497	19	quality	quality	NOUN
dpc-4793	497	20	of	of	ADP
dpc-4793	497	21	life	life	NOUN
dpc-4793	497	22	.	.	PUNCT
dpc-4793	498	1	the	the	DET
dpc-4793	498	2	findings	finding	NOUN
dpc-4793	498	3	of	of	ADP
dpc-4793	498	4	this	this	DET
dpc-4793	498	5	study	study	NOUN
dpc-4793	498	6	highlight	highlight	VERB
dpc-4793	498	7	the	the	DET
dpc-4793	498	8	efficacy	efficacy	NOUN
dpc-4793	498	9	of	of	ADP
dpc-4793	498	10	various	various	ADJ
dpc-4793	498	11	treatments	treatment	NOUN
dpc-4793	498	12	in	in	ADP
dpc-4793	498	13	improving	improve	VERB
dpc-4793	498	14	symptoms	symptom	NOUN
dpc-4793	498	15	,	,	PUNCT
dpc-4793	498	16	with	with	ADP
dpc-4793	498	17	secukinumab	secukinumab	NOUN
dpc-4793	498	18	300	300	NUM
dpc-4793	498	19	mg	mg	NOUN
dpc-4793	498	20	q4w	q4w	PROPN
dpc-4793	498	21	and	and	CCONJ
dpc-4793	498	22	bimekizumab	bimekizumab	NOUN
dpc-4793	498	23	320	320	NUM
dpc-4793	498	24	mg	mg	PROPN
dpc-4793	498	25	q4w	q4w	PROPN
dpc-4793	498	26	deemed	deem	VERB
dpc-4793	498	27	most	most	ADV
dpc-4793	498	28	effective	effective	ADJ
dpc-4793	498	29	in	in	ADP
dpc-4793	498	30	improving	improve	VERB
dpc-4793	498	31	pssi	pssi	ADJ
dpc-4793	498	32	and	and	CCONJ
dpc-4793	498	33	iga	iga	PROPN
dpc-4793	498	34	,	,	PUNCT
dpc-4793	498	35	respectively	respectively	ADV
dpc-4793	498	36	.	.	PUNCT
dpc-4793	499	1	these	these	DET
dpc-4793	499	2	interventions	intervention	NOUN
dpc-4793	499	3	were	be	AUX
dpc-4793	499	4	deemed	deem	VERB
dpc-4793	499	5	most	most	ADV
dpc-4793	499	6	effective	effective	ADJ
dpc-4793	499	7	among	among	ADP
dpc-4793	499	8	biologic	biologic	ADJ
dpc-4793	499	9	agents	agent	NOUN
dpc-4793	499	10	analyzed	analyze	VERB
dpc-4793	499	11	,	,	PUNCT
dpc-4793	499	12	indicating	indicate	VERB
dpc-4793	499	13	that	that	SCONJ
dpc-4793	499	14	they	they	PRON
dpc-4793	499	15	may	may	AUX
dpc-4793	499	16	be	be	AUX
dpc-4793	499	17	helpful	helpful	ADJ
dpc-4793	499	18	among	among	ADP
dpc-4793	499	19	patients	patient	NOUN
dpc-4793	499	20	with	with	ADP
dpc-4793	499	21	moderate	moderate	ADJ
dpc-4793	499	22	-	-	PUNCT
dpc-4793	499	23	to	to	ADP
dpc-4793	499	24	-	-	PUNCT
dpc-4793	499	25	severe	severe	ADJ
dpc-4793	499	26	scalp	scalp	NOUN
dpc-4793	499	27	psoriasis	psoriasis	NOUN
dpc-4793	499	28	that	that	PRON
dpc-4793	499	29	is	be	AUX
dpc-4793	499	30	refractory	refractory	NOUN
dpc-4793	499	31	to	to	ADP
dpc-4793	499	32	traditional	traditional	ADJ
dpc-4793	499	33	first	first	ADJ
dpc-4793	499	34	-	-	PUNCT
dpc-4793	499	35	line	line	NOUN
dpc-4793	499	36	treatments	treatment	NOUN
dpc-4793	499	37	.	.	PUNCT
dpc-4793	500	1	to	to	PART
dpc-4793	500	2	address	address	VERB
dpc-4793	500	3	these	these	DET
dpc-4793	500	4	limitations	limitation	NOUN
dpc-4793	500	5	,	,	PUNCT
dpc-4793	500	6	future	future	ADJ
dpc-4793	500	7	studies	study	NOUN
dpc-4793	500	8	should	should	AUX
dpc-4793	500	9	conduct	conduct	VERB
dpc-4793	500	10	head	head	NOUN
dpc-4793	500	11	-	-	PUNCT
dpc-4793	500	12	to	to	ADP
dpc-4793	500	13	-	-	PUNCT
dpc-4793	500	14	head	head	NOUN
dpc-4793	500	15	trials	trial	NOUN
dpc-4793	500	16	comparing	compare	VERB
dpc-4793	500	17	various	various	ADJ
dpc-4793	500	18	treatments	treatment	NOUN
dpc-4793	500	19	directly	directly	ADV
dpc-4793	500	20	,	,	PUNCT
dpc-4793	500	21	using	use	VERB
dpc-4793	500	22	standardized	standardized	ADJ
dpc-4793	500	23	outcome	outcome	NOUN
dpc-4793	500	24	measures	measure	NOUN
dpc-4793	500	25	and	and	CCONJ
dpc-4793	500	26	consistent	consistent	ADJ
dpc-4793	500	27	timing	timing	NOUN
dpc-4793	500	28	of	of	ADP
dpc-4793	500	29	assessments	assessment	NOUN
dpc-4793	500	30	.	.	PUNCT
dpc-4793	501	1	in	in	ADP
dpc-4793	501	2	this	this	DET
dpc-4793	501	3	study	study	NOUN
dpc-4793	501	4	,	,	PUNCT
dpc-4793	501	5	certain	certain	ADJ
dpc-4793	501	6	studies	study	NOUN
dpc-4793	501	7	found	find	VERB
dpc-4793	501	8	in	in	ADP
dpc-4793	501	9	the	the	DET
dpc-4793	501	10	systematic	systematic	ADJ
dpc-4793	501	11	review	review	NOUN
dpc-4793	501	12	could	could	AUX
dpc-4793	501	13	not	not	PART
dpc-4793	501	14	be	be	AUX
dpc-4793	501	15	included	include	VERB
dpc-4793	501	16	as	as	SCONJ
dpc-4793	501	17	they	they	PRON
dpc-4793	501	18	did	do	AUX
dpc-4793	501	19	not	not	PART
dpc-4793	501	20	use	use	VERB
dpc-4793	501	21	an	an	DET
dpc-4793	501	22	outcome	outcome	NOUN
dpc-4793	501	23	that	that	PRON
dpc-4793	501	24	was	be	AUX
dpc-4793	501	25	being	be	AUX
dpc-4793	501	26	assessed	assess	VERB
dpc-4793	501	27	for	for	ADP
dpc-4793	501	28	the	the	DET
dpc-4793	501	29	network	network	NOUN
dpc-4793	501	30	meta	meta	NOUN
dpc-4793	501	31	-	-	PUNCT
dpc-4793	501	32	analysis	analysis	NOUN
dpc-4793	501	33	.	.	PUNCT
dpc-4793	502	1	thus	thus	ADV
dpc-4793	502	2	,	,	PUNCT
dpc-4793	502	3	standardization	standardization	NOUN
dpc-4793	502	4	is	be	AUX
dpc-4793	502	5	not	not	PART
dpc-4793	502	6	only	only	ADV
dpc-4793	502	7	crucial	crucial	ADJ
dpc-4793	502	8	for	for	ADP
dpc-4793	502	9	the	the	DET
dpc-4793	502	10	generalizability	generalizability	NOUN
dpc-4793	502	11	of	of	ADP
dpc-4793	502	12	the	the	DET
dpc-4793	502	13	results	result	NOUN
dpc-4793	502	14	but	but	CCONJ
dpc-4793	502	15	also	also	ADV
dpc-4793	502	16	to	to	PART
dpc-4793	502	17	facilitate	facilitate	VERB
dpc-4793	502	18	evidence	evidence	NOUN
dpc-4793	502	19	synthesis	synthesis	NOUN
dpc-4793	502	20	.	.	PUNCT
dpc-4793	503	1	furthermore	furthermore	ADV
dpc-4793	503	2	,	,	PUNCT
dpc-4793	503	3	there	there	PRON
dpc-4793	503	4	should	should	AUX
dpc-4793	503	5	be	be	AUX
dpc-4793	503	6	efforts	effort	NOUN
dpc-4793	503	7	to	to	PART
dpc-4793	503	8	recruit	recruit	VERB
dpc-4793	503	9	a	a	DET
dpc-4793	503	10	more	more	ADV
dpc-4793	503	11	diverse	diverse	ADJ
dpc-4793	503	12	patient	patient	ADJ
dpc-4793	503	13	population	population	NOUN
dpc-4793	503	14	for	for	ADP
dpc-4793	503	15	clinical	clinical	ADJ
dpc-4793	503	16	trials	trial	NOUN
dpc-4793	503	17	to	to	PART
dpc-4793	503	18	increase	increase	VERB
dpc-4793	503	19	the	the	DET
dpc-4793	503	20	generalizability	generalizability	NOUN
dpc-4793	503	21	of	of	ADP
dpc-4793	503	22	findings	finding	NOUN
dpc-4793	503	23	to	to	ADP
dpc-4793	503	24	underrepresented	underrepresented	ADJ
dpc-4793	503	25	groups	group	NOUN
dpc-4793	503	26	.	.	PUNCT
dpc-4793	504	1	lastly	lastly	ADV
dpc-4793	504	2	,	,	PUNCT
dpc-4793	504	3	studies	study	NOUN
dpc-4793	504	4	with	with	ADP
dpc-4793	504	5	long	long	ADJ
dpc-4793	504	6	-	-	PUNCT
dpc-4793	504	7	term	term	NOUN
dpc-4793	504	8	follow	follow	NOUN
dpc-4793	504	9	-	-	PUNCT
dpc-4793	504	10	up	up	NOUN
dpc-4793	504	11	are	be	AUX
dpc-4793	504	12	needed	need	VERB
dpc-4793	504	13	to	to	PART
dpc-4793	504	14	assess	assess	VERB
dpc-4793	504	15	adverse	adverse	ADJ
dpc-4793	504	16	events	event	NOUN
dpc-4793	504	17	associated	associate	VERB
dpc-4793	504	18	with	with	ADP
dpc-4793	504	19	prolonged	prolonged	ADJ
dpc-4793	504	20	therapy	therapy	NOUN
dpc-4793	504	21	and	and	CCONJ
dpc-4793	504	22	the	the	DET
dpc-4793	504	23	durability	durability	NOUN
dpc-4793	504	24	of	of	ADP
dpc-4793	504	25	treatment	treatment	NOUN
dpc-4793	504	26	responses	response	NOUN
dpc-4793	504	27	over	over	ADP
dpc-4793	504	28	time	time	NOUN
dpc-4793	504	29	.	.	PUNCT
dpc-4793	505	1	references	reference	NOUN
dpc-4793	505	2	1	1	NUM
dpc-4793	505	3	.	.	PUNCT
dpc-4793	506	1	van	van	PROPN
dpc-4793	506	2	de	de	X
dpc-4793	506	3	kerkhof	kerkhof	PROPN
dpc-4793	506	4	pc	pc	PROPN
dpc-4793	506	5	,	,	PUNCT
dpc-4793	506	6	de	de	X
dpc-4793	506	7	hoop	hoop	NOUN
dpc-4793	506	8	d	d	PROPN
dpc-4793	506	9	,	,	PUNCT
dpc-4793	506	10	de	de	PROPN
dpc-4793	506	11	korte	korte	PROPN
dpc-4793	506	12	j	j	PROPN
dpc-4793	506	13	,	,	PUNCT
dpc-4793	506	14	kuipers	kuipers	PROPN
dpc-4793	506	15	mv	mv	PROPN
dpc-4793	506	16	.	.	PROPN
dpc-4793	506	17	scalp	scalp	NOUN
dpc-4793	506	18	psoriasis	psoriasis	NOUN
dpc-4793	506	19	,	,	PUNCT
dpc-4793	506	20	clinical	clinical	ADJ
dpc-4793	506	21	presentations	presentation	NOUN
dpc-4793	506	22	and	and	CCONJ
dpc-4793	506	23	therapeutic	therapeutic	ADJ
dpc-4793	506	24	management	management	NOUN
dpc-4793	506	25	.	.	PUNCT
dpc-4793	507	1	dermatology	dermatology	NOUN
dpc-4793	507	2	1998;197(4):326	1998;197(4):326	NUM
dpc-4793	507	3	-	-	SYM
dpc-4793	507	4	34	34	NUM
dpc-4793	507	5	.	.	PUNCT
dpc-4793	507	6	doi	doi	NOUN
dpc-4793	507	7	:	:	PUNCT
dpc-4793	507	8	10.1159/000018026	10.1159/000018026	NUM
dpc-4793	507	9	.	.	PUNCT
dpc-4793	508	1	pmid	pmid	NOUN
dpc-4793	508	2	:	:	PUNCT
dpc-4793	508	3	9873169	9873169	NUM
dpc-4793	508	4	.	.	PUNCT
dpc-4793	509	1	2	2	X
dpc-4793	509	2	.	.	X
dpc-4793	509	3	crowley	crowley	PROPN
dpc-4793	509	4	j.	j.	PROPN
dpc-4793	509	5	scalp	scalp	PROPN
dpc-4793	509	6	psoriasis	psoriasis	NOUN
dpc-4793	509	7	:	:	PUNCT
dpc-4793	509	8	an	an	DET
dpc-4793	509	9	overview	overview	NOUN
dpc-4793	509	10	of	of	ADP
dpc-4793	509	11	the	the	DET
dpc-4793	509	12	disease	disease	NOUN
dpc-4793	509	13	and	and	CCONJ
dpc-4793	509	14	available	available	ADJ
dpc-4793	509	15	therapies	therapy	NOUN
dpc-4793	509	16	.	.	PUNCT
dpc-4793	510	1	j	j	PROPN
dpc-4793	510	2	drugs	drug	NOUN
dpc-4793	510	3	dermatol	dermatol	VERB
dpc-4793	510	4	2010;9(8):912	2010;9(8):912	NUM
dpc-4793	510	5	-	-	SYM
dpc-4793	510	6	8	8	NUM
dpc-4793	510	7	.	.	PUNCT
dpc-4793	511	1	pmid	pmid	NOUN
dpc-4793	511	2	:	:	PUNCT
dpc-4793	511	3	20684141	20684141	NUM
dpc-4793	511	4	.	.	PUNCT
dpc-4793	512	1	3	3	X
dpc-4793	512	2	.	.	X
dpc-4793	512	3	mrowietz	mrowietz	PROPN
dpc-4793	512	4	u	u	NOUN
dpc-4793	512	5	,	,	PUNCT
dpc-4793	512	6	macheleidt	macheleidt	PROPN
dpc-4793	512	7	o	o	NOUN
dpc-4793	512	8	,	,	PUNCT
dpc-4793	512	9	eicke	eicke	PROPN
dpc-4793	512	10	c.	c.	PROPN
dpc-4793	512	11	effective	effective	ADJ
dpc-4793	512	12	treatment	treatment	NOUN
dpc-4793	512	13	and	and	CCONJ
dpc-4793	512	14	improvement	improvement	NOUN
dpc-4793	512	15	of	of	ADP
dpc-4793	512	16	quality	quality	NOUN
dpc-4793	512	17	of	of	ADP
dpc-4793	512	18	life	life	NOUN
dpc-4793	512	19	in	in	ADP
dpc-4793	512	20	patients	patient	NOUN
dpc-4793	512	21	with	with	ADP
dpc-4793	512	22	scalp	scalp	NOUN
dpc-4793	512	23	psoriasis	psoriasis	NOUN
dpc-4793	512	24	by	by	ADP
dpc-4793	512	25	topical	topical	ADJ
dpc-4793	512	26	use	use	NOUN
dpc-4793	512	27	of	of	ADP
dpc-4793	512	28	calcipotriol	calcipotriol	PROPN
dpc-4793	512	29	/	/	SYM
dpc-4793	512	30	betamethasone	betamethasone	PROPN
dpc-4793	512	31	(	(	PUNCT
dpc-4793	512	32	xamiol	xamiol	PROPN
dpc-4793	512	33	®	®	PROPN
dpc-4793	512	34	-gel	-gel	NOUN
dpc-4793	512	35	):	):	PUNCT
dpc-4793	512	36	results	result	NOUN
dpc-4793	512	37	.	.	PUNCT
dpc-4793	513	1	j	j	NOUN
dpc-4793	513	2	dtsch	dtsch	PROPN
dpc-4793	513	3	dermatol	dermatol	NOUN
dpc-4793	513	4	ges	ge	NOUN
dpc-4793	513	5	2011;9(10):825	2011;9(10):825	PROPN
dpc-4793	513	6	-	-	SYM
dpc-4793	513	7	31	31	NUM
dpc-4793	513	8	.	.	PUNCT
dpc-4793	514	1	doi	doi	NOUN
dpc-4793	514	2	:	:	PUNCT
dpc-4793	514	3	10.1111	10.1111	NUM
dpc-4793	514	4	/	/	SYM
dpc-4793	514	5	j.1610	j.1610	ADJ
dpc-4793	514	6	-0387.2011.07695.x	-0387.2011.07695.x	PROPN
dpc-4793	514	7	[	[	X
dpc-4793	514	8	published	publish	VERB
dpc-4793	514	9	online	online	ADV
dpc-4793	514	10	first	first	ADV
dpc-4793	514	11	:	:	PUNCT
dpc-4793	514	12	20110512	20110512	NUM
dpc-4793	514	13	]	]	PUNCT
dpc-4793	514	14	.	.	PUNCT
dpc-4793	515	1	pmid	pmid	NOUN
dpc-4793	515	2	:	:	PUNCT
dpc-4793	515	3	21564540	21564540	NUM
dpc-4793	515	4	.	.	PUNCT
dpc-4793	516	1	4	4	X
dpc-4793	516	2	.	.	X
dpc-4793	516	3	wang	wang	PROPN
dpc-4793	516	4	ts	ts	PROPN
dpc-4793	516	5	,	,	PUNCT
dpc-4793	516	6	tsai	tsai	PROPN
dpc-4793	517	1	tf	tf	PROPN
dpc-4793	517	2	.	.	PUNCT
dpc-4793	518	1	managing	manage	VERB
dpc-4793	518	2	scalp	scalp	NOUN
dpc-4793	518	3	psoriasis	psoriasis	NOUN
dpc-4793	518	4	:	:	PUNCT
dpc-4793	518	5	an	an	DET
dpc-4793	518	6	evidence	evidence	NOUN
dpc-4793	518	7	-	-	PUNCT
dpc-4793	518	8	based	base	VERB
dpc-4793	518	9	review	review	NOUN
dpc-4793	518	10	.	.	PUNCT
dpc-4793	519	1	am	be	AUX
dpc-4793	519	2	j	j	PROPN
dpc-4793	519	3	clin	clin	PROPN
dpc-4793	519	4	dermatol	dermatol	NOUN
dpc-4793	519	5	2017;18(1):17	2017;18(1):17	NUM
dpc-4793	519	6	-	-	SYM
dpc-4793	519	7	43	43	NUM
dpc-4793	519	8	.	.	PUNCT
dpc-4793	520	1	doi	doi	NOUN
dpc-4793	520	2	:	:	PUNCT
dpc-4793	520	3	10.1007	10.1007	NUM
dpc-4793	520	4	/s40257	/s40257	NOUN
dpc-4793	520	5	-	-	PUNCT
dpc-4793	520	6	016	016	NUM
dpc-4793	520	7	-	-	PUNCT
dpc-4793	520	8	0222	0222	NUM
dpc-4793	520	9	-	-	PUNCT
dpc-4793	520	10	4	4	NUM
dpc-4793	520	11	.	.	PUNCT
dpc-4793	521	1	pmid	pmid	NOUN
dpc-4793	521	2	:	:	PUNCT
dpc-4793	521	3	27650520	27650520	NUM
dpc-4793	521	4	.	.	PUNCT
dpc-4793	522	1	5	5	X
dpc-4793	522	2	.	.	X
dpc-4793	522	3	blakely	blakely	PROPN
dpc-4793	522	4	k	k	PROPN
dpc-4793	522	5	,	,	PUNCT
dpc-4793	522	6	gooderham	gooderham	PROPN
dpc-4793	522	7	m.	m.	NOUN
dpc-4793	522	8	management	management	NOUN
dpc-4793	522	9	of	of	ADP
dpc-4793	522	10	scalp	scalp	NOUN
dpc-4793	522	11	psoriasis	psoriasis	NOUN
dpc-4793	522	12	:	:	PUNCT
dpc-4793	522	13	current	current	ADJ
dpc-4793	522	14	perspectives	perspective	NOUN
dpc-4793	522	15	.	.	PUNCT
dpc-4793	523	1	psoriasis	psoriasis	NOUN
dpc-4793	523	2	(	(	PUNCT
dpc-4793	523	3	auckl	auckl	NOUN
dpc-4793	523	4	)	)	PUNCT
dpc-4793	523	5	2016;6:33	2016;6:33	NOUN
dpc-4793	523	6	-	-	PUNCT
dpc-4793	523	7	40	40	NUM
dpc-4793	523	8	.	.	PUNCT
dpc-4793	524	1	doi	doi	NOUN
dpc-4793	524	2	:	:	PUNCT
dpc-4793	524	3	10.2147	10.2147	NUM
dpc-4793	524	4	/ptt.s85330	/ptt.s85330	PUNCT
dpc-4793	524	5	pmid	pmid	NOUN
dpc-4793	524	6	:	:	PUNCT
dpc-4793	524	7	29387592	29387592	NUM
dpc-4793	524	8	.	.	PUNCT
dpc-4793	525	1	6	6	X
dpc-4793	525	2	.	.	X
dpc-4793	525	3	chan	chan	PROPN
dpc-4793	525	4	cs	cs	PROPN
dpc-4793	525	5	,	,	PUNCT
dpc-4793	525	6	van	van	PROPN
dpc-4793	525	7	voorhees	voorhees	PROPN
dpc-4793	525	8	as	as	ADP
dpc-4793	525	9	,	,	PUNCT
dpc-4793	525	10	lebwohl	lebwohl	VERB
dpc-4793	525	11	mg	mg	PROPN
dpc-4793	525	12	,	,	PUNCT
dpc-4793	525	13	et	et	PROPN
dpc-4793	525	14	al	al	PROPN
dpc-4793	525	15	.	.	PROPN
dpc-4793	525	16	treatment	treatment	NOUN
dpc-4793	525	17	of	of	ADP
dpc-4793	525	18	severe	severe	ADJ
dpc-4793	525	19	scalp	scalp	NOUN
dpc-4793	525	20	psoriasis	psoriasis	NOUN
dpc-4793	525	21	:	:	PUNCT
dpc-4793	525	22	from	from	ADP
dpc-4793	525	23	the	the	DET
dpc-4793	525	24	medical	medical	ADJ
dpc-4793	525	25	board	board	NOUN
dpc-4793	525	26	of	of	ADP
dpc-4793	525	27	the	the	DET
dpc-4793	525	28	national	national	ADJ
dpc-4793	525	29	psoriasis	psoriasis	NOUN
dpc-4793	525	30	foundation	foundation	NOUN
dpc-4793	525	31	.	.	PUNCT
dpc-4793	526	1	j	j	PROPN
dpc-4793	526	2	am	be	AUX
dpc-4793	526	3	acad	acad	ADJ
dpc-4793	526	4	dermatol	dermatol	NOUN
dpc-4793	526	5	2009;60(6):962	2009;60(6):962	PROPN
dpc-4793	526	6	-	-	SYM
dpc-4793	526	7	71	71	NUM
dpc-4793	526	8	.	.	PUNCT
dpc-4793	527	1	doi	doi	NOUN
dpc-4793	527	2	:	:	PUNCT
dpc-4793	527	3	10.1016	10.1016	NUM
dpc-4793	527	4	/	/	SYM
dpc-4793	527	5	j.jaad.2008.11.890	j.jaad.2008.11.890	PROPN
dpc-4793	527	6	pmid	pmid	NOUN
dpc-4793	527	7	:	:	PUNCT
dpc-4793	527	8	19375191	19375191	NUM
dpc-4793	527	9	.	.	PUNCT
dpc-4793	528	1	7	7	X
dpc-4793	528	2	.	.	X
dpc-4793	528	3	alsenaid	alsenaid	VERB
dpc-4793	528	4	a	a	PRON
dpc-4793	528	5	,	,	PUNCT
dpc-4793	528	6	ezmerli	ezmerli	PROPN
dpc-4793	528	7	m	m	PROPN
dpc-4793	528	8	,	,	PUNCT
dpc-4793	528	9	srour	srour	PROPN
dpc-4793	528	10	j	j	PROPN
dpc-4793	528	11	,	,	PUNCT
dpc-4793	528	12	heppt	heppt	ADJ
dpc-4793	528	13	m	m	PROPN
dpc-4793	528	14	,	,	PUNCT
dpc-4793	528	15	illigens	illigen	VERB
dpc-4793	528	16	bm	bm	PROPN
dpc-4793	528	17	,	,	PUNCT
dpc-4793	528	18	prinz	prinz	PROPN
dpc-4793	528	19	jc	jc	PROPN
dpc-4793	528	20	.	.	PROPN
dpc-4793	528	21	biologics	biologic	NOUN
dpc-4793	528	22	and	and	CCONJ
dpc-4793	528	23	small	small	ADJ
dpc-4793	528	24	molecules	molecule	NOUN
dpc-4793	528	25	in	in	ADP
dpc-4793	528	26	patients	patient	NOUN
dpc-4793	528	27	with	with	ADP
dpc-4793	528	28	scalp	scalp	NOUN
dpc-4793	528	29	psoriasis	psoriasis	NOUN
dpc-4793	528	30	:	:	PUNCT
dpc-4793	528	31	a	a	DET
dpc-4793	528	32	systematic	systematic	ADJ
dpc-4793	528	33	review	review	NOUN
dpc-4793	528	34	.	.	PUNCT
dpc-4793	529	1	j	j	PROPN
dpc-4793	529	2	dermatolog	dermatolog	PROPN
dpc-4793	529	3	treat	treat	VERB
dpc-4793	529	4	2022;33(1):473	2022;33(1):473	NUM
dpc-4793	529	5	-	-	SYM
dpc-4793	529	6	82	82	NUM
dpc-4793	529	7	.	.	PUNCT
dpc-4793	530	1	and	and	CCONJ
dpc-4793	530	2	phototherapeutic	phototherapeutic	ADJ
dpc-4793	530	3	treatments	treatment	NOUN
dpc-4793	530	4	due	due	ADP
dpc-4793	530	5	to	to	ADP
dpc-4793	530	6	the	the	DET
dpc-4793	530	7	presence	presence	NOUN
dpc-4793	530	8	of	of	ADP
dpc-4793	530	9	hair	hair	NOUN
dpc-4793	530	10	,	,	PUNCT
dpc-4793	530	11	and	and	CCONJ
dpc-4793	530	12	patients	patient	NOUN
dpc-4793	530	13	often	often	ADV
dpc-4793	530	14	struggle	struggle	VERB
dpc-4793	530	15	with	with	ADP
dpc-4793	530	16	adherence	adherence	NOUN
dpc-4793	530	17	due	due	ADP
dpc-4793	530	18	to	to	ADP
dpc-4793	530	19	poor	poor	ADJ
dpc-4793	530	20	cosmetic	cosmetic	ADJ
dpc-4793	530	21	results	result	NOUN
dpc-4793	530	22	[	[	X
dpc-4793	530	23	1	1	NUM
dpc-4793	530	24	,	,	PUNCT
dpc-4793	530	25	7	7	NUM
dpc-4793	530	26	,	,	PUNCT
dpc-4793	530	27	8	8	NUM
dpc-4793	530	28	]	]	PUNCT
dpc-4793	530	29	.	.	PUNCT
dpc-4793	531	1	however	however	ADV
dpc-4793	531	2	,	,	PUNCT
dpc-4793	531	3	current	current	ADJ
dpc-4793	531	4	clinical	clinical	ADJ
dpc-4793	531	5	decision	decision	NOUN
dpc-4793	531	6	making	make	VERB
dpc-4793	531	7	tools	tool	NOUN
dpc-4793	531	8	still	still	ADV
dpc-4793	531	9	endorse	endorse	VERB
dpc-4793	531	10	topical	topical	ADJ
dpc-4793	531	11	corticosteroids	corticosteroid	NOUN
dpc-4793	531	12	as	as	ADP
dpc-4793	531	13	the	the	DET
dpc-4793	531	14	firstline	firstline	NOUN
dpc-4793	531	15	treatment	treatment	NOUN
dpc-4793	531	16	for	for	ADP
dpc-4793	531	17	patients	patient	NOUN
dpc-4793	531	18	,	,	PUNCT
dpc-4793	531	19	and	and	CCONJ
dpc-4793	531	20	agents	agent	NOUN
dpc-4793	531	21	such	such	ADJ
dpc-4793	531	22	as	as	ADP
dpc-4793	531	23	ciclosporin	ciclosporin	NOUN
dpc-4793	531	24	,	,	PUNCT
dpc-4793	531	25	methotrexate	methotrexate	NOUN
dpc-4793	531	26	,	,	PUNCT
dpc-4793	531	27	fumaric	fumaric	ADJ
dpc-4793	531	28	esters	ester	NOUN
dpc-4793	531	29	,	,	PUNCT
dpc-4793	531	30	and	and	CCONJ
dpc-4793	531	31	acitretin	acitretin	NOUN
dpc-4793	531	32	as	as	ADP
dpc-4793	531	33	second	second	ADJ
dpc-4793	531	34	-	-	PUNCT
dpc-4793	531	35	line	line	NOUN
dpc-4793	531	36	agents	agent	NOUN
dpc-4793	531	37	for	for	ADP
dpc-4793	531	38	moderate	moderate	ADJ
dpc-4793	531	39	-	-	PUNCT
dpc-4793	531	40	severe	severe	ADJ
dpc-4793	531	41	or	or	CCONJ
dpc-4793	531	42	treatment	treatment	NOUN
dpc-4793	531	43	-	-	PUNCT
dpc-4793	531	44	resistant	resistant	ADJ
dpc-4793	531	45	psoriasis	psoriasis	NOUN
dpc-4793	531	46	[	[	X
dpc-4793	531	47	50	50	NUM
dpc-4793	531	48	]	]	PUNCT
dpc-4793	531	49	.	.	PUNCT
dpc-4793	532	1	despite	despite	SCONJ
dpc-4793	532	2	their	their	PRON
dpc-4793	532	3	clear	clear	ADJ
dpc-4793	532	4	advantages	advantage	NOUN
dpc-4793	532	5	,	,	PUNCT
dpc-4793	532	6	the	the	DET
dpc-4793	532	7	widespread	widespread	ADJ
dpc-4793	532	8	adoption	adoption	NOUN
dpc-4793	532	9	of	of	ADP
dpc-4793	532	10	biologics	biologic	NOUN
dpc-4793	532	11	in	in	ADP
dpc-4793	532	12	psoriasis	psoriasis	NOUN
dpc-4793	532	13	treatment	treatment	NOUN
dpc-4793	532	14	is	be	AUX
dpc-4793	532	15	constrained	constrain	VERB
dpc-4793	532	16	by	by	ADP
dpc-4793	532	17	cost	cost	NOUN
dpc-4793	532	18	,	,	PUNCT
dpc-4793	532	19	administration	administration	NOUN
dpc-4793	532	20	challenges	challenge	NOUN
dpc-4793	532	21	,	,	PUNCT
dpc-4793	532	22	and	and	CCONJ
dpc-4793	532	23	uncertainties	uncertainty	NOUN
dpc-4793	532	24	surrounding	surround	VERB
dpc-4793	532	25	long	long	ADJ
dpc-4793	532	26	-	-	PUNCT
dpc-4793	532	27	term	term	NOUN
dpc-4793	532	28	efficacy	efficacy	NOUN
dpc-4793	532	29	and	and	CCONJ
dpc-4793	532	30	safety	safety	NOUN
dpc-4793	532	31	.	.	PUNCT
dpc-4793	533	1	foremost	foremost	ADV
dpc-4793	533	2	among	among	ADP
dpc-4793	533	3	these	these	PRON
dpc-4793	533	4	is	be	AUX
dpc-4793	533	5	the	the	DET
dpc-4793	533	6	substantial	substantial	ADJ
dpc-4793	533	7	cost	cost	NOUN
dpc-4793	533	8	associated	associate	VERB
dpc-4793	533	9	with	with	ADP
dpc-4793	533	10	biologics	biologic	NOUN
dpc-4793	533	11	,	,	PUNCT
dpc-4793	533	12	far	far	ADV
dpc-4793	533	13	exceeding	exceed	VERB
dpc-4793	533	14	that	that	PRON
dpc-4793	533	15	of	of	ADP
dpc-4793	533	16	traditional	traditional	ADJ
dpc-4793	533	17	medications	medication	NOUN
dpc-4793	533	18	.	.	PUNCT
dpc-4793	534	1	despite	despite	SCONJ
dpc-4793	534	2	efforts	effort	NOUN
dpc-4793	534	3	such	such	ADJ
dpc-4793	534	4	as	as	ADP
dpc-4793	534	5	patient	patient	ADJ
dpc-4793	534	6	assistance	assistance	NOUN
dpc-4793	534	7	programs	program	NOUN
dpc-4793	534	8	and	and	CCONJ
dpc-4793	534	9	savings	saving	NOUN
dpc-4793	534	10	coupons	coupon	NOUN
dpc-4793	534	11	,	,	PUNCT
dpc-4793	534	12	cost	cost	NOUN
dpc-4793	534	13	-	-	PUNCT
dpc-4793	534	14	related	relate	VERB
dpc-4793	534	15	barriers	barrier	NOUN
dpc-4793	534	16	persist	persist	VERB
dpc-4793	534	17	,	,	PUNCT
dpc-4793	534	18	leading	lead	VERB
dpc-4793	534	19	to	to	ADP
dpc-4793	534	20	discontinuation	discontinuation	NOUN
dpc-4793	534	21	of	of	ADP
dpc-4793	534	22	treatment	treatment	NOUN
dpc-4793	534	23	and	and	CCONJ
dpc-4793	534	24	hindering	hinder	VERB
dpc-4793	534	25	cost	cost	NOUN
dpc-4793	534	26	-	-	PUNCT
dpc-4793	534	27	effective	effective	ADJ
dpc-4793	534	28	care	care	NOUN
dpc-4793	534	29	.	.	PUNCT
dpc-4793	535	1	moreover	moreover	ADV
dpc-4793	535	2	,	,	PUNCT
dpc-4793	535	3	the	the	DET
dpc-4793	535	4	need	need	NOUN
dpc-4793	535	5	for	for	ADP
dpc-4793	535	6	injections	injection	NOUN
dpc-4793	535	7	or	or	CCONJ
dpc-4793	535	8	infusions	infusion	NOUN
dpc-4793	535	9	adds	add	VERB
dpc-4793	535	10	another	another	DET
dpc-4793	535	11	layer	layer	NOUN
dpc-4793	535	12	of	of	ADP
dpc-4793	535	13	inconvenience	inconvenience	NOUN
dpc-4793	535	14	,	,	PUNCT
dpc-4793	535	15	impacting	impact	VERB
dpc-4793	535	16	adherence	adherence	NOUN
dpc-4793	535	17	and	and	CCONJ
dpc-4793	535	18	posing	pose	VERB
dpc-4793	535	19	logistical	logistical	ADJ
dpc-4793	535	20	challenges	challenge	NOUN
dpc-4793	535	21	particularly	particularly	ADV
dpc-4793	535	22	for	for	ADP
dpc-4793	535	23	travelers	traveler	NOUN
dpc-4793	535	24	who	who	PRON
dpc-4793	535	25	must	must	AUX
dpc-4793	535	26	navigate	navigate	VERB
dpc-4793	535	27	storage	storage	NOUN
dpc-4793	535	28	and	and	CCONJ
dpc-4793	535	29	transportation	transportation	NOUN
dpc-4793	535	30	requirements	requirement	NOUN
dpc-4793	535	31	.	.	PUNCT
dpc-4793	536	1	additionally	additionally	ADV
dpc-4793	536	2	,	,	PUNCT
dpc-4793	536	3	while	while	SCONJ
dpc-4793	536	4	biologics	biologic	NOUN
dpc-4793	536	5	offer	offer	VERB
dpc-4793	536	6	promise	promise	NOUN
dpc-4793	536	7	for	for	ADP
dpc-4793	536	8	long	long	ADJ
dpc-4793	536	9	-	-	PUNCT
dpc-4793	536	10	term	term	NOUN
dpc-4793	536	11	maintenance	maintenance	NOUN
dpc-4793	536	12	due	due	ADP
dpc-4793	536	13	to	to	ADP
dpc-4793	536	14	their	their	PRON
dpc-4793	536	15	lower	low	ADJ
dpc-4793	536	16	toxicity	toxicity	NOUN
dpc-4793	536	17	compared	compare	VERB
dpc-4793	536	18	to	to	ADP
dpc-4793	536	19	alternatives	alternative	NOUN
dpc-4793	536	20	,	,	PUNCT
dpc-4793	536	21	uncertainties	uncertainty	NOUN
dpc-4793	536	22	remain	remain	VERB
dpc-4793	536	23	regarding	regard	VERB
dpc-4793	536	24	their	their	PRON
dpc-4793	536	25	efficacy	efficacy	NOUN
dpc-4793	536	26	and	and	CCONJ
dpc-4793	536	27	safety	safety	NOUN
dpc-4793	536	28	over	over	ADP
dpc-4793	536	29	extended	extended	ADJ
dpc-4793	536	30	periods	period	NOUN
dpc-4793	536	31	.	.	PUNCT
dpc-4793	537	1	limited	limited	ADJ
dpc-4793	537	2	long	long	ADJ
dpc-4793	537	3	-	-	PUNCT
dpc-4793	537	4	term	term	NOUN
dpc-4793	537	5	clinical	clinical	ADJ
dpc-4793	537	6	data	datum	NOUN
dpc-4793	537	7	and	and	CCONJ
dpc-4793	537	8	the	the	DET
dpc-4793	537	9	potential	potential	NOUN
dpc-4793	537	10	for	for	SCONJ
dpc-4793	537	11	patients	patient	NOUN
dpc-4793	537	12	to	to	PART
dpc-4793	537	13	develop	develop	VERB
dpc-4793	537	14	anti	anti	ADJ
dpc-4793	537	15	-	-	ADJ
dpc-4793	537	16	drug	drug	ADJ
dpc-4793	537	17	antibodies	antibody	NOUN
dpc-4793	537	18	raise	raise	VERB
dpc-4793	537	19	concerns	concern	NOUN
dpc-4793	537	20	about	about	ADP
dpc-4793	537	21	treatment	treatment	NOUN
dpc-4793	537	22	durability	durability	NOUN
dpc-4793	537	23	and	and	CCONJ
dpc-4793	537	24	effectiveness	effectiveness	NOUN
dpc-4793	537	25	[	[	X
dpc-4793	537	26	51	51	NUM
dpc-4793	537	27	]	]	PUNCT
dpc-4793	537	28	.	.	PUNCT
dpc-4793	538	1	limitations	limitation	VERB
dpc-4793	538	2	the	the	DET
dpc-4793	538	3	strengths	strength	NOUN
dpc-4793	538	4	of	of	ADP
dpc-4793	538	5	this	this	DET
dpc-4793	538	6	review	review	NOUN
dpc-4793	538	7	include	include	VERB
dpc-4793	538	8	its	its	PRON
dpc-4793	538	9	comprehensive	comprehensive	ADJ
dpc-4793	538	10	nature	nature	NOUN
dpc-4793	538	11	,	,	PUNCT
dpc-4793	538	12	encompassing	encompass	VERB
dpc-4793	538	13	a	a	DET
dpc-4793	538	14	wide	wide	ADJ
dpc-4793	538	15	range	range	NOUN
dpc-4793	538	16	of	of	ADP
dpc-4793	538	17	treatments	treatment	NOUN
dpc-4793	538	18	and	and	CCONJ
dpc-4793	538	19	outcome	outcome	VERB
dpc-4793	538	20	measures	measure	NOUN
dpc-4793	538	21	for	for	ADP
dpc-4793	538	22	scalp	scalp	NOUN
dpc-4793	538	23	psoriasis	psoriasis	NOUN
dpc-4793	538	24	,	,	PUNCT
dpc-4793	538	25	the	the	DET
dpc-4793	538	26	use	use	NOUN
dpc-4793	538	27	of	of	ADP
dpc-4793	538	28	a	a	DET
dpc-4793	538	29	network	network	NOUN
dpc-4793	538	30	metaanalysis	metaanalysis	NOUN
dpc-4793	538	31	methodology	methodology	NOUN
dpc-4793	538	32	to	to	PART
dpc-4793	538	33	compare	compare	VERB
dpc-4793	538	34	these	these	PRON
dpc-4793	538	35	simultaneously	simultaneously	ADV
dpc-4793	538	36	,	,	PUNCT
dpc-4793	538	37	and	and	CCONJ
dpc-4793	538	38	a	a	DET
dpc-4793	538	39	systematic	systematic	ADJ
dpc-4793	538	40	approach	approach	NOUN
dpc-4793	538	41	enhancing	enhance	VERB
dpc-4793	538	42	the	the	DET
dpc-4793	538	43	reliability	reliability	NOUN
dpc-4793	538	44	and	and	CCONJ
dpc-4793	538	45	validity	validity	NOUN
dpc-4793	538	46	of	of	ADP
dpc-4793	538	47	the	the	DET
dpc-4793	538	48	findings	finding	NOUN
dpc-4793	538	49	.	.	PUNCT
dpc-4793	539	1	however	however	ADV
dpc-4793	539	2	,	,	PUNCT
dpc-4793	539	3	this	this	DET
dpc-4793	539	4	study	study	NOUN
dpc-4793	539	5	was	be	AUX
dpc-4793	539	6	not	not	PART
dpc-4793	539	7	without	without	ADP
dpc-4793	539	8	limitations	limitation	NOUN
dpc-4793	539	9	.	.	PUNCT
dpc-4793	540	1	due	due	ADP
dpc-4793	540	2	to	to	ADP
dpc-4793	540	3	the	the	DET
dpc-4793	540	4	heterogeneity	heterogeneity	NOUN
dpc-4793	540	5	in	in	ADP
dpc-4793	540	6	the	the	DET
dpc-4793	540	7	timing	timing	NOUN
dpc-4793	540	8	of	of	ADP
dpc-4793	540	9	outcome	outcome	NOUN
dpc-4793	540	10	reporting	reporting	NOUN
dpc-4793	540	11	,	,	PUNCT
dpc-4793	540	12	trials	trial	NOUN
dpc-4793	540	13	with	with	ADP
dpc-4793	540	14	durations	duration	NOUN
dpc-4793	540	15	between	between	ADP
dpc-4793	540	16	8	8	NUM
dpc-4793	540	17	and	and	CCONJ
dpc-4793	540	18	12	12	NUM
dpc-4793	540	19	weeks	week	NOUN
dpc-4793	540	20	were	be	AUX
dpc-4793	540	21	pooled	pool	VERB
dpc-4793	540	22	,	,	PUNCT
dpc-4793	540	23	and	and	CCONJ
dpc-4793	540	24	trials	trial	NOUN
dpc-4793	540	25	beyond	beyond	ADP
dpc-4793	540	26	12	12	NUM
dpc-4793	540	27	weeks	week	NOUN
dpc-4793	540	28	were	be	AUX
dpc-4793	540	29	included	include	VERB
dpc-4793	540	30	,	,	PUNCT
dpc-4793	540	31	which	which	PRON
dpc-4793	540	32	may	may	AUX
dpc-4793	540	33	have	have	AUX
dpc-4793	540	34	favored	favor	VERB
dpc-4793	540	35	treatments	treatment	NOUN
dpc-4793	540	36	with	with	ADP
dpc-4793	540	37	longer	long	ADJ
dpc-4793	540	38	trial	trial	NOUN
dpc-4793	540	39	durations	duration	NOUN
dpc-4793	540	40	and	and	CCONJ
dpc-4793	540	41	thus	thus	ADV
dpc-4793	540	42	increased	increase	VERB
dpc-4793	540	43	time	time	NOUN
dpc-4793	540	44	to	to	PART
dpc-4793	540	45	improve	improve	VERB
dpc-4793	540	46	psoriasis	psoriasis	NOUN
dpc-4793	540	47	.	.	PUNCT
dpc-4793	541	1	combining	combine	VERB
dpc-4793	541	2	different	different	ADJ
dpc-4793	541	3	dosing	dosing	ADJ
dpc-4793	541	4	regimens	regimen	NOUN
dpc-4793	541	5	of	of	ADP
dpc-4793	541	6	treatments	treatment	NOUN
dpc-4793	541	7	to	to	PART
dpc-4793	541	8	incorporate	incorporate	VERB
dpc-4793	541	9	more	more	ADJ
dpc-4793	541	10	information	information	NOUN
dpc-4793	541	11	may	may	AUX
dpc-4793	541	12	also	also	ADV
dpc-4793	541	13	have	have	AUX
dpc-4793	541	14	introduced	introduce	VERB
dpc-4793	541	15	limitations	limitation	NOUN
dpc-4793	541	16	due	due	ADP
dpc-4793	541	17	to	to	ADP
dpc-4793	541	18	heterogeneity	heterogeneity	NOUN
dpc-4793	541	19	and	and	CCONJ
dpc-4793	541	20	comparability	comparability	NOUN
dpc-4793	541	21	issues	issue	NOUN
dpc-4793	541	22	across	across	ADP
dpc-4793	541	23	the	the	DET
dpc-4793	541	24	different	different	ADJ
dpc-4793	541	25	treatment	treatment	NOUN
dpc-4793	541	26	groups	group	NOUN
dpc-4793	541	27	.	.	PUNCT
dpc-4793	542	1	this	this	DET
dpc-4793	542	2	analysis	analysis	NOUN
dpc-4793	542	3	was	be	AUX
dpc-4793	542	4	further	far	ADV
dpc-4793	542	5	limited	limit	VERB
dpc-4793	542	6	by	by	ADP
dpc-4793	542	7	differences	difference	NOUN
dpc-4793	542	8	in	in	ADP
dpc-4793	542	9	trial	trial	NOUN
dpc-4793	542	10	design	design	NOUN
dpc-4793	542	11	and	and	CCONJ
dpc-4793	542	12	heterogeneity	heterogeneity	NOUN
dpc-4793	542	13	in	in	ADP
dpc-4793	542	14	the	the	DET
dpc-4793	542	15	populations	population	NOUN
dpc-4793	542	16	involved	involve	VERB
dpc-4793	542	17	.	.	PUNCT
dpc-4793	543	1	for	for	ADP
dpc-4793	543	2	example	example	NOUN
dpc-4793	543	3	,	,	PUNCT
dpc-4793	543	4	though	though	SCONJ
dpc-4793	543	5	most	most	ADJ
dpc-4793	543	6	studies	study	NOUN
dpc-4793	543	7	that	that	PRON
dpc-4793	543	8	reported	report	VERB
dpc-4793	543	9	race-/ethnicity	race-/ethnicity	NOUN
dpc-4793	543	10	-	-	PUNCT
dpc-4793	543	11	based	base	VERB
dpc-4793	543	12	data	datum	NOUN
dpc-4793	543	13	had	have	VERB
dpc-4793	543	14	a	a	DET
dpc-4793	543	15	majority	majority	NOUN
dpc-4793	543	16	of	of	ADP
dpc-4793	543	17	caucasian	caucasian	ADJ
dpc-4793	543	18	populations	population	NOUN
dpc-4793	543	19	,	,	PUNCT
dpc-4793	543	20	there	there	PRON
dpc-4793	543	21	were	be	VERB
dpc-4793	543	22	some	some	DET
dpc-4793	543	23	studies	study	NOUN
dpc-4793	543	24	with	with	ADP
dpc-4793	543	25	only	only	ADV
dpc-4793	543	26	racial	racial	ADJ
dpc-4793	543	27	minorities	minority	NOUN
dpc-4793	543	28	and	and	CCONJ
dpc-4793	543	29	significant	significant	ADJ
dpc-4793	543	30	heterogeneity	heterogeneity	NOUN
dpc-4793	543	31	in	in	ADP
dpc-4793	543	32	the	the	DET
dpc-4793	543	33	country	country	NOUN
dpc-4793	543	34	of	of	ADP
dpc-4793	543	35	study	study	NOUN
dpc-4793	543	36	completion	completion	NOUN
dpc-4793	543	37	.	.	PUNCT
dpc-4793	544	1	the	the	DET
dpc-4793	544	2	generalizability	generalizability	NOUN
dpc-4793	544	3	of	of	ADP
dpc-4793	544	4	these	these	DET
dpc-4793	544	5	results	result	NOUN
dpc-4793	544	6	is	be	AUX
dpc-4793	544	7	also	also	ADV
dpc-4793	544	8	limited	limit	VERB
dpc-4793	544	9	in	in	ADP
dpc-4793	544	10	populations	population	NOUN
dpc-4793	544	11	underrepresented	underrepresente	VERB
dpc-4793	544	12	in	in	ADP
dpc-4793	544	13	the	the	DET
dpc-4793	544	14	included	include	VERB
dpc-4793	544	15	clinical	clinical	ADJ
dpc-4793	544	16	trials	trial	NOUN
dpc-4793	544	17	,	,	PUNCT
dpc-4793	544	18	such	such	ADJ
dpc-4793	544	19	as	as	ADP
dpc-4793	544	20	racial	racial	ADJ
dpc-4793	544	21	minorities	minority	NOUN
dpc-4793	544	22	and	and	CCONJ
dpc-4793	544	23	older	old	ADJ
dpc-4793	544	24	patients	patient	NOUN
dpc-4793	544	25	.	.	PUNCT
dpc-4793	545	1	review	review	VERB
dpc-4793	545	2	|	|	ADV
dpc-4793	545	3	dermatol	dermatol	ADJ
dpc-4793	545	4	pract	pract	NOUN
dpc-4793	545	5	concept	concept	NOUN
dpc-4793	545	6	.	.	PUNCT
dpc-4793	546	1	2025;15(2):4793	2025;15(2):4793	NUM
dpc-4793	546	2	11	11	NUM
dpc-4793	546	3	controlled	control	VERB
dpc-4793	546	4	trial	trial	NOUN
dpc-4793	546	5	.	.	PUNCT
dpc-4793	547	1	br	br	X
dpc-4793	547	2	j	j	PROPN
dpc-4793	547	3	dermatol	dermatol	NOUN
dpc-4793	547	4	2022;186(1):30	2022;186(1):30	NOUN
dpc-4793	547	5	-	-	SYM
dpc-4793	547	6	39	39	NUM
dpc-4793	547	7	.	.	PUNCT
dpc-4793	548	1	doi	doi	NOUN
dpc-4793	548	2	:	:	PUNCT
dpc-4793	548	3	10.1111	10.1111	NUM
dpc-4793	548	4	/bjd.20481	/bjd.20481	ADJ
dpc-4793	549	1	pmid	pmid	NOUN
dpc-4793	549	2	:	:	PUNCT
dpc-4793	549	3	33991341	33991341	NUM
dpc-4793	549	4	.	.	PUNCT
dpc-4793	550	1	21	21	NUM
dpc-4793	550	2	.	.	PUNCT
dpc-4793	550	3	rattanakaemakorn	rattanakaemakorn	VERB
dpc-4793	550	4	p	p	X
dpc-4793	550	5	,	,	PUNCT
dpc-4793	550	6	triyangkulsri	triyangkulsri	ADJ
dpc-4793	550	7	k	k	NOUN
dpc-4793	550	8	,	,	PUNCT
dpc-4793	550	9	iamsumang	iamsumang	PROPN
dpc-4793	550	10	w	w	PROPN
dpc-4793	550	11	,	,	PUNCT
dpc-4793	550	12	suchonwanit	suchonwanit	VERB
dpc-4793	551	1	p.	p.	NOUN
dpc-4793	551	2	308	308	NUM
dpc-4793	551	3	-	-	PUNCT
dpc-4793	551	4	nm	nm	NOUN
dpc-4793	551	5	excimer	excimer	NOUN
dpc-4793	551	6	lamp	lamp	NOUN
dpc-4793	551	7	vs.	vs.	ADP
dpc-4793	551	8	combination	combination	NOUN
dpc-4793	551	9	of	of	ADP
dpc-4793	551	10	308	308	NUM
dpc-4793	551	11	-	-	PUNCT
dpc-4793	551	12	nm	nm	NOUN
dpc-4793	551	13	excimer	excimer	NOUN
dpc-4793	551	14	lamp	lamp	NOUN
dpc-4793	551	15	and	and	CCONJ
dpc-4793	551	16	10	10	NUM
dpc-4793	551	17	%	%	NOUN
dpc-4793	551	18	liquor	liquor	NOUN
dpc-4793	551	19	carbonis	carbonis	NOUN
dpc-4793	551	20	detergens	detergen	VERB
dpc-4793	551	21	in	in	ADP
dpc-4793	551	22	patients	patient	NOUN
dpc-4793	551	23	with	with	ADP
dpc-4793	551	24	scalp	scalp	NOUN
dpc-4793	551	25	psoriasis	psoriasis	NOUN
dpc-4793	551	26	:	:	PUNCT
dpc-4793	551	27	a	a	DET
dpc-4793	551	28	randomized	randomized	ADJ
dpc-4793	551	29	,	,	PUNCT
dpc-4793	551	30	single	single	ADJ
dpc-4793	551	31	-	-	PUNCT
dpc-4793	551	32	blinded	blind	VERB
dpc-4793	551	33	,	,	PUNCT
dpc-4793	551	34	controlled	control	VERB
dpc-4793	551	35	trial	trial	NOUN
dpc-4793	551	36	.	.	PUNCT
dpc-4793	552	1	front	front	ADJ
dpc-4793	552	2	med	med	PROPN
dpc-4793	552	3	(	(	PUNCT
dpc-4793	552	4	lausanne	lausanne	PROPN
dpc-4793	552	5	)	)	PUNCT
dpc-4793	552	6	2021;8:677948	2021;8:677948	NOUN
dpc-4793	552	7	.	.	PUNCT
dpc-4793	553	1	doi	doi	NOUN
dpc-4793	553	2	:	:	PUNCT
dpc-4793	553	3	10.3389	10.3389	NUM
dpc-4793	553	4	/	/	SYM
dpc-4793	553	5	fmed	fme	VERB
dpc-4793	553	6	.2021.677948	.2021.677948	PROPN
dpc-4793	553	7	pmid	pmid	NOUN
dpc-4793	553	8	:	:	PUNCT
dpc-4793	553	9	34211988	34211988	NUM
dpc-4793	553	10	.	.	PUNCT
dpc-4793	554	1	22	22	NUM
dpc-4793	554	2	.	.	PUNCT
dpc-4793	555	1	zhou	zhou	PROPN
dpc-4793	555	2	j	j	PROPN
dpc-4793	555	3	,	,	PUNCT
dpc-4793	555	4	yi	yi	PROPN
dpc-4793	555	5	x	x	PROPN
dpc-4793	555	6	,	,	PUNCT
dpc-4793	555	7	li	li	PROPN
dpc-4793	555	8	y	y	PROPN
dpc-4793	555	9	,	,	PUNCT
dpc-4793	555	10	ding	de	VERB
dpc-4793	555	11	y.	y.	PROPN
dpc-4793	555	12	efficacy	efficacy	PROPN
dpc-4793	555	13	assessment	assessment	NOUN
dpc-4793	555	14	of	of	ADP
dpc-4793	555	15	uva1	uva1	PROPN
dpc-4793	555	16	and	and	CCONJ
dpc-4793	555	17	narrowband	narrowband	VERB
dpc-4793	555	18	uvb	uvb	ADJ
dpc-4793	555	19	for	for	ADP
dpc-4793	555	20	treatment	treatment	NOUN
dpc-4793	555	21	of	of	ADP
dpc-4793	555	22	scalp	scalp	NOUN
dpc-4793	555	23	psoriasis	psoriasis	NOUN
dpc-4793	555	24	.	.	PUNCT
dpc-4793	556	1	lasers	laser	NOUN
dpc-4793	556	2	med	me	VERB
dpc-4793	556	3	sci	sci	PROPN
dpc-4793	556	4	2018;33(9):1979	2018;33(9):1979	NUM
dpc-4793	556	5	-	-	SYM
dpc-4793	556	6	82	82	NUM
dpc-4793	556	7	.	.	PUNCT
dpc-4793	557	1	doi	doi	NOUN
dpc-4793	557	2	:	:	PUNCT
dpc-4793	557	3	10.1007	10.1007	NUM
dpc-4793	557	4	/	/	SYM
dpc-4793	557	5	s10103	s10103	NOUN
dpc-4793	557	6	-	-	PUNCT
dpc-4793	557	7	018	018	NUM
dpc-4793	557	8	-	-	PUNCT
dpc-4793	557	9	2564	2564	NUM
dpc-4793	557	10	-	-	PUNCT
dpc-4793	557	11	z	z	NOUN
dpc-4793	557	12	pmid	pmid	NOUN
dpc-4793	557	13	:	:	PUNCT
dpc-4793	557	14	29915975	29915975	NUM
dpc-4793	557	15	.	.	PUNCT
dpc-4793	558	1	23	23	NUM
dpc-4793	558	2	.	.	X
dpc-4793	559	1	buckley	buckley	PROPN
dpc-4793	559	2	c	c	PROPN
dpc-4793	559	3	,	,	PUNCT
dpc-4793	559	4	hoffmann	hoffmann	PROPN
dpc-4793	559	5	v	v	PROPN
dpc-4793	559	6	,	,	PUNCT
dpc-4793	559	7	shapiro	shapiro	PROPN
dpc-4793	559	8	j	j	PROPN
dpc-4793	559	9	,	,	PUNCT
dpc-4793	559	10	saari	saari	PROPN
dpc-4793	559	11	s	s	PROPN
dpc-4793	559	12	,	,	PUNCT
dpc-4793	559	13	cambazard	cambazard	ADJ
dpc-4793	559	14	f	f	PROPN
dpc-4793	559	15	,	,	PUNCT
dpc-4793	559	16	milsgaard	milsgaard	PROPN
dpc-4793	559	17	m.	m.	PROPN
dpc-4793	559	18	calcipotriol	calcipotriol	PROPN
dpc-4793	559	19	plus	plus	CCONJ
dpc-4793	559	20	betamethasone	betamethasone	NOUN
dpc-4793	559	21	dipropionate	dipropionate	NOUN
dpc-4793	559	22	scalp	scalp	NOUN
dpc-4793	559	23	formulation	formulation	NOUN
dpc-4793	559	24	is	be	AUX
dpc-4793	559	25	effective	effective	ADJ
dpc-4793	559	26	and	and	CCONJ
dpc-4793	559	27	well	well	ADV
dpc-4793	559	28	tolerated	tolerate	VERB
dpc-4793	559	29	in	in	ADP
dpc-4793	559	30	the	the	DET
dpc-4793	559	31	treatment	treatment	NOUN
dpc-4793	559	32	of	of	ADP
dpc-4793	559	33	scalp	scalp	NOUN
dpc-4793	559	34	psoriasis	psoriasis	NOUN
dpc-4793	559	35	:	:	PUNCT
dpc-4793	559	36	a	a	DET
dpc-4793	559	37	phase	phase	NOUN
dpc-4793	559	38	ii	ii	NOUN
dpc-4793	559	39	study	study	NOUN
dpc-4793	559	40	.	.	PUNCT
dpc-4793	560	1	dermatology	dermatology	NOUN
dpc-4793	560	2	2008;217(2	2008;217(2	NUM
dpc-4793	560	3	):	):	PUNCT
dpc-4793	560	4	107	107	NUM
dpc-4793	560	5	-	-	SYM
dpc-4793	560	6	13	13	NUM
dpc-4793	560	7	.	.	PUNCT
dpc-4793	561	1	doi	doi	NOUN
dpc-4793	561	2	:	:	PUNCT
dpc-4793	561	3	10.1159/000130425	10.1159/000130425	NUM
dpc-4793	561	4	pmid	pmid	NOUN
dpc-4793	561	5	:	:	PUNCT
dpc-4793	561	6	18463448	18463448	NUM
dpc-4793	561	7	.	.	PUNCT
dpc-4793	562	1	24	24	NUM
dpc-4793	562	2	.	.	PUNCT
dpc-4793	562	3	jemec	jemec	PROPN
dpc-4793	562	4	gbe	gbe	PROPN
dpc-4793	562	5	,	,	PUNCT
dpc-4793	562	6	ganslandt	ganslandt	NOUN
dpc-4793	562	7	c	c	NOUN
dpc-4793	562	8	,	,	PUNCT
dpc-4793	562	9	ortonne	ortonne	VERB
dpc-4793	562	10	j	j	PROPN
dpc-4793	562	11	-	-	PROPN
dpc-4793	562	12	p	p	PROPN
dpc-4793	562	13	,	,	PUNCT
dpc-4793	562	14	et	et	PROPN
dpc-4793	562	15	al	al	PROPN
dpc-4793	562	16	.	.	PUNCT
dpc-4793	563	1	a	a	DET
dpc-4793	563	2	new	new	ADJ
dpc-4793	563	3	scalp	scalp	NOUN
dpc-4793	563	4	formulation	formulation	NOUN
dpc-4793	563	5	of	of	ADP
dpc-4793	563	6	calcipotriene	calcipotriene	NOUN
dpc-4793	563	7	plus	plus	CCONJ
dpc-4793	563	8	betamethasone	betamethasone	NOUN
dpc-4793	563	9	compared	compare	VERB
dpc-4793	563	10	with	with	ADP
dpc-4793	563	11	its	its	PRON
dpc-4793	563	12	active	active	ADJ
dpc-4793	563	13	ingredients	ingredient	NOUN
dpc-4793	563	14	and	and	CCONJ
dpc-4793	563	15	the	the	DET
dpc-4793	563	16	vehicle	vehicle	NOUN
dpc-4793	563	17	in	in	ADP
dpc-4793	563	18	the	the	DET
dpc-4793	563	19	treatment	treatment	NOUN
dpc-4793	563	20	of	of	ADP
dpc-4793	563	21	scalp	scalp	NOUN
dpc-4793	563	22	psoriasis	psoriasis	NOUN
dpc-4793	563	23	:	:	PUNCT
dpc-4793	563	24	a	a	DET
dpc-4793	563	25	randomized	randomized	ADJ
dpc-4793	563	26	,	,	PUNCT
dpc-4793	563	27	double	double	ADJ
dpc-4793	563	28	-	-	PUNCT
dpc-4793	563	29	blind	blind	ADJ
dpc-4793	563	30	,	,	PUNCT
dpc-4793	563	31	controlled	control	VERB
dpc-4793	563	32	trial	trial	NOUN
dpc-4793	563	33	.	.	PUNCT
dpc-4793	564	1	j	j	PROPN
dpc-4793	564	2	am	be	AUX
dpc-4793	564	3	acad	acad	ADJ
dpc-4793	564	4	dermatol	dermatol	NOUN
dpc-4793	564	5	2008;59(3):455	2008;59(3):455	PROPN
dpc-4793	564	6	-	-	SYM
dpc-4793	564	7	63	63	NUM
dpc-4793	564	8	.	.	PUNCT
dpc-4793	565	1	doi	doi	NOUN
dpc-4793	565	2	:	:	PUNCT
dpc-4793	565	3	10.1016	10.1016	NUM
dpc-4793	565	4	/	/	SYM
dpc-4793	565	5	j.jaad.2008.04.027	j.jaad.2008.04.027	PROPN
dpc-4793	565	6	.	.	PUNCT
dpc-4793	566	1	pmid	pmid	NOUN
dpc-4793	566	2	:	:	PUNCT
dpc-4793	566	3	18694678	18694678	NUM
dpc-4793	566	4	.	.	PUNCT
dpc-4793	567	1	25	25	NUM
dpc-4793	567	2	.	.	PUNCT
dpc-4793	567	3	kragballe	kragballe	PROPN
dpc-4793	568	1	k	k	PROPN
dpc-4793	568	2	,	,	PUNCT
dpc-4793	568	3	hoffmann	hoffmann	PROPN
dpc-4793	568	4	v	v	PROPN
dpc-4793	568	5	,	,	PUNCT
dpc-4793	568	6	ortonne	ortonne	NOUN
dpc-4793	568	7	jp	jp	NOUN
dpc-4793	568	8	,	,	PUNCT
dpc-4793	568	9	tan	tan	PROPN
dpc-4793	568	10	j	j	PROPN
dpc-4793	568	11	,	,	PUNCT
dpc-4793	568	12	nordin	nordin	PROPN
dpc-4793	568	13	p	p	PROPN
dpc-4793	568	14	,	,	PUNCT
dpc-4793	568	15	segaert	segaert	ADJ
dpc-4793	568	16	s.	s.	PROPN
dpc-4793	568	17	efficacy	efficacy	PROPN
dpc-4793	568	18	and	and	CCONJ
dpc-4793	568	19	safety	safety	NOUN
dpc-4793	568	20	of	of	ADP
dpc-4793	568	21	calcipotriol	calcipotriol	PROPN
dpc-4793	568	22	plus	plus	CCONJ
dpc-4793	568	23	betamethasone	betamethasone	NOUN
dpc-4793	568	24	dipropionate	dipropionate	NOUN
dpc-4793	568	25	scalp	scalp	NOUN
dpc-4793	568	26	formulation	formulation	NOUN
dpc-4793	568	27	compared	compare	VERB
dpc-4793	568	28	with	with	ADP
dpc-4793	568	29	calcipotriol	calcipotriol	NOUN
dpc-4793	568	30	scalp	scalp	NOUN
dpc-4793	568	31	solution	solution	NOUN
dpc-4793	568	32	in	in	ADP
dpc-4793	568	33	the	the	DET
dpc-4793	568	34	treatment	treatment	NOUN
dpc-4793	568	35	of	of	ADP
dpc-4793	568	36	scalp	scalp	NOUN
dpc-4793	568	37	psoriasis	psoriasis	NOUN
dpc-4793	568	38	:	:	PUNCT
dpc-4793	568	39	a	a	DET
dpc-4793	568	40	randomized	randomized	ADJ
dpc-4793	568	41	controlled	control	VERB
dpc-4793	568	42	trial	trial	NOUN
dpc-4793	568	43	.	.	PUNCT
dpc-4793	569	1	br	br	X
dpc-4793	569	2	j	j	PROPN
dpc-4793	569	3	dermatol	dermatol	NOUN
dpc-4793	569	4	2009;161(1):159	2009;161(1):159	NUM
dpc-4793	569	5	-	-	SYM
dpc-4793	569	6	66	66	NUM
dpc-4793	569	7	.	.	PUNCT
dpc-4793	570	1	doi	doi	NOUN
dpc-4793	570	2	:	:	PUNCT
dpc-4793	570	3	10.1111	10.1111	NUM
dpc-4793	570	4	/j.1365	/j.1365	NOUN
dpc-4793	570	5	-	-	PUNCT
dpc-4793	570	6	2133.2009.09116.x	2133.2009.09116.x	NUM
dpc-4793	570	7	pmid	pmid	NOUN
dpc-4793	570	8	:	:	PUNCT
dpc-4793	570	9	19416259	19416259	NUM
dpc-4793	570	10	.	.	PUNCT
dpc-4793	571	1	26	26	NUM
dpc-4793	571	2	.	.	PUNCT
dpc-4793	572	1	liu	liu	PROPN
dpc-4793	572	2	l	l	PROPN
dpc-4793	572	3	,	,	PUNCT
dpc-4793	572	4	zhang	zhang	PROPN
dpc-4793	572	5	c	c	PROPN
dpc-4793	572	6	,	,	PUNCT
dpc-4793	572	7	wang	wang	PROPN
dpc-4793	572	8	j	j	PROPN
dpc-4793	572	9	,	,	PUNCT
dpc-4793	572	10	et	et	PROPN
dpc-4793	572	11	al	al	PROPN
dpc-4793	572	12	.	.	PROPN
dpc-4793	572	13	comparison	comparison	NOUN
dpc-4793	572	14	of	of	ADP
dpc-4793	572	15	safety	safety	NOUN
dpc-4793	572	16	and	and	CCONJ
dpc-4793	572	17	efficacy	efficacy	NOUN
dpc-4793	572	18	between	between	ADP
dpc-4793	572	19	calcipotriol	calcipotriol	PROPN
dpc-4793	572	20	plus	plus	CCONJ
dpc-4793	572	21	betamethasone	betamethasone	NOUN
dpc-4793	572	22	dipropionate	dipropionate	NOUN
dpc-4793	572	23	gel	gel	NOUN
dpc-4793	572	24	and	and	CCONJ
dpc-4793	572	25	calcipotriol	calcipotriol	NOUN
dpc-4793	572	26	scalp	scalp	NOUN
dpc-4793	572	27	solution	solution	NOUN
dpc-4793	572	28	as	as	ADP
dpc-4793	572	29	long	long	ADJ
dpc-4793	572	30	-	-	PUNCT
dpc-4793	572	31	term	term	NOUN
dpc-4793	572	32	treatment	treatment	NOUN
dpc-4793	572	33	for	for	ADP
dpc-4793	572	34	scalp	scalp	NOUN
dpc-4793	572	35	psoriasis	psoriasis	NOUN
dpc-4793	572	36	in	in	ADP
dpc-4793	572	37	chinese	chinese	ADJ
dpc-4793	572	38	patients	patient	NOUN
dpc-4793	572	39	:	:	PUNCT
dpc-4793	572	40	a	a	DET
dpc-4793	572	41	national	national	ADJ
dpc-4793	572	42	,	,	PUNCT
dpc-4793	572	43	multicentre	multicentre	ADJ
dpc-4793	572	44	,	,	PUNCT
dpc-4793	572	45	prospective	prospective	ADJ
dpc-4793	572	46	,	,	PUNCT
dpc-4793	572	47	randomized	randomize	VERB
dpc-4793	572	48	,	,	PUNCT
dpc-4793	572	49	active	active	ADJ
dpc-4793	572	50	-	-	PUNCT
dpc-4793	572	51	controlled	control	VERB
dpc-4793	572	52	phase	phase	NOUN
dpc-4793	572	53	4	4	NUM
dpc-4793	572	54	trial	trial	NOUN
dpc-4793	572	55	.	.	PUNCT
dpc-4793	573	1	eur	eur	PROPN
dpc-4793	573	2	j	j	PROPN
dpc-4793	573	3	dermatol	dermatol	ADJ
dpc-4793	573	4	2020;30(5):580	2020;30(5):580	NUM
dpc-4793	573	5	-	-	SYM
dpc-4793	573	6	90	90	NUM
dpc-4793	573	7	.	.	PUNCT
dpc-4793	573	8	doi	doi	NOUN
dpc-4793	573	9	:	:	PUNCT
dpc-4793	573	10	10.1684	10.1684	NUM
dpc-4793	573	11	/	/	SYM
dpc-4793	573	12	ejd.2020.3876	ejd.2020.3876	PROPN
dpc-4793	573	13	.	.	PUNCT
dpc-4793	574	1	pmid	pmid	NOUN
dpc-4793	574	2	:	:	PUNCT
dpc-4793	574	3	33052103	33052103	NUM
dpc-4793	574	4	.	.	PUNCT
dpc-4793	575	1	27	27	NUM
dpc-4793	575	2	.	.	PUNCT
dpc-4793	575	3	ma	ma	PROPN
dpc-4793	575	4	l	l	PROPN
dpc-4793	575	5	,	,	PUNCT
dpc-4793	575	6	yang	yang	PROPN
dpc-4793	575	7	q	q	PROPN
dpc-4793	575	8	,	,	PUNCT
dpc-4793	575	9	yang	yang	PROPN
dpc-4793	575	10	h	h	PROPN
dpc-4793	575	11	,	,	PUNCT
dpc-4793	575	12	et	et	PROPN
dpc-4793	575	13	al	al	PROPN
dpc-4793	575	14	.	.	PROPN
dpc-4793	575	15	calcipotriol	calcipotriol	PROPN
dpc-4793	575	16	plus	plus	CCONJ
dpc-4793	575	17	betamethasone	betamethasone	PROPN
dpc-4793	575	18	dipropionate	dipropionate	PROPN
dpc-4793	575	19	gel	gel	NOUN
dpc-4793	575	20	compared	compare	VERB
dpc-4793	575	21	with	with	ADP
dpc-4793	575	22	calcipotriol	calcipotriol	NOUN
dpc-4793	575	23	scalp	scalp	NOUN
dpc-4793	575	24	solution	solution	NOUN
dpc-4793	575	25	in	in	ADP
dpc-4793	575	26	the	the	DET
dpc-4793	575	27	treatment	treatment	NOUN
dpc-4793	575	28	of	of	ADP
dpc-4793	575	29	scalp	scalp	NOUN
dpc-4793	575	30	psoriasis	psoriasis	NOUN
dpc-4793	575	31	:	:	PUNCT
dpc-4793	575	32	a	a	DET
dpc-4793	575	33	randomized	randomized	ADJ
dpc-4793	575	34	,	,	PUNCT
dpc-4793	575	35	controlled	control	VERB
dpc-4793	575	36	trial	trial	NOUN
dpc-4793	575	37	investigating	investigate	VERB
dpc-4793	575	38	efficacy	efficacy	NOUN
dpc-4793	575	39	and	and	CCONJ
dpc-4793	575	40	safety	safety	NOUN
dpc-4793	575	41	in	in	ADP
dpc-4793	575	42	a	a	DET
dpc-4793	575	43	chinese	chinese	ADJ
dpc-4793	575	44	population	population	NOUN
dpc-4793	575	45	.	.	PUNCT
dpc-4793	576	1	int	int	NOUN
dpc-4793	576	2	j	j	PROPN
dpc-4793	576	3	dermatol	dermatol	NOUN
dpc-4793	576	4	2016;55(1):106	2016;55(1):106	PROPN
dpc-4793	576	5	-	-	PUNCT
dpc-4793	576	6	13	13	NUM
dpc-4793	576	7	.	.	PUNCT
dpc-4793	577	1	doi	doi	NOUN
dpc-4793	577	2	:	:	PUNCT
dpc-4793	577	3	10.1111	10.1111	NUM
dpc-4793	577	4	/	/	SYM
dpc-4793	577	5	ijd.12788	ijd.12788	X
dpc-4793	577	6	pmid	pmid	NOUN
dpc-4793	577	7	:	:	PUNCT
dpc-4793	577	8	26094549	26094549	NUM
dpc-4793	577	9	.	.	PUNCT
dpc-4793	578	1	28	28	NUM
dpc-4793	578	2	.	.	PUNCT
dpc-4793	579	1	van	van	PROPN
dpc-4793	579	2	de	de	X
dpc-4793	579	3	kerkhof	kerkhof	PROPN
dpc-4793	579	4	pc	pc	PROPN
dpc-4793	579	5	,	,	PUNCT
dpc-4793	579	6	hoffmann	hoffmann	PROPN
dpc-4793	579	7	v	v	PROPN
dpc-4793	579	8	,	,	PUNCT
dpc-4793	579	9	anstey	anstey	PROPN
dpc-4793	579	10	a	a	PRON
dpc-4793	579	11	,	,	PUNCT
dpc-4793	579	12	et	et	PROPN
dpc-4793	579	13	al	al	PROPN
dpc-4793	579	14	.	.	PUNCT
dpc-4793	580	1	a	a	DET
dpc-4793	580	2	new	new	ADJ
dpc-4793	580	3	scalp	scalp	NOUN
dpc-4793	580	4	formulation	formulation	NOUN
dpc-4793	580	5	of	of	ADP
dpc-4793	580	6	calcipotriol	calcipotriol	PROPN
dpc-4793	580	7	plus	plus	CCONJ
dpc-4793	580	8	betamethasone	betamethasone	NOUN
dpc-4793	580	9	dipropionate	dipropionate	NOUN
dpc-4793	580	10	compared	compare	VERB
dpc-4793	580	11	with	with	ADP
dpc-4793	580	12	each	each	PRON
dpc-4793	580	13	of	of	ADP
dpc-4793	580	14	its	its	PRON
dpc-4793	580	15	active	active	ADJ
dpc-4793	580	16	ingredients	ingredient	NOUN
dpc-4793	580	17	in	in	ADP
dpc-4793	580	18	the	the	DET
dpc-4793	580	19	same	same	ADJ
dpc-4793	580	20	vehicle	vehicle	NOUN
dpc-4793	580	21	for	for	ADP
dpc-4793	580	22	the	the	DET
dpc-4793	580	23	treatment	treatment	NOUN
dpc-4793	580	24	of	of	ADP
dpc-4793	580	25	scalp	scalp	NOUN
dpc-4793	580	26	psoriasis	psoriasis	NOUN
dpc-4793	580	27	:	:	PUNCT
dpc-4793	580	28	a	a	DET
dpc-4793	580	29	randomized	randomized	ADJ
dpc-4793	580	30	,	,	PUNCT
dpc-4793	580	31	double	double	ADJ
dpc-4793	580	32	-	-	PUNCT
dpc-4793	580	33	blind	blind	ADJ
dpc-4793	580	34	,	,	PUNCT
dpc-4793	580	35	controlled	control	VERB
dpc-4793	580	36	trial	trial	NOUN
dpc-4793	580	37	.	.	PUNCT
dpc-4793	581	1	br	br	X
dpc-4793	581	2	j	j	PROPN
dpc-4793	581	3	dermatol	dermatol	NOUN
dpc-4793	581	4	2009;160(1):170	2009;160(1):170	NUM
dpc-4793	581	5	-	-	SYM
dpc-4793	581	6	6	6	NUM
dpc-4793	581	7	.	.	PUNCT
dpc-4793	582	1	doi	doi	NOUN
dpc-4793	582	2	:	:	PUNCT
dpc-4793	582	3	10.1111	10.1111	NUM
dpc-4793	582	4	/j.1365	/j.1365	NOUN
dpc-4793	582	5	-	-	PUNCT
dpc-4793	582	6	2133.2008.08927.x	2133.2008.08927.x	NUM
dpc-4793	582	7	pmid	pmid	NOUN
dpc-4793	582	8	:	:	PUNCT
dpc-4793	582	9	19067709	19067709	NUM
dpc-4793	582	10	.	.	PUNCT
dpc-4793	583	1	29	29	NUM
dpc-4793	583	2	.	.	PUNCT
dpc-4793	584	1	patel	patel	PROPN
dpc-4793	584	2	ds	ds	PROPN
dpc-4793	584	3	,	,	PUNCT
dpc-4793	584	4	veverka	veverka	PROPN
dpc-4793	584	5	ka	ka	PROPN
dpc-4793	584	6	,	,	PUNCT
dpc-4793	584	7	hansen	hansen	PROPN
dpc-4793	584	8	jb	jb	PROPN
dpc-4793	584	9	,	,	PUNCT
dpc-4793	584	10	yamauchi	yamauchi	PROPN
dpc-4793	584	11	ps	ps	PROPN
dpc-4793	584	12	,	,	PUNCT
dpc-4793	584	13	alonso	alonso	PROPN
dpc-4793	584	14	llamazares	llamazares	PROPN
dpc-4793	584	15	j	j	PROPN
dpc-4793	584	16	,	,	PUNCT
dpc-4793	584	17	lebwohl	lebwohl	PROPN
dpc-4793	584	18	m.	m.	NOUN
dpc-4793	584	19	efficacy	efficacy	NOUN
dpc-4793	584	20	of	of	ADP
dpc-4793	584	21	fixed	fix	VERB
dpc-4793	584	22	-	-	PUNCT
dpc-4793	584	23	combination	combination	NOUN
dpc-4793	584	24	calcipotriene	calcipotriene	NOUN
dpc-4793	584	25	0.005	0.005	NUM
dpc-4793	584	26	%	%	NOUN
dpc-4793	584	27	and	and	CCONJ
dpc-4793	584	28	betamethasone	betamethasone	PROPN
dpc-4793	584	29	dipropionate	dipropionate	PROPN
dpc-4793	584	30	0.064	0.064	NUM
dpc-4793	584	31	%	%	NOUN
dpc-4793	584	32	foam	foam	NOUN
dpc-4793	584	33	for	for	ADP
dpc-4793	584	34	scalp	scalp	NOUN
dpc-4793	584	35	plaque	plaque	NOUN
dpc-4793	584	36	psoriasis	psoriasis	NOUN
dpc-4793	584	37	:	:	PUNCT
dpc-4793	584	38	additional	additional	ADJ
dpc-4793	584	39	analysis	analysis	NOUN
dpc-4793	584	40	of	of	ADP
dpc-4793	584	41	a	a	DET
dpc-4793	584	42	phase	phase	NOUN
dpc-4793	584	43	ii	ii	NOUN
dpc-4793	584	44	,	,	PUNCT
dpc-4793	584	45	randomized	randomize	VERB
dpc-4793	584	46	clinical	clinical	ADJ
dpc-4793	584	47	study	study	NOUN
dpc-4793	584	48	.	.	PUNCT
dpc-4793	585	1	j	j	PROPN
dpc-4793	585	2	clin	clin	PROPN
dpc-4793	585	3	aesthet	aesthet	PROPN
dpc-4793	585	4	dermatol	dermatol	NOUN
dpc-4793	585	5	2020;13(5):12	2020;13(5):12	NUM
dpc-4793	585	6	-	-	SYM
dpc-4793	585	7	18	18	NUM
dpc-4793	585	8	pmid	pmid	NOUN
dpc-4793	585	9	:	:	PUNCT
dpc-4793	585	10	32802249	32802249	NUM
dpc-4793	585	11	.	.	PUNCT
dpc-4793	586	1	30	30	NUM
dpc-4793	586	2	.	.	PUNCT
dpc-4793	587	1	reygagne	reygagne	VERB
dpc-4793	588	1	p	p	X
dpc-4793	588	2	,	,	PUNCT
dpc-4793	588	3	mrowietz	mrowietz	ADJ
dpc-4793	588	4	u	u	NOUN
dpc-4793	588	5	,	,	PUNCT
dpc-4793	588	6	decroix	decroix	PROPN
dpc-4793	588	7	j	j	PROPN
dpc-4793	588	8	,	,	PUNCT
dpc-4793	588	9	et	et	PROPN
dpc-4793	588	10	al	al	PROPN
dpc-4793	588	11	.	.	PUNCT
dpc-4793	589	1	clobetasol	clobetasol	PROPN
dpc-4793	589	2	propionate	propionate	PROPN
dpc-4793	589	3	shampoo	shampoo	NOUN
dpc-4793	589	4	0.05	0.05	NUM
dpc-4793	589	5	%	%	NOUN
dpc-4793	589	6	and	and	CCONJ
dpc-4793	589	7	calcipotriol	calcipotriol	NOUN
dpc-4793	589	8	solution	solution	NOUN
dpc-4793	589	9	0.005	0.005	NUM
dpc-4793	589	10	%	%	NOUN
dpc-4793	589	11	:	:	PUNCT
dpc-4793	589	12	a	a	DET
dpc-4793	589	13	randomized	randomized	ADJ
dpc-4793	589	14	comparison	comparison	NOUN
dpc-4793	589	15	of	of	ADP
dpc-4793	589	16	efficacy	efficacy	NOUN
dpc-4793	589	17	and	and	CCONJ
dpc-4793	589	18	safety	safety	NOUN
dpc-4793	589	19	in	in	ADP
dpc-4793	589	20	subjects	subject	NOUN
dpc-4793	589	21	with	with	ADP
dpc-4793	589	22	scalp	scalp	NOUN
dpc-4793	589	23	psoriasis	psoriasis	NOUN
dpc-4793	589	24	.	.	PUNCT
dpc-4793	590	1	j	j	PROPN
dpc-4793	590	2	dermatolog	dermatolog	PROPN
dpc-4793	590	3	treat	treat	VERB
dpc-4793	590	4	2005;16(1):31	2005;16(1):31	NUM
dpc-4793	590	5	-	-	PUNCT
dpc-4793	590	6	6	6	NUM
dpc-4793	590	7	.	.	PUNCT
dpc-4793	591	1	doi	doi	NOUN
dpc-4793	591	2	:	:	PUNCT
dpc-4793	591	3	10.1080	10.1080	NUM
dpc-4793	591	4	/09546630410024853	/09546630410024853	SYM
dpc-4793	591	5	.	.	PUNCT
dpc-4793	592	1	31	31	NUM
dpc-4793	592	2	.	.	PUNCT
dpc-4793	593	1	saraceno	saraceno	PROPN
dpc-4793	593	2	r	r	PROPN
dpc-4793	593	3	,	,	PUNCT
dpc-4793	593	4	camplone	camplone	NOUN
dpc-4793	593	5	g	g	NOUN
dpc-4793	593	6	,	,	PUNCT
dpc-4793	593	7	d’agostino	d’agostino	PROPN
dpc-4793	593	8	m	m	PROPN
dpc-4793	593	9	,	,	PUNCT
dpc-4793	593	10	et	et	PROPN
dpc-4793	593	11	al	al	PROPN
dpc-4793	593	12	.	.	PROPN
dpc-4793	593	13	efficacy	efficacy	NOUN
dpc-4793	593	14	and	and	CCONJ
dpc-4793	593	15	maintenance	maintenance	NOUN
dpc-4793	593	16	strategies	strategy	NOUN
dpc-4793	593	17	of	of	ADP
dpc-4793	593	18	two	two	NUM
dpc-4793	593	19	-	-	PUNCT
dpc-4793	593	20	compound	compound	NOUN
dpc-4793	593	21	formulation	formulation	NOUN
dpc-4793	593	22	doi	doi	NOUN
dpc-4793	593	23	:	:	PUNCT
dpc-4793	593	24	10.1080/09546634.2020.1770167	10.1080/09546634.2020.1770167	NUM
dpc-4793	593	25	[	[	X
dpc-4793	593	26	published	publish	VERB
dpc-4793	593	27	online	online	ADV
dpc-4793	593	28	first	first	ADV
dpc-4793	593	29	:	:	PUNCT
dpc-4793	593	30	20200619	20200619	NUM
dpc-4793	593	31	]	]	PUNCT
dpc-4793	593	32	.	.	PUNCT
dpc-4793	594	1	pmid	pmid	NOUN
dpc-4793	594	2	:	:	PUNCT
dpc-4793	594	3	32406275	32406275	NUM
dpc-4793	594	4	.	.	PUNCT
dpc-4793	595	1	8	8	X
dpc-4793	595	2	.	.	PUNCT
dpc-4793	596	1	schlager	schlager	PROPN
dpc-4793	596	2	jg	jg	PROPN
dpc-4793	596	3	,	,	PUNCT
dpc-4793	596	4	rosumeck	rosumeck	PROPN
dpc-4793	596	5	s	s	PROPN
dpc-4793	596	6	,	,	PUNCT
dpc-4793	596	7	werner	werner	PROPN
dpc-4793	596	8	rn	rn	PROPN
dpc-4793	596	9	,	,	PUNCT
dpc-4793	596	10	et	et	PROPN
dpc-4793	596	11	al	al	PROPN
dpc-4793	596	12	.	.	PUNCT
dpc-4793	596	13	topical	topical	ADJ
dpc-4793	596	14	treatments	treatment	NOUN
dpc-4793	596	15	for	for	ADP
dpc-4793	596	16	scalp	scalp	NOUN
dpc-4793	596	17	psoriasis	psoriasis	NOUN
dpc-4793	596	18	.	.	PUNCT
dpc-4793	597	1	cochrane	cochrane	NOUN
dpc-4793	597	2	database	database	PROPN
dpc-4793	597	3	syst	syst	PROPN
dpc-4793	597	4	rev	rev	PROPN
dpc-4793	597	5	2016;2(2):cd009687	2016;2(2):cd009687	PROPN
dpc-4793	597	6	.	.	PUNCT
dpc-4793	598	1	doi	doi	NOUN
dpc-4793	598	2	:	:	PUNCT
dpc-4793	599	1	10.1002/14651858.cd009687.pub2	10.1002/14651858.cd009687.pub2	NUM
dpc-4793	599	2	.	.	PUNCT
dpc-4793	600	1	9	9	X
dpc-4793	600	2	.	.	X
dpc-4793	600	3	feldman	feldman	PROPN
dpc-4793	600	4	sr	sr	PROPN
dpc-4793	600	5	,	,	PUNCT
dpc-4793	600	6	ravis	ravis	PROPN
dpc-4793	600	7	sm	sm	PROPN
dpc-4793	600	8	,	,	PUNCT
dpc-4793	600	9	fleischer	fleischer	PROPN
dpc-4793	600	10	ab	ab	PROPN
dpc-4793	600	11	,	,	PUNCT
dpc-4793	600	12	jr	jr	PROPN
dpc-4793	600	13	.	.	PROPN
dpc-4793	600	14	,	,	PUNCT
dpc-4793	600	15	et	et	PROPN
dpc-4793	600	16	al	al	PROPN
dpc-4793	600	17	.	.	PUNCT
dpc-4793	601	1	betamethasone	betamethasone	PROPN
dpc-4793	601	2	valerate	valerate	PROPN
dpc-4793	601	3	in	in	ADP
dpc-4793	601	4	foam	foam	NOUN
dpc-4793	601	5	vehicle	vehicle	NOUN
dpc-4793	601	6	is	be	AUX
dpc-4793	601	7	effective	effective	ADJ
dpc-4793	601	8	with	with	ADP
dpc-4793	601	9	both	both	CCONJ
dpc-4793	601	10	daily	daily	ADJ
dpc-4793	601	11	and	and	CCONJ
dpc-4793	601	12	twice	twice	DET
dpc-4793	601	13	a	a	DET
dpc-4793	601	14	day	day	NOUN
dpc-4793	601	15	dosing	dosing	NOUN
dpc-4793	601	16	:	:	PUNCT
dpc-4793	601	17	a	a	DET
dpc-4793	601	18	single	single	ADJ
dpc-4793	601	19	-	-	PUNCT
dpc-4793	601	20	blind	blind	ADJ
dpc-4793	601	21	,	,	PUNCT
dpc-4793	601	22	open	open	ADJ
dpc-4793	601	23	-	-	PUNCT
dpc-4793	601	24	label	label	NOUN
dpc-4793	601	25	study	study	NOUN
dpc-4793	601	26	in	in	ADP
dpc-4793	601	27	the	the	DET
dpc-4793	601	28	treatment	treatment	NOUN
dpc-4793	601	29	of	of	ADP
dpc-4793	601	30	scalp	scalp	NOUN
dpc-4793	601	31	psoriasis	psoriasis	NOUN
dpc-4793	601	32	.	.	PUNCT
dpc-4793	602	1	j	j	PROPN
dpc-4793	602	2	cutan	cutan	PROPN
dpc-4793	602	3	med	med	PROPN
dpc-4793	602	4	surg	surg	NOUN
dpc-4793	602	5	2001;5(5):386	2001;5(5):386	NUM
dpc-4793	602	6	-	-	SYM
dpc-4793	602	7	9	9	NUM
dpc-4793	602	8	.	.	PUNCT
dpc-4793	602	9	doi	doi	NOUN
dpc-4793	602	10	:	:	PUNCT
dpc-4793	602	11	10.1007	10.1007	NUM
dpc-4793	602	12	/	/	SYM
dpc-4793	602	13	s10227	s10227	NOUN
dpc-4793	602	14	-	-	PUNCT
dpc-4793	602	15	001	001	NUM
dpc-4793	602	16	-	-	PUNCT
dpc-4793	602	17	0005	0005	NUM
dpc-4793	602	18	-	-	PUNCT
dpc-4793	602	19	1	1	NUM
dpc-4793	602	20	.	.	PUNCT
dpc-4793	603	1	pmid	pmid	NOUN
dpc-4793	603	2	:	:	PUNCT
dpc-4793	603	3	11907847	11907847	NUM
dpc-4793	603	4	.	.	PUNCT
dpc-4793	604	1	10	10	NUM
dpc-4793	604	2	.	.	PUNCT
dpc-4793	605	1	aslam	aslam	PROPN
dpc-4793	605	2	s	s	PROPN
dpc-4793	605	3	,	,	PUNCT
dpc-4793	605	4	emmanuel	emmanuel	PROPN
dpc-4793	605	5	p.	p.	PROPN
dpc-4793	605	6	formulating	formulate	VERB
dpc-4793	605	7	a	a	DET
dpc-4793	605	8	researchable	researchable	ADJ
dpc-4793	605	9	question	question	NOUN
dpc-4793	605	10	:	:	PUNCT
dpc-4793	605	11	a	a	DET
dpc-4793	605	12	critical	critical	ADJ
dpc-4793	605	13	step	step	NOUN
dpc-4793	605	14	for	for	ADP
dpc-4793	605	15	facilitating	facilitate	VERB
dpc-4793	605	16	good	good	ADJ
dpc-4793	605	17	clinical	clinical	ADJ
dpc-4793	605	18	research	research	NOUN
dpc-4793	605	19	.	.	PUNCT
dpc-4793	606	1	indian	indian	PROPN
dpc-4793	606	2	j	j	PROPN
dpc-4793	606	3	sex	sex	NOUN
dpc-4793	606	4	transm	transm	PROPN
dpc-4793	606	5	dis	dis	PROPN
dpc-4793	606	6	aids	aid	VERB
dpc-4793	606	7	2010;31(1):47	2010;31(1):47	NUM
dpc-4793	606	8	-	-	SYM
dpc-4793	606	9	50	50	NUM
dpc-4793	606	10	.	.	PUNCT
dpc-4793	607	1	doi	doi	NOUN
dpc-4793	607	2	:	:	PUNCT
dpc-4793	607	3	10.4103/0253	10.4103/0253	NUM
dpc-4793	607	4	-	-	SYM
dpc-4793	607	5	7184	7184	NUM
dpc-4793	607	6	.69003	.69003	NOUN
dpc-4793	607	7	.	.	PUNCT
dpc-4793	608	1	pmid	pmid	NOUN
dpc-4793	608	2	:	:	PUNCT
dpc-4793	608	3	21808439	21808439	NUM
dpc-4793	608	4	.	.	PUNCT
dpc-4793	609	1	11	11	NUM
dpc-4793	609	2	.	.	PUNCT
dpc-4793	609	3	page	page	NOUN
dpc-4793	609	4	mj	mj	PROPN
dpc-4793	609	5	,	,	PUNCT
dpc-4793	609	6	mckenzie	mckenzie	PROPN
dpc-4793	609	7	je	je	PROPN
dpc-4793	609	8	,	,	PUNCT
dpc-4793	609	9	bossuyt	bossuyt	NOUN
dpc-4793	609	10	pm	pm	NOUN
dpc-4793	609	11	,	,	PUNCT
dpc-4793	609	12	et	et	PROPN
dpc-4793	609	13	al	al	PROPN
dpc-4793	609	14	.	.	PUNCT
dpc-4793	610	1	the	the	DET
dpc-4793	610	2	prisma	prisma	PROPN
dpc-4793	610	3	2020	2020	NUM
dpc-4793	610	4	statement	statement	NOUN
dpc-4793	610	5	:	:	PUNCT
dpc-4793	610	6	an	an	DET
dpc-4793	610	7	updated	update	VERB
dpc-4793	610	8	guideline	guideline	NOUN
dpc-4793	610	9	for	for	ADP
dpc-4793	610	10	reporting	report	VERB
dpc-4793	610	11	systematic	systematic	ADJ
dpc-4793	610	12	reviews	review	NOUN
dpc-4793	610	13	.	.	PUNCT
dpc-4793	611	1	bmj	bmj	PROPN
dpc-4793	611	2	2021;372	2021;372	NUM
dpc-4793	611	3	:	:	PUNCT
dpc-4793	611	4	n71	n71	ADJ
dpc-4793	611	5	.	.	PUNCT
dpc-4793	612	1	doi	doi	NOUN
dpc-4793	612	2	:	:	PUNCT
dpc-4793	612	3	10.1136	10.1136	NUM
dpc-4793	612	4	/	/	SYM
dpc-4793	612	5	bmj.n71	bmj.n71	PROPN
dpc-4793	612	6	pmid	pmid	PROPN
dpc-4793	612	7	:	:	PUNCT
dpc-4793	612	8	33782057	33782057	NUM
dpc-4793	612	9	.	.	PUNCT
dpc-4793	613	1	12	12	NUM
dpc-4793	613	2	.	.	PUNCT
dpc-4793	614	1	sterne	sterne	PROPN
dpc-4793	614	2	jac	jac	PROPN
dpc-4793	614	3	,	,	PUNCT
dpc-4793	614	4	savović	savović	PROPN
dpc-4793	614	5	j	j	PROPN
dpc-4793	614	6	,	,	PUNCT
dpc-4793	614	7	page	page	NOUN
dpc-4793	614	8	mj	mj	PROPN
dpc-4793	614	9	,	,	PUNCT
dpc-4793	614	10	et	et	PROPN
dpc-4793	614	11	al	al	PROPN
dpc-4793	614	12	.	.	PROPN
dpc-4793	614	13	rob	rob	PROPN
dpc-4793	615	1	2	2	NUM
dpc-4793	615	2	:	:	PUNCT
dpc-4793	615	3	a	a	DET
dpc-4793	615	4	revised	revise	VERB
dpc-4793	615	5	tool	tool	NOUN
dpc-4793	615	6	for	for	ADP
dpc-4793	615	7	assessing	assess	VERB
dpc-4793	615	8	risk	risk	NOUN
dpc-4793	615	9	of	of	ADP
dpc-4793	615	10	bias	bias	NOUN
dpc-4793	615	11	in	in	ADP
dpc-4793	615	12	randomised	randomised	ADJ
dpc-4793	615	13	trials	trial	NOUN
dpc-4793	615	14	.	.	PUNCT
dpc-4793	616	1	bmj	bmj	PROPN
dpc-4793	616	2	.	.	PUNCT
dpc-4793	617	1	2019;366	2019;366	NUM
dpc-4793	617	2	:	:	PUNCT
dpc-4793	617	3	l4898	l4898	PROPN
dpc-4793	617	4	.	.	PUNCT
dpc-4793	617	5	doi:10.1136	doi:10.1136	PROPN
dpc-4793	617	6	/	/	SYM
dpc-4793	617	7	bmj.l4898	bmj.l4898	PROPN
dpc-4793	617	8	.	.	PUNCT
dpc-4793	618	1	pmid	pmid	NOUN
dpc-4793	618	2	:	:	PUNCT
dpc-4793	618	3	31462531	31462531	NUM
dpc-4793	618	4	.	.	PUNCT
dpc-4793	619	1	13	13	NUM
dpc-4793	619	2	.	.	PUNCT
dpc-4793	619	3	bagel	bagel	PROPN
dpc-4793	619	4	j	j	PROPN
dpc-4793	619	5	,	,	PUNCT
dpc-4793	619	6	duffin	duffin	PROPN
dpc-4793	619	7	kc	kc	PROPN
dpc-4793	619	8	,	,	PUNCT
dpc-4793	619	9	moore	moore	PROPN
dpc-4793	619	10	a	a	PROPN
dpc-4793	619	11	,	,	PUNCT
dpc-4793	619	12	et	et	PROPN
dpc-4793	619	13	al	al	PROPN
dpc-4793	619	14	.	.	PUNCT
dpc-4793	620	1	the	the	DET
dpc-4793	620	2	effect	effect	NOUN
dpc-4793	620	3	of	of	ADP
dpc-4793	620	4	secukinumab	secukinumab	NOUN
dpc-4793	620	5	on	on	ADP
dpc-4793	620	6	moderate	moderate	ADJ
dpc-4793	620	7	-	-	PUNCT
dpc-4793	620	8	to	to	ADP
dpc-4793	620	9	-	-	PUNCT
dpc-4793	620	10	severe	severe	ADJ
dpc-4793	620	11	scalp	scalp	NOUN
dpc-4793	620	12	psoriasis	psoriasis	NOUN
dpc-4793	620	13	:	:	PUNCT
dpc-4793	620	14	results	result	NOUN
dpc-4793	620	15	of	of	ADP
dpc-4793	620	16	a	a	DET
dpc-4793	620	17	24	24	NUM
dpc-4793	620	18	-	-	PUNCT
dpc-4793	620	19	week	week	NOUN
dpc-4793	620	20	,	,	PUNCT
dpc-4793	620	21	randomized	randomize	VERB
dpc-4793	620	22	,	,	PUNCT
dpc-4793	620	23	double	double	ADJ
dpc-4793	620	24	-	-	PUNCT
dpc-4793	620	25	blind	blind	ADJ
dpc-4793	620	26	,	,	PUNCT
dpc-4793	620	27	placebo	placebo	NOUN
dpc-4793	620	28	-	-	PUNCT
dpc-4793	620	29	controlled	control	VERB
dpc-4793	620	30	phase	phase	NOUN
dpc-4793	620	31	3b	3b	NUM
dpc-4793	620	32	study	study	NOUN
dpc-4793	620	33	.	.	PUNCT
dpc-4793	621	1	j	j	PROPN
dpc-4793	621	2	am	be	AUX
dpc-4793	621	3	acad	acad	ADJ
dpc-4793	621	4	dermatol	dermatol	NOUN
dpc-4793	621	5	2017;77(4):667	2017;77(4):667	NUM
dpc-4793	621	6	-	-	SYM
dpc-4793	621	7	74	74	NUM
dpc-4793	621	8	.	.	PUNCT
dpc-4793	622	1	doi	doi	NOUN
dpc-4793	622	2	:	:	PUNCT
dpc-4793	622	3	10.1016	10.1016	NUM
dpc-4793	622	4	/	/	SYM
dpc-4793	622	5	j.jaad.2017.05.033	j.jaad.2017.05.033	VERB
dpc-4793	623	1	[	[	X
dpc-4793	623	2	published	publish	VERB
dpc-4793	623	3	online	online	ADV
dpc-4793	623	4	first	first	ADV
dpc-4793	623	5	:	:	PUNCT
dpc-4793	623	6	20170802	20170802	NUM
dpc-4793	623	7	]	]	PUNCT
dpc-4793	623	8	.	.	PUNCT
dpc-4793	624	1	pmid	pmid	NOUN
dpc-4793	624	2	:	:	PUNCT
dpc-4793	624	3	28780364	28780364	NUM
dpc-4793	624	4	.	.	PUNCT
dpc-4793	625	1	14	14	NUM
dpc-4793	625	2	.	.	PUNCT
dpc-4793	626	1	elewski	elewski	PROPN
dpc-4793	626	2	b	b	PROPN
dpc-4793	626	3	,	,	PUNCT
dpc-4793	626	4	rich	rich	ADJ
dpc-4793	626	5	p	p	NOUN
dpc-4793	626	6	,	,	PUNCT
dpc-4793	626	7	lain	lain	PROPN
dpc-4793	626	8	e	e	NOUN
dpc-4793	626	9	,	,	PUNCT
dpc-4793	626	10	soung	soung	PROPN
dpc-4793	626	11	j	j	PROPN
dpc-4793	626	12	,	,	PUNCT
dpc-4793	626	13	lewitt	lewitt	PROPN
dpc-4793	626	14	gm	gm	PROPN
dpc-4793	626	15	,	,	PUNCT
dpc-4793	626	16	jacobson	jacobson	PROPN
dpc-4793	626	17	a.	a.	PROPN
dpc-4793	626	18	efficacy	efficacy	PROPN
dpc-4793	626	19	of	of	ADP
dpc-4793	626	20	brodalumab	brodalumab	NOUN
dpc-4793	626	21	in	in	ADP
dpc-4793	626	22	the	the	DET
dpc-4793	626	23	treatment	treatment	NOUN
dpc-4793	626	24	of	of	ADP
dpc-4793	626	25	scalp	scalp	NOUN
dpc-4793	626	26	and	and	CCONJ
dpc-4793	626	27	nail	nail	NOUN
dpc-4793	626	28	psoriasis	psoriasis	NOUN
dpc-4793	626	29	:	:	PUNCT
dpc-4793	626	30	results	result	VERB
dpc-4793	626	31	from	from	ADP
dpc-4793	626	32	three	three	NUM
dpc-4793	626	33	phase	phase	NOUN
dpc-4793	626	34	3	3	NUM
dpc-4793	626	35	trials	trial	NOUN
dpc-4793	626	36	.	.	PUNCT
dpc-4793	627	1	j	j	PROPN
dpc-4793	627	2	dermatolog	dermatolog	PROPN
dpc-4793	627	3	treat	treat	VERB
dpc-4793	627	4	2022;33(1):261	2022;33(1):261	NUM
dpc-4793	627	5	-	-	SYM
dpc-4793	627	6	65	65	NUM
dpc-4793	627	7	.	.	PUNCT
dpc-4793	628	1	doi	doi	NOUN
dpc-4793	628	2	:	:	PUNCT
dpc-4793	628	3	10.1080/09546634.2020.1749546	10.1080/09546634.2020.1749546	NUM
dpc-4793	628	4	pmid	pmid	NOUN
dpc-4793	628	5	:	:	PUNCT
dpc-4793	628	6	32250714	32250714	NUM
dpc-4793	628	7	.	.	PUNCT
dpc-4793	629	1	15	15	NUM
dpc-4793	629	2	.	.	PUNCT
dpc-4793	629	3	bagel	bagel	PROPN
dpc-4793	629	4	j	j	PROPN
dpc-4793	629	5	,	,	PUNCT
dpc-4793	629	6	lynde	lynde	PROPN
dpc-4793	629	7	c	c	PROPN
dpc-4793	629	8	,	,	PUNCT
dpc-4793	629	9	tyring	tyre	VERB
dpc-4793	629	10	s	s	PRON
dpc-4793	629	11	,	,	PUNCT
dpc-4793	629	12	kricorian	kricorian	ADJ
dpc-4793	629	13	g	g	PROPN
dpc-4793	629	14	,	,	PUNCT
dpc-4793	629	15	shi	shi	PROPN
dpc-4793	629	16	y	y	PROPN
dpc-4793	629	17	,	,	PUNCT
dpc-4793	629	18	klekotka	klekotka	PROPN
dpc-4793	629	19	p.	p.	PROPN
dpc-4793	629	20	moderate	moderate	ADJ
dpc-4793	629	21	to	to	ADP
dpc-4793	629	22	severe	severe	ADJ
dpc-4793	629	23	plaque	plaque	NOUN
dpc-4793	629	24	psoriasis	psoriasis	NOUN
dpc-4793	629	25	with	with	ADP
dpc-4793	629	26	scalp	scalp	NOUN
dpc-4793	629	27	involvement	involvement	NOUN
dpc-4793	629	28	:	:	PUNCT
dpc-4793	629	29	a	a	DET
dpc-4793	629	30	randomized	randomized	ADJ
dpc-4793	629	31	,	,	PUNCT
dpc-4793	629	32	double	double	ADJ
dpc-4793	629	33	-	-	PUNCT
dpc-4793	629	34	blind	blind	ADJ
dpc-4793	629	35	,	,	PUNCT
dpc-4793	629	36	placebo	placebo	NOUN
dpc-4793	629	37	-	-	PUNCT
dpc-4793	629	38	controlled	control	VERB
dpc-4793	629	39	study	study	NOUN
dpc-4793	629	40	of	of	ADP
dpc-4793	629	41	etanercept	etanercept	NOUN
dpc-4793	629	42	.	.	PUNCT
dpc-4793	630	1	j	j	PROPN
dpc-4793	630	2	am	be	AUX
dpc-4793	630	3	acad	acad	ADJ
dpc-4793	630	4	dermatol	dermatol	NOUN
dpc-4793	630	5	2012;67(1):86	2012;67(1):86	NUM
dpc-4793	630	6	-	-	SYM
dpc-4793	630	7	92	92	NUM
dpc-4793	630	8	.	.	PUNCT
dpc-4793	631	1	doi	doi	NOUN
dpc-4793	631	2	:	:	PUNCT
dpc-4793	631	3	10.1016	10.1016	NUM
dpc-4793	631	4	/	/	SYM
dpc-4793	631	5	j.jaad	j.jaad	ADV
dpc-4793	631	6	.2011.07.034	.2011.07.034	PUNCT
dpc-4793	632	1	[	[	X
dpc-4793	632	2	published	publish	VERB
dpc-4793	632	3	online	online	ADV
dpc-4793	632	4	first	first	ADV
dpc-4793	632	5	:	:	PUNCT
dpc-4793	632	6	20111020	20111020	NUM
dpc-4793	632	7	]	]	PUNCT
dpc-4793	632	8	.	.	PUNCT
dpc-4793	633	1	pmid	pmid	NOUN
dpc-4793	633	2	:	:	PUNCT
dpc-4793	633	3	22014541	22014541	NUM
dpc-4793	633	4	.	.	PUNCT
dpc-4793	634	1	16	16	NUM
dpc-4793	634	2	.	.	PUNCT
dpc-4793	635	1	reich	reich	PROPN
dpc-4793	635	2	k	k	PROPN
dpc-4793	635	3	,	,	PUNCT
dpc-4793	635	4	leonardi	leonardi	PROPN
dpc-4793	635	5	c	c	PROPN
dpc-4793	635	6	,	,	PUNCT
dpc-4793	635	7	lebwohl	lebwohl	PROPN
dpc-4793	635	8	m	m	PROPN
dpc-4793	635	9	,	,	PUNCT
dpc-4793	635	10	et	et	PROPN
dpc-4793	635	11	al	al	PROPN
dpc-4793	635	12	.	.	PROPN
dpc-4793	635	13	sustained	sustain	VERB
dpc-4793	635	14	response	response	NOUN
dpc-4793	635	15	with	with	ADP
dpc-4793	635	16	ixekizumab	ixekizumab	NOUN
dpc-4793	635	17	treatment	treatment	NOUN
dpc-4793	635	18	of	of	ADP
dpc-4793	635	19	moderate	moderate	ADJ
dpc-4793	635	20	-	-	PUNCT
dpc-4793	635	21	to	to	ADP
dpc-4793	635	22	-	-	PUNCT
dpc-4793	635	23	severe	severe	ADJ
dpc-4793	635	24	psoriasis	psoriasis	NOUN
dpc-4793	635	25	with	with	ADP
dpc-4793	635	26	scalp	scalp	NOUN
dpc-4793	635	27	involvement	involvement	NOUN
dpc-4793	635	28	:	:	PUNCT
dpc-4793	635	29	results	result	VERB
dpc-4793	635	30	from	from	ADP
dpc-4793	635	31	three	three	NUM
dpc-4793	635	32	phase	phase	NOUN
dpc-4793	635	33	3	3	NUM
dpc-4793	635	34	trials	trial	NOUN
dpc-4793	635	35	(	(	PUNCT
dpc-4793	635	36	uncover-1	uncover-1	PROPN
dpc-4793	635	37	,	,	PUNCT
dpc-4793	635	38	uncover-2	uncover-2	NUM
dpc-4793	635	39	,	,	PUNCT
dpc-4793	635	40	uncover-3	uncover-3	NUM
dpc-4793	635	41	)	)	PUNCT
dpc-4793	635	42	.	.	PUNCT
dpc-4793	636	1	j	j	PROPN
dpc-4793	636	2	dermatolog	dermatolog	PROPN
dpc-4793	636	3	treat	treat	VERB
dpc-4793	636	4	2017;28(4):282	2017;28(4):282	PROPN
dpc-4793	636	5	-	-	SYM
dpc-4793	636	6	87	87	NUM
dpc-4793	636	7	.	.	PUNCT
dpc-4793	637	1	doi	doi	NOUN
dpc-4793	637	2	:	:	PUNCT
dpc-4793	637	3	10.1080/09546634.2016.1249820	10.1080/09546634.2016.1249820	NUM
dpc-4793	637	4	pmid	pmid	NOUN
dpc-4793	637	5	:	:	PUNCT
dpc-4793	637	6	27759463	27759463	NUM
dpc-4793	637	7	.	.	PUNCT
dpc-4793	638	1	17	17	NUM
dpc-4793	638	2	.	.	PUNCT
dpc-4793	639	1	seo	seo	NOUN
dpc-4793	639	2	sj	sj	PROPN
dpc-4793	639	3	,	,	PUNCT
dpc-4793	639	4	shin	shin	PROPN
dpc-4793	639	5	bs	bs	PROPN
dpc-4793	639	6	,	,	PUNCT
dpc-4793	639	7	lee	lee	PROPN
dpc-4793	639	8	jh	jh	PROPN
dpc-4793	639	9	,	,	PUNCT
dpc-4793	639	10	jeong	jeong	PROPN
dpc-4793	639	11	h.	h.	PROPN
dpc-4793	639	12	efficacy	efficacy	PROPN
dpc-4793	639	13	and	and	CCONJ
dpc-4793	639	14	safety	safety	NOUN
dpc-4793	639	15	of	of	ADP
dpc-4793	639	16	brodalumab	brodalumab	NOUN
dpc-4793	639	17	in	in	ADP
dpc-4793	639	18	the	the	DET
dpc-4793	639	19	korean	korean	ADJ
dpc-4793	639	20	population	population	NOUN
dpc-4793	639	21	for	for	ADP
dpc-4793	639	22	the	the	DET
dpc-4793	639	23	treatment	treatment	NOUN
dpc-4793	639	24	of	of	ADP
dpc-4793	639	25	moderate	moderate	ADJ
dpc-4793	639	26	to	to	ADP
dpc-4793	639	27	severe	severe	ADJ
dpc-4793	639	28	plaque	plaque	NOUN
dpc-4793	639	29	psoriasis	psoriasis	NOUN
dpc-4793	639	30	:	:	PUNCT
dpc-4793	639	31	a	a	DET
dpc-4793	639	32	randomized	randomized	ADJ
dpc-4793	639	33	,	,	PUNCT
dpc-4793	639	34	phase	phase	NOUN
dpc-4793	639	35	iii	iii	NOUN
dpc-4793	639	36	,	,	PUNCT
dpc-4793	639	37	double	double	ADJ
dpc-4793	639	38	-	-	PUNCT
dpc-4793	639	39	blind	blind	ADJ
dpc-4793	639	40	,	,	PUNCT
dpc-4793	639	41	placebo	placebo	NOUN
dpc-4793	639	42	-	-	PUNCT
dpc-4793	639	43	controlled	control	VERB
dpc-4793	639	44	study	study	NOUN
dpc-4793	639	45	.	.	PUNCT
dpc-4793	640	1	j	j	PROPN
dpc-4793	640	2	dermatol	dermatol	NOUN
dpc-4793	640	3	2021;48(6):807	2021;48(6):807	PROPN
dpc-4793	640	4	-	-	SYM
dpc-4793	640	5	17	17	NUM
dpc-4793	640	6	.	.	PUNCT
dpc-4793	641	1	doi	doi	NOUN
dpc-4793	641	2	:	:	PUNCT
dpc-4793	641	3	10.1111/1346	10.1111/1346	NUM
dpc-4793	641	4	-	-	SYM
dpc-4793	641	5	8138.15733	8138.15733	ADJ
dpc-4793	641	6	pmid	pmid	NOUN
dpc-4793	641	7	:	:	PUNCT
dpc-4793	641	8	33373480	33373480	NUM
dpc-4793	641	9	.	.	PUNCT
dpc-4793	642	1	18	18	NUM
dpc-4793	642	2	.	.	X
dpc-4793	642	3	nakagawa	nakagawa	PROPN
dpc-4793	642	4	h	h	PROPN
dpc-4793	642	5	,	,	PUNCT
dpc-4793	642	6	niiro	niiro	NOUN
dpc-4793	642	7	h	h	NOUN
dpc-4793	642	8	,	,	PUNCT
dpc-4793	642	9	ootaki	ootaki	PROPN
dpc-4793	642	10	k.	k.	PROPN
dpc-4793	642	11	brodalumab	brodalumab	PROPN
dpc-4793	642	12	,	,	PUNCT
dpc-4793	642	13	a	a	DET
dpc-4793	642	14	human	human	ADJ
dpc-4793	642	15	anti	anti	ADJ
dpc-4793	642	16	-	-	ADJ
dpc-4793	642	17	interleukin-17	interleukin-17	ADJ
dpc-4793	642	18	-	-	PUNCT
dpc-4793	642	19	receptor	receptor	NOUN
dpc-4793	642	20	antibody	antibody	NOUN
dpc-4793	642	21	in	in	ADP
dpc-4793	642	22	the	the	DET
dpc-4793	642	23	treatment	treatment	NOUN
dpc-4793	642	24	of	of	ADP
dpc-4793	642	25	japanese	japanese	ADJ
dpc-4793	642	26	patients	patient	NOUN
dpc-4793	642	27	with	with	ADP
dpc-4793	642	28	moderate	moderate	ADJ
dpc-4793	642	29	-	-	PUNCT
dpc-4793	642	30	to	to	ADP
dpc-4793	642	31	-	-	PUNCT
dpc-4793	642	32	severe	severe	ADJ
dpc-4793	642	33	plaque	plaque	NOUN
dpc-4793	642	34	psoriasis	psoriasis	NOUN
dpc-4793	642	35	:	:	PUNCT
dpc-4793	642	36	efficacy	efficacy	NOUN
dpc-4793	642	37	and	and	CCONJ
dpc-4793	642	38	safety	safety	NOUN
dpc-4793	642	39	results	result	NOUN
dpc-4793	642	40	from	from	ADP
dpc-4793	642	41	a	a	DET
dpc-4793	642	42	phase	phase	NOUN
dpc-4793	642	43	ii	ii	NOUN
dpc-4793	642	44	randomized	randomize	VERB
dpc-4793	642	45	controlled	control	VERB
dpc-4793	642	46	study	study	NOUN
dpc-4793	642	47	.	.	PUNCT
dpc-4793	643	1	j	j	PROPN
dpc-4793	643	2	dermatol	dermatol	NOUN
dpc-4793	643	3	sci	sci	PROPN
dpc-4793	643	4	2016;81(1):44	2016;81(1):44	PROPN
dpc-4793	643	5	-	-	PUNCT
dpc-4793	643	6	52	52	NUM
dpc-4793	643	7	.	.	PUNCT
dpc-4793	644	1	doi	doi	NOUN
dpc-4793	644	2	:	:	PUNCT
dpc-4793	644	3	10.1016	10.1016	NUM
dpc-4793	644	4	/	/	SYM
dpc-4793	644	5	j.jdermsci	j.jdermsci	PROPN
dpc-4793	644	6	.2015.10.009	.2015.10.009	PUNCT
dpc-4793	645	1	pmid	pmid	NOUN
dpc-4793	645	2	:	:	PUNCT
dpc-4793	645	3	26547109	26547109	NUM
dpc-4793	645	4	.	.	PUNCT
dpc-4793	646	1	19	19	NUM
dpc-4793	646	2	.	.	X
dpc-4793	647	1	langley	langley	PROPN
dpc-4793	647	2	rg	rg	PROPN
dpc-4793	647	3	,	,	PUNCT
dpc-4793	647	4	rich	rich	ADJ
dpc-4793	647	5	p	p	X
dpc-4793	647	6	,	,	PUNCT
dpc-4793	647	7	menter	menter	X
dpc-4793	647	8	a	a	NOUN
dpc-4793	647	9	,	,	PUNCT
dpc-4793	647	10	et	et	PROPN
dpc-4793	647	11	al	al	PROPN
dpc-4793	647	12	.	.	PUNCT
dpc-4793	647	13	improvement	improvement	NOUN
dpc-4793	647	14	of	of	ADP
dpc-4793	647	15	scalp	scalp	NOUN
dpc-4793	647	16	and	and	CCONJ
dpc-4793	647	17	nail	nail	NOUN
dpc-4793	647	18	lesions	lesion	NOUN
dpc-4793	647	19	with	with	ADP
dpc-4793	647	20	ixekizumab	ixekizumab	NOUN
dpc-4793	647	21	in	in	ADP
dpc-4793	647	22	a	a	DET
dpc-4793	647	23	phase	phase	NOUN
dpc-4793	647	24	2	2	NUM
dpc-4793	647	25	trial	trial	NOUN
dpc-4793	647	26	in	in	ADP
dpc-4793	647	27	patients	patient	NOUN
dpc-4793	647	28	with	with	ADP
dpc-4793	647	29	chronic	chronic	ADJ
dpc-4793	647	30	plaque	plaque	NOUN
dpc-4793	647	31	psoriasis	psoriasis	NOUN
dpc-4793	647	32	.	.	PUNCT
dpc-4793	648	1	j	j	PROPN
dpc-4793	648	2	eur	eur	PROPN
dpc-4793	648	3	acad	acad	PROPN
dpc-4793	648	4	dermatol	dermatol	NOUN
dpc-4793	648	5	venereol	venereol	NOUN
dpc-4793	648	6	2015;29(9):1763	2015;29(9):1763	PROPN
dpc-4793	648	7	-	-	SYM
dpc-4793	648	8	70	70	NUM
dpc-4793	648	9	.	.	PUNCT
dpc-4793	649	1	doi	doi	NOUN
dpc-4793	649	2	:	:	PUNCT
dpc-4793	649	3	10.1111	10.1111	NUM
dpc-4793	649	4	/	/	SYM
dpc-4793	649	5	jdv.12996	jdv.12996	NUM
dpc-4793	649	6	pmid	pmid	NOUN
dpc-4793	649	7	:	:	PUNCT
dpc-4793	649	8	25693783	25693783	NUM
dpc-4793	649	9	.	.	PUNCT
dpc-4793	650	1	20	20	NUM
dpc-4793	650	2	.	.	PUNCT
dpc-4793	651	1	thaçi	thaçi	PROPN
dpc-4793	651	2	d	d	PROPN
dpc-4793	651	3	,	,	PUNCT
dpc-4793	651	4	eyerich	eyerich	PROPN
dpc-4793	651	5	k	k	NOUN
dpc-4793	651	6	,	,	PUNCT
dpc-4793	651	7	pinter	pinter	VERB
dpc-4793	651	8	a	a	NOUN
dpc-4793	651	9	,	,	PUNCT
dpc-4793	651	10	et	et	PROPN
dpc-4793	651	11	al	al	PROPN
dpc-4793	651	12	.	.	PUNCT
dpc-4793	652	1	direct	direct	ADJ
dpc-4793	652	2	comparison	comparison	NOUN
dpc-4793	652	3	of	of	ADP
dpc-4793	652	4	risankizumab	risankizumab	NOUN
dpc-4793	652	5	and	and	CCONJ
dpc-4793	652	6	fumaric	fumaric	ADJ
dpc-4793	652	7	acid	acid	NOUN
dpc-4793	652	8	esters	ester	NOUN
dpc-4793	652	9	in	in	ADP
dpc-4793	652	10	systemic	systemic	ADJ
dpc-4793	652	11	therapy	therapy	NOUN
dpc-4793	652	12	-	-	PUNCT
dpc-4793	652	13	naïve	naïve	ADJ
dpc-4793	652	14	patients	patient	NOUN
dpc-4793	652	15	with	with	ADP
dpc-4793	652	16	moderate	moderate	ADJ
dpc-4793	652	17	-	-	PUNCT
dpc-4793	652	18	to	to	ADP
dpc-4793	652	19	-	-	PUNCT
dpc-4793	652	20	severe	severe	ADJ
dpc-4793	652	21	plaque	plaque	NOUN
dpc-4793	652	22	psoriasis	psoriasis	NOUN
dpc-4793	652	23	:	:	PUNCT
dpc-4793	652	24	a	a	DET
dpc-4793	652	25	randomized	randomized	ADJ
dpc-4793	652	26	12	12	NUM
dpc-4793	652	27	review	review	NOUN
dpc-4793	652	28	|	|	ADV
dpc-4793	652	29	dermatol	dermatol	ADJ
dpc-4793	652	30	pract	pract	NOUN
dpc-4793	652	31	concept	concept	NOUN
dpc-4793	652	32	.	.	PUNCT
dpc-4793	653	1	2025;15(2):4793	2025;15(2):4793	NUM
dpc-4793	653	2	40	40	NUM
dpc-4793	653	3	.	.	PUNCT
dpc-4793	654	1	okubo	okubo	PROPN
dpc-4793	654	2	y	y	PROPN
dpc-4793	654	3	,	,	PUNCT
dpc-4793	654	4	natsume	natsume	PROPN
dpc-4793	654	5	s	s	PROPN
dpc-4793	654	6	,	,	PUNCT
dpc-4793	654	7	usui	usui	NOUN
dpc-4793	654	8	k	k	PROPN
dpc-4793	654	9	,	,	PUNCT
dpc-4793	654	10	muro	muro	PROPN
dpc-4793	654	11	m	m	PROPN
dpc-4793	654	12	,	,	PUNCT
dpc-4793	654	13	tsuboi	tsuboi	PROPN
dpc-4793	654	14	r.	r.	PROPN
dpc-4793	654	15	combination	combination	NOUN
dpc-4793	654	16	therapy	therapy	NOUN
dpc-4793	654	17	using	use	VERB
dpc-4793	654	18	maxacalcitol	maxacalcitol	PROPN
dpc-4793	654	19	and	and	CCONJ
dpc-4793	654	20	corticosteroid	corticosteroid	ADJ
dpc-4793	654	21	lotions	lotion	NOUN
dpc-4793	654	22	preliminary	preliminary	ADJ
dpc-4793	654	23	to	to	ADP
dpc-4793	654	24	monotherapy	monotherapy	NOUN
dpc-4793	654	25	with	with	ADP
dpc-4793	654	26	maxacalcitol	maxacalcitol	NOUN
dpc-4793	654	27	lotion	lotion	NOUN
dpc-4793	654	28	for	for	ADP
dpc-4793	654	29	scalp	scalp	NOUN
dpc-4793	654	30	psoriasis	psoriasis	NOUN
dpc-4793	654	31	.	.	PUNCT
dpc-4793	655	1	j	j	PROPN
dpc-4793	655	2	dermatolog	dermatolog	PROPN
dpc-4793	655	3	treat	treat	VERB
dpc-4793	655	4	2014;25(1):34	2014;25(1):34	NUM
dpc-4793	655	5	-	-	SYM
dpc-4793	655	6	7	7	NUM
dpc-4793	655	7	.	.	PUNCT
dpc-4793	656	1	doi	doi	NOUN
dpc-4793	656	2	:	:	PUNCT
dpc-4793	656	3	10.3109	10.3109	NUM
dpc-4793	656	4	/09546634.2012.687087	/09546634.2012.687087	PUNCT
dpc-4793	656	5	pmid	pmid	NOUN
dpc-4793	656	6	:	:	PUNCT
dpc-4793	656	7	22515652	22515652	NUM
dpc-4793	656	8	.	.	PUNCT
dpc-4793	657	1	41	41	NUM
dpc-4793	657	2	.	.	PUNCT
dpc-4793	658	1	bahraini	bahraini	PROPN
dpc-4793	658	2	p	p	PROPN
dpc-4793	658	3	,	,	PUNCT
dpc-4793	658	4	rajabi	rajabi	NOUN
dpc-4793	658	5	m	m	PROPN
dpc-4793	658	6	,	,	PUNCT
dpc-4793	658	7	mansouri	mansouri	PROPN
dpc-4793	658	8	p	p	NOUN
dpc-4793	658	9	,	,	PUNCT
dpc-4793	658	10	sarafian	sarafian	ADJ
dpc-4793	658	11	g	g	PROPN
dpc-4793	658	12	,	,	PUNCT
dpc-4793	658	13	chalangari	chalangari	PROPN
dpc-4793	658	14	r	r	PROPN
dpc-4793	658	15	,	,	PUNCT
dpc-4793	658	16	azizian	azizian	PROPN
dpc-4793	658	17	z.	z.	PROPN
dpc-4793	658	18	turmeric	turmeric	PROPN
dpc-4793	658	19	tonic	tonic	NOUN
dpc-4793	658	20	as	as	ADP
dpc-4793	658	21	a	a	DET
dpc-4793	658	22	treatment	treatment	NOUN
dpc-4793	658	23	in	in	ADP
dpc-4793	658	24	scalp	scalp	NOUN
dpc-4793	658	25	psoriasis	psoriasis	NOUN
dpc-4793	658	26	:	:	PUNCT
dpc-4793	658	27	a	a	DET
dpc-4793	658	28	randomized	randomized	ADJ
dpc-4793	658	29	placebo	placebo	NOUN
dpc-4793	658	30	-	-	PUNCT
dpc-4793	658	31	control	control	NOUN
dpc-4793	658	32	clinical	clinical	ADJ
dpc-4793	658	33	trial	trial	NOUN
dpc-4793	658	34	.	.	PUNCT
dpc-4793	659	1	j	j	PROPN
dpc-4793	659	2	cosmet	cosmet	VERB
dpc-4793	659	3	dermatol	dermatol	NOUN
dpc-4793	659	4	2018;17(3):461	2018;17(3):461	NUM
dpc-4793	659	5	-	-	SYM
dpc-4793	659	6	66	66	NUM
dpc-4793	659	7	doi	doi	NOUN
dpc-4793	659	8	:	:	PUNCT
dpc-4793	659	9	10.1111	10.1111	NUM
dpc-4793	659	10	/	/	SYM
dpc-4793	659	11	jocd.12513	jocd.12513	PROPN
dpc-4793	659	12	pmid	pmid	PROPN
dpc-4793	659	13	:	:	PUNCT
dpc-4793	659	14	22515652	22515652	NUM
dpc-4793	659	15	.	.	PUNCT
dpc-4793	660	1	42	42	NUM
dpc-4793	660	2	.	.	PUNCT
dpc-4793	661	1	jury	jury	NOUN
dpc-4793	661	2	cs	cs	PROPN
dpc-4793	661	3	,	,	PUNCT
dpc-4793	661	4	mchugh	mchugh	PROPN
dpc-4793	661	5	l	l	PROPN
dpc-4793	661	6	,	,	PUNCT
dpc-4793	661	7	shankland	shankland	NOUN
dpc-4793	661	8	gs	gs	NOUN
dpc-4793	661	9	,	,	PUNCT
dpc-4793	661	10	burden	burden	NOUN
dpc-4793	661	11	ad	ad	NOUN
dpc-4793	661	12	.	.	PUNCT
dpc-4793	662	1	a	a	DET
dpc-4793	662	2	randomized	randomized	ADJ
dpc-4793	662	3	,	,	PUNCT
dpc-4793	662	4	placebo	placebo	NOUN
dpc-4793	662	5	-	-	PUNCT
dpc-4793	662	6	controlled	control	VERB
dpc-4793	662	7	trial	trial	NOUN
dpc-4793	662	8	of	of	ADP
dpc-4793	662	9	oral	oral	ADJ
dpc-4793	662	10	itraconazole	itraconazole	NOUN
dpc-4793	662	11	in	in	ADP
dpc-4793	662	12	scalp	scalp	NOUN
dpc-4793	662	13	psoriasis	psoriasis	NOUN
dpc-4793	662	14	.	.	PUNCT
dpc-4793	663	1	j.	j.	PROPN
dpc-4793	663	2	dermatol	dermatol	PROPN
dpc-4793	663	3	.	.	PUNCT
dpc-4793	664	1	treat	treat	NOUN
dpc-4793	664	2	.	.	PUNCT
dpc-4793	665	1	2000;11(2):85	2000;11(2):85	NUM
dpc-4793	665	2	-	-	SYM
dpc-4793	665	3	89	89	NUM
dpc-4793	665	4	.	.	PUNCT
dpc-4793	666	1	doi	doi	NOUN
dpc-4793	666	2	:	:	PUNCT
dpc-4793	666	3	10.1080/095466	10.1080/095466	NUM
dpc-4793	666	4	30050517469	30050517469	NUM
dpc-4793	666	5	.	.	PUNCT
dpc-4793	667	1	43	43	NUM
dpc-4793	667	2	.	.	PUNCT
dpc-4793	668	1	rich	rich	ADJ
dpc-4793	668	2	p	p	NOUN
dpc-4793	668	3	,	,	PUNCT
dpc-4793	668	4	gooderham	gooderham	PROPN
dpc-4793	668	5	m	m	PROPN
dpc-4793	668	6	,	,	PUNCT
dpc-4793	668	7	bachelez	bachelez	PROPN
dpc-4793	668	8	h	h	NOUN
dpc-4793	668	9	,	,	PUNCT
dpc-4793	668	10	et	et	PROPN
dpc-4793	668	11	al	al	PROPN
dpc-4793	668	12	.	.	PROPN
dpc-4793	669	1	apremilast	apremilast	PROPN
dpc-4793	669	2	,	,	PUNCT
dpc-4793	669	3	an	an	DET
dpc-4793	669	4	oral	oral	ADJ
dpc-4793	669	5	phosphodiesterase	phosphodiesterase	NOUN
dpc-4793	669	6	4	4	NUM
dpc-4793	669	7	inhibitor	inhibitor	NOUN
dpc-4793	669	8	,	,	PUNCT
dpc-4793	669	9	in	in	ADP
dpc-4793	669	10	patients	patient	NOUN
dpc-4793	669	11	with	with	ADP
dpc-4793	669	12	difficult	difficult	ADJ
dpc-4793	669	13	-	-	PUNCT
dpc-4793	669	14	to	to	AUX
dpc-4793	669	15	-	-	PUNCT
dpc-4793	669	16	treat	treat	VERB
dpc-4793	669	17	nail	nail	NOUN
dpc-4793	669	18	and	and	CCONJ
dpc-4793	669	19	scalp	scalp	NOUN
dpc-4793	669	20	psoriasis	psoriasis	NOUN
dpc-4793	669	21	:	:	PUNCT
dpc-4793	669	22	results	result	NOUN
dpc-4793	669	23	of	of	ADP
dpc-4793	669	24	2	2	NUM
dpc-4793	669	25	phase	phase	NOUN
dpc-4793	669	26	iii	iii	NOUN
dpc-4793	669	27	randomized	randomize	VERB
dpc-4793	669	28	,	,	PUNCT
dpc-4793	669	29	controlled	control	VERB
dpc-4793	669	30	trials	trial	NOUN
dpc-4793	669	31	(	(	PUNCT
dpc-4793	669	32	esteem	esteem	NOUN
dpc-4793	669	33	1	1	NUM
dpc-4793	669	34	and	and	CCONJ
dpc-4793	669	35	esteem	esteem	VERB
dpc-4793	669	36	2	2	NUM
dpc-4793	669	37	)	)	PUNCT
dpc-4793	669	38	.	.	PUNCT
dpc-4793	670	1	j	j	PROPN
dpc-4793	670	2	am	be	AUX
dpc-4793	670	3	acad	acad	ADJ
dpc-4793	670	4	dermatol	dermatol	NOUN
dpc-4793	670	5	2016;74(1):134	2016;74(1):134	PROPN
dpc-4793	670	6	-	-	PUNCT
dpc-4793	670	7	42	42	NUM
dpc-4793	670	8	.	.	PUNCT
dpc-4793	671	1	doi	doi	NOUN
dpc-4793	671	2	:	:	PUNCT
dpc-4793	671	3	10.1016	10.1016	NUM
dpc-4793	671	4	/	/	SYM
dpc-4793	671	5	j.jaad.2015.09.001	j.jaad.2015.09.001	PROPN
dpc-4793	671	6	.	.	PUNCT
dpc-4793	672	1	pmid	pmid	NOUN
dpc-4793	672	2	:	:	PUNCT
dpc-4793	672	3	26549249	26549249	NUM
dpc-4793	672	4	.	.	PUNCT
dpc-4793	673	1	44	44	NUM
dpc-4793	673	2	.	.	PUNCT
dpc-4793	674	1	blauvelt	blauvelt	VERB
dpc-4793	674	2	a	a	PRON
dpc-4793	674	3	,	,	PUNCT
dpc-4793	674	4	papp	papp	PROPN
dpc-4793	674	5	ka	ka	PROPN
dpc-4793	674	6	,	,	PUNCT
dpc-4793	674	7	griffiths	griffiths	PROPN
dpc-4793	674	8	ce	ce	PROPN
dpc-4793	674	9	,	,	PUNCT
dpc-4793	674	10	et	et	PROPN
dpc-4793	674	11	al	al	PROPN
dpc-4793	674	12	.	.	PROPN
dpc-4793	674	13	efficacy	efficacy	NOUN
dpc-4793	674	14	and	and	CCONJ
dpc-4793	674	15	safety	safety	NOUN
dpc-4793	674	16	of	of	ADP
dpc-4793	674	17	guselkumab	guselkumab	NOUN
dpc-4793	674	18	,	,	PUNCT
dpc-4793	674	19	an	an	DET
dpc-4793	674	20	anti	anti	ADJ
dpc-4793	674	21	-	-	ADJ
dpc-4793	674	22	interleukin-23	interleukin-23	ADJ
dpc-4793	674	23	monoclonal	monoclonal	NOUN
dpc-4793	674	24	antibody	antibody	NOUN
dpc-4793	674	25	,	,	PUNCT
dpc-4793	674	26	compared	compare	VERB
dpc-4793	674	27	with	with	ADP
dpc-4793	674	28	adalimumab	adalimumab	NOUN
dpc-4793	674	29	for	for	ADP
dpc-4793	674	30	the	the	DET
dpc-4793	674	31	continuous	continuous	ADJ
dpc-4793	674	32	treatment	treatment	NOUN
dpc-4793	674	33	of	of	ADP
dpc-4793	674	34	patients	patient	NOUN
dpc-4793	674	35	with	with	ADP
dpc-4793	674	36	moderate	moderate	ADJ
dpc-4793	674	37	to	to	ADP
dpc-4793	674	38	severe	severe	ADJ
dpc-4793	674	39	psoriasis	psoriasis	NOUN
dpc-4793	674	40	:	:	PUNCT
dpc-4793	674	41	results	result	VERB
dpc-4793	674	42	from	from	ADP
dpc-4793	674	43	the	the	DET
dpc-4793	674	44	phase	phase	NOUN
dpc-4793	674	45	iii	iii	NOUN
dpc-4793	674	46	,	,	PUNCT
dpc-4793	674	47	double	double	ADJ
dpc-4793	674	48	-	-	PUNCT
dpc-4793	674	49	blinded	blind	VERB
dpc-4793	674	50	,	,	PUNCT
dpc-4793	674	51	placeboand	placeboand	VERB
dpc-4793	674	52	active	active	ADJ
dpc-4793	674	53	comparator	comparator	NOUN
dpc-4793	674	54	-	-	PUNCT
dpc-4793	674	55	controlled	control	VERB
dpc-4793	674	56	voyage	voyage	NOUN
dpc-4793	674	57	1	1	NUM
dpc-4793	674	58	trial	trial	NOUN
dpc-4793	674	59	.	.	PUNCT
dpc-4793	675	1	j	j	PROPN
dpc-4793	675	2	am	be	AUX
dpc-4793	675	3	acad	acad	ADJ
dpc-4793	675	4	dermatol	dermatol	NOUN
dpc-4793	675	5	2017;76(3):405	2017;76(3):405	PROPN
dpc-4793	675	6	-	-	SYM
dpc-4793	675	7	17	17	NUM
dpc-4793	675	8	.	.	PUNCT
dpc-4793	676	1	doi	doi	NOUN
dpc-4793	676	2	:	:	PUNCT
dpc-4793	676	3	10.1016	10.1016	NUM
dpc-4793	676	4	/j.jaad.2016.11.041	/j.jaad.2016.11.041	PUNCT
dpc-4793	677	1	pmid	pmid	NOUN
dpc-4793	677	2	:	:	PUNCT
dpc-4793	677	3	28057360	28057360	NUM
dpc-4793	677	4	.	.	PUNCT
dpc-4793	678	1	45	45	NUM
dpc-4793	678	2	.	.	PUNCT
dpc-4793	678	3	bergstrom	bergstrom	PROPN
dpc-4793	678	4	kg	kg	PROPN
dpc-4793	678	5	,	,	PUNCT
dpc-4793	678	6	arambula	arambula	PROPN
dpc-4793	678	7	k	k	PROPN
dpc-4793	678	8	,	,	PUNCT
dpc-4793	678	9	kimball	kimball	PROPN
dpc-4793	678	10	ab	ab	PROPN
dpc-4793	678	11	.	.	PROPN
dpc-4793	678	12	medication	medication	NOUN
dpc-4793	678	13	formulation	formulation	NOUN
dpc-4793	678	14	affects	affect	VERB
dpc-4793	678	15	quality	quality	NOUN
dpc-4793	678	16	of	of	ADP
dpc-4793	678	17	life	life	NOUN
dpc-4793	678	18	:	:	PUNCT
dpc-4793	678	19	a	a	DET
dpc-4793	678	20	randomized	randomized	ADJ
dpc-4793	678	21	single	single	ADJ
dpc-4793	678	22	-	-	PUNCT
dpc-4793	678	23	blind	blind	ADJ
dpc-4793	678	24	study	study	NOUN
dpc-4793	678	25	of	of	ADP
dpc-4793	678	26	clobetasol	clobetasol	NOUN
dpc-4793	678	27	propionate	propionate	NOUN
dpc-4793	678	28	foam	foam	NOUN
dpc-4793	678	29	0.05	0.05	NUM
dpc-4793	678	30	%	%	NOUN
dpc-4793	678	31	compared	compare	VERB
dpc-4793	678	32	with	with	ADP
dpc-4793	678	33	a	a	DET
dpc-4793	678	34	combined	combined	ADJ
dpc-4793	678	35	program	program	NOUN
dpc-4793	678	36	of	of	ADP
dpc-4793	678	37	clobetasol	clobetasol	NOUN
dpc-4793	678	38	cream	cream	NOUN
dpc-4793	678	39	0.05	0.05	NUM
dpc-4793	678	40	%	%	NOUN
dpc-4793	678	41	and	and	CCONJ
dpc-4793	678	42	solution	solution	NOUN
dpc-4793	678	43	0.05	0.05	NUM
dpc-4793	678	44	%	%	NOUN
dpc-4793	678	45	for	for	ADP
dpc-4793	678	46	the	the	DET
dpc-4793	678	47	treatment	treatment	NOUN
dpc-4793	678	48	of	of	ADP
dpc-4793	678	49	psoriasis	psoriasis	NOUN
dpc-4793	678	50	.	.	PUNCT
dpc-4793	679	1	cutis	cutis	NOUN
dpc-4793	679	2	2003;72(5):407	2003;72(5):407	PROPN
dpc-4793	679	3	-	-	SYM
dpc-4793	679	4	11	11	NUM
dpc-4793	679	5	.	.	PUNCT
dpc-4793	680	1	pmid	pmid	NOUN
dpc-4793	680	2	:	:	PUNCT
dpc-4793	680	3	14655784	14655784	NUM
dpc-4793	680	4	.	.	PUNCT
dpc-4793	681	1	46	46	NUM
dpc-4793	681	2	.	.	PUNCT
dpc-4793	681	3	stein	stein	PROPN
dpc-4793	681	4	gold	gold	PROPN
dpc-4793	681	5	l	l	PROPN
dpc-4793	681	6	,	,	PUNCT
dpc-4793	681	7	papp	papp	PROPN
dpc-4793	681	8	k	k	PROPN
dpc-4793	681	9	,	,	PUNCT
dpc-4793	681	10	pariser	pariser	NOUN
dpc-4793	681	11	d	d	PROPN
dpc-4793	681	12	,	,	PUNCT
dpc-4793	681	13	et	et	PROPN
dpc-4793	681	14	al	al	PROPN
dpc-4793	681	15	.	.	PROPN
dpc-4793	681	16	efficacy	efficacy	NOUN
dpc-4793	681	17	and	and	CCONJ
dpc-4793	681	18	safety	safety	NOUN
dpc-4793	681	19	of	of	ADP
dpc-4793	681	20	apremilast	apremilast	NOUN
dpc-4793	681	21	in	in	ADP
dpc-4793	681	22	patients	patient	NOUN
dpc-4793	681	23	with	with	ADP
dpc-4793	681	24	mild	mild	ADJ
dpc-4793	681	25	-	-	PUNCT
dpc-4793	681	26	to	to	ADP
dpc-4793	681	27	-	-	PUNCT
dpc-4793	681	28	moderate	moderate	ADJ
dpc-4793	681	29	plaque	plaque	NOUN
dpc-4793	681	30	psoriasis	psoriasis	NOUN
dpc-4793	681	31	:	:	PUNCT
dpc-4793	681	32	results	result	NOUN
dpc-4793	681	33	of	of	ADP
dpc-4793	681	34	a	a	DET
dpc-4793	681	35	phase	phase	NOUN
dpc-4793	681	36	3	3	NUM
dpc-4793	681	37	,	,	PUNCT
dpc-4793	681	38	multicenter	multicenter	NOUN
dpc-4793	681	39	,	,	PUNCT
dpc-4793	681	40	randomized	randomize	VERB
dpc-4793	681	41	,	,	PUNCT
dpc-4793	681	42	double	double	ADJ
dpc-4793	681	43	-	-	PUNCT
dpc-4793	681	44	blind	blind	ADJ
dpc-4793	681	45	,	,	PUNCT
dpc-4793	681	46	placebo	placebo	NOUN
dpc-4793	681	47	-	-	PUNCT
dpc-4793	681	48	controlled	control	VERB
dpc-4793	681	49	trial	trial	NOUN
dpc-4793	681	50	.	.	PUNCT
dpc-4793	682	1	j	j	PROPN
dpc-4793	682	2	am	be	AUX
dpc-4793	682	3	acad	acad	X
dpc-4793	682	4	dermatol	dermatol	NOUN
dpc-4793	682	5	2022;86(1):77	2022;86(1):77	PROPN
dpc-4793	682	6	-	-	PUNCT
dpc-4793	682	7	85	85	NUM
dpc-4793	682	8	.	.	PUNCT
dpc-4793	683	1	doi	doi	NOUN
dpc-4793	683	2	:	:	PUNCT
dpc-4793	683	3	10.1016	10.1016	NUM
dpc-4793	683	4	/	/	SYM
dpc-4793	683	5	j.jaad.2021.07.040	j.jaad.2021.07.040	PROPN
dpc-4793	683	6	pmid	pmid	PROPN
dpc-4793	683	7	:	:	PUNCT
dpc-4793	683	8	34343599	34343599	NUM
dpc-4793	683	9	.	.	PUNCT
dpc-4793	684	1	47	47	NUM
dpc-4793	684	2	.	.	PUNCT
dpc-4793	685	1	camela	camela	ADP
dpc-4793	685	2	e	e	PROPN
dpc-4793	685	3	,	,	PUNCT
dpc-4793	685	4	ocampo	ocampo	PROPN
dpc-4793	685	5	-	-	PUNCT
dpc-4793	685	6	garza	garza	PROPN
dpc-4793	685	7	ss	ss	PROPN
dpc-4793	685	8	,	,	PUNCT
dpc-4793	685	9	cinelli	cinelli	PROPN
dpc-4793	685	10	e	e	PROPN
dpc-4793	685	11	,	,	PUNCT
dpc-4793	685	12	villani	villani	PROPN
dpc-4793	685	13	a	a	X
dpc-4793	685	14	,	,	PUNCT
dpc-4793	685	15	fabbrocini	fabbrocini	NOUN
dpc-4793	685	16	g	g	NOUN
dpc-4793	685	17	,	,	PUNCT
dpc-4793	685	18	megna	megna	PROPN
dpc-4793	685	19	m.	m.	NOUN
dpc-4793	685	20	therapeutic	therapeutic	ADJ
dpc-4793	685	21	update	update	NOUN
dpc-4793	685	22	of	of	ADP
dpc-4793	685	23	biologics	biologic	NOUN
dpc-4793	685	24	and	and	CCONJ
dpc-4793	685	25	small	small	ADJ
dpc-4793	685	26	molecules	molecule	NOUN
dpc-4793	685	27	for	for	ADP
dpc-4793	685	28	scalp	scalp	NOUN
dpc-4793	685	29	psoriasis	psoriasis	NOUN
dpc-4793	685	30	:	:	PUNCT
dpc-4793	685	31	a	a	DET
dpc-4793	685	32	systematic	systematic	ADJ
dpc-4793	685	33	review	review	NOUN
dpc-4793	685	34	.	.	PUNCT
dpc-4793	686	1	dermatol	dermatol	NOUN
dpc-4793	686	2	ther	ther	VERB
dpc-4793	686	3	2021;34(2):e14857	2021;34(2):e14857	NUM
dpc-4793	686	4	doi	doi	NOUN
dpc-4793	686	5	:	:	PUNCT
dpc-4793	686	6	10.1111	10.1111	NUM
dpc-4793	686	7	/	/	SYM
dpc-4793	686	8	dth.14857	dth.14857	PRON
dpc-4793	686	9	pmid	pmid	NOUN
dpc-4793	686	10	:	:	PUNCT
dpc-4793	686	11	33559275	33559275	NUM
dpc-4793	686	12	.	.	PUNCT
dpc-4793	687	1	48	48	NUM
dpc-4793	687	2	.	.	PUNCT
dpc-4793	687	3	takeda	takeda	PROPN
dpc-4793	688	1	k	k	PROPN
dpc-4793	688	2	,	,	PUNCT
dpc-4793	688	3	arase	arase	NOUN
dpc-4793	688	4	s	s	PROPN
dpc-4793	688	5	,	,	PUNCT
dpc-4793	688	6	takahashi	takahashi	PROPN
dpc-4793	688	7	s.	s.	PROPN
dpc-4793	688	8	side	side	NOUN
dpc-4793	688	9	effects	effect	NOUN
dpc-4793	688	10	of	of	ADP
dpc-4793	688	11	topical	topical	ADJ
dpc-4793	688	12	corticosteroids	corticosteroid	NOUN
dpc-4793	688	13	and	and	CCONJ
dpc-4793	688	14	their	their	PRON
dpc-4793	688	15	prevention	prevention	NOUN
dpc-4793	688	16	.	.	PUNCT
dpc-4793	689	1	drugs	drug	NOUN
dpc-4793	689	2	1988;36	1988;36	NUM
dpc-4793	689	3	suppl	suppl	PROPN
dpc-4793	689	4	5:15	5:15	NUM
dpc-4793	689	5	-	-	PUNCT
dpc-4793	689	6	23	23	NUM
dpc-4793	689	7	.	.	PUNCT
dpc-4793	690	1	doi	doi	NOUN
dpc-4793	690	2	:	:	PUNCT
dpc-4793	690	3	10.2165/00003495	10.2165/00003495	NUM
dpc-4793	690	4	-	-	SYM
dpc-4793	690	5	198800365	198800365	NUM
dpc-4793	690	6	-	-	PUNCT
dpc-4793	690	7	00005	00005	NUM
dpc-4793	690	8	.	.	PUNCT
dpc-4793	691	1	pmid	pmid	NOUN
dpc-4793	691	2	:	:	PUNCT
dpc-4793	691	3	3076129	3076129	NUM
dpc-4793	691	4	.	.	PUNCT
dpc-4793	692	1	49	49	NUM
dpc-4793	692	2	.	.	PUNCT
dpc-4793	693	1	fotiadou	fotiadou	PROPN
dpc-4793	693	2	c	c	PROPN
dpc-4793	693	3	,	,	PUNCT
dpc-4793	693	4	lazaridou	lazaridou	PROPN
dpc-4793	693	5	e	e	NOUN
dpc-4793	693	6	,	,	PUNCT
dpc-4793	693	7	sotiriou	sotiriou	ADJ
dpc-4793	693	8	e	e	NOUN
dpc-4793	693	9	,	,	PUNCT
dpc-4793	693	10	kyrgidis	kyrgidi	VERB
dpc-4793	693	11	a	a	PRON
dpc-4793	693	12	,	,	PUNCT
dpc-4793	693	13	apalla	apalla	PROPN
dpc-4793	693	14	z	z	PROPN
dpc-4793	693	15	,	,	PUNCT
dpc-4793	693	16	ioannides	ioannide	NOUN
dpc-4793	693	17	d.	d.	PROPN
dpc-4793	693	18	scalp	scalp	NOUN
dpc-4793	693	19	psoriasis	psoriasis	NOUN
dpc-4793	693	20	and	and	CCONJ
dpc-4793	693	21	biologic	biologic	NOUN
dpc-4793	693	22	agents	agent	NOUN
dpc-4793	693	23	:	:	PUNCT
dpc-4793	693	24	a	a	DET
dpc-4793	693	25	retrospective	retrospective	ADJ
dpc-4793	693	26	,	,	PUNCT
dpc-4793	693	27	comparative	comparative	ADJ
dpc-4793	693	28	study	study	NOUN
dpc-4793	693	29	from	from	ADP
dpc-4793	693	30	a	a	DET
dpc-4793	693	31	tertiary	tertiary	ADJ
dpc-4793	693	32	psoriasis	psoriasis	NOUN
dpc-4793	693	33	referral	referral	NOUN
dpc-4793	693	34	centre	centre	NOUN
dpc-4793	693	35	.	.	PUNCT
dpc-4793	694	1	j	j	PROPN
dpc-4793	694	2	eur	eur	PROPN
dpc-4793	694	3	acad	acad	PROPN
dpc-4793	694	4	dermatol	dermatol	NOUN
dpc-4793	694	5	venereol	venereol	NOUN
dpc-4793	694	6	2016;30(12):2091	2016;30(12):2091	NUM
dpc-4793	694	7	-	-	SYM
dpc-4793	694	8	96	96	NUM
dpc-4793	694	9	.	.	PUNCT
dpc-4793	695	1	doi	doi	NOUN
dpc-4793	695	2	:	:	PUNCT
dpc-4793	695	3	10.1111	10.1111	NUM
dpc-4793	695	4	/jdv.13780	/jdv.13780	NOUN
dpc-4793	695	5	pmid	pmid	NOUN
dpc-4793	695	6	:	:	PUNCT
dpc-4793	695	7	27406435	27406435	NUM
dpc-4793	695	8	.	.	PUNCT
dpc-4793	696	1	50	50	NUM
dpc-4793	696	2	.	.	X
dpc-4793	697	1	feldman	feldman	PROPN
dpc-4793	697	2	sr	sr	PROPN
dpc-4793	697	3	.	.	PUNCT
dpc-4793	698	1	treatment	treatment	NOUN
dpc-4793	698	2	of	of	ADP
dpc-4793	698	3	psoriasis	psoriasis	NOUN
dpc-4793	698	4	in	in	ADP
dpc-4793	698	5	adults	adult	NOUN
dpc-4793	698	6	.	.	PUNCT
dpc-4793	699	1	2023	2023	NUM
dpc-4793	699	2	.	.	X
dpc-4793	700	1	51	51	NUM
dpc-4793	700	2	.	.	PUNCT
dpc-4793	700	3	hoffman	hoffman	PROPN
dpc-4793	700	4	mb	mb	PROPN
dpc-4793	700	5	,	,	PUNCT
dpc-4793	700	6	hill	hill	PROPN
dpc-4793	700	7	d	d	PROPN
dpc-4793	700	8	,	,	PUNCT
dpc-4793	700	9	feldman	feldman	PROPN
dpc-4793	700	10	sr	sr	PROPN
dpc-4793	700	11	.	.	PUNCT
dpc-4793	701	1	current	current	ADJ
dpc-4793	701	2	challenges	challenge	NOUN
dpc-4793	701	3	and	and	CCONJ
dpc-4793	701	4	emerging	emerge	VERB
dpc-4793	701	5	drug	drug	NOUN
dpc-4793	701	6	delivery	delivery	NOUN
dpc-4793	701	7	strategies	strategy	NOUN
dpc-4793	701	8	for	for	ADP
dpc-4793	701	9	the	the	DET
dpc-4793	701	10	treatment	treatment	NOUN
dpc-4793	701	11	of	of	ADP
dpc-4793	701	12	psoriasis	psoriasis	NOUN
dpc-4793	701	13	.	.	PUNCT
dpc-4793	701	14	  	  	SPACE
dpc-4793	702	1	expert	expert	ADJ
dpc-4793	702	2	opin	opin	NOUN
dpc-4793	702	3	drug	drug	NOUN
dpc-4793	702	4	deliv	deliv	NOUN
dpc-4793	702	5	.	.	PUNCT
dpc-4793	703	1	2016;13(10):1461	2016;13(10):1461	NUM
dpc-4793	703	2	-	-	SYM
dpc-4793	703	3	1473	1473	NUM
dpc-4793	703	4	.	.	PUNCT
dpc-4793	704	1	doi:10.1080	doi:10.1080	PROPN
dpc-4793	704	2	/17425247.2016.1188801	/17425247.2016.1188801	PROPN
dpc-4793	704	3	.	.	PUNCT
dpc-4793	705	1	calcipotriol	calcipotriol	PROPN
dpc-4793	705	2	and	and	CCONJ
dpc-4793	705	3	betamethasone	betamethasone	PROPN
dpc-4793	705	4	dipropionate	dipropionate	PROPN
dpc-4793	705	5	gel	gel	NOUN
dpc-4793	705	6	(	(	PUNCT
dpc-4793	705	7	xamiol	xamiol	NOUN
dpc-4793	705	8	®	®	NOUN
dpc-4793	705	9	gel	gel	NOUN
dpc-4793	705	10	)	)	PUNCT
dpc-4793	705	11	in	in	ADP
dpc-4793	705	12	the	the	DET
dpc-4793	705	13	treatment	treatment	NOUN
dpc-4793	705	14	of	of	ADP
dpc-4793	705	15	scalp	scalp	NOUN
dpc-4793	705	16	psoriasis	psoriasis	NOUN
dpc-4793	705	17	:	:	PUNCT
dpc-4793	705	18	results	result	VERB
dpc-4793	705	19	from	from	ADP
dpc-4793	705	20	a	a	DET
dpc-4793	705	21	study	study	NOUN
dpc-4793	705	22	in	in	ADP
dpc-4793	705	23	885	885	NUM
dpc-4793	705	24	patients	patient	NOUN
dpc-4793	705	25	.	.	PUNCT
dpc-4793	706	1	j	j	PROPN
dpc-4793	706	2	dermatolog	dermatolog	PROPN
dpc-4793	706	3	treat	treat	VERB
dpc-4793	706	4	2014;25(1):30	2014;25(1):30	NUM
dpc-4793	706	5	-	-	SYM
dpc-4793	706	6	3	3	NUM
dpc-4793	706	7	.	.	PUNCT
dpc-4793	706	8	doi	doi	NOUN
dpc-4793	706	9	:	:	PUNCT
dpc-4793	706	10	10.3109	10.3109	NUM
dpc-4793	706	11	/09546634.2013.800182	/09546634.2013.800182	PUNCT
dpc-4793	706	12	pmid	pmid	NOUN
dpc-4793	706	13	:	:	PUNCT
dpc-4793	706	14	23621170	23621170	NUM
dpc-4793	706	15	.	.	PUNCT
dpc-4793	707	1	32	32	NUM
dpc-4793	707	2	.	.	X
dpc-4793	708	1	tyring	tyre	VERB
dpc-4793	708	2	s	s	PROPN
dpc-4793	708	3	,	,	PUNCT
dpc-4793	708	4	mendoza	mendoza	PROPN
dpc-4793	708	5	n	n	CCONJ
dpc-4793	708	6	,	,	PUNCT
dpc-4793	708	7	appell	appell	PROPN
dpc-4793	708	8	m	m	PROPN
dpc-4793	708	9	,	,	PUNCT
dpc-4793	708	10	et	et	PROPN
dpc-4793	708	11	al	al	PROPN
dpc-4793	708	12	.	.	PUNCT
dpc-4793	709	1	a	a	DET
dpc-4793	709	2	calcipotriene/	calcipotriene/	NUM
dpc-4793	709	3	betamethasone	betamethasone	NOUN
dpc-4793	709	4	dipropionate	dipropionate	VERB
dpc-4793	709	5	two	two	NUM
dpc-4793	709	6	-	-	PUNCT
dpc-4793	709	7	compound	compound	NOUN
dpc-4793	709	8	scalp	scalp	NOUN
dpc-4793	709	9	formulation	formulation	NOUN
dpc-4793	709	10	in	in	ADP
dpc-4793	709	11	the	the	DET
dpc-4793	709	12	treatment	treatment	NOUN
dpc-4793	709	13	of	of	ADP
dpc-4793	709	14	scalp	scalp	NOUN
dpc-4793	709	15	psoriasis	psoriasis	NOUN
dpc-4793	709	16	in	in	ADP
dpc-4793	709	17	hispanic	hispanic	ADJ
dpc-4793	709	18	/	/	SYM
dpc-4793	709	19	latino	latino	ADJ
dpc-4793	709	20	and	and	CCONJ
dpc-4793	709	21	black	black	ADJ
dpc-4793	709	22	/	/	SYM
dpc-4793	709	23	african	african	ADJ
dpc-4793	709	24	american	american	ADJ
dpc-4793	709	25	patients	patient	NOUN
dpc-4793	709	26	:	:	PUNCT
dpc-4793	709	27	results	result	NOUN
dpc-4793	709	28	of	of	ADP
dpc-4793	709	29	the	the	DET
dpc-4793	709	30	randomized	randomized	ADJ
dpc-4793	709	31	,	,	PUNCT
dpc-4793	709	32	8	8	NUM
dpc-4793	709	33	-	-	PUNCT
dpc-4793	709	34	week	week	NOUN
dpc-4793	709	35	,	,	PUNCT
dpc-4793	709	36	double	double	ADJ
dpc-4793	709	37	-	-	PUNCT
dpc-4793	709	38	blind	blind	ADJ
dpc-4793	709	39	phase	phase	NOUN
dpc-4793	709	40	of	of	ADP
dpc-4793	709	41	a	a	DET
dpc-4793	709	42	clinical	clinical	ADJ
dpc-4793	709	43	trial	trial	NOUN
dpc-4793	709	44	.	.	PUNCT
dpc-4793	710	1	int	int	NOUN
dpc-4793	710	2	j	j	PROPN
dpc-4793	710	3	dermatol	dermatol	NOUN
dpc-4793	710	4	2010;49(11):1328	2010;49(11):1328	NUM
dpc-4793	710	5	-	-	SYM
dpc-4793	710	6	33	33	NUM
dpc-4793	710	7	.	.	PUNCT
dpc-4793	711	1	doi	doi	NOUN
dpc-4793	711	2	:	:	PUNCT
dpc-4793	711	3	10.1111	10.1111	NUM
dpc-4793	711	4	/	/	SYM
dpc-4793	711	5	j.1365	j.1365	NOUN
dpc-4793	711	6	-	-	PUNCT
dpc-4793	711	7	4632.2010.04598.x	4632.2010.04598.x	NOUN
dpc-4793	711	8	.	.	PUNCT
dpc-4793	712	1	pmid	pmid	NOUN
dpc-4793	712	2	:	:	PUNCT
dpc-4793	712	3	20964660	20964660	NUM
dpc-4793	712	4	.	.	PUNCT
dpc-4793	713	1	33	33	NUM
dpc-4793	713	2	.	.	PUNCT
dpc-4793	714	1	van	van	PROPN
dpc-4793	714	2	voorhees	voorhees	PROPN
dpc-4793	714	3	as	as	ADP
dpc-4793	714	4	,	,	PUNCT
dpc-4793	714	5	stein	stein	PROPN
dpc-4793	714	6	gold	gold	PROPN
dpc-4793	714	7	l	l	PROPN
dpc-4793	714	8	,	,	PUNCT
dpc-4793	714	9	lebwohl	lebwohl	PROPN
dpc-4793	714	10	m	m	PROPN
dpc-4793	714	11	,	,	PUNCT
dpc-4793	714	12	et	et	PROPN
dpc-4793	714	13	al	al	PROPN
dpc-4793	714	14	.	.	PROPN
dpc-4793	714	15	efficacy	efficacy	NOUN
dpc-4793	714	16	and	and	CCONJ
dpc-4793	714	17	safety	safety	NOUN
dpc-4793	714	18	of	of	ADP
dpc-4793	714	19	apremilast	apremilast	NOUN
dpc-4793	714	20	in	in	ADP
dpc-4793	714	21	patients	patient	NOUN
dpc-4793	714	22	with	with	ADP
dpc-4793	714	23	moderate	moderate	ADJ
dpc-4793	714	24	to	to	ADP
dpc-4793	714	25	severe	severe	ADJ
dpc-4793	714	26	plaque	plaque	NOUN
dpc-4793	714	27	psoriasis	psoriasis	NOUN
dpc-4793	714	28	of	of	ADP
dpc-4793	714	29	the	the	DET
dpc-4793	714	30	scalp	scalp	NOUN
dpc-4793	714	31	:	:	PUNCT
dpc-4793	714	32	results	result	NOUN
dpc-4793	714	33	of	of	ADP
dpc-4793	714	34	a	a	DET
dpc-4793	714	35	phase	phase	NOUN
dpc-4793	714	36	3b	3b	NOUN
dpc-4793	714	37	,	,	PUNCT
dpc-4793	714	38	multicenter	multicenter	NOUN
dpc-4793	714	39	,	,	PUNCT
dpc-4793	714	40	randomized	randomize	VERB
dpc-4793	714	41	,	,	PUNCT
dpc-4793	714	42	placebo	placebo	NOUN
dpc-4793	714	43	-	-	PUNCT
dpc-4793	714	44	controlled	control	VERB
dpc-4793	714	45	,	,	PUNCT
dpc-4793	714	46	double	double	ADJ
dpc-4793	714	47	-	-	PUNCT
dpc-4793	714	48	blind	blind	ADJ
dpc-4793	714	49	study	study	NOUN
dpc-4793	714	50	.	.	PUNCT
dpc-4793	715	1	j	j	PROPN
dpc-4793	715	2	am	be	AUX
dpc-4793	715	3	acad	acad	ADJ
dpc-4793	715	4	dermatol	dermatol	NOUN
dpc-4793	715	5	2020;83(1):96	2020;83(1):96	NUM
dpc-4793	715	6	-	-	SYM
dpc-4793	715	7	103	103	NUM
dpc-4793	715	8	.	.	PUNCT
dpc-4793	716	1	doi	doi	NOUN
dpc-4793	716	2	:	:	PUNCT
dpc-4793	716	3	10.1016	10.1016	NUM
dpc-4793	716	4	/	/	SYM
dpc-4793	716	5	j.jaad.2020.01.072	j.jaad.2020.01.072	PROPN
dpc-4793	716	6	34	34	NUM
dpc-4793	716	7	.	.	PUNCT
dpc-4793	717	1	reich	reich	PROPN
dpc-4793	717	2	k	k	PROPN
dpc-4793	717	3	,	,	PUNCT
dpc-4793	717	4	armstrong	armstrong	PROPN
dpc-4793	717	5	aw	aw	PROPN
dpc-4793	717	6	,	,	PUNCT
dpc-4793	717	7	foley	foley	PROPN
dpc-4793	717	8	p	p	X
dpc-4793	717	9	,	,	PUNCT
dpc-4793	717	10	et	et	PROPN
dpc-4793	717	11	al	al	PROPN
dpc-4793	717	12	.	.	PROPN
dpc-4793	717	13	efficacy	efficacy	NOUN
dpc-4793	717	14	and	and	CCONJ
dpc-4793	717	15	safety	safety	NOUN
dpc-4793	717	16	of	of	ADP
dpc-4793	717	17	guselkumab	guselkumab	NOUN
dpc-4793	717	18	,	,	PUNCT
dpc-4793	717	19	an	an	DET
dpc-4793	717	20	anti	anti	ADJ
dpc-4793	717	21	-	-	ADJ
dpc-4793	717	22	interleukin-23	interleukin-23	ADJ
dpc-4793	717	23	monoclonal	monoclonal	NOUN
dpc-4793	717	24	antibody	antibody	NOUN
dpc-4793	717	25	,	,	PUNCT
dpc-4793	717	26	compared	compare	VERB
dpc-4793	717	27	with	with	ADP
dpc-4793	717	28	adalimumab	adalimumab	NOUN
dpc-4793	717	29	for	for	ADP
dpc-4793	717	30	the	the	DET
dpc-4793	717	31	treatment	treatment	NOUN
dpc-4793	717	32	of	of	ADP
dpc-4793	717	33	patients	patient	NOUN
dpc-4793	717	34	with	with	ADP
dpc-4793	717	35	moderate	moderate	ADJ
dpc-4793	717	36	to	to	ADP
dpc-4793	717	37	severe	severe	ADJ
dpc-4793	717	38	psoriasis	psoriasis	NOUN
dpc-4793	717	39	with	with	ADP
dpc-4793	717	40	randomized	randomized	ADJ
dpc-4793	717	41	withdrawal	withdrawal	NOUN
dpc-4793	717	42	and	and	CCONJ
dpc-4793	717	43	retreatment	retreatment	NOUN
dpc-4793	717	44	:	:	PUNCT
dpc-4793	717	45	results	result	NOUN
dpc-4793	717	46	from	from	ADP
dpc-4793	717	47	the	the	DET
dpc-4793	717	48	phase	phase	NOUN
dpc-4793	717	49	iii	iii	NOUN
dpc-4793	717	50	,	,	PUNCT
dpc-4793	717	51	double	double	ADJ
dpc-4793	717	52	-	-	PUNCT
dpc-4793	717	53	blind	blind	ADJ
dpc-4793	717	54	,	,	PUNCT
dpc-4793	717	55	placebo	placebo	NOUN
dpc-4793	717	56	and	and	CCONJ
dpc-4793	717	57	active	active	ADJ
dpc-4793	717	58	comparator	comparator	NOUN
dpc-4793	717	59	-	-	PUNCT
dpc-4793	717	60	controlled	control	VERB
dpc-4793	717	61	voyage	voyage	NOUN
dpc-4793	717	62	2	2	NUM
dpc-4793	717	63	trial	trial	NOUN
dpc-4793	717	64	.	.	PUNCT
dpc-4793	718	1	j	j	PROPN
dpc-4793	718	2	am	be	AUX
dpc-4793	718	3	acad	acad	ADJ
dpc-4793	718	4	dermatol	dermatol	NOUN
dpc-4793	718	5	2017;76(3):418	2017;76(3):418	NOUN
dpc-4793	718	6	-	-	SYM
dpc-4793	718	7	31	31	NUM
dpc-4793	718	8	.	.	PUNCT
dpc-4793	719	1	doi	doi	NOUN
dpc-4793	719	2	:	:	PUNCT
dpc-4793	719	3	10.1016	10.1016	NUM
dpc-4793	719	4	/	/	SYM
dpc-4793	719	5	j.jaad.2016.11.042	j.jaad.2016.11.042	PROPN
dpc-4793	719	6	pmid	pmid	PROPN
dpc-4793	719	7	:	:	PUNCT
dpc-4793	719	8	28057361	28057361	NUM
dpc-4793	719	9	.	.	PUNCT
dpc-4793	720	1	35	35	NUM
dpc-4793	720	2	.	.	NOUN
dpc-4793	721	1	ohtsuki	ohtsuki	PROPN
dpc-4793	721	2	m	m	PROPN
dpc-4793	721	3	,	,	PUNCT
dpc-4793	721	4	kubo	kubo	PROPN
dpc-4793	721	5	h	h	PROPN
dpc-4793	721	6	,	,	PUNCT
dpc-4793	721	7	morishima	morishima	PROPN
dpc-4793	721	8	h	h	PROPN
dpc-4793	721	9	,	,	PUNCT
dpc-4793	721	10	goto	goto	ADJ
dpc-4793	721	11	r	r	NOUN
dpc-4793	721	12	,	,	PUNCT
dpc-4793	721	13	zheng	zheng	PROPN
dpc-4793	721	14	r	r	PROPN
dpc-4793	721	15	,	,	PUNCT
dpc-4793	721	16	nakagawa	nakagawa	PROPN
dpc-4793	721	17	h.	h.	PROPN
dpc-4793	721	18	guselkumab	guselkumab	PROPN
dpc-4793	721	19	,	,	PUNCT
dpc-4793	721	20	an	an	DET
dpc-4793	721	21	anti	anti	ADJ
dpc-4793	721	22	-	-	ADJ
dpc-4793	721	23	interleukin-23	interleukin-23	ADJ
dpc-4793	721	24	monoclonal	monoclonal	NOUN
dpc-4793	721	25	antibody	antibody	NOUN
dpc-4793	721	26	,	,	PUNCT
dpc-4793	721	27	for	for	ADP
dpc-4793	721	28	the	the	DET
dpc-4793	721	29	treatment	treatment	NOUN
dpc-4793	721	30	of	of	ADP
dpc-4793	721	31	moderate	moderate	ADJ
dpc-4793	721	32	to	to	ADP
dpc-4793	721	33	severe	severe	ADJ
dpc-4793	721	34	plaque	plaque	NOUN
dpc-4793	721	35	-	-	PUNCT
dpc-4793	721	36	type	type	NOUN
dpc-4793	721	37	psoriasis	psoriasis	NOUN
dpc-4793	721	38	in	in	ADP
dpc-4793	721	39	japanese	japanese	ADJ
dpc-4793	721	40	patients	patient	NOUN
dpc-4793	721	41	:	:	PUNCT
dpc-4793	721	42	efficacy	efficacy	NOUN
dpc-4793	721	43	and	and	CCONJ
dpc-4793	721	44	safety	safety	NOUN
dpc-4793	721	45	results	result	NOUN
dpc-4793	721	46	from	from	ADP
dpc-4793	721	47	a	a	DET
dpc-4793	721	48	phase	phase	NOUN
dpc-4793	721	49	3	3	NUM
dpc-4793	721	50	,	,	PUNCT
dpc-4793	721	51	randomized	randomize	VERB
dpc-4793	721	52	,	,	PUNCT
dpc-4793	721	53	double	double	ADJ
dpc-4793	721	54	-	-	PUNCT
dpc-4793	721	55	blind	blind	ADJ
dpc-4793	721	56	,	,	PUNCT
dpc-4793	721	57	placebo	placebo	NOUN
dpc-4793	721	58	-	-	PUNCT
dpc-4793	721	59	controlled	control	VERB
dpc-4793	721	60	study	study	NOUN
dpc-4793	721	61	.	.	PUNCT
dpc-4793	722	1	j	j	PROPN
dpc-4793	722	2	dermatol	dermatol	NOUN
dpc-4793	722	3	2018;45(9):1053	2018;45(9):1053	NUM
dpc-4793	722	4	-	-	SYM
dpc-4793	722	5	62	62	NUM
dpc-4793	722	6	.	.	PUNCT
dpc-4793	723	1	doi	doi	NOUN
dpc-4793	723	2	:	:	PUNCT
dpc-4793	723	3	10.1111/1346	10.1111/1346	NUM
dpc-4793	723	4	-	-	SYM
dpc-4793	723	5	8138	8138	NUM
dpc-4793	723	6	.14504	.14504	NOUN
dpc-4793	723	7	pmid	pmid	NOUN
dpc-4793	723	8	:	:	PUNCT
dpc-4793	723	9	29905383	29905383	NUM
dpc-4793	723	10	.	.	PUNCT
dpc-4793	724	1	36	36	NUM
dpc-4793	724	2	.	.	PUNCT
dpc-4793	725	1	thaçi	thaçi	PROPN
dpc-4793	725	2	d	d	PROPN
dpc-4793	725	3	,	,	PUNCT
dpc-4793	725	4	pinter	pinter	VERB
dpc-4793	725	5	a	a	PRON
dpc-4793	725	6	,	,	PUNCT
dpc-4793	725	7	sebastian	sebastian	PROPN
dpc-4793	725	8	m	m	PROPN
dpc-4793	725	9	,	,	PUNCT
dpc-4793	725	10	et	et	PROPN
dpc-4793	725	11	al	al	PROPN
dpc-4793	725	12	.	.	PROPN
dpc-4793	725	13	guselkumab	guselkumab	NOUN
dpc-4793	725	14	is	be	AUX
dpc-4793	725	15	superior	superior	ADJ
dpc-4793	725	16	to	to	ADP
dpc-4793	725	17	fumaric	fumaric	ADJ
dpc-4793	725	18	acid	acid	NOUN
dpc-4793	725	19	esters	ester	NOUN
dpc-4793	725	20	in	in	ADP
dpc-4793	725	21	patients	patient	NOUN
dpc-4793	725	22	with	with	ADP
dpc-4793	725	23	moderate	moderate	ADJ
dpc-4793	725	24	-	-	PUNCT
dpc-4793	725	25	to	to	ADP
dpc-4793	725	26	-	-	PUNCT
dpc-4793	725	27	severe	severe	ADJ
dpc-4793	725	28	plaque	plaque	NOUN
dpc-4793	725	29	psoriasis	psoriasis	NOUN
dpc-4793	725	30	who	who	PRON
dpc-4793	725	31	are	be	AUX
dpc-4793	725	32	naive	naive	ADJ
dpc-4793	725	33	to	to	ADP
dpc-4793	725	34	systemic	systemic	ADJ
dpc-4793	725	35	treatment	treatment	NOUN
dpc-4793	725	36	:	:	PUNCT
dpc-4793	725	37	results	result	VERB
dpc-4793	725	38	from	from	ADP
dpc-4793	725	39	a	a	DET
dpc-4793	725	40	randomized	randomized	ADJ
dpc-4793	725	41	,	,	PUNCT
dpc-4793	725	42	active	active	ADJ
dpc-4793	725	43	-	-	PUNCT
dpc-4793	725	44	comparator	comparator	NOUN
dpc-4793	725	45	-	-	PUNCT
dpc-4793	725	46	controlled	control	VERB
dpc-4793	725	47	phase	phase	NOUN
dpc-4793	725	48	iiib	iiib	NOUN
dpc-4793	725	49	trial	trial	NOUN
dpc-4793	725	50	(	(	PUNCT
dpc-4793	725	51	polaris	polaris	PROPN
dpc-4793	725	52	)	)	PUNCT
dpc-4793	725	53	.	.	PUNCT
dpc-4793	726	1	br	br	PROPN
dpc-4793	726	2	j	j	PROPN
dpc-4793	726	3	dermatol	dermatol	NOUN
dpc-4793	726	4	2020;183(2):265	2020;183(2):265	NUM
dpc-4793	726	5	-	-	SYM
dpc-4793	726	6	75	75	NUM
dpc-4793	726	7	.	.	PUNCT
dpc-4793	727	1	doi	doi	NOUN
dpc-4793	727	2	:	:	PUNCT
dpc-4793	727	3	10.1111	10.1111	NUM
dpc-4793	727	4	/bjd.18696	/bjd.18696	ADJ
dpc-4793	727	5	pmid	pmid	NOUN
dpc-4793	727	6	:	:	PUNCT
dpc-4793	727	7	31705526	31705526	NUM
dpc-4793	727	8	.	.	PUNCT
dpc-4793	728	1	37	37	NUM
dpc-4793	728	2	.	.	PUNCT
dpc-4793	729	1	reich	reich	PROPN
dpc-4793	729	2	k	k	PROPN
dpc-4793	729	3	,	,	PUNCT
dpc-4793	729	4	papp	papp	PROPN
dpc-4793	729	5	ka	ka	PROPN
dpc-4793	729	6	,	,	PUNCT
dpc-4793	729	7	blauvelt	blauvelt	VERB
dpc-4793	729	8	a	a	PRON
dpc-4793	729	9	,	,	PUNCT
dpc-4793	729	10	et	et	PROPN
dpc-4793	729	11	al	al	PROPN
dpc-4793	729	12	.	.	PROPN
dpc-4793	729	13	bimekizumab	bimekizumab	PROPN
dpc-4793	729	14	versus	versus	ADP
dpc-4793	729	15	ustekinumab	ustekinumab	NOUN
dpc-4793	729	16	for	for	ADP
dpc-4793	729	17	the	the	DET
dpc-4793	729	18	treatment	treatment	NOUN
dpc-4793	729	19	of	of	ADP
dpc-4793	729	20	moderate	moderate	ADJ
dpc-4793	729	21	to	to	ADP
dpc-4793	729	22	severe	severe	ADJ
dpc-4793	729	23	plaque	plaque	NOUN
dpc-4793	729	24	psoriasis	psoriasis	NOUN
dpc-4793	729	25	(	(	PUNCT
dpc-4793	729	26	be	be	AUX
dpc-4793	729	27	vivid	vivid	ADJ
dpc-4793	729	28	):	):	PUNCT
dpc-4793	729	29	efficacy	efficacy	NOUN
dpc-4793	729	30	and	and	CCONJ
dpc-4793	729	31	safety	safety	NOUN
dpc-4793	729	32	from	from	ADP
dpc-4793	729	33	a	a	DET
dpc-4793	729	34	52	52	NUM
dpc-4793	729	35	-	-	PUNCT
dpc-4793	729	36	week	week	NOUN
dpc-4793	729	37	,	,	PUNCT
dpc-4793	729	38	multicentre	multicentre	NOUN
dpc-4793	729	39	,	,	PUNCT
dpc-4793	729	40	double	double	ADJ
dpc-4793	729	41	-	-	PUNCT
dpc-4793	729	42	blind	blind	ADJ
dpc-4793	729	43	,	,	PUNCT
dpc-4793	729	44	active	active	ADJ
dpc-4793	729	45	comparator	comparator	NOUN
dpc-4793	729	46	and	and	CCONJ
dpc-4793	729	47	placebo	placebo	NOUN
dpc-4793	729	48	controlled	control	VERB
dpc-4793	729	49	phase	phase	NOUN
dpc-4793	729	50	3	3	NUM
dpc-4793	729	51	trial	trial	NOUN
dpc-4793	729	52	.	.	PUNCT
dpc-4793	730	1	lancet	lancet	PROPN
dpc-4793	730	2	2021;397(10273):487	2021;397(10273):487	NUM
dpc-4793	730	3	-	-	SYM
dpc-4793	730	4	98	98	NUM
dpc-4793	730	5	.	.	PUNCT
dpc-4793	731	1	doi	doi	NOUN
dpc-4793	731	2	:	:	PUNCT
dpc-4793	731	3	10.1016	10.1016	NUM
dpc-4793	731	4	/s0140	/s0140	PROPN
dpc-4793	731	5	-	-	PUNCT
dpc-4793	731	6	6736(21)00125	6736(21)00125	NUM
dpc-4793	731	7	-	-	PUNCT
dpc-4793	731	8	2	2	NUM
dpc-4793	731	9	.	.	NOUN
dpc-4793	731	10	38	38	NUM
dpc-4793	731	11	.	.	PUNCT
dpc-4793	732	1	gordon	gordon	PROPN
dpc-4793	732	2	kb	kb	PROPN
dpc-4793	732	3	,	,	PUNCT
dpc-4793	732	4	foley	foley	PROPN
dpc-4793	732	5	p	p	PROPN
dpc-4793	732	6	,	,	PUNCT
dpc-4793	732	7	krueger	krueger	PROPN
dpc-4793	732	8	jg	jg	PROPN
dpc-4793	732	9	,	,	PUNCT
dpc-4793	732	10	et	et	PROPN
dpc-4793	732	11	al	al	PROPN
dpc-4793	732	12	.	.	PROPN
dpc-4793	732	13	bimekizumab	bimekizumab	PROPN
dpc-4793	732	14	efficacy	efficacy	PROPN
dpc-4793	732	15	and	and	CCONJ
dpc-4793	732	16	safety	safety	NOUN
dpc-4793	732	17	in	in	ADP
dpc-4793	732	18	moderate	moderate	ADJ
dpc-4793	732	19	to	to	ADP
dpc-4793	732	20	severe	severe	ADJ
dpc-4793	732	21	plaque	plaque	NOUN
dpc-4793	732	22	psoriasis	psoriasis	NOUN
dpc-4793	732	23	(	(	PUNCT
dpc-4793	732	24	be	be	AUX
dpc-4793	732	25	ready	ready	ADJ
dpc-4793	732	26	):	):	PUNCT
dpc-4793	732	27	a	a	DET
dpc-4793	732	28	multicentre	multicentre	NOUN
dpc-4793	732	29	,	,	PUNCT
dpc-4793	732	30	double	double	ADJ
dpc-4793	732	31	-	-	PUNCT
dpc-4793	732	32	blind	blind	ADJ
dpc-4793	732	33	,	,	PUNCT
dpc-4793	732	34	placebo	placebo	NOUN
dpc-4793	732	35	-	-	PUNCT
dpc-4793	732	36	controlled	control	VERB
dpc-4793	732	37	,	,	PUNCT
dpc-4793	732	38	randomised	randomise	VERB
dpc-4793	732	39	withdrawal	withdrawal	NOUN
dpc-4793	732	40	phase	phase	NOUN
dpc-4793	732	41	3	3	NUM
dpc-4793	732	42	trial	trial	NOUN
dpc-4793	732	43	.	.	PUNCT
dpc-4793	733	1	lancet	lancet	PROPN
dpc-4793	733	2	2021;397(10273):475	2021;397(10273):475	NUM
dpc-4793	733	3	-	-	SYM
dpc-4793	733	4	86	86	NUM
dpc-4793	733	5	.	.	PUNCT
dpc-4793	734	1	doi	doi	NOUN
dpc-4793	734	2	:	:	PUNCT
dpc-4793	734	3	10.1016	10.1016	NUM
dpc-4793	734	4	/	/	SYM
dpc-4793	734	5	s0140	s0140	PROPN
dpc-4793	734	6	-	-	PUNCT
dpc-4793	734	7	6736(21)00126	6736(21)00126	NUM
dpc-4793	734	8	-	-	PUNCT
dpc-4793	734	9	4	4	NUM
dpc-4793	734	10	.	.	PUNCT
dpc-4793	735	1	pmid	pmid	NOUN
dpc-4793	735	2	:	:	PUNCT
dpc-4793	735	3	33549192	33549192	NUM
dpc-4793	735	4	.	.	PUNCT
dpc-4793	736	1	39	39	NUM
dpc-4793	736	2	.	.	PUNCT
dpc-4793	737	1	lebwohl	lebwohl	PROPN
dpc-4793	737	2	m	m	PROPN
dpc-4793	737	3	,	,	PUNCT
dpc-4793	737	4	tyring	tyre	VERB
dpc-4793	737	5	s	s	PRON
dpc-4793	737	6	,	,	PUNCT
dpc-4793	737	7	bukhalo	bukhalo	NOUN
dpc-4793	737	8	m	m	PROPN
dpc-4793	737	9	,	,	PUNCT
dpc-4793	737	10	et	et	PROPN
dpc-4793	737	11	al	al	PROPN
dpc-4793	737	12	.	.	PUNCT
dpc-4793	737	13	fixed	fix	VERB
dpc-4793	737	14	combination	combination	NOUN
dpc-4793	737	15	aerosol	aerosol	NOUN
dpc-4793	737	16	foam	foam	NOUN
dpc-4793	737	17	calcipotriene	calcipotriene	NOUN
dpc-4793	737	18	0.005	0.005	NUM
dpc-4793	737	19	%	%	NOUN
dpc-4793	737	20	(	(	PUNCT
dpc-4793	737	21	cal	cal	NOUN
dpc-4793	737	22	)	)	PUNCT
dpc-4793	737	23	plus	plus	CCONJ
dpc-4793	737	24	betamethasone	betamethasone	PROPN
dpc-4793	737	25	dipropionate	dipropionate	PROPN
dpc-4793	737	26	0.064	0.064	NUM
dpc-4793	737	27	%	%	NOUN
dpc-4793	737	28	(	(	PUNCT
dpc-4793	737	29	bd	bd	PROPN
dpc-4793	737	30	)	)	PUNCT
dpc-4793	737	31	is	be	AUX
dpc-4793	737	32	more	more	ADV
dpc-4793	737	33	efficacious	efficacious	ADJ
dpc-4793	737	34	than	than	ADP
dpc-4793	737	35	cal	cal	ADJ
dpc-4793	737	36	or	or	CCONJ
dpc-4793	737	37	bd	bd	PROPN
dpc-4793	737	38	aerosol	aerosol	NOUN
dpc-4793	737	39	foam	foam	NOUN
dpc-4793	737	40	alone	alone	ADV
dpc-4793	737	41	for	for	ADP
dpc-4793	737	42	psoriasis	psoriasis	NOUN
dpc-4793	737	43	vulgaris	vulgaris	NOUN
dpc-4793	737	44	:	:	PUNCT
dpc-4793	737	45	a	a	DET
dpc-4793	737	46	randomized	randomized	ADJ
dpc-4793	737	47	,	,	PUNCT
dpc-4793	737	48	double	double	ADJ
dpc-4793	737	49	-	-	PUNCT
dpc-4793	737	50	blind	blind	ADJ
dpc-4793	737	51	,	,	PUNCT
dpc-4793	737	52	multicenter	multicenter	NOUN
dpc-4793	737	53	,	,	PUNCT
dpc-4793	737	54	three	three	NUM
dpc-4793	737	55	-	-	PUNCT
dpc-4793	737	56	arm	arm	NOUN
dpc-4793	737	57	,	,	PUNCT
dpc-4793	737	58	phase	phase	NOUN
dpc-4793	737	59	2	2	NUM
dpc-4793	737	60	study	study	NOUN
dpc-4793	737	61	.	.	PUNCT
dpc-4793	738	1	j	j	PROPN
dpc-4793	738	2	clin	clin	PROPN
dpc-4793	738	3	aesthet	aesthet	PROPN
dpc-4793	738	4	dermatol	dermatol	NOUN
dpc-4793	739	1	2016;9(2):34	2016;9(2):34	NUM
dpc-4793	739	2	-	-	SYM
dpc-4793	739	3	41	41	NUM
dpc-4793	739	4	pmid	pmid	NOUN
dpc-4793	739	5	:	:	PUNCT
dpc-4793	739	6	27313822	27313822	NUM
dpc-4793	739	7	.	.	PUNCT